The Impact of the Second Coordination Sphere in Phosphatase Model Complexes by Bosch, Simone
  
 
 
 
The Impact of the Second Coordination 
Sphere in  
Phosphatase Model Complexes 
 
 
 
 
INAUGURAL-DISSERTATION 
 
 
 
 
zur 
Erlangung der Doktorwürde 
der 
Naturwissenschaftlich-Mathematischen Gesamtfakultät 
der 
Ruprecht-Karls-Universität 
Heidelberg 
 
 
 
 
 
vorgelegt von 
Diplom-Chemikerin Simone Bosch 
aus Nördlingen 
 
 
 
 
  
  
 
  
 
 
 
 
 
 
INAUGURAL-DISSERTATION 
 
 
 
 
zur 
Erlangung der Doktorwürde 
der 
Naturwissenschaftlich-Mathematischen Gesamtfakultät 
der 
Ruprecht-Karls-Universität 
Heidelberg 
 
 
 
 
 
 
vorgelegt von 
Diplom-Chemikerin Simone Bosch 
aus Nördlingen 
 
 
 
 
Tag der mündlichen Prüfung: 24. April 2015  
  
 
 
  
The Impact of the Second Coordination 
Sphere in  
Phosphatase Model Complexes 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gutachter:  Prof. Dr. Peter Comba 
  Prof. Dr. Roland Krämer  
  
 
 
  
Die vorliegende Arbeit wurde in der Zeit von März 2011 bis Januar 2015 unter der Betreuung von 
Prof. Dr. Peter Comba am Anorganisch-Chemischen Institut der Ruprecht-Karls-Universität 
Heidelberg angefertigt. 
 
Auszüge dieser Arbeit wurden bereits und werden sinngemäß sowie abschnittsweise wörtlich in 
den folgenden wissenschaftlichen Journalen veröffentlicht: 
 
1. “Dinuclear Zinc(II) Complexes with Hydrogen Bond Donors as Structural and Functional 
Phosphatase Models”; Simone Bosch, Peter Comba, Lawrence R. Gahan, Gerhard Schenk, Inorg. 
Chem. 2014, 53, 9036-9051. 
 
2. “Selective Coordination of Gallium(III), Zinc(II) and Copper(II) by an Asymmetric 
Dinucleating Ligand: A Model for Metallophosphatases”; Simone Bosch, Peter Comba, Lawrence 
R. Gahan, Graeme R. Hanson, Christopher J. Noble, Gerhard Schenk, Hubert Wadepohl; 
manuscript in preparation. 
 
3. “An Approach to More Accurate Model Systems for Purple Acid Phosphatases (PAPs)”; 
Paul V. Bernhardt, Simone Bosch, Peter Comba, Lawrence R. Gahan, Graeme R. Hanson, Valeriu 
Mereacre, Christopher J. Noble, Annie K. Powell, Gerhard Schenk, Hubert Wadepohl; manuscript 
in preparation. 
 
4. “Asymmetric Mono- and Dinuclear GaIII and ZnII Complexes as Models for Purple Acid 
Phosphatases (PAPs)”; Simone Bosch, Peter Comba, Lawrence R. Gahan and Gerhard Schenk; 
manuscript in preparation. 
 
  
  
  
 
 
 
 
 
 
 
Meiner Familie. 
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
„Man sollte alles so einfach wie möglich sehen – aber auch nicht einfacher.‟ 
Albert Einstein 
 
  
  
 
ACKNOWLEDGEMENTS 
ACKNOWLEDGEMENTS 
 
First and foremost I thank my advisor, Peter Comba, for the fascinating and challenging topic of 
my PhD thesis. Throughout the four years, I enjoyed the scientific freedom and I appreciated your 
all-time ‘open’ office door for discussions and chats. I am also very thankful for enabling me to 
cooperate with the University of Queensland. I owe my deepest gratitude to you! 
Many thanks also to my associate advisors Lawrence Gahan, Graeme Hanson and Gary Schenk 
from the University of Queensland, who welcomed and included me in their working groups. I 
always appreciated you being so encouraging and enthusiastic to talk about my data. It was a 
great benefit for me! 
Thanks to all the people that helped me at the UQ, including Tri Le for NMR assistance – especially 
for all the 2D experiments and a lot of nice chats, George Blazak for microanalysis measurements, 
Graham MacFarlane and Brett Hamilton for mass analytic measurements. A big ‚thank you‘ to 
Paul Bernhardt for X-ray data collection and teaching me all about structure refinement. Thanks 
to Chris Noble for his assistance with the EPR measurements and advice in the simulation of the 
spectra. Special thanks to Sandrine Kingston-Ducrot for her help with all the formularities related 
to this thesis.  
Also a big ‚thank you‘ to Marlies Schilli and Karin Stelzer for all your help with administrative 
issues. I am also greatly indepted to the staff of the chemistry department in Heidelberg, 
including Markus Enders and Beate Termin for the NMR experiments, Hubert Wadepohl and 
Heidrun Haungs for the X-ray structures, Jürgen Gross and his team for the mass analytic 
measurements and the staff of the microanalytic laboratory. Thanks also to Valeriu Mereacre 
and Annie Powell from the KIT for the Mössbauer experiments. 
For the financial support I thank the Graduate College 850 for the scholarship as well as the HGS 
MathComp and DAAD for travel funds.  
A huge ‘thank you’ to Lena Daumann for introducing me to everyone as well as showing me all 
the facilities and equipment during my stay at the University of Queensland. I really enjoyed 
working with you! Thanks for all your advices and scientific and private support. I am also greatly 
indepted to the others of the UQ group who have assisted me in countless ways; thanks to 
Maram Basha, Manfredi Miraula, Marcelo Pedroso, Emer Phelan and Asha Roberts.  
Special thanks to my ‘Forschis’, Marie-Louise Morkos, Christiane Antoni, Julia Ricken, Esther 
Kimmle and Clarissa Benzin. I am also very thankful to Philipp Butzug and Maik Jakob for their 
consistent technical support and to Marion Kerscher for the great discussions and chats not only 
during our great after-work beer sessions. I also would like to express my appreciation to Bodo 
ACKNOWLEDGEMENTS 
 
Martin for the computational support. A huge ‘thank you’ to my great lab partners, Tine Graef, 
Nina Mehrkens, Johannes Straub and Michael Westphal. Thank you very much for ‘endless’ 
scientific discussions, answering ‘stupid’ computer questions, singing, dancing and whizzling, … 
the great time in Lab 105! Also a heartfelt thanks to all the past and present colleagues and 
friends of the Comba and Linti research groups for the encouragement and support, the amusing 
coffee and beer breaks, the skiing seminars and the memorable time in INF 503. A special ‘thanks’ 
to Michael Morgen for reading and correcting this thesis. 
I would like to also express my appreciation to the nice people I met in Australia: Alicia, George, 
Liz, Matthias, Mathilde, Paul, Ryan, Shad, Tanja and Tobsn, making my social life downunder so 
comfortable and exciting. ‘Thanks’ also to James Namnoum for practicing my English skills during 
our great afterwork beer sessions. A huge ‘thanks’ also to my personal ‘food supplier’ for the 
delicious snacks and for the psychological support during writing this thesis. 
 
Finally, I thank my parents, Hilde and Franz, as well as my siblings and their ‘plus ones’, Vroni & 
Marcus, Harry & Sabine, Marina and Franz & Nadine, for their encouragement and support when 
I needed it most. Last, but no least, I thank from the bottom of my heart my wonderful 
housemate, Sandra Schmitt, for her endless support in various inventive ways ;-). I would have 
not done it without you! 
 
TABLE OF CONTENTS 
I 
TABLE OF CONTENTS 
 
Abbreviations and Acronyms ................................................................................................................ V 
Table of Compounds and Abbreviations  ............................................................................................. IX 
Abstract ............................................................................................................................................... XV 
Kurzzusammenfassung ...................................................................................................................... XVII 
Chapter 1 Introduction....................................................................................................................... 1 
1.1 Osteoporosis – An Enfeebling Disease .................................................................................. 2 
1.2 Biological Significance and Stability of Phosphoesters ......................................................... 2 
1.3 Phosphatases – Phosphoester Cleaving Enzymes ................................................................. 3 
1.4 Structure of Phosphatases .................................................................................................... 5 
1.5 Significance of the Second Coordination Sphere in Phosphatases ....................................... 8 
1.6 Biomimetics – a Useful Tool to Study Enzymes .................................................................... 9 
Chapter 2 Ligand Design and  Syntheses ......................................................................................... 11 
2.1 Introduction ........................................................................................................................ 12 
2.2 Synthesis of Ligand H3SIM1 .................................................................................................. 17 
2.3 Synthesis of Ligand HSIM2 ................................................................................................... 20 
2.4 Synthesis of Ligand H4SIM3 .................................................................................................. 21 
2.5 Synthesis of Ligand H4SIM4 .................................................................................................. 22 
2.6 Summary ............................................................................................................................. 23 
Chapter 3 Coordination Behavior of Asymmetric Ligands ............................................................... 25 
3.1 Introduction ........................................................................................................................ 26 
3.2 Complexation Behavior of Ligand H3SIM1 ........................................................................... 30 
3.2.1 Complexation Studies with ZnII ................................................................................... 30 
3.2.2 Coordination Studies with GaIII .................................................................................... 34 
3.2.3 Formation of a Heterodinuclear GaIIIZnII Complex ...................................................... 38 
3.2.4 Complexation Studies with CuII ................................................................................... 42 
3.2.5 Complexation Studies with FeIII ................................................................................... 53 
3.3 Complexation Behavior of Ligand H4SIM3 ........................................................................... 55 
3.3.1 Complexation Studies with ZnII ................................................................................... 56 
3.3.2 Complexation Studies with GaIII .................................................................................. 59 
3.3.3 Complexation Studies with FeIII ................................................................................... 60 
3.3.4 Formation of a Heterodinuclear GaIIIZnII Complex ...................................................... 64 
3.4 Complexation Behavior of Ligand H4SIM4 ........................................................................... 66 
3.4.1 Complexation Studies with ZnII ................................................................................... 66 
TABLE OF CONTENTS 
II 
3.4.2 Complexation Studies with GaIII .................................................................................. 68 
3.5 Summary .............................................................................................................................. 69 
Chapter 4 Dizinc Model Complexes ................................................................................................. 71 
4.1 Introduction ......................................................................................................................... 72 
4.2 Synthesis of Dizinc(II) Complexes ........................................................................................ 75 
4.3 Structural Characterization of Dizinc(II) Complexes ............................................................ 75 
4.4 Summary .............................................................................................................................. 93 
Chapter 5 Diiron Model Complexes ................................................................................................. 95 
5.1 Introduction ......................................................................................................................... 96 
5.2 Synthesis of Diiron(II) Model Complexes ............................................................................ 99 
5.3 Structural Characterization of Diiron(II) Complexes ......................................................... 100 
5.4 Studies toward the Formation of a Heterovalent FeIIIFeII Complex................................... 125 
5.5 Summary ............................................................................................................................ 130 
Chapter 6 Studies of the Phosphatase Mechanism ....................................................................... 131 
6.1 Enzymatic Mechanisms of Phosphoester Cleavage .......................................................... 132 
6.2 Phosphoester Substrates Employed in Cleavage Studies .................................................. 137 
6.3 General Procedures ........................................................................................................... 139 
6.3.1 pH Dependence Assays ............................................................................................. 139 
6.3.2 Substrate Concentration Dependence Assays .......................................................... 140 
6.3.3 Turn Over Numbers ................................................................................................... 140 
Chapter 7 Phosphatase Activity of Dizinc Complexes .................................................................... 141 
7.1 Introduction ....................................................................................................................... 142 
7.2 Phosphoester Hydrolysis Studies of Dizinc(II) Complexes ................................................. 148 
7.3 Summary ............................................................................................................................ 162 
Chapter 8 Phosphatase Activity  of Diiron Complexes ................................................................... 165 
8.1 Introduction ....................................................................................................................... 166 
8.2 Phosphoester Hydrolysis Studies of Diiron Complexes ..................................................... 168 
8.3 Summary ............................................................................................................................ 173 
Chapter 9 Phosphatase Activity of Heterovalent Heterodinuclear Complexes ............................. 175 
9.1 Introduction ....................................................................................................................... 176 
9.2 pH Behavior of GaIIIZnII Complexes .................................................................................... 180 
9.3 Phosphoester Hydrolysis Studies with GaIIIZnII Complexes ............................................... 181 
9.4 Summary ............................................................................................................................ 191 
Chapter 10 Conclusions and Outlook ........................................................................................... 193 
Chapter 11 Experimental Section ................................................................................................. 199 
11.1 General Remarks ............................................................................................................... 200 
TABLE OF CONTENTS 
III 
11.2 Material and Methods....................................................................................................... 200 
11.2.1 Chemicals .................................................................................................................. 200 
11.2.2 Physical Measurements ............................................................................................ 200 
11.2.3 Phosphoester Hydrolysis Experiments ...................................................................... 203 
11.3 Syntheses of Precursors .................................................................................................... 205 
11.3.1 2,6-Bis(chloromethyl)-4-methylphenol (22) ............................................................. 205 
11.3.2 3-(Chloromethyl)-2-hydroxy-5-methylbenzaldehyde (5) .......................................... 206 
11.3.3 Bis(pyridin-2-ylmethyl)amine (2) .............................................................................. 207 
11.3.4 2-(((Pyridin-2-ylmethyl)amino)methyl)phenol (16) .................................................. 208 
11.3.5 2-(Aminomethyl)phenol (20) ..................................................................................... 209 
11.3.6 N-(6-pivaloylamido-2-pyridylmethyl)-N-(2-pyridylmethyl)amin (18) ....................... 210 
11.3.7 N,N-bis((2-pivaloylamidopyridin-6-yl)methyl)amin (3) ............................................. 213 
11.4 Synthesis of Ligand H3L2 .................................................................................................... 215 
11.5 Synthesis of Ligand H3SIM1 ................................................................................................ 216 
11.5.1 3-((Bis(pyridin-2-ylmethyl)amino)methyl)-2-hydroxy-5-methylbenzaldehyde (12) . 216 
11.5.2 Ligand H3SIM1 ............................................................................................................ 217 
11.6 Synthesis of Ligand HSIM2 ................................................................................................. 218 
11.7 Synthesis of Ligand H4SIM3 ................................................................................................ 220 
11.7.1 2-Hydroxy-3-(((2-hydroxybenzyl)(pyridin-2-ylmethyl)amino)methyl)-5-methyl-
benzaldehyde (17) ..................................................................................................... 220 
11.7.2 Ligand H4SIM3 ............................................................................................................ 221 
11.8 Synthesis of Ligand H4SIM4 ................................................................................................ 223 
11.8.1 N-(6-(((3-formyl-2-hydroxy-5-methylbenzyl)(pyridin-2-ylmethyl)amino)methyl)-
pyridin-2-yl)pivalamide (19) ...................................................................................... 223 
11.8.2 N-(6-(((2-hydroxy-3-(((2-hydroxybenzyl)amino)methyl)-5-methylbenzyl)(pyridin-
2-ylmethyl)amino)methyl)pyridin-2-yl)pivalamide (21) ............................................ 224 
11.8.3 Ligand H4SIM4 ............................................................................................................ 225 
11.9 Synthesis of Dizinc(II) Complexes ...................................................................................... 226 
11.9.1 General Procedure .................................................................................................... 226 
11.9.2 Synthesis of [ZnII2(L1)(µ-OAc)2]PF6 ............................................................................. 226 
11.9.3 Synthesis of [ZnII2(H2L2)(µ-OAc)2]PF6.......................................................................... 227 
11.9.4 Synthesis of [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 ............................................................... 228 
11.9.5 Synthesis of [ZnII2(SIM2)(µ-OAc)2]PF6 ......................................................................... 229 
11.9.6 Synthesis of [Zn2(H2SIM3)(µ-OAc)(OH)] ..................................................................... 231 
11.10 Syntheses of Diiron(II) Complexes ................................................................................. 232 
11.10.1 General Procedure ................................................................................................ 232 
11.10.2 Synthesis of [FeII2(H2SIM1)(µ-OAc)2]PF6 ................................................................. 232 
TABLE OF CONTENTS 
IV 
11.10.3 Synthesis of [FeII2(H2L2)(µ-OAc)2]PF6 ...................................................................... 233 
11.11 Syntheses of Phosphoester Substrates ......................................................................... 234 
11.11.1 Synthesis of BDNPP ............................................................................................... 234 
11.11.2 Synthesis of DNPP .................................................................................................. 235 
Bibliography ....................................................................................................................................... 237 
Appendix ............................................................................................................................................ 249 
 
 
ABBREVIATIONS AND ACRONYMS 
V 
ABBREVIATIONS AND ACRONYMS 
 
Å  Ångström (10-10 m) 
Abs  absorbance 
AIBN  2,2’-azobis(2-methylpropionitrile) 
Ala  alanine 
Alox  aluminium oxide 
AP  Alkaline Phosphatase 
Arg  arginine 
Asn  asparagine 
Asp  aspartate 
ATP  adenosine triphosphate 
ax  axial 
B  magnetic field 
BDNPP  2,4-bis(dinitrophenyl)phosphate 
B.M.  Bohr magneton 
BPNPP  bis(4-nitrophenyl)phosphate 
bpy  2,2‘-bipyridine 
bsPAP  bovine spleen PAP 
Bu  butyl 
calcd.  calculated 
CAPS  3-(cyclohexylamino)-1-propanesulfonic acid 
CCDC  Cambridge Crystallographic Data Centre 
CEPT  concerted proton-electron transfer 
CHES  2-(cyclohexylamino)ethanesulfonic acid 
conc.  concentrated 
COSY  correlation spectroscopy 
CT  charge transfer 
CV  cyclovoltammetry 
Cys  cysteine 
d  day(s) 
D  axial zero field splitting parameter 
DEE  diethylether 
DFT  density functional theory 
ABBREVIATIONS AND ACRONYMS 
VI 
DMF  N,N-dimethylformamide 
DNA  deoxyribonucleic acid 
DNPP  2,4-dinitrophenylphosphate 
DPP  diphenylphosphate 
E  rhombic zero field splitting parameter 
E1/2  half wave potential 
E.coli  Escherichia coli 
EFG  electron field gradient 
EPR  electron paramagnetic resonance 
eq.  equivalents / equatorial 
ESI  electrospray ionization 
Et  ethyl 
et al.  et alii 
EtOAc  ethyl acetate 
FA  fatty acid 
Fc (Fc+)  ferrocen (ferrocenium) 
FNOR  Flavodiiron Nitric Oxide Reductase 
FTIR  Fourier transform infrared spectroscopy 
g  Landé g factor 
Glu  glutamine 
h  hour(s) / Boltzmann constant 
HEPES  4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid 
His  histidine 
HMBC  heteronuclear multiple bond correlation 
HPNPP  2-hydroxypropyl-4-nitrophenylphosphate 
HRMS  high resolution mass spectrometry 
hs  high spin 
HSQC  heteronuclear single quantum correlation 
IAP  intestinal AP  
imp  impurity 
IR  infrared 
kbPAP  kidney bean PAP 
kcat  first order rate constant 
Kcom  comproportionation constant 
KM  Michaelis constant 
ABBREVIATIONS AND ACRONYMS 
VII 
LPS  lipopolysaccharide 
ls  low spin 
lut  2,6-lutidine 
m  meta 
M  molar 
m/z  mass-to-charge ratio 
MALDI  matrix-assisted laser desorption/ionization 
Me  methyl 
MES  2-(N-morpholino)ethanesulfonic acid 
min  minute(s) 
MMO  Methane Monooxygenase 
MS  mass spectrometry 
NBS  N-bromosuccinimide 
NIR  near infra red 
NMR  nuclear magnetic resonance 
NOESY  nuclear Overhauser effect spectroscopy 
Ns  4-nitrobenzenesulfonyl 
o  ortho 
OAc  acetate 
OBz  benzoate 
p  para 
p. a.  pro analysi 
PAP  Purple Acid Phosphatase 
PCC  pyridinium chlorochromate 
Ph  phenyl 
Piv  pivaloyl 
PNPP  4-nitrophenylphosphate 
ppa  3-phenylpropionate 
PPi  pyrophosphate 
ppm  parts per million 
PTFE  polytetrafluoroethylene 
Py  pyridine / pyridinyl 
r  radius 
Rf  retention factor 
RNA  ribonucleic acid 
ABBREVIATIONS AND ACRONYMS 
VIII 
RNR  Ribonucleotide Reductase 
ROS  reactive oxygen species 
rt  room temperature (25°C) 
S  spin quantum number 
Ser  serine 
SOD  Superoxide Dismutase 
SQUID  superconducting quantum interference device 
sub  substitution 
t  tert 
THF  tetrahydrofuran 
TLC  thin layer chromatography 
TNAP  tissue-nonspecific AP  
TON  turn over number 
TRAP  Tartrate-resistant Acid Phosphatase 
TRAcP  Tartrate-resistant Acid Phosphatase 
Ts  4-toluenesulfonyl 
Tyr  tyrosine 
ufPAP  uteroferrin PAP 
UV  ultra violet 
V0  initial velocity/rate 
Vis  visible 
vmax  maximum velocity/rate 
vol%  volume percent 
vs.  versus 
w%  weight percent 
Z  charge 
ZFS  zero field splitting 
βe  Bohr magneton 
δ  NMR chemical shift 
ε  extinction coefficient 
λ  wave length 
ν  frequency 
 
TABLE OF COMPOUNDS AND ABBREVIATIONS 
IX 
TABLE OF COMPOUNDS AND ABBREVIATIONS a 
 
 
 
  
                                                          
a listed are all compounds that are mentioned in this thesis. 
TABLE OF COMPOUNDS AND ABBREVIATIONS 
X 
 
 
 
TABLE OF COMPOUNDS AND ABBREVIATIONS 
XI 
 
 
TABLE OF COMPOUNDS AND ABBREVIATIONS 
XII 
 
 
TABLE OF COMPOUNDS AND ABBREVIATIONS 
XIII 
 
 
 
 XIV 
 
 
ABSTRACT 
XV 
ABSTRACT 
 
Osteoporosis is a disease caused by excessive bone resorption resulting in a skeletal disorder and 
thus leads to higher risk of fractures. More than 75 million people in the United States, Europe 
and Japan are effected by osteoporosis. Thus, there is a urgent need to develop new and effective 
therapeutic agents for this enfeebling disease. The enzyme Purple Acid Phosphatase (PAP) is an 
important target for the development of new anti-osteoporotic drug leads. The major goal of this 
thesis is to better emulate the synergy that occurs between the primary and secondary 
coordination sphere within the active site of phosphatase enzymes, such as PAP. This was 
perceived by development of synthetic methods for new biomimetics, i.e. low-molecular weight 
metal complexes. Therefore, asymmetric dinucleating ligands which mimic the peptide backbone 
of the active site of PAP including the ability to form hydrogen bonds with a phosphoester 
substrate or a nucleophile were designed and synthesized (Chart 1).  
 
Chart 1: Ligands H3SIM1, HSIM2, H4SIM3, and H4SIM4 developed and ligands HL1 and H3L2 additionally employed 
in the course of this thesis. 
Using these ligands, more accurate model systems for the enzyme active site were achievable as 
they combine the two essential structural features known to influence the catalytic activity 
towards the hydrolysis of phosphoesters, i.e. the asymmetry of the dinuclear active site and the 
capacity for hydrogen bond formation. The latter was verified by the observation of hydrogen 
bonds in the X-ray structures of dizinc(II) and diiron(II) complexes. Moreover, two dizinc(II) 
complexes revealed strikingly different structures compared to the common structure known for 
phenoxido-bridged phosphatase models. In fact, the two ligands bearing two pivaloyl-amide 
moieties in an asymmetric manner formed dizinc(II) complexes with two different ZnII sites and 
an unusual hydroxido co-ligand, representing two important features in the active site of PAP, 
the difference of the metal sites and the nucleophile needed for the phosphoester hydrolysis. In 
addition, hydrogen bond formation detected in these X-ray structures was accounted for the 
stabilization of the hydroxido co-ligand.  
In this work, a new synthetic approach towards more sophisticated model systems for the active 
form of mammalian PAP was developed. Chemical oxidation of the diiron(II) complex of H3SIM1 
results in the generation of the FeIIIFeII complex that has been specifically designed to both satisfy 
ABSTRACT 
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the requirement of a heterovalent diiron core and to mimic the second coordination sphere of 
the active site of PAP. Similarly, more accurate model systems for the active site of plant PAPs 
have been generated in the form of heterovalent heterodinuclear complexes of ligand H3SIM1 
and H4SIM4 bearing, adjacent to the GaIIIZnII core, functionalities capable of forming hydrogen 
bonds. Analysis of the complexation behavior of the respective ligands revealed the selective 
formation of the GaIIIZnII complexes in solution.  
The model complexes described above imitate successfully the extensive hydrogen bond 
network that is formed by the second coordination sphere within the active site of PAP as well 
as in a structural and functional similar phosphatase, Alkaline Phosphatase. Thus, those 
complexes allow to study the impact of hydrogen bonds on the reaction mechanism. The main 
impact of the secondary interactions in the dizinc(II) complexes was found to be the increased 
substrate affinity. This catalytic parameter was shown to be dependent on both the hydrogen 
bonding sites and the type of the hydrogen bonding groups. Although the substrate affinity of 
the GaIIIZnII complex was revealed to be lower compared to the dizinc(II) complex, a 50-fold faster 
hydrolysis rate and a 6-fold increased efficiency was detected for the heterodinuclear complex. 
Moreover, the mechanism previously proposed, in which the phosphoester is activated by the 
ZnII center and the GaIII being accountable for providing the hydroxide nucleophile at near 
physiological condition, was supported in this study and an accelerating effect by the interplay 
of the two metal ions was detected. However, the inhibition was found to be favored in the 
GaIIIZnII complex compared to the respective monogallium(III) complex, most likely due to 
bridging coordination of the hydrolysis product, additionally stabilized by coordination of the 
adjacent pivaloyl-amide residue. The proposed arrangement in the catalyst-hydrolysis product 
adduct derives from a structure of a stable phosphoester-bridged dizinc(II) complex bearing the 
same ligand backbone. However, the GaIIIZnII complex of H3SIM1 is the first heterodinuclear 
model complex that mimics the essential function of PAPs, the ability to cleave phosphomono-
esters and therefore supports the crucial impact of the second coordination sphere in the active 
site of PAP. 
 
KURZZUSAMMENFASSUNG 
XVII 
KURZZUSAMMENFASSUNG 
 
Osteoporose ist eine Krankheit, die aufgrund exzessiver Knochenresorption zu Fehlordnung im 
Skelett und infolgedessen zu einem erhöhten Frakturrisiko führt. Mehr als 75 Millionen 
Menschen in den USA, Europa und Japan leiden an Osteoporose. Aus diesem Grund ergibt sich 
eine akute Notwendigkeit neue und effektive Wirkstoffe für diese Krankheit zu entwickeln. Als 
Ausgangspunkt für die Entwicklung neuer antiosteoporotischer Wirkstoff-Leitstrukturen ist das 
Haupttarget das Enzym „violette saure Phosphatase“ (Purple Acid Phosphatase, PAP). Das 
wesentliche Ziel dieser Arbeit ist die Synergie, die zwischen der primären und sekundären 
Koordinationssphäre innerhalb der aktiven Tasche von Phosphatase-Enzymen wie PAP auftritt, 
besser nachzubilden. Dies wurde durch die Entwicklung synthetischer Methoden für neuartige 
Biomimetika (Metallkomplexe mit geringem Molekulargewicht) ermöglicht. Hierfür wurden 
asymmetrische Liganden mit zwei Koordinationsstellen konzipiert und entwickelt, die das Peptid-
Rückgrat der aktiven Tasche von PAP imitieren, einschließlich der Fähigkeit Wasserstoffbrücken 
zu Phosphoester-Substraten oder einem Nukleophil zu bilden (Abbildung 1). 
 
Abbildung 1: Im Laufe dieser Arbeit entwickelte Liganden H3SIM1, HSIM2, H4SIM3 und H4SIM4 sowie zusätzlich 
verwendete Liganden HL1 und H3L2. 
Mit Verwendung dieser Liganden konnten verbesserte Modellsysteme für die aktive Tasche 
dargestellt werden. Dies wurde durch die Kombination der zwei essentiellen strukturellen 
Eigenschaften erzielt, welche bekanntlich die katalytische Aktivität bezüglich der Phosphoester-
Hydrolyse beeinflussen; die Asymmetrie der dinuklearen aktiven Tasche und die Kapazität zur 
Wasserstoffbrückenbildung. Letztere wurde durch die in den Kristallstrukturen sichtbaren 
Wasserstoffbrücken der dinuklearen Zink(II)- und Eisen(II)-Komplexe bestätigt. Darüber hinaus 
zeigten zwei dinukleare Zink(II)-Komplexe auffallend abweichende Strukturen verglichen mit 
bekannten Strukturen von Phenoxido-verbrückten Phosphatase-Modellen. Unter Verwendung 
der zwei Liganden, die zwei Pivaloylamid-Substituenten in einer asymmetrischen Anordnung 
tragen, bildeten sich zweikernige Zink(II)-Komplexe mit unterschiedlichen ZnII Zentren und einem 
ungewöhnlichen Hydroxido-co-Liganden. Somit imitieren diese Komplexe zwei wichtige 
Eigenschaften der aktiven Tasche von PAP, die Verschiedenheit der Metallkoordinationssphäre 
und das für die Phosphoesterhydrolyse benötigte Nukleophil. Die Stabilisierung des Hydroxido-
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co-Liganden wurde den Wasserstoffbrückenbindungen, die in den Kristallstrukturen detektiert 
wurden, zugeschrieben.  
In dieser Arbeit wurde eine neue Synthesestrategie für ausgereiftere Modellsysteme der aktiven 
Tasche der Säugetier-PAP entwickelt. Der FeIIIFeII-Komplex des Liganden H3SIM1 wurde durch 
chemische Oxidation des entsprechenden Di-Eisen(II)-Komplexes in Lösung dargestellt. Dieser 
heterovalente Di-Eisen-Komplex wurde spezifisch entworfen, um den Anforderungen eines 
heterovalenten Di-Eisen-Kerns zu entsprechen und die zweite Koordinationssphäre der aktiven 
Tasche der PAP zu imitieren. Gleichermaßen wurden exaktere Modellsysteme für die aktive 
Tasche von Pflanzen-PAP in Form von heterovalenten heterodinuklearen Komplexen der 
Liganden H3SIM1 und H4SIM4 dargestellt. Diese Komplexe enthalten Funktionalitäten in der 
näheren Umgebung des GaIIIZnII Zentrums, die zur Wasserstoffbrückenbindung befähigt sind. Die 
Untersuchung des Komplexierungsverhaltens der entsprechenden Liganden zeigten die selektive 
Bildung der GaIIIZnII-Komplexe in Lösung.  
In den verwendeten Modellkomplexen wird erfolgreich das ausgedehnte Wasserstoffbrücken-
netzwerk, das in der zweiten Koordinationssphäre innerhalb der aktiven Tasche von PAP genauso 
wie in der strukturell und funktionell ähnlichen alkalischen Phosphatase auftritt, imitiert. Diese 
ermöglichten die Rolle der Wasserstoffbrückenbindungen im Reaktionsmechanismus zu 
untersuchen. Der größte Einfluss der sekundären Wechselwirkungen in den Di-Zink(II)-
Komplexen wurde in der erhöhten Substrataffinität gefunden. Es wurde nachgewiesen, dass 
dieser katalytische Parameter, sowohl von der Anordnung als auch von der Art der Wasserstoff-
brückendonoren abhängt. Obwohl die Substrataffinität des GaIIIZnII-Komplexes niedriger ist als 
die des homodinuklearen Zink(II)-Komplexes, wurde eine 50-fach schnellere Hydrolysegeschwin-
digkeit und eine sechsfach erhöhte Effizienz für den heterodinuklearen Komplex beobachtet. 
Darüber hinaus konnte in dieser Studie der bisherige vorgeschlagene Mechanismus, in dem der 
Phosphoester durch das ZnII-Zentrum aktiviert wird und das GaIII-Zentrum das Hydroxid-
Nukleophil unter annähernd physiologischen Bedingen bereitstellt, bestätigt und ein 
Beschleunigungseffekt durch das Zusammenspiel der beiden Metallionen gefunden werden. 
Ebenso konnte gezeigt werden, dass die Inhibierung des GaIIIZnII-Komplexes im Vergleich zum 
Monogallium(III)-Komplex begünstigt ist. Dies lässt sich auf eine verbrückende Koordination des 
Hydrolyseproduktes und dessen Stabilisierung durch die Koordination des benachbarten 
Pivaloylamid-Substituenten zurückführen. Diese postulierte Anordnung im Katalysator-Hydro-
lyseprodukt-Addukt wurde von einer Struktur eines stabilen Phosphoester-verbrückten Di-
Zink(II)-Komplexes desselben Ligandenrückgrats abgeleitet. Der GaIIIZnII-Komplex des Liganden 
H3SIM1 ist der erste heterodinukleare Modellkomplex, der Phosphomonoester spalten kann, was 
KURZZUSAMMENFASSUNG 
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die essentielle Funktion von PAPs darstellt. Dies verdeutlicht die wesentliche Relevanz der 
zweiten Koordinationssphäre in der aktiven Tasche von PAP. 
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1.1 OSTEOPOROSIS – AN ENFEEBLING DISEASE 
 
Osteoporosis is a disease resulting in a skeletal disorder caused by excessive bone resorption.1 
At greatest risk are the elderly and in particular post-menopausal women.2 Current treatments 
for osteoporosis include vitamin and calcium dietary supplements. Bisphosphonates are the most 
common drugs administered to lower bone resorption rates, but these have significant side-
effects and/or compliance issues.3 Thus, osteoporosis is a major health problem and there is an 
urgent need to develop new and effective therapeutic agents for this enfeebling disease.  
Several lines of evidence validate the enzyme Purple Acid Phosphatase (PAP) as an important 
target for the discovery and development of new anti-osteoporotic drug leads, such as (i) 
elevated concentrations of PAP in the human serum are associated with an increase in bone 
turnover,4 (ii) elevated serum concentrations of human PAP are observed in patients with 
osteoporosis,5 (iii) mice lacking the gene encoding PAP suffer from deformed bone structure 
(osteopetrosis),6 and (iv) mice over-expressing PAP are osteoporotic.7, 8 For those reasons PAP is 
already used as a main biochemical marker for the diagnosis of osteoporosis.9 Moreover, detailed 
understanding of the catalytic mechanism of PAP encourages the rational design of antiosteo-
porotic drugs.10 
1.2 BIOLOGICAL SIGNIFICANCE AND STABILITY OF 
PHOSPHOESTERS 
 
Phosphate esters, also called phosphoesters, are very important in the chemistry of life as they 
fulfill a variety of key roles.11 The P-O bonds are extremely stable due to the exceedingly slow 
uncatalyzed hydrolysis although it is favored thermodynamically.11 Therefore, phosphoester 
linkages are particularly well-suited in biology and therefore ubiquitous in nature as they link for 
example the nucleosides in deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). For example, 
the strength of the phosphoester P-O bond is illustrated dramatically in the fact that DNA has a 
half-life of 30,000,000 years.12 However, phosphoesters are also found in phospholipids, the 
major component of cell membranes and in many small molecules that play a key role in 
metabolism including several organic cofactors and secondary messengers.11 Reversible 
phosphorylation of proteins is an extremely important regulatory mechanism.13, 14 The 
transformation of serine, threonine or tyrosine residues into phosphomonoesters induces 
conformational changes in enzymes and receptors leading to activation or inactivation.11 In this 
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way, phosphorylation and phosphoester cleavage is an effective ’molecular switch’ to control 
protein function.11 
1.3 PHOSPHATASES – PHOSPHOESTER CLEAVING 
ENZYMES 
 
Whilst the stability of phosphoester bonds is critical to life, so is the capacity to efficiently 
manipulate these bonds. Nature has managed to achieve this remarkable feat through the 
evolution of a diverse range of enzymes that are able to drastically reduce the activation energies 
of specific P-O hydrolysis reactions and thereby to accelerate those by factors of > 1015 relative 
to the uncatalyzed cleavage.11, 15 This task is adopted by phosphatases which are amongst the 
most efficient enzymes known and are involved in signal transduction in bacteria,16, 17 
phospholipid degradation,18-20 as well as regulation of phosphate levels in plants, fungi and 
mammals.11, 21-28 Purple Acid Phosphatases (PAPs) and Alkaline Phosphatases (APs) are two of 
the best characterized hydrolytic enzymes and are predominantly discussed in this thesis.11 As 
the names imply the former are most active at low pH, and the latter under alkaline conditions.11 
Although it has been thought for a long time that APs and PAPs are strictly phosphomono-
esterases it was found that both are also able to operate as phosphodiesterases.29, 30 
Alkaline Phosphatase 
APs are unique in the class of phosphomonoesterases in the sense that they appear to be 
nonspecific.30 Furthermore, APs hydrolyze not only phosphomonoesters, but also a variety of O- 
and S-phosphothioates, phosphoamidates, thiophosphates and phosphate.30 Moreover, APs do 
not only catalyze hydrolysis reactions but also transphosphorylations in the presence of high 
concentrations of phosphate acceptors.31 Mammalian APs occur in different isozymes with very 
different in vivo functions.31 In general, APs are commonly named after the tissue where they are 
predominantly expressed.31 The major functions of APs established to date is bone mineralization 
by tissue-nonspecific AP (TNAP), abundant in skeletal tissues, and intestinal absorption by 
intestinal AP (IAP), abundant in the gut.31 
Recent studies on TNAP-deficient mice showed that hydrolyzing the mineralization inhibitor 
pyrophosphate (PPi) was the major function of TNAP in bone tissue, thus facilitating mineral 
precipitation and growth.32 PPi prevents initial crystal formation and crystal growth by physically 
coating the nascent hydroxyapatite crystals.32 Therefore, TNAP functions to maintain an 
appropriate concentration of this inhibitor to ensure normal bone mineralization.32 Another 
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proposal for the function of TNAP in bone matrix has been the generation of the inorganic 
phosphate (Pi) needed for hydroxyapatite crystallization.32  
The biological functions of IAP are diverse, including (i) lipid intestinal absorption,33, 34 
(ii) regulation of bicarbonate secretion,35, 36 (iii) detoxification of bacterial lipopolysaccharide 
(LPS),37, 38 and (iv) protection against LPS-induced intestinal inflammation.39, 40 In more detail, 
pancreatic lipase hydrolyze triglycerides into glycerol and free fatty acids (FAs). For the 
subsequent FA absorption, the involvement of IAP has been proposed through regulation of the 
FA carrier protein FA transporter/CD36 (FAT/CD36).40 The possibility exists that IAP modulates 
the FA absorption by controlling the level of phosphorylation of FAT/CD36 and/or by locally 
hydrolyzing the extracellular ATP, since the CD36-mediated FA uptake (i) decreases with 
increasing phosphorylation of FAT/CD36, (ii) is inhibited by extracellular ATP, and (iii) is restored 
after the addition of AP.40 The latter modulation mechanism of IAP is also utilized for the 
regulation of the bicarbonate secretion which works in a loop involving IAP, extracellular ATP and 
G-coupled purinergic receptor P2Y1.40 ATP stimulates the P2Y1 receptors which, in turn, stimulate 
the secretion of bicarbonate by enterocytes.40 Therefore, the ATPase activity of IAP regulates the 
local ATP concentration and subsequently the bicarbonate secretion. In contrast, the 
detoxification of LPS is encompassed directly by the dephosphorylation of its toxic diphosphoryl-
lipid A moiety.40 In this way the LPS-induced intestinal inflammation induced by the Toll-like 
receptor 4 (TLR4) is suppressed, since the dephosphorylated LPS is no longer able to trigger 
TLR4.40 
Purple Acid Phosphatase 
PAPs are ubiquitous enzymes found in animals, plants, fungi and bacteria and are associated with 
a variety of biological functions. PAPs are resistant to inhibition by L-tartrate and thus are 
frequently referred to as tartrate-resistant acid phosphatase (TRAcPs or TRAPs).29 
Mammalian PAPs, abundantly expressed in osteoclasts, activated macrophages and dendritic 
cells,41-43 have been implicated with (i) iron transport in pregnant pigs,44 (ii) the generation of 
reactive oxygen species (ROS),45 and (iii) increased bone resorption.9, 46 Specifically, it has been 
suggested that PAPs play an important role in the immune defense system producing hydroxyl 
and superoxide radicals based on the Haber–Weiss–Fenton-type reactions (Scheme 1).29, 47 
 
Scheme 1: Generation of ROS by PAPs by Haber-Weiss-Fenton type reactions.29 
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As mentioned previously, PAPs were also shown to play a crucial role in bone metabolism since 
transgenic mice, in which osteoclasts overexpress and secrete PAP, display increased levels of 
bone resorption and consequently symptoms of mild osteoporosis.7 In contrast, knock-out 
transgenic mice completely lacking PAP reveal the opposite phenotype, osteopetrosis.6 It is 
believed that PAP dephosphorylates bone matrix proteins such as osteopontin which are 
involved in the adhesion of osteoclasts to the bone surface and are, upon dephosphorylation, no 
longer capable of fulfilling this function.46 However, it has also been speculated that PAP is 
involved in the ATP-dependent regulation of bone calcium homeostasis due to the fact that PAP 
is also an efficient ATPase.48 
Contrary to mammalian PAP, assignment of specific functions has been more difficult for plant 
PAP due to its appearance in multiple isoforms with diverse metal ion compositions.49-58 
However, it has been speculated that plant PAPs play a major function in phosphate metabolism 
mobilizing inorganic phosphate from organophosphates in the soil.50-52, 57, 59 It has also been 
proposed that plant PAPs are involved in the storage of phosphorus in plant seeds via hydrolysis 
of phytic acid, the major compound accountable for the phosphorus storage.60 Interestingly, it 
has been found that the extracellular ROS concentration in plants increases in response to a 
pathogen attack or biotic and abiotic stress, similarly as observed for mammals.61 Therefore, 
plant PAPs seem to be bifunctional, similar to mammalian PAPs, catalyzing both hydrolytic 
reactions and peroxidations.45, 47, 62, 63 Although not yet clear, the purpose of this peroxidation 
activity in plants, microbe may be killing during pathogen attack.29, 61 
1.4 STRUCTURE OF PHOSPHATASES 
 
APs and PAPs belong to the enzyme family of dinuclear metallohydrolases which require two 
dinuclear centers to perform a hydrolytic reaction. The presence of two closely spaced metal ions 
in the active site can have advantages over just one metal ion, such as (i) a lowered 
thermodynamic driving force for redox reactions due to charge-delocalization, (ii) a lowered 
activation barrier for solvent and enzyme reorganization, (iii) preorientation and electrostatic 
activation of substrates, (iv) easier formation of hydrolysis-initiating nucleophiles, and 
(v) stabilization of transition states generated throughout the hydrolysis reaction.28 The binding 
of the two metals in the active site is facilitated by precisely positioned ligating amino acid side 
chains of the peptide backbone which are defined as the primary coordination sphere.  
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Alkaline Phosphatase 
AP has been structurally characterized as an enzyme-phosphate complex isolated from E. coli 
(Chart 2, left).64 Here the phosphate is non-covalently bound at the active center and the 
structure therefore likely represents an authentic intermediate of the phosphoester hydrolysis 
reaction.30 AP is a homodimeric protein with 449 amino acids building up the subunits and two 
ZnII centers and a single Mg2+ center coordinated in each active site.11 Whilst one ZnII ion is 
coordinated by two histidine and one aspartate residue of the peptide backbone, the second ZnII 
center is ligated by one histidine and two aspartate residues.64 In the resting state the proximal 
serine side chain coordinates the latter ZnII ion, but is exchanged by a phosphate oxygen atom in 
the enzyme-phosphate complex.30 The Mg2+, ion which appears to play only an ancillary, 
structural role, is linked to the dizinc(II) site by a Mg-Zn bridging aspartate and is additionally 
coordinated by a glutamate, a threonine and three water molecules.64 The three metal ions in AP 
form a triangle in which the metal-metal distances are 3.94 Å, 4.88 Å, and 7.09 Å.30 Therefore, 
the Mg2+ appears not to be close enough to participate directly in the hydrolysis mechanism, but 
could contribute to the shape of the electrostatic potential around the active center or provide 
an additional metal bound water in the vicinity of Ser102 functioning as a general acid/base for 
regulating the protonation state of Ser102.30, 65 A comparison of the amino acid sequence of the 
phosphorylated peptides isolated from the enzyme with the complete amino acid sequence 
showed that the phosphorylated residue is Ser102 suggesting that this amino acid residue 
functions as nucleophile in the catalytic mechanism.30 
 
 
Chart 2: Schematic depiction of the active site of AP (left)30, 64, 65 and PAP (right),45 including essential amino 
acids in the second coordination sphere (depicted in green). 
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Purple Acid Phosphatase 
Several crystal structures of PAPs, isolated from various plant, animal, and fungal sources, have 
been published.29 Mammalian PAPs isolated from pig (ufPAP), cow, human, mouse and rat are 
approximately 35 kDa monomeric proteins with a FeIIIFeII center and share at least 80% amino 
acid sequence identity.21, 29, 49, 66 Plant PAPs extracted from red kidney bean (kbPAP), sweet 
potato, soybean, duckweed, tomato, potato, and thale cress revealed 55 – 60 kDa homodimeric 
enzymes and amino acid sequence identity of at least 65%.21, 29, 49, 66 The metal composition in 
the active sites of plant PAPs is either FeIIIZnII or FeIIIMnII.23, 24, 67, 68 Although the homology 
between the mammalian and plant PAP amino acid sequences is less than 20%, their catalytic 
sites display a remarkable similarity.29 The two metal ions were found to be coordinated by seven 
invariant amino acid residues (Chart 2, right).45 The FeIII ion is coordinated by a histidine, an 
aspartate and a tyrosine amino acid side chain. This tyrosine ligand in the ‘chromophoric’ site is 
accountable for the characteristic purple color of the enzyme due to its ligand to metal charge-
transfer (LMCT) transition.69 The MII ion (MII = FeII, ZnII or MnII) in the ‘redox-active’ site is 
surrounded by an asparagine and two histidines residues. The coordination spheres of the FeIII 
and MII ions were completed by a bridging aspartate residue, a modeled bridging hydroxide 
ligand and a modeled terminal water ligand for the resting state for ufPAP, but the number of 
terminal and bridging aqua and hydroxide ligands is ambiguous.70 Although PAPs are rather 
specific in their metal ion selection in vivo, it has been shown with in vitro studies that on the one 
hand the FeII ion of the diiron ufPAP can be exchanged by ZnII, NiII, CuII, and MnII and on the other 
hand the FeIII ion can be replaced by GaIII and AlIII without loss of catalytic activity.29 Similarly, 
catalytic activity could be reconstituted by replacement of ZnII by FeII in kbPAP.29 However, PAPs 
are the only dinuclear metallohydrolases where the necessity for a heterovalent active site for 
catalysis has been clearly established.21 
In general, the primary coordination sphere in the active site of dinuclear enzymes is supposed 
to define (i) the coordination modes, (ii) the separation, and (iii) the electron density of the two 
metal ions coordinated. Interestingly, in both crystal structures discussed here the two metal 
centers reside in chemically different environments. The differing coordination environments of 
dinuclear metallohydrolases are often defined as the α- and β-site.28 In fact, the peptide 
backbones of the active sites of AP and PAP form an asymmetric dinucleating core with a harder 
and a softer metal site suggesting that the metal ions have distinct functions in the catalytic 
mechanism. However, mutation studies (discussed below) of some non-coordinating amino acids 
of both, AP and PAP, revealed that those are also essential for the activity.13, 65, 71-74 
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1.5 SIGNIFICANCE OF THE SECOND COORDINATION 
SPHERE IN PHOSPHATASES 
 
Amino acids that are not directly coordinated to the metal ions in the active site but are 
indespensable to the activity are defined as the second coordination sphere.75 Those amino acids 
alter the physical and chemical properties of the active site, needed for the catalytic trans-
formation by non-covalent interactions, hydrophobic effects and van der Waals forces.75 
Alkaline Phosphatase 
In the crystal structure of the enzyme-phosphate complex of AP an extensive hydrogen bonding 
network was determined. More precisely, the two phosphate oxygens, which are not 
coordinated to the two ZnII centers, form hydrogen bonds to an adjacent guanidinium group of 
an arginine residue (Arg166) and one of them also to the amide group of the serine residue in 
the primary coordination sphere (Ser102).30 Furthermore, Arg166 is additionally involved in 
hydrogen bonding to other amino acid side chains.30 The influence of the proximal Arg166 
residue was investigated with site-directed mutagenesis studies in which this amino acid was 
exchanged by lysine, glutamine, serine or alanine.71, 72 All mutants revealed decreased phosphate 
affinity but retained catalytic activity. In a similar study the possibility that Arg166 was 
responsible for the preference of AP for phosphomonoesters was demonstrated.65, 73 Moreover, 
investigations of linear free-energy relationships have been suggested that electrostatic 
interactions of the phosphate with both ZnII ions and Arg166 are critical stabilizing factors in the 
trigonal bipyramidal transition structure of the phosphoester hydrolysis reaction.65 
Purple Acid Phosphatase 
Previous studies have shown that not only the amino acids in the first coordination sphere are 
crucial for catalytic activity of PAPs but also the three histidine residues nearby the metal centers 
(Chart 2, right).45, 74 With the aid of site-directed mutagenesis with rat bone PAP the influence of 
these residues regarding the phosphatase activity and the generation of reactive oxygen species 
(ROS) of PAP was analyzed. These experiments led to the conclusion that the replacement of the 
histidine residues 216 and 113 with alanine or glutamine seriously impaired the phosphatase 
activity compared to the wild-type enzyme, while the mutants retained a high capacity to form 
ROS.45, 74 From this it appears that the acid phosphatase activity and the ROS-generating capacity 
are independent of each other. More importantly, these results point out that the hydrogen 
bonding network built up by these histidine residues plays an essential role in the mechanism of 
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the phosphoester hydrolysis.26, 76 Interestingly, the mutant in which His113 was exchanged by a 
glutamine residue, technically capable to form hydrogen bonds, exhibited also decreased 
phosphoester hydrolysis activity. This initial contradiction to the former hypothesis was clarified 
by exchanging His113 with an asparagine residue, which led to an even higher phosphoester 
hydrolysis activity than the native enzyme. Since asparagine has the same functionalities than 
glutamine, but with a shorter side chain, the optimum geometry for hydrogen bonding and 
following phosphoester hydrolysis appears to be achieved in the asparagine mutant.  
Although the importance of the second coordination sphere of AP and PAP has been clearly 
demonstrated, the precise role of the amino acid side chains proximal to the dinuclear active site 
is still not completely understood. This is primarily due to challenges in examination of functions 
of specific amino acids in complicated protein matrices, but also caused by difficulties in the 
characterization of non-covalent bonds.75 In this regard the development of simplified model 
systems, which incorporate the key features of the native metalloenzymes, represents a feasible 
experimental approach. 
1.6 BIOMIMETICS – A USEFUL TOOL TO STUDY ENZYMES 
 
Due to the fact that PAP activity is directly linked to bone resorption this enzyme has become a 
major target for the development of antiosteoporotic chemotherapeutics.29 Efforts for a rational 
design of such compounds is greatly helped by the detailed knowledge about the functional 
domains of PAPs. In fact, the wealth of information gained in recent years about the structure 
and the catalytic mechanism of mammalian AP has aided in the development of pharmacological 
products able to modulate AP activity and in the understanding of AP correlated diseases such 
as hypophosphatasia, a rare and sometimes fatal metabolic bone disease, caused by the 
deficiency in TNAP isozyme.32 
In complement with X-ray structural, spectroscopic, mutagenesis and isotope effect studies of 
the respective enzyme a useful and important tool to establish the precise mechanism of an 
enzyme-catalyzed reaction are low-molecular weight synthetic mimics, also called biomimetics. 
Due to the fact that the active sites of many phosphatases contain metal ions, metal complexes 
are used as biomimetics to emulate key structural aspects of these enzymes. Model complexes 
have the advantages over their enzymatic counterparts since (i) they are generally more stable, 
(ii) they can be more readily crystallized, and (iii) provide easy accessible structural information 
on metal ion conformation.77 In addition, model complexes can be designed to mimic one or 
more key features of a sophisticated enzyme active site. In this way, the relative importance of 
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specific structural or chemical features, or combinations thereof with respect to the overall 
catalytic efficiency of the enzyme, can be studied separately.  
In this thesis the use of dinuclear model complexes as biomimetics of APs and PAPs, in order to 
gain a deeper understanding of the influence and the precise role of the second coordination 
sphere with regard to the catalytic phosphoester hydrolysis mechanism, will be presented. 
 
 11 
Chapter 2  
Ligand Design and  
Synthesesb
                                                          
b Parts of this chapter are published in “Dinuclear Zinc(II) Complexes with Hydrogen Bond Donors as Structural 
and Functional Phosphatase Models”; Simone Bosch, Peter Comba, Lawrence R. Gahan, Gerhard Schenk, 
Inorg. Chem. 2014, 53, 9036-9051. and will be published in “Asymmetric Mono- and Dinuclear GaIII and ZnII 
Complexes as Models for Purple Acid Phosphatases (PAPs)”; Simone Bosch, Lawrence R. Gahan and Gerhard 
Schenk; manuscript in preparation.  
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2.1 INTRODUCTION 
 
In nature transition metal ions bound in the active site of enzymes are used extensively to 
encompass the catalysis of a broad range of reactions. While in some metalloenzymes the 
transformation of a substrate molecule takes place at a single metal center, several classes of 
metalloenzymes make use of the cooperativity of two metal centers within their active site to 
achieve full catalytic efficiency.78 In the latter case the removal of one metal center often results 
in a decrease of activity. An important example of enzymes containing dinuclear active sites are 
metallohydrolases, which hydrolyze substrates such as urea, peptides, phosphoesters 
and -anhydrides, thioesters and even DNA and RNA. While most of the hydrolases bind two 
metals of the same kind in close proximity to each other, there are two other members of the 
hydrolase superfamily which have been shown to bind two different metal ions in their active 
sites, Purple Acid Phosphatases (PAPs) and Ser/Thr Proteins Phosphatases (PPs).9, 21, 79, 80 
Moreover, the two chemically distinct coordination environments around the metal centers have 
been found to be essential for catalytic activity.21, 24, 81-85 The amino acid backbone of the active 
site in PAPs generate two different coordination sites, which favor the binding to a specific metal, 
though their individual roles remain a matter of debate. 
Owing to the relatively low resolution of protein crystal structures, model complexes often play 
an important role in the structural characterization of the active sites in metalloproteins. Low 
molecular weight mimics of phosphoesterases simplify the study of both the environment of the 
metal ions and the hydrolysis of phosphoesters, and can provide insight into possible catalytic 
mechanisms.81 Therefore, small metal complexes have been used extensively to model the active 
site of phosphoesterases.81 Moreover, dinuclear complexes have been shown to bind phosphates 
more strongly and to be significantly more reactive for the cleavage of phosphate esters 
compared to their mononuclear counterparts.86-89 Some of the most active dimetallic systems 
are those in which the ligand structure places the metal ions in a way that it promotes 
cooperative interactions with the substrate (either via double Lewis acid activation, or Lewis acid 
activation coupled with provision of a metal-bound hydroxide nucleophile).80, 84 Due to the fact 
that for simple oxido- or hydroxido-bridged mononuclear complexes dissociation is likely, 
attention has been focused on bridging dinucleating ligand systems. In these the ligand must 
accommodate two metals with an appropriate metal-metal separation that reproduce the 
intermetallic distance of the enzyme. This is mostly achieved using a linker moiety between the 
two coordination sites. Different ligand backbone linkers have been successfully used by this 
means to model the structural features of hydrolases and examples are illustrated in Chart 3.  
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Chart 3: Schematic depiction of ligand types that have been used to model the active site in PAPs: f.l.t.r. 
phenolate-based, alkoxo-based and imidazolate-based ligands. 
Among others, phenolate-, alkoxo-, and imidazolate have been deployed as scaffolds for a range 
of ligands varying in the aminomethyl-substituents (depicted as Rx in Chart 3) in order to tune 
the coordination behavior of the ligands towards specific metal ions.81, 90-99 The phenolate-linker 
is one of the most commonly used ligand scaffolds,90, 92-96, 99 for example in the symmetric ligands 
HL1 and H3L3 (see Chart 4).100, 101 (The nomenclature of the ligands denotes the number of protons 
which can potentially be abstracted from the ligands upon deprotonation; HL1 contains one 
potentially acidic phenolate residue, accordingly HL1, while H3L3 bears three acidic protons and 
the nomenclature is adjusted accordingly. This nomenclature will be used throughout this thesis.) 
The phenolate-linker arranges the two coordination sites the way that (i) the two metal ions are 
separated by about 3 – 4 Å, (ii) the two metal ions are bridged by an oxygen atom as present in 
the native active site, and (iii) exogenous water and hydroxido ligands are bound in a syn 
configuration. The latter structural feature was shown to be essential for phosphoester cleavage 
as a complex with two H2O molecules in anti configuration was not active.102 
 
Chart 4: Symmetric and asymmetric phenolate-based ligands related to the ligands developed in the present 
thesis, previously used to model the active site peptide backbone of PAP.81, 103 
It should be noted, that an important feature of metalloenzymes, especially those with 
heterodinuclear active sites, is that the surrounding protein matrix usually provides chemically 
distinct binding environments for the individual metal centers, commonly referred to as site 
asymmetry at metallobiosites.91 Typically, asymmetric dinucleating ligands are used to mimic this 
coordination environment of the metals in metallohydrolases, which dictate the steric and 
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electronic features of each metal center.81 Terminal phenolate residues are often used to mimic 
the tyrosinate donor found in the active site of PAP.102 Numerous asymmetric ligands have been 
developed so far in order to imitate the peptide backbone of phosphatases with coordination 
number asymmetry (dissimilar number of donor atoms), i.e. H2L5, and/or donor asymmetry 
(different types of donor atoms), i.e. H2L4 and H2L5.81, 94, 103 
Unfortunately, the accessibility of asymmetric dinucleating ligands is often hampered by various 
synthetic problems. Several approaches have been proposed to overcome this problem. The 
most facile route starting from a symmetric, doubly chloro-substituted phenolate-bridging unit 
was published for the synthesis of H2L4 by Neves et al.,94 whereby successive reaction with two 
amines generally results in the formation of considerable amounts of symmetric byproducts. The 
statistical mixture of the desired asymmetric ligand and the two unintended symmetric ligands 
is usually difficult to separate by conventional chromatography methods utilizing polar silica or 
aluminia because of the high polarity of the products. An elegant solution for this problem was 
suggested by Kahn et al.104 Starting also from a symmetric dicarbonyl-functionalized phenolate 
bridging unit, gadolinium(III) ions were used to protect one of the reactive carbonyl functions by 
coordination, whereby the remaining free carbonyl function leads to an imine by reaction with 
an amine. Precipitation of GdIII in form of gadolinium(III) oxalate yielded the free carbonyl 
functionalized monoimine, which reacts with another different amine to afford the asymmetric 
diimine. Due to the fact that this approach only works for small-scale reactions, more efficient 
routes towards the class of asymmetric ligands were developed starting from already asymmetric 
bridging units.105 In the case of the phenolate-based ligands the stepwise synthetic procedure 
starts usually with 2-hydroxy-3-(hydroxylmethyl)-5-methylbenzaldehyde (1). Latour et al. 
(Scheme 2a) and Nordlander et al. (Scheme 2b) reported a procedure generating asymmetric 
dinucleating ligands using this starting material.106, 107 Whilst Latour et al. accomplished the 
incorporation of the two unequal amine side-arms by stepwise generation of a chloro 
functionality and following nucleophilic substitution,106 Nordlander et al. achieved one 
attachment of an amine side-arm by amination of the carbonyl moiety present in the starting 
material and the second amine was incorporated by chlorination and subsequent nucleophilic 
substitution with a second amine following the same procedure as undertaken by Latour et al.107 
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Scheme 2: Schematic representation of procedures applied by Latour et al. and Nordlander et al. to synthesize 
asymmetric dinucleating ligands.106, 107 
Many metalloenzymes that catalyze the cleavage of phosphate esters also possess a hydrogen 
bonding microenvironment around the metal centers, which is essential for their activity 
attributed to transition state stabilization.29, 108 In order to study the impact of hydrogen bond 
donors nearby the metal centers on the hydrolysis activity within the active site of phosphatases, 
different dinucleating ligands, depicted in Chart 5, have been developed. The hydrogen bonding 
interaction of PAPs were mimicked either by a cyclam-linker as in H2L6,108, 109 while in the other 
ligands the hydrogen bonding network was incorporated into the ligands by amino and pivaloyl-
amide residues at the pyridine side-arms. Feng et al. developed a range of alkoxo-based 
mononucleating ligands and the dinucleating ligand HL7 which also take into account the second 
coordination sphere.110-113 Moreover two HL1 derivatives, H3L2 and HL8, which carry hydrogen 
bond donors proximal to the metal coordinating sites have been developed.109, 114 In the latter, 
two hydrogen bond donors, one proximal to the metal center each, are rigidly preorganized to 
interact with a phosphoester substrate and/or to activate the hydroxido nucleophile coordinated 
to the dimetal core. 
 
Chart 5: Previously published ligands bearing hydrogen bond donors mimicking the peptide backbone of 
phosphatases active sites.108, 112-114 
LIGAND DESIGN AND SYNTHESES 
16 
The intention of this thesis was to study the role of a hydrogen bond network in the reaction 
mechanism of phosphatase biomimetics. Thus, dinuclear complexes were designed, which 
combine the essential structural features of the active site of phosphatases, such as (i) two metal 
ions accommodated in a well-suited metal···metal separation, (ii) asymmetry of the two binding 
sites, and (iii) hydrogen bond donors proximal to the metal centers. Specifically, asymmetric 
ligands bearing two amide or amine groups as mimics of the second coordination sphere of the 
enzyme were synthesized and are depicted in Chart 6. Incorporation of two pivaloyl-amide 
residues in H3SIM1 in an asymmetrical manner, in contrast to H3L2, realized the hydrogen bonding 
capacity as well as the asymmetry of the two binding sites. Similarly, HSIM2 bears two amine 
moieties in an asymmetric fashion, contrary to its symmetric counterpart HL8. While in H3SIM1 
and HSIM2 the asymmetry of the metal binding sites is caused by the moieties of the second 
coordination sphere, H4SIM3 and H4SIM4 were designed in the way that the primary coordination 
sphere of the two binding sites is unlike. Moreover, both asymmetric ligands, H4SIM3 and H4SIM4, 
bear hydrogen bond donors either proximal to one or proximal to both binding sites. The ligands 
discussed in this thesis leave vacant coordination sites and facilitate the interaction of the metal 
centers with specific substrates.  
 
Chart 6: Overview of the ligands synthesized in this work. 
The following chapter will give an introduction to the synthetic pathways developed for the 
preparation of the asymmetric ligands H3SIM1, HSIM2, H4SIM3 and H4SIM4 (Chart 6). In addition, 
detailed experimental procedures as well as analytical results are given in Chapter 11.   
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2.2 SYNTHESIS OF LIGAND H3SIM1 
 
In order to gain further insight into the role of the hydrogen bonding network of PAPs in the 
catalytic mechanism, four asymmetric ligands bearing amide or amine residues with the capacity 
to form hydrogen bonds were developed. H3SIM1 was designed in order to investigate especially 
the impact of the positioning of the hydrogen bond donating groups in the active site of PAPs. 
The structure of H3SIM1 is based on the symmetric ligands HL1 and H3L2. While HL1 provides no 
hydrogen bond donors, H3L2 bears two pivaloyl-amide moieties, one amide moiety proximal to 
each coordination site. In contrast, H3SIM1 was designed in the way that a hydrogen bonding 
network is only available at one of the two binding sites, while the primary coordination sphere 
remains unchanged and therefore comparable to HL1 and H3L2.  
In the process of finding a suitable synthetic pathway for the preparation of H3SIM1 the 
approaches illustrated in Scheme 2 were combined and the number of reaction steps minimized. 
In this way, the retrosynthetic analysis of the ligand H3SIM1 yield two possible pathways 
(Scheme 3). Both pathways share the same asymmetric starting material 2-hydroxy-3-
(hydroxymethyl)-5-methylbenzaldehyde (1). The suggested stepwise reaction with two different 
secondary amines enables the selective formation of the asymmetric ligand. Therefore, pathway 
a) suggests an initial amination and the subsequent nucleophilic substitution while pathway b) 
follows the reverse order.  
 
Scheme 3: Retrosynthetic analysis of ligand H3SIM1. 
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The precursors needed for both synthetic routes, i.e. compound 1, 2, and 3 were synthesized 
according to known procedures.115-121 Starting with 2,6-bis(hydroxylmethyl)-4-methylphenol (4), 
the aldehyde functionality in compound 1 was formed by oxidation with MnO2 in chloroform 
(Scheme 4a).120 During the reaction both the monoaldehyde 1 and its dialdehyde derivative were 
formed and separated through column chromatography yielding compound 1 in a moderate yield 
of 46%. A selective procedure for the preparation of compound 1 was also tested. Protection of 
one alcohol group as the cyclic acetal of 2,2-dimethoxypropane in acetone enables the selective 
oxidation of the remaining alcohol group in dichloromethane using pyridinium chlorochromate 
(PCC) as oxidant (Scheme 4b).122 The following deprotection with hydrochloric acid in a mixture 
of acetonitrile and water led exclusively to compound 1 with an overall yield of the three reaction 
steps of 74%.123 However, this alternative route includes two additional synthetic steps and is 
therefore more time-consuming. Chlorination of the alcohol group in compound 1 with 
concentrated hydrochloric acid in ethanol generated compound 5 in 67% yield (Scheme 4).121 
Compound 5, which contains one aldehyde group and one chloromethyl group, was chosen as 
the building block for the selective synthesis of the asymmetric dinucleating ligands H3SIM1, 
HSIM2, H4SIM3, and H4SIM4 as those functionalities make this phenol compound able to react 
stepwise with two different secondary amines thereby forming the two unequal coordination 
sites of the ligands. 
 
Scheme 4: Comparison of the statistical and selective synthesis of compound 1 and the following formation of 
compound 5. 
The two secondary amines, compound 2 and compound 3, were synthesized adapting published 
methods.115, 119 Compound 2 was generated by amination of picolylaldehyde with 2-(amino-
methyl)pyridine in methanol and subsequent hydrogenation with sodium borohydride in a 
moderate yield of 63%. The preparation of compound 3 was more challenging and the synthetic 
pathway is included in Scheme 5.  
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Scheme 5: Synthesis of ligand H3SIM1. 
The amino functionality of 2-amino-6-methylpyridine (8) was protected prior to bromination via 
generation of the respective pivaloyl-amido derivative (95% yield). During the bromination of 
N-(6-methylpyridin-2-yl)pivalamide (9) a variety of side products appeared (Scheme 6). 
 
Scheme 6: Bromination of compound 9 yielding the mixture of compound 10, 13, and 14. 
Thus, different modifications regarding the type and the concentration of the bromine source, 
the solvent and the use of UV light were examined in order to minimize the concentration of ring-
brominated derivative 13 and dibrominated species 14 at maximal conversion of the starting 
material (9). In this way, a procedure was developed which leads to an adequate amount of side-
chain monobrominated compound 10. The isolation of the desired compound 10 was achieved 
by column chromatography and subsequent crystallization by ultrasonication in a yield of 44%.  
In the next step two equivalents of compound 10 were treated with potassium carbonate and 
one equivalent of 2-nitrobenzoylsulfonamide in dimethylformamide to form compound 11 in a 
yield of 98% (Scheme 5). Subsequent reaction of compound 11 with potassium carbonate and 
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thiophenol in anhydrous dimethylformamide realized the formation of compound 3 in 81% yield 
(Scheme 5).  
The attachment of the secondary amines 2 and 3 to the bridging phenol building block 1 was 
initially tested following pathway a) in Scheme 3, adapting the procedures reported by 
Nordlander et al. (Scheme 7).107 While the amination of compound 1 with compound 2 yield 
compound 15 in 85% yield, the following chlorination with thionylchloride and the nucleophilic 
substitution with compound 3 were found to be an unreliable procedure to obtain H3SIM1 in a 
satisfactory yield. 
 
Scheme 7: Failed synthetic route to ligand H3SIM1. 
In order to circumvent the previous drawbacks, the alternative strategy of pathway b) was 
explored (Scheme 3), and the complete eight-step synthetic route is shown in Scheme 5. 
Nucleophilic substitution of the chlorine atom of compound 5 with amine 2 yields compound 12 
(61% yield). The formation of ligand H3SIM1 was realized by amination of the remaining carbonyl 
functionality with the secondary amine 3 in anhydrous solution and subsequent hydrogenation 
with sodium triacetoxyborohydride.  
Unfortunately, recrystallization from acetonitrile of the crude product, obtained after the 
workup of the reaction mixture, gave H3SIM1 in a yield of only 27%. However, a purification 
procedure via column chromatography was developed to yield H3SIM1 in slightly higher yield of 
30%. A similar method was also used for the purification of the symmetric ligand H3L2, prepared 
for comparison according to published procedures.109, 114 
2.3 SYNTHESIS OF LIGAND HSIM2 
 
Ligand HSIM2 was designed with two amino functionalities adjacent to one binding site, in order 
to study the influence of the steric hindrance contrived by the bulky pivaloyl-amide residues in 
H3SIM1 with unchanged position of the hydrogen bonding donors. Moreover, comparison to the 
published ligand HL1, lacking hydrogen bond donors, and to HL8, bearing two amine 
functionalities in a symmetric manner, enables the investigation of the effect of the two 
asymmetrically incorporated amino substituents.  
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Ligand HSIM2 is accessible by deprotection of the two pivaloyl-amide moieties of ligand H3SIM1. 
Therefore, the cleavage of the protecting amide bonds in ligand H3SIM1 was studied under 
various conditions. It was determined that deprotection of H3SIM1 under acidic conditions results 
in decomposition, similar to the chemistry previously detected during treatment of H3L2 with hot 
hydrochloric acid.109 However, heating of H3SIM1 in ethanol solution under basic conditions at 
70° for three days was efficient (Scheme 8). Microwaves radiation under basic conditions also 
promotes the deprotection of H3SIM1, but this could not been undertaken on a larger scale due 
to instrumental restrictions. 
 
Scheme 8: Synthesis of ligand HSIM2. 
Purification of the crude product of HSIM2 obtained after workup of the reaction mixture was 
undertaken via column chromatography with alumina. 
2.4 SYNTHESIS OF LIGAND H4SIM3 
 
The paradigm for the construction of PAP biomimetics, both structural and functional, is that the 
ligands permit discrimination between trivalent and divalent metal ions and therefore bear the 
capacity to stabilize a heterodinuclear site. Furthermore, the pivaloyl-amide residues were 
incorporated into the asymmetric ligand H2L4, leading to H4SIM3 and H4SIM4, in order to provide 
both the capability of coordination asymmetry and the ability for hydrogen bonding of the 
substrate and/or nucleophile. Both ligands provide two different coordination pockets: a softer 
nitrogen-rich N3O compartment for the divalent metal ion and a harder N2O2 donor set in the 
other binding site for the trivalent metal ion.  
Ligand H4SIM3 was accessible applying the optimized procedure for the synthesis of ligand H3SIM1 
using compound 16 as secondary amine in the first step (Scheme 9). Compound 16 was 
synthesized after a published method by reaction of salicylaldehyde with 2-(aminomethyl)-
pyridine and subsequent treatment with sodium borohydride (99% yield).124, 125  
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Scheme 9. Synthesis of ligand H4SIM3. 
This secondary amine 16 was used as nucleophile after treatment with triethylamine in the 
nucleophilic substitution with compound 5 generating compound 17 in a moderate yield of 55%. 
The second amine side-arm was introduced by treatment of compound 17 with compound 3 
under anhydrous conditions and following hydrogenation with sodium triacetoxyborohydride. 
Purification of the crude product of H4SIM3 obtained after workup of the reaction mixture was 
undertaken with column chromatography with silica. 
2.5 SYNTHESIS OF LIGAND H4SIM4 
 
In H4SIM3 the hydrogen bond donating pivaloyl-amide residues are incorporated in an 
asymmetric manner as both are proximal to one binding site. Furthermore, the symmetric 
counterpart of H4SIM3, H4SIM4, was designed bearing one pivaloyl-amide residue proximal to 
both binding sites and thus combining an asymmetric primary coordination sphere with a 
symmetric primary coordination sphere regarding the two metal centers.  
For the synthesis of H4SIM4 the synthetic strategy applied for the preparation of H3SIM1 and 
H4SIM3 was changed slightly. Instead of attaching two secondary amines to the asymmetric 
phenol building block, the second coordination site was built up in two steps due to the better 
accessibility of the reactants (Scheme 10). In the first step the secondary amine 18 was used as 
nucleophile for substitution of the chloro functionality of compound 5. In this way, compound 19 
was formed in 96% yield. Compound 18 containing only one amidated pyridine was synthesized 
as published previously.109, 114 Thereby, the dibrominated byproduct 14 obtained by bromination 
of compound 9 (Scheme 6) was treated with silver nitrate in acetone to generate a formyl 
functionality, i.e. N-(6-formylpyridine-2-yl)pivalamide. Subsequent amination with 2-(amino-
methyl)pyridine and hydrogenation with sodium borohydride yield compound 18 in an overall 
yield of 95% for the two reaction steps.  
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Amination of the remaining aldehyde functionality of compound 19 with 2-(aminomethyl)phenol 
(20) an subsequent hydrogenation with sodium borohydride resulted in compound 21. 2-(amino-
methyl)phenol (20) was prepared according to a literature known procedure by reduction of 
salicylamide with borane/tetrahydrofuran complex.126 Compound 21 was converted to ligand 
H4SIM4 by nucleophilic substitution using compound 10 as reactant.  
 
Scheme 10: Synthesis of ligand H4SIM4. 
Similar to the synthetic procedures of H3SIM1 and H4SIM3, the crude product of H4SIM4 was 
purified via column chromatography.  
2.6 SUMMARY 
 
Four asymmetric, dinucleating ligands were designed and prepared, which provide two different 
coordination sites, mimicking the peptide backbone surrounding the dimetallic core in the active 
site of phosphatases. Ligand H3SIM1 and HSIM2 are derivatives of HL1, but with the capacity to 
form a hydrogen bonding network to the substrate/nucleophile during the catalytic hydrolysis of 
phosphoesters as present in the active site of the native enzymes. In HSIM2 two amino 
substituents function as hydrogen bond donors, the groups capable to form hydrogen bonds in 
H3SIM1 are two sterically demanding pivaloyl-amide residues. In both HSIM2 and H3SIM1 the 
hydrogen bond donors are positioned in an asymmetric manner regarding the two coordination 
sites, while in the previously published ligand H3L2 two pivaloyl-amide residues have been 
incorporated into HL1 in a symmetrical fashion. Similarly, two derivatives of H2L4 have been 
developed bearing two pivaloyl-amide residues either in a symmetric (H4SIM4) or an asymmetric 
fashion (H4SIM3). Thus, these two ligands H4SIM3 and H4SIM4 provide two distinct coordination 
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sites, a softer N3O and a harder N2O2, and are therefore able to discriminate the coordination of 
tri- and divalent metal ions. For the synthesis of H3SIM1 and H4SIM3 a three step approach starting 
with 2-hydroxy-3-(hydroxylmethyl)-5-methylbenzaldehyde was evaluated similar to Nordlander 
et al.,107 but avoiding the delicate chlorination with thionylchloride. H4SIM4 was prepared in a 
similar procedure except of the stepwise generation of the second coordination site. The 
synthesis of HSIM2 was realized by deprotection of ligand H3SIM1 under basic conditions. The 
detailed synthetic procedures and analytic results are given in Chapter 11. 
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Chapter 3  
Coordination Behavior of 
Asymmetric Ligandsc 
 
                                                          
c Main parts of this chapter will be published in “Selective Coordination of Gallium(III), Zinc(II) and Copper(II) by 
an Asymmetric Dinucleating Ligand: A Model for Metallophosphatases”; Simone Bosch, Peter Comba, Lawrence 
R. Gahan, Graeme R. Hanson, Christopher J. Noble, Gerhard Schenk, Hubert Wadepohl; manuscript in 
preparation. 
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3.1 INTRODUCTION 
 
As certain hydrolases are of particular interest in the development of biologically active 
compounds against many diseases, there is special interest in understanding the detailed 
mechanism of the reaction which takes place within their active sites.127 In addition to enzymatic 
studies, modeling the structure and reactivity of the corresponding metalloenzymes using model 
complexes has been shown to be very instructive in the study of the structural and functional 
properties of the enzymes themselves. 
Several classes of metalloenzymes have a dinuclear active site in which two metal ions cooperate 
in order to perform the transformation of various substrates. Representative examples of 
structurally characterized homo- and heterodinuclear active sites relevant for hydrolysis include 
those in Alkaline Phosphatase [ZnIIZnII],64 Purple Acid Phosphatase ([FeIIIZnII],83, 128 [FeIIIFeII],27, 129 
[FeIIIMnII]67, 85), human Protein Phosphatase 1 [FeIIIMnII]130 and bovine erythrocyte Superoxide 
Dismutase [CuIIZnII].131-133 In the homo- and heterodinuclear active sites of these metalloenzymes 
the surrounding protein matrix usually provides chemically distinct binding environments for the 
individual metal centers. Although it is known that the lack of symmetry of the active center is 
an essential structural feature and decisive factor for the catalytic mechanism and efficiency,107, 
134, 135 there are only a few well-characterized heterodinuclear complexes as model systems for 
hydrolases.29, 81, 136 The paucity of examples is possibly attributable to the relatively late discovery 
of heterodinuclear metalloenzymes, but is more likely due to the difficulties in the selective 
binding of two metal ions at specific sites in the complexes. Nature has had millions of years to 
perfect site selectivity, unlike coordination chemists. 
A challenge in the preparation of PAP biomimetics is the requirement for the stabilization of a 
heterovalent dinuclear core,81 because the coordination of two different metal ions by a 
dinucleating ligand may result in the formation of both discrete homo- and heterodinuclear 
complexes, and metal site isomers in which the sites are crystallographically disordered 
occupied. These complications have been circumvented somewhat by designing ligands that 
either bind metal ions selectively in their pockets or strongly enough to prevent 
disproportionation and metal mixing.137 
Some heterovalent and heterometallic systems have been prepared by using symmetrical ligands 
such as HL1, HL9, HL10, HL11 etc. (see Table of Compounds), which do not exhibit metal site 
selectivity, but offer the opportunity to prepare heterometallic or heterovalent complexes by 
careful control of the synthetic conditions. Examples include the biomimetics for the 
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heterodivalent reduced form of PAP, [FeIIIFeII(L11)(OAc)2](BPh4)2, and the mixed-valent FeIIIFeII and 
FeIIIZnII complexes of HL1, [FeIIIFeII(L1)(OPr)2](BPh4)2 and [FeIIIZnII(L1)(OAc)2](BPh4)2; 
crystallographic analysis of the latter suggests the presence of a small degree of disorder in the 
metal occupancies.138, 139 However, in many cases the issue of disorder and non-site-selectivity 
has not been addressed, perhaps not even considered.  
Another strategy to circumvent the difficulties in selective binding of two different metal centers 
has been the use of asymmetric ligands bearing two binding pockets which differ either in the 
number and/or the type of coordinating donors. One of the most common ligands used for this 
purpose is H2L4 (Chart 7) which contains a harder N2O2 metal ion binding site (A) and a softer N3O 
metal ion binding site (B). Using H2L4 a variety of heterodinuclear model complexes, which mimic 
the active site structure of PAP more adequately, has been developed and characterized; 
examples include [FeIIIFeII(L4)(µ-OAc)2]+,140 [FeIIIFeII(L4)(µ-OBz)2]+,106 [FeIIICuII(L4)(µ-OAc)2]+,92 
[FeIIIMnII(L4)(µ-OAc)2]+,96 [FeIIINiII(L4)(µ-OAc)2]+,141 [FeIIINiII(L4)(µ-OAc)(OH2)2]2+,142 
[FeIIIZnII(L4)(µ-OAc)2]+,143 [FeIIIZnII(L4)(OH2)(µ-OH)]2+,90, 144 [FeIIICdII(L4)(µ-OAc)2]+,145 
[[FeIIIHgII(L4)(µ-OH)]2]2+,145 [FeIIICoII(L4)(µ-OAc)2]+,146 [GaIIICoII(L4)(µ-OAc)2]+,146 
[GaIIIZnII(L4)(µ-OAc)2]+66 and [MnIIIMnII(L4)(µ-OAc)2]+.147, 148 The preparation procedure for these 
complexes commonly involves the simultaneous or stepwise addition of two different metal salts 
to the ligand solution, where the selective formation of heterodinuclear complexes is 
theoretically possible. However, investigations of the species distribution were not always 
undertaken. In at least one case, selective binding has been investigated. Belle et al. illustrated a 
very elegant way to study the selective binding of ligand H3L12 of zinc(II) ions by NMR 
spectroscopy via stepwise addition of zinc(II) salt, thereby demonstrating that H3L12 selectively 
forms a monozinc(II) complex, in which the zinc(II) is coordinated to the N3O binding 
compartment.149 This finding was confirmed by the crystal structure of 
[FeIIIZnII(L12)(µ-O2P(OPh)2)2] which was obtained after further addition of triethylamine and 
iron(III) perchlorate to the monozinc(II) synthon.149 Similarly, the respective FeIIICuII complex 
[FeIIICuII(L12)(µ-OEt)]ClO4 was prepared by the stepwise complexation of CuII in the softer binding 
compartment and FeIII in the harder coordination site after addition of triethylamine.150 The site-
directed complexation was confirmed by the crystal structure of the mononuclear complex 
[CuII(H3L12)(OAc)]BPh4;150 this study represents one of the few cases when the mononuclear 
synthon during the synthesis of heterovalent dinuclear complexes was isolated.  
Heterovalent dinuclear model complexes have successfully modeled the physiochemical 
properties of metalloproteins and even the catalytic activity, but with a much lower efficiency. 
This discrepancy between the catalytic efficiencies of model systems and native enzymes is 
suggested, to a large extent, to be due to the lack of many important intermolecular interactions. 
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In many cases, the amino acid residues close to the active site are known to be necessary for 
efficient enzymatic activity because mutation of these residues can cause deactivation or even 
inactivation of the catalyst.74, 151 For example, in PAP, histidine residues proximal to the metal 
centers in the active site have been shown to play an essential role in substrate binding and 
activation; mutations of a histidine to an alanine residue in the second coordination sphere of 
kbPAP resulted in a sharp decrease in activity.74 Moreover, theoretical studies have recently 
reinforced the importance of the proximal histidine residues within the active site of PAP to 
properly describe coordination of the substrate and stabilization of the transition state.151, 152 
Furthermore, Comba et al. developed a FeIIIFeII model complex with hydrogen bond donors in 
close distance to the catalytic site, which presented the highest catalytic efficiency ever reported 
for a PAP model in relation to phosphodiester hydrolysis.108 Similarly, the extension of a FeIIIZnII 
PAP model complex by (3-aminopropyl)silica and a FeIIICuII PAP model complex by a small 
polyethyleneimine chain led to an increase in phosphoester hydrolysis activity. This finding was 
attributed to the interaction of the polar side chains with the substrate, mimicking in this way 
the microenvironment around the active site of the native enzymes.151, 153  
As part of the effort to probe the properties of biologically important, mixed valent, dinuclear 
centers, and to consider the hydrogen bond network of the second coordination sphere of the 
native metalloproteins, as well as the influences of asymmetric binding sites, three ligands have 
been synthesized (Chart 7). In this chapter coordination behavior studies of these asymmetric 
ligands towards ZnII, CuII, GaIII and FeIII ions will be discussed, in addition to their ability to 
selectively form a mononuclear synthon, which can then potentially be used to synthesize 
authentic hetereodinuclear model complexes for PAP.  
The choice of the metal ions in this study (ZnII, CuII, GaIII, and FeIII) is driven by a number of factors. 
The use of ZnII ions is inspired by the fact that many (> 300) metalloenzymes incorporate ZnII 
within their active sites.30, 154-156 Although CuII has not been found in native phosphatases, it was 
chosen to be studied within this thesis as there are some CuII complexes showing catalytic activity 
towards phosphoester hydrolysis acceleration; Kovari et al. developed monocopper(II) 
complexes bearing ammonium groups proximal to the metal center which revealed a higher 
bis(4-nitrophenyl)phosphate (BNPP) hydrolysis rate than its ZnII counterpart;157-159 Neves et al. 
showed asymmetric dicopper(II) complexes accelerated phosphoester hydrolysis, especially via 
the introduction of a sterically demanding group in close distance to the metal centers;160, 161 
Chin et al. investigated a 6000-fold acceleration of bis(2,4-dinitro-phenyl)phosphate (BDNPP) 
hydrolysis by the introduction of amino groups in a CuII-o-phenanthroline complex;162 and 
recently Comba et al. reported the phosphatase activity of a dicopper(II) complex of a cyclic 
pseudopeptide.163 
COORDINATION BEHAVIOR OF ASYMMETRIC LIGANDS 
29 
CuII has, similar to ZnII, substitutional flexibility and a relatively high ionization potential/Lewis 
acidity (see Table 1), which makes it both promising in regards to polarize P-O bonds in phosphate 
ester substrates and to activate the phosphorus center towards nucleophilic attack.  
Table 1: Selected physico-chemical properties of metal ions relevant to this work. 
ion 
ionic radius 
(Å)a 164 
charge density 
(Z/r) (Å-1)a 164 
ionization 
potential (eV)164 
pKa of  
bound H2O 165 
ksub (s-1)b 166 
ZnII 0.74 2.7 17.96 9.0 ~ 6·108 
CuII 0.73 2.8 20.29 8.0 4.4·109 
FeII 0.61 3.3 16.19 9.5 4.4·106 
GaIII 0.62 4.8 30.73 2.6 4.0·102 
FeIII 0.55 5.5 30.65 2.2 1.6·102 
a ionic radii in crystals for a coordination number of 6.  
b water exchange rate of the hexaaqua metal complexes in water at 25°C.  
 
Additionally, the pKa values of water molecules ligated to CuII and ZnII ions often fall in the range 
of 7-9, enabling complexes of these ions to promote hydrolytic reactions under physiological or 
near physiological conditions.11 Moreover, the study of their coordination chemistry is feasible 
spectroscopically with NMR spectroscopy in the case of ZnII and EPR spectroscopy in the case of 
CuII, besides mass spectrometry, UV-vis-NIR spectroscopy and X-ray diffraction. 
The investigation of GaIII coordination by the asymmetric ligands was chosen as it is an excellent 
mimic of FeIII with a similar ionic radius and Lewis acidity (Table 1). Furthermore, the FeIII center 
in pig PAP and bovine spleen PAP has been replaced by GaIII, resulting in GaIIIFeII and GaIIIZnII 
derivatives, which exhibit catalytic activities similar to those of the native forms.66, 142, 167 These 
findings give evidence that diamagnetic GaIII can act as a functional analogue of the paramagnetic 
FeIII site in PAP model systems. Therefore, it is optimally suited to mimic FeIII ions when NMR 
techniques are used. GaIII is characterized by a well-defined coordination chemistry and absence 
of redox chemistry, which allows detailed reactivity studies without interference due to 
competing oxidation states.  
In the present chapter the complexation studies of the asymmetric ligands H3SIM1, H4SIM3 and 
H4SIM4 (Chart 7) with ZnII, CuII, GaIII, and FeIII ions are reported. Although the primary coordination 
sphere of the two coordination sites are equivalent in H3SIM1, the secondary coordination sphere 
differs due to two pivaloyl-amide moieties adjacent to one binding site (binding site C). H4SIM3 
and H4SIM4 provide two distinctly different binding compartments: a N3O donor set in the softer 
compartment (binding site C and binding site E) versus a rather harder N2O2 binding pocket 
(binding site A and binding site D) (Chart 7). While H4SIM3 and H4SIM4 bear equal primary 
coordination spheres, the secondary coordination spheres differ in regard to the position of the 
two pivaloyl-amide moieties proximal to the metal centers. 
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Chart 7: Ligands discussed in this chapter and the nomenclature of their binding compartments. 
3.2 COMPLEXATION BEHAVIOR OF LIGAND H3SIM1 
 
Although ligand H3SIM1 (Chart 8) provides two coordination pockets with identical primary 
coordination spheres, built up by a bridging phenoxido group, a tertiary amine and two pyridine 
moieties, the two coordination sites differ in their surroundings.  
 
Chart 8: Assignment of the binding sites provided by ligand H3SIM1 and the numbering of its atoms. 
While binding site B (see Chart 8 for the nomenclature) offers an unhindered access to the 
ligating atoms, binding site C is sterically hindered by the demanding pivaloyl-amide substituents 
of the pyridine side-arms. Therefore, the requirement of two inequivalent binding sites as 
present in native phosphatases is given in this ligand.  
3.2.1 COMPLEXATION STUDIES WITH ZNII 
 
The coordination features of ligand H3SIM1 towards ZnII ions were analyzed using NMR 
spectroscopic techniques. Aliquots of an acetonitrile solution of zinc(II) perchlorate (0.518 M) 
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were added stepwise to the ligand dissolved in acetonitrile (33.6 mM). After each addition, the 
mixture was heated for five minutes at 50°C and the 1H NMR spectrum was then monitored to 
follow the changes in the proton environments. 13C NMR spectra were recorded and two-
dimensional NMR experiments (NOESY, COSY, HSQC, and HMBC) were undertaken after addition 
of one and after addition of two equivalents of metal salt. In addition, mass spectra were 
recorded of the samples employed in the NMR experiments.  
NMR Studies 
Stepwise addition of zinc(II) perchlorate to H3SIM1 in deuterated acetonitrile resulted in a slight 
shift of the resonances and the initial rise of a second set of resonances, while the resonances 
assigned to the free ligand decreased (Figure 1). In the spectrum of an 1:1 mixture of zinc(II) 
perchlorate and H3SIM1 the resonances assigned to the ligand disappeared and only a set of nine 
resonances assigned to the monozinc(II) complex remained (Figure 1d). Further addition of ZnII 
ions led to the decrease of the resonances assigned to the monozinc(II) complex and the 
appearance of a set of resonances assigned to the dizinc(II) complex. After the addition of two 
equivalents of ZnII ions to H3SIM1 only the dizinc(II) complex is present in the solution, according 
to the 1H NMR spectrum (Figure 1g).  
 
Figure 1: Comparison of 1H NMR spectra of a) H3SIM1 with b) 0.50 eq, c) 0.75 eq, d) 1.00 eq, e) 1.50 eq , f) 
1.75 eq, g) 2.00 eq, and h) 2.50 eq ZnII(ClO4)2 in CD3CN/D2O. 
There is a possibility that the equilibrium between monozinc(II) complexes, in which the ZnII ion 
is coordinated in either of the two coordination sites, is more rapid than the NMR time scale. 
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Therefore, in order to investigate this possibility the variable temperature 1H NMR spectra of the 
monozinc(II) complex and the dizinc(II) complex were recorded in the temperature range from 
282 K to 245 K. No change in the spectra were detected, suggesting that the ZnII ion is selectively 
bound to one coordination site only. 
In order to investigate the exact position of the ZnII ion within the monozinc(II) complex all 
resonances in the spectra of the monozinc(II) as well as the dizinc(II) complex species were 
assigned to the corresponding H-atoms (Figure 2). Two dimensional NMR methods were 
employed: Firstly, the COSY NMR spectra were used to assign the resonances of the pyridyl 
H-atoms. H1 (d) is the most characteristic H-atom, the resonance of which is shifted downfield 
due to its ortho position to the pyridine N-atom (see Chart 8 for the atom numbering). 
Commencing with the identified resonance of H1 (d), the resonances of H2 (d), H3 (t) and H4 (d) 
were assigned by their cross peaks in the COSY NMR spectrum and their characteristic splitting 
(given in brackets). The remaining resonance in the region between 6.5 ppm and 8.7 ppm of the 
1H NMR spectra, which is split in a triplet, was allocated to H24 (t) due to its position between 
two similar pyridine H-atoms. The two resonances connected by a cross peak to the H24 
resonance and split in doublets are assigned to H23 (d) and H25 (d) (the specific assignments 
were determined by cross peaks in the HMBC NMR spectra between C26 and H25). Similarly, the 
remaining two singlets in the aromatic region of the 1H NMR spectra were assigned to H15 (s) 
and H18 (s) (the specific correlation was assigned by cross peaks to the respective methylene 
C-atom, C13 and C21, in the HMBC spectra). Subsequently, HSQC and HMBC NMR spectra were 
used to assign the 13C NMR resonances. The resonances of the methylene H-atoms were 
allocated by interpretation of the cross peaks in the HMBC NMR spectra. 
The comparison of the interpreted 1H NMR spectra of the free ligand, the monozinc(II) and the 
dizinc(II) species, depicted in Figure 2, revealed that in the case of the monozinc(II) complex, 
particularly the resonances of the pyridine H-atoms in binding site B, underwent shifts compared 
to the analogous resonances in the spectrum of the free ligand, while the resonances 
corresponding to the H-atoms of binding site C were almost unaffected. However, addition of a 
second equivalent of the zinc(II) salt resulted in a shift of the amidated pyridine H-atom 
resonances, while the resonances corresponding to H-atoms in binding site B remained almost 
at the same positions as in the spectrum recorded of the monozinc(II) complex. Moreover, the 
resonance of H6, which was present in form of a singlet in the spectrum of the free ligand, split 
to a doublet of doublets after addition of one equivalent of zinc(II) perchlorate. All other 
methylene resonances remained as singlets. The addition of a second equivalent of zinc(II) 
perchlorate resulted in a splitting of the resonance of H27. It is suggested that the splitting of the 
resonances arises from the constrained flexibility of the methylene groups by coordination, 
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leading to two H-atoms bound to the same C-atom but in different electronic environments. 
Furthermore, the characteristic 13C resonance of the amide carbonyl C-atom experienced only a 
slight shift from 177.9 ppm to 178.8 ppm by the formation of a monozinc(II) complex, but after 
coordination of the second ZnII ion this resonance is found at 184.2 ppm. 
These findings are interpreted as the ZnII ions being bound regioselectively by the amide-free 
coordination site up to the addition of one equivalent of zinc(II) perchlorate, leading to the sole 
formation of a monozinc(II) complex. Only when a higher than equimolar amount of ZnII ions is 
present in solution the dizinc(II) complex of ligand H3SIM1 was generated. It is worth mentioning 
that the same results were obtained when the experiment was conducted in deuterated 
methanol. 
 
Figure 2: Comparison of 1H NMR spectra of a) H3SIM1 in CD3CN, b) with 1 eq, and c) 2 eq ZnII(ClO4)2. 
The distinct coordination of zinc(II) ions to the two unequal binding sites in ligand H3SIM1 is also 
observed in the X-ray structure of [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6, which will be discussed in 
Chapter 4.3 in more detail. In that structure the ZnII ion bound to coordination site C is six 
coordinated, while the ZnII ion in binding site B forms a trigonal bipyramidal coordination 
geometry.  
Mass Spectrometry 
During the NMR titration experiments samples were taken and ESI+ mass spectra recorded. The 
mass spectrum of the equimolar solution of H3SIM1 and zinc(II) perchlorate showed, in addition 
to the peak assigned to free ligand, peaks with the isotopic pattern characteristic for a 
monozinc(II) species (Figure 3a). The main species at m/z 791.3 could be assigned to 
[ZnII(H2SIM1)]+. In the mass spectra conducted with the sample taken after addition of two 
equivalents of zinc(II) perchlorate to H3SIM1 the peaks show the characteristic isotopic pattern 
for dizinc(II) species (Figure 3b). In this case the main peak at m/z 951.3 was assigned to the 
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species [ZnII2(D2SIM1)(CH3OH)2(CH3O)]+. Therefore, the results obtained from mass spectrometry 
support the assumption of a stepwise coordination of ZnII ions by the asymmetric ligand H3SIM1. 
 
Figure 3: Characteristic isotopic pattern found in ESI+ mass spectrometric results (experimental (top) and 
calculated (bottom)) of H3SIM1 with a) 1 eq of ZnII(ClO4)2 ([ZnII(H2SIM1)(H2O)2]+), b) 2 eq of ZnII(ClO4)2 
([ZnII2(H2SIM1)(CH3O)2(CD3O)]+), c) 2 eq of GaIII(NO3)3 ([GaIII(H2SIM1)(H2O)4(OH)]+), d) 1 eq of ZnII(ClO4)2 and 1 eq 
of GaIII(NO3)3 ([GaIIIZnII(SIM1)]2+) e) 1 eq of CuII(OTf)2 ([CuII(H2SIM1)]+) and f) 2 eq of CuII(OTf)2 ([CuII2(HSIM1)]+) in 
methanol. 
3.2.2 COORDINATION STUDIES WITH GAIII 
 
Analogous to the ZnII coordination behavior of ligand H3SIM1, the coordination chemistry of 
H3SIM1 with GaIII ions was investigated employing the NMR titration method, using gallium(III) 
nitrate or gallium(III) perchlorate as metal source. In these experiments the reaction mixtures 
were heated for 45 minutes at 50°C after every second addition, to ensure complete 
complexation.  
NMR Studies 
Figure 4 shows the coordination process monitored by 1H NMR spectroscopy while gallium(III) 
nitrate dissolved in D2O (0.518 M) was added stepwise to H3SIM1 in CD3CN (33.6 mM). Initially, 
the increase of the GaIII ion concentration resulted in the formation of a new species. In the 
equimolar mixture of H3SIM1 with gallium(III) nitrate only one species was present and its 1H NMR 
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spectrum remained unchanged during addition of further gallium(III) salt. These results indicate 
that H3SIM1 forms selectively a monogallium(III) complex.  
 
Figure 4: Comparison of 1H NMR spectra of a) H3SIM1 in CD3CN, with b) 1.00 eq, c) 1.50 eq and d) 2.00 eq 
GaIII(NO3)3 in D2O. 
The assignment of the resonances clarified the exact position of the GaIII ion in the 
monogallium(III) complex. While the resonances associated to binding site C, H18, H23, H25, 
were shifted upfield by about 0.2 ppm, or were not effected as in the case of H24, when one 
equivalent of gallium(III) nitrate is present in solution, the impact on the resonances of binding 
site B is more pronounced. The resonances of H1, H2 and H3 exhibit a downfield shift of up to 
0.4 ppm, and H15 revealed an upfield shift by 0.4 ppm. Furthermore, the carbonyl 13C NMR 
resonance was found at 179.4 ppm, which is similar to the resonance observed in the spectrum 
of the monozinc(II) complex in which the ZnII ion is bound in the amide-free binding site. In the 
case of the methylene resonances, only the resonance of H6 split into two doublets upon 
complexation with GaIII, suggesting the positon of the GaIII ion in binding site B, as depicted in 
Figure 4. 
Mass Spectrometry 
The mass spectrometric measurement of a sample taken from the NMR titration experiment 
after addition of two equivalents of gallium(III) nitrate resulted in a spectrum with the main peak 
found at m/z 885.3. This peak shows the characteristic pattern for a species containing a single 
GaIII ion (Figure 3c) and was assigned to the monogallium(III) complex [GaIII(H2SIM1)(OH)(OH2)4]+.  
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X-ray Diffraction 
During heating a solution of H3SIM1 (40.3 mM) in deuterated methanol with one equivalent of 
gallium(III) perchlorate at 50°C, a white solid precipitated after about 15 minutes. 
Recrystallization of this solid from acetonitrile with diffusion of diethyl ether yielded white 
crystals suitable for X-ray data collection. Figure 5 shows a plot of the molecular structure, and 
Table 2 gives selected structural parameters (Table 2 also includes structural parameters of 
[GaIIIZnII(H2SIM1)(OAc)2(µ-OH)]+ which will be introduced at a later point). The structure consists 
of a [GaIII(H2SIM1)(µ-OH)]+ dimer, in which the two GaIII ions are coordinated in an octahedral 
geometry and bridged by two hydroxido ions (Figure 5a). The remaining coordination sites of the 
GaIII ion in the monomer subunit (Figure 5b) are occupied by two pyridines, the tertiary amine 
and the phenolate donor groups provided by the ligand. Moreover, hydrogen bonding between 
the pivaloyl amide moieties of the metal-free binding site C and perchlorate oxygen atoms 
(3.154 Å and 3.120 Å) is visualized in the plot of Figure 5b. 
Table 2: Selected bond lengths (Å) and angles (°) for [GaIII(H2SIM1)(µ-OH)]+ and [GaIIIZnII(H2SIM1)(OAc)2(µ-OH)]+. 
 [GaIII(H2SIM1)(µ-OH)]+ [GaIIIZnII(H2SIM1)(OAc)2(µ-OH)]+ 
Ga(1)…Zn(1) - 6.1122(9) 
Ga(1)…Ga(2) 3.083 3.0183(12) 
Ga(1)-O(1) 1.911(3) 1.871(4) 
Ga(1)-O(6) 1.894(4) 1.976(4) 
Ga(1)-O(6)` 2.016(3) 1.880(3) 
Ga(1)-N(1) 2.063(4) 2.063(5) 
Ga(1)-N(2) 2.128(4) 2.097(4) 
Ga(1)-N(3) 2.066(4) 2.066(5) 
Zn(1)-N(4) - 2.143(5) 
Zn(1)-N(5) - 2.085(5) 
Zn(1)-N(6) - 2.199(5) 
Zn(1)-O(2A) - 1.969(4) 
Zn(1)-O(2B) - 2.002(4) 
Zn(1)-O(3B) - 2.386(5) 
N(2)-Ga(1)-N(1) 77.92(16) 77.5(2) 
N(2)-Ga(1)-N(3) 80.65(16) 79.82(19) 
N(2)-Ga(1)-O(1) 94.13(15) 94.15(17) 
N(2)-Ga(1)-O(6) 169.14(15) 93.98(17) 
N(2)-Ga(1)-O(6)` 93.33(15) 170.86(17) 
N(5)-Zn(1)-N(4) - 80.6(2) 
N(5)-Zn(1)-N(6) - 77.71(19) 
N(5)-Zn(1)-O(2A) - 114.59(19) 
N(5)-Zn(1)-O(2B) - 148.9(2) 
N(5)-Zn(1)-O(3B) - 90.77(18) 
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Figure 5: Structures of [GaIII(H2SIM1)(µ-OH)]2(ClO4)2: a) full dimer and b) monomeric subunit, also showing 
hydrogen bonding (green dotted lines; counter ions, non-coordinated solvent molecules, and hydrogen atoms, 
not involved in hydrogen bonding, have been omitted for clarity; crystallographic data and ORTEP plots with 
50% probability level of thermal ellipsoids appear in the Appendix, Table 30 and Figure 70). 
In contrast, the ligand HL9 with four unsubstituded pyridine arms crystallized as digallium(III) 
complex of the form [GaIII2(L9)(OH)2(OH2)2](ClO4)3 when treated with gallium(III) nitrate and 
tetraethylammonium perchlorate. Whilst the phenolate moiety of the ligand HL9 bridges the two 
GaIII ions of this dinuclear complex [GaIII2(L9)(OH)2(OH2)2]3+, the phenolate of H3SIM1 is 
coordinated terminally to the GaIII center in [GaIII(H2SIM1)(µ-OH)]+. In agreement with this 
observation is the elongated average GaIII-OPh distance in [GaIII2(L9)(OH)2(OH2)2]3+ (2.043 Å), 
compared to the corresponding value found in [GaIII(H2SIM1)(µ-OH)]+ (1.911 Å), while the 
GaIII-Namine (2.122 Å vs. 2.128 Å) and GaIII-NPy (2.078 Å vs. 2.065 Å) distances are similar in both 
complexes.  
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The X-ray crystal structural analysis confirms the assignment of the NMR spectra (see above), i.e. 
that the GaIII ion is bound to binding site A of ligand H3SIM1 and indicates that the sterically 
demanding pivaloyl-amide residues hinder the coordination of GaIII ions in binding site B of ligand 
H3SIM1.  
3.2.3 FORMATION OF A HETERODINUCLEAR GAIIIZNII COMPLEX 
 
The results obtained from the investigation of the coordination behavior of H3SIM1 with ZnII and 
GaIII ions showed that ZnII is coordinated stepwise, firstly in the less hindered binding site B and 
subsequently, only after complete formation of the monozinc(II) complex, the ZnII coordination 
takes place in binding site C. The presence of GaIII ions in solution also resulted in the formation 
of the monogallium(III) complex containing the GaIII ion in binding site B, but the subsequent 
generation of a digallium(III) complex, could not be achieved. The possibility of the synthesis of 
a heterodinuclear complex, containing GaIII selectively in binding site B and ZnII exclusively in 
binding site C, was tested using NMR spectroscopic and mass spectrometric techniques. 
NMR Studies 
To study the coordination chemistry of H3SIM1 towards a mixture of GaIII and ZnII different 
strategies were followed, including (i) addition of zinc(II) perchlorate to the monogallium(III) 
complex of H3SIM1, (ii) addition of gallium(III) nitrate to the monozinc(II) complex of H3SIM1, and 
(iii) addition of gallium(III) nitrate to the dizinc(II) complex of H3SIM1. The latter experiment was 
performed in order to verify the stronger binding of GaIII in comparison to ZnII by H3SIM1 in 
binding site B. All three experiments resulted in a similar spectrum; the resonances assigned to 
protons in binding site B were broadened and two sets of signals assigned to protons in binding 
site C were present (Figure 6), suggesting a mixture of two different species, which differ 
specifically in the coordination mode of the metal bound in binding site C. It was shown that the 
ratio of the two species is dependent on temperature, time, and donor properties of the solvent 
used. Moreover, after the NMR experiment samples were left to react at room temperature for 
seven days the presence of one main species could be detected. 
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Figure 6: Comparison of 1H NMR spectra of a) [ZnII(H2SIM1)(solv)x] in CD3CN/D2O with b) 1.0 eq GaIII(NO3)3 in 
D2O heated for 15 minutes at 50°C, and c) the mixture after 7 days at room temperature. 
The chemical shifts of the resonances of both species, detected in the samples treated with GaIII 
and ZnII, vary when compared with the resonances found in the monozinc(II) complex, dizinc(II) 
complex, and monogallium(III) complex of H3SIM1, discussed above, and therefore exclude the 
possibility of a mixture of complexes with different metal composition. The amide groups 
adjacent the metal center in binding site C are likely to employ multiple coordination modes 
leading to a mixture of two different species, in which the environment of protons in binding site 
C varied and therefore the chemical shifts are unequal. The impact of the coordination modes of 
the amide groups on the protons in binding site B is limited and therefore only a broadening was 
detected. 
The monozinc(II) complex of H3SIM1 contains the ZnII ion in the less hindered coordination site B 
and GaIII ions were not coordinated by the amide containing binding site C, as explained above. 
Thus, a metal exchange is proposed to proceed during the formation of the heterodinuclear 
GaIIIZnII complex. This suggestion is supported by the finding that the addition of gallium(III) 
nitrate to the dizinc(II) complex of H3SIM1, as well as the addition of zinc(II) perchlorate to the 
monogallium(III) complex of H3SIM1, resulted in the same 1H NMR spectrum as did the addition 
of gallium(III) nitrate to the monozinc(II) complex.  
Mass Spectrometry 
The sole formation of the heterodinuclear complex was also supported by ESI+ mass 
spectrometry, because the main signals exhibit the pattern characteristic for GaZn species and 
the main peak at m/z 430.1 could be assigned to the [GaIIIZnII(SIM1)]2+ complex (Figure 3d).  
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X-ray Diffraction  
The heterodinuclear complex was prepared by heating an equimolar mixture of ligand H3SIM1 
and zinc(II) perchlorate in methanol (40 mM) for 15 minutes and subsequent addition of 
gallium(III) nitrate, sodium acetate and sodium hexafluorophosphate. Diffusion of diethylether 
in the methanolic complex solution (22 mM) gave colorless crystals suitable for data collection. 
Figure 7 shows the structure obtained; Table 2 shows selected distances and valence angles. The 
structure was solved and includes a [GaIIIZnII(H2SIM1)(OAc)2(µ-OH)]+ complex cation, a hexa-
fluorophosphate counterion and a diethylether solvent molecule in the elemental cell. 
Crystallographic data obtained for the structure are displayed in Table 30 (see Appendix). In 
contrast to complexes derived with similar ligands, included the dizinc(II) complex of H3SIM1 
(discussed in detail in Chapter 4.3), the two metal ions are not bridged by the phenolate 
backbone. Moreover, the model system forms dimers, bridged by two hydroxide ions between 
the GaIII ions (Figure 7b) comparable to the monogallium(III) complex of H3SIM1, 
[GaIII(H2SIM1)(µ-OH)]+ (Figure 5). The two GaIII ions and the two hydroxido bridges form an 
asymmetric arrangement with the GaIII-OH distances differing with the values of 1.880(3) Å and 
1.976(4) Å. This arrangement is comparably found in [GaIII(H2SIM1)(µ-OH)]+, but with a higher 
difference between the GaIII-OH distances (1.894(4) Å and 2.016(3) Å); the Ga···Ga separation is 
slightly elongated in [GaIII(H2SIM1)(µ-OH)]+ (3.083 Å) compared to [GaIIIZnII(H2SIM1)(OAc)2(µ-OH)]+ 
(3.0183(12) Å). In addition to the two bridging hydroxido co-ligands, the GaIII ions are coordinated 
by a phenolate, two pyridines, and a tertiary amine group provided by the ligand backbone. While 
the GaIII-NPy distances between the GaIII center and the coordinated pyridine residues in 
[GaIIIZnII(H2SIM1)(OAc)2(µ-OH)]+ are equal to the ones found in [GaIII(H2SIM1)(µ-OH)]+, the 
GaIII-Namine and GaIII-OPh distances between the GaIII ion and the tertiary amine and the phenolate 
moiety, respectively, are slightly shortened by 0.03 Å and 0.04 Å.  
In addition to the GaIII ion coordinated in binding site B a ZnII ion is coordinated in the more 
hindered binding site C of ligand H3SIM1. The donors around the ZnII ions form a distorted 
octahedral coordination geometry with the two coordinating pyridines in the axial positions. The 
square plane of the ZnII ions is occupied by the tertiary amine of the ligand backbone and two 
acetate co-ligands, one in a chelating, the other in a terminal binding mode. The ZnII-O distances 
to the chelating acetate co-ligand differ by 0.38 Å (2.002(4) Å and 2.386(5) Å) and in accordance 
with that finding the coordination mode of the acetate is asymmetric. Comparison of the 
structure of [GaIIIZnII(H2SIM1)(OAc)2(µ-OH)]+ with the structure of [ZnII2(H2SIM1)(OAc)(µ-OH)]+, 
which will be discussed in detail in Chapter 4.3, showed that the coordination arrangements 
differ as in the latter the pyridine residues are part of the trigonal plane while the tertiary amine 
occupies the axial position. The Zn(1)-NPy distances in [GaIIIZnII(H2SIM1)(OAc)2(µ-OH)]+ are 
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elongated (2.143(5) Å and 2.199(5) Å vs. 2.057(3) Å and 2.102(3) Å) and the Zn(1)-Namine distance 
is shortened (2.085(5) Å vs. 2.233(2) Å) compared to the respective distances found in the 
trigonal bipyramidal coordinated ZnII center of the dizinc(II) complex (discussed in detail in 
Chapter 4.3). In the octahedral coordination sphere around the GaIII ion in 
[GaIIIZnII(H2SIM1)(OAc)2(µ-OH)]+ the GaIII-N distances are all shorter than found in 
[ZnII2(H2SIM1)(OAc)(µ-OH)]+, as expected due to the higher charge density of GaIII compared to 
ZnII. 
Based on the short distances between the amide nitrogen atoms and the nearby acetate oxygen 
atoms, a hydrogen bond network is proposed in [GaIIIZnII(H2SIM1)(OAc)2(µ-OH)]+. N(7) forms a 
hydrogen bond to the chelating acetate co-ligand (N(7)-O(2B) 2.871 Å) and N(8), respectively, to 
the terminal acetate co-ligand (N(8)-O(2A) 3.004 Å). Moreover, the terminal acetate co-ligand 
itself stabilizes the hydroxido-bridges between the GaIII ions (O(3A)-O(6) 2.808 Å) by hydrogen 
bonds. The previously observed effect that hydrogen bonding enlarges the angle between the 
pyridine planes and the plane containing the amide group (NCO) was also found in the structure 
of [GaIIIZnII(H2SIM1)(OAc)2(µ-OH)]+.168 This angle was found to be 18.85° in case of the N(7) amide 
residue, while a value of 11.05° was measured in the case of the N(8) amide moiety, supposing a 
preserved C-H∙∙∙O=C interaction between the carbonyl oxygen and the nearby hydrogen atom in 
5-position of the pyridine ring in the latter case. 
Ga1 O1
O6
O6`
N1
N2 N3
N6 N8
Zn1
N5
N4
N7
O2a
O2b
O3a
O3b
O6`
O6
Ga1`
Ga1
a) b)
 
Figure 7: Structures of a) [GaIIIZnII(H2SIM1)(OAc)2(µ-OH)]+ and b) the respective dimer 
[GaIIIZnII(H2SIM1)(OAc)2(µ-OH)]22+ showing hydrogen bonding (green dotted lines; counter ions, non-
coordinated solvent molecules, and hydrogen atoms, not involved in hydrogen bonding, have been omitted for 
clarity; crystallographic data and ORTEP plots with 50% probability level of thermal ellipsoids appear in the 
Appendix, Table 30 and Figure 71). 
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The X-ray crystallographic data highlight the selectivity of the two different binding sites in ligand 
H3SIM1 towards GaIII and ZnII ions. This enables H3SIM1 to form a more accurate PAP model 
complex that takes main structural features of the native enzymes into account, including the 
presence of two different metal ions with different oxidation states, and which are accompanied 
by hydrogen bond donors in close distance. 
3.2.4 COMPLEXATION STUDIES WITH CUII 
 
Due to the diamagnetism of ZnII and GaIII ions their coordination chemistry can be optimally 
monitored by NMR spectroscopy. In contrast, CuII ions have an incomplete d shell configuration 
(Ar)3d9 and are paramagnetic. The d9 system, on the other hand, plays a crucial role in several 
other characterization methods, such as electronic spectroscopy and electron paramagnetic 
resonance (EPR). Consequently, the coordination behavior of H3SIM1 with CuII ions was studied 
using these methods. 
UV-vis-NIR Spectroscopy 
The stepwise addition of copper(II) triflate to H3SIM1 in methanol was followed by UV-vis-NIR 
spectroscopy (Figure 8). Besides the intense absorptions below 300 nm (π-π* transitions of the 
ligand backbone), the spectra show broad transitions at 459 nm and 654 nm with intensity ratios 
of around 3.3:1. Table 3 lists the observed transitions and the corresponding ε values.  
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Figure 8: UV-vis-NIR spectra of a methanolic solution of H3SIM1 treated with 0.6 eq, 1.0 eq, 1.4 eq, 1.8 eq and 
2.0 eq (bottom to top) of copper(II) triflate for 12 hours at rt (solid lines) and with 2.0 eq of copper(II) acetate 
(dotted line). 
Treatment of a methanolic solution of H3SIM1 with two equivalents of copper(II) acetate resulted 
in a similar spectrum with broad transitions at 447 nm and 681 nm with an intensity ratio of 5.0:1. 
The spectral data are similar to that reported for the complex [CuII2(L1)(OAc)2]+, bearing a similar 
ligand backbone as H3SIM1, but lacking the two pivaloyl-amide residues.169  
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Table 3: UV-vis-NIR spectroscopic properties of the CuII complexes of H3SIM1. 
mixture 
molar ratio 
wavelength 
[nm] 
ε 
[l mol-1 cm-1] 
transition 
H3SIM1 : Cu(OTf)2 459 393 d-d 
1 : 1 654 114 LMCT 
H3SIM1 : Cu(OTf)2 459 1016 d-d 
1 : 2 654 314 LMCT 
H3SIM1 : Cu(OAc)2 447 1068 d-d 
1 : 2 681 215 LMCT 
 
Furthermore, the presence of the d-d bands in the region between 400 nm and 500 nm is typical 
for axial CuII sites. The fact that the d-d bands of the two CuII centers are not resolved suggests a 
rather similar coordination environment, as expected because of the identical primary 
coordination spheres of the CuII centers. The continuous increase in intensity of both bands 
throughout the addition of copper(II) triflate to the methanolic ligand solution is in agreement 
with both a single mononuclear site and mono- and dinuclear sites of similar coordination 
geometry. However, the relatively featureless spectra do not allow unambiguous support for a 
detailed interpretation.  
EPR Spectroscopy  
EPR measurements allow the difference between the magnetic energy levels to be determined. 
Magnetic energy levels are degenerate in absence of a magnetic field, but when a magnetic field 
is applied the energy levels split up, known as the Zeeman phenomenon (Figure 9). Magnetic 
energy levels are described by the magnetic quantum number ms and two ms states with an 
energy difference of hν = gβeB are generated by a magnetic field B in the case of a S = ½ system 
(h: Boltzmann constant, ν: frequency, g: magnetic tensor, βe: Bohr magneton). The symmetry of 
the magnetic tensor g, which reflects the symmetry of the coordination environment around the 
CuII ions, encompass the detection of one, two or three signals in the spectrum and therefore is 
used to investigate the coordination geometry of copper(II) complexes. 
   
Figure 9: The Zeeman effect in the EPR experiment for a) spin S = ½ and b) spin S = 1.  
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In order to investigate the coordination chemistry of H3SIM1 with CuII ions, X-band EPR spectra 
of frozen methanolic solutions of H3SIM1 with copper(II) triflate were recorded. Figure 10 
illustrates the spectra obtained and compares them to the spectrum of copper(II) triflate in 
methanol and Table 4 summarizes the parameters derived from simulating the experimental EPR 
spectra. Here, χ, σ and τ present the Euler angles which describe the orientation of the 
coordination polyhedron of the CuII centers and are illustrated in Figure 13. 
 
Figure 10: Experimental EPR spectra (black, ν = 9.4 GHz, T = 140 K) and computer simulated spectra (red) of a) 
CuII(OTf)2 in methanol, b) H3SIM1 and CuII(OTf)2 (1:0.8), c) H3SIM1 and CuII(OTf)2 (1:2.0), and d) Δms = ±2 
transition.  
The first and second derivative spectra (Figure 10b and 11) of a mixture of H3SIM1 and copper(II) 
trifluoromethanesulfonate in the ratio of 1:0.8 and 1:0.95 in methanol show a single species. 
Numerical differentiation and Fourier filtering (Hamming function) were undertaken to increase 
the spectral resolution. Importantly, the cutoff of the Hamming function was adjusted so that 
the high frequency noise was mininimized without distorting the spectrum. The second 
derivative spectrum (Figure 11) reveals 14N superhyperfine splitting on the parallel CuII hyperfine 
resonances. Computer simulation of the second derivative spectrum with a rhombic spin 
Hamiltonian yields the spectrum shown in Figure 11, which is in excellent agreement with that 
of the experimental spectrum. The anisotropic spectrum of the mononuclear complex is typical 
for a single axially distorted CuII site with a dx2-y2 ground state, leading to spin allowed Δms = ±1 
transitions above g = 2. Importantly, the simulation assumed two equivalent nitrogen nuclei, 
indicating that the equatorial plane contains two nitrogen nuclei. It appears that CuII selectively 
occupies a single site and, by analogy to the observations with ZnII (and GaIII), this is probably site 
A, though site B cannot be ruled out. 
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Figure 11: Second derivative of experimental EPR spectrum (black, ν = 9.4 GHz, T = 140 K) and computer 
simulated spectrum (red) of H3SIM1 and CuII(OTf)2 (1:0.95) in methanol. (63Cu hyperfine interaction Ax,y,z (14N) = 
12.0·10-4, 12.0·10-4, 12.0·10-4 cm-1 (two magnetically equivalent nitrogen nuclei). Linewidth (g- and A-strain 
linewidth model), Rx,y,z = 10.0·10-4, 10.0·10-4, 5.0·10-4 cm-1; (g/g)x,y,z = 1·10-4, 1·10-4, -1·10-5; Ax,y,z = 0.1·10-4, 
0.1·10-4, 4.7·10-4 cm-1. The 63Cu and 14N perpendicular hyperfine resonances are not resolved in the spectra and 
thus the linewidth in the simulated spectrum results from a combination of Ax,y (63Cu, 14N) and corresponding 
linewidth parameters). 
With increasing CuII concentration (CuII:H3SIM1 ratio of 2:1), a new spectrum develops with 
features typical for dinuclear CuII systems with two non-identical CuII centers (Figure 10c). Besides 
the resonances centered around g = 2, arising from allowed Δms = ±1 transitions, weak 
resonances are also observed around geff = 4.3, arising from the formally forbidden Δms = ±2 
transitions (Figure 10d). Interestingly, the EPR spectrum obtained from a mixture of H3SIM1 with 
CuII acetate (1:2) shows the same general features but with more intense Δms = ±2 resonances 
(Figure 12). However, the observed spectrum in the spin-allowed region is quite different, with 
resonances around 320 mT, attributable to solvated CuII ions (depicted in grey in Figure 12) and 
broad resonances around 260 mT and 360 mT, associated with the Δms = ±1 transitions of a 
dinuclear complex. The latter spectrum is characteristic for a dinuclear CuII complex, in which the 
two CuII ions are dipole-dipole coupled. The strong exchange interaction in the former spectrum 
could derive from bridging through the phenolate ligand backbone, in a structure supported by 
a bridging acetate co-ligand.  
The features of the strongly interacting dinuclear CuII system, the Δms = ±2 transition and the two 
broad bands at 260 mT and 360 mT, are also visible in the spectrum obtained with the 1:2 mixture 
of H3SIM1 with copper(II) trifluoromethanosulfonate (Figure 10c), suggesting that a small amount 
of the dicopper(II) complex in solution has a similar structure (species (2) in the structures shown 
in Figure 10). Computer simulation of the spectra are based on two CuII centers, coordinated to 
the ligand with a CuII···CuII distance of 3.415 Å (Figure 10d; the relative orientations of the two 
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CuII centers are given in Table 4, which also lists the g- and A-matrices used in the simulations of 
the various spectra). Importantly, this solution structural analysis is in good agreement with the 
crystal structural analysis discussed below. 
  
Figure 12: Experimental EPR spectra of a mixture of H3SIM1 with CuII(OAc)2 (1:2) (black, ν = 9.4 GHz, T = 140 K), 
computer simulated spectra (red), and experimental EPR spectrum of free CuII(OAc)2 (grey) in methanol. 
From the EPR simulation of the intense signal in the spectrum in Figure 10d, it emerges that it 
originates from a dinuclear CuII species with a Cu···Cu distance of 7.2 Å and is proposed to arise 
from a complex in which the two CuII centers are not bridged by the phenolate ligand backbone 
(species (1) in the structures given in Figure 8). Here, the two pyridine donors in each 
coordination site are on opposite side of the phenolate linker. 
Table 4: EPR data for copper(II) complexes of H3SIM1.  
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  Cu(1) Cu(2) Cu(1) Cu(2) Cu(1) Cu(2) 
gx 2.044 2.054 2.055 2.054 2.054 2.054 2.060 
gy 2.062 2.055 2.065 2.055 2.055 2.090 2.090 
gz 2.262 2.242 2.270 2.245 2.245 2.245 2.245 
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Figure 13: Definition of the Euler angles χ, τ and ρ used for EPR simulation using the program Xsophe.170  
Mass Spectrometry  
The ESI+ mass spectrometric measurements of a mixture of H3SIM1 and copper(II) triflate in a 1:2 
ratio in methanol resulted in a spectrum with the main peaks at m/z 1003.2 and m/z 427.1, which 
match the mass of the species [CuII2(HSIM1)(F3CSO3)]+ and [CuII2(HSIM1)]2+ and revealed isotopic 
pattern typical for species containing two Cu atoms (Figure 3f). These signals were not detected 
in the spectrum recorded with the mixture in a ratio of 1:0.8. In contrast, this mixture revealed 
signals of the metal-free ligand and signals with isotopic pattern characteristic for a mononuclear 
CuII complex (Figure 3e), i.e. a signal at m/z 790.3 which was assigned to [CuII(H2SIM1)]+. The 
spectrum recorded with the mixture of H3SIM1 and two equivalents of copper(II) acetate shows 
signals with the isotopic pattern typical for dinuclear CuII complexes. The main signals at 
m/z 471.2 and m/z 911.2 were assigned to [CuII2(H2SIM1)(OAc)(CH3OH)]2+ and 
[CuII2(HSIM1)(OAc)]+. 
X-ray Diffraction 
Treatment of a methanolic solution of H3SIM1 (27 mM) with CuII acetate (2.0 eq), heating for 
15 minutes at 50°C, followed by addition of sodium hexafluorophosphate (1.5 eq), filtration and 
diffusion of diethylether, resulted in brown crystals, suitable for X-ray data collection. Figure 14 
shows a plot of the molecular structure and Table 5 gives selected structural parameters.  
The molecular structure consists of a [CuII2(HSIM1)(µ-OAc)]+ complex cation and a hexafluoro-
phosphate counter anion. The two CuII centers have different coordination geometries and are 
doubly bridged by the phenolate of the ligand backbone and an acetate co-ligand. Cu(1) is also 
coordinated to two pyridine moieties and a tertiary amine donor, resulting in a distorted square-
pyramidal geometry (τ = 0.46),171 while Cu(2) exhibits a distorted octahedral geometry, emerging 
from the two bridging ligands, two pyridine residues, a tertiary amine nitrogen, and an oxygen 
atom of one of the proximal amide groups. The coordination of the pivaloyl-amide moiety is 
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stabilized by a hydrogen bond formed with the second pivaloyl-amide group visible by the short 
N(7)-O(5) distance with a value of 3.461 Å, illustrated as green dotted lines in Figure 14.  
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Figure 14: Structure of [CuII2(HSIM1)(µ-OAc)]+, also showing intramolecular hydrogen bonding (green dotted 
lines; counter ions and hydrogen atoms, not involved in hydrogen bonding, have been omitted for clarity; 
crystallographic data and ORTEP plots with 50% probability level of thermal ellipsoids appear in the Appendix, 
Table 30 and Figure 72). 
Table 5: Selected bond lengths (Å) and angles (°) for [CuII2(HSIM1)(µ-OAc)]PF6 
 
[CuII2(HSIM1)(µ-OAc)]+ 
Cu(1)…Cu(2) 3.577 
Cu(1)-O(1) 1.9061(16) 
Cu(1)-O(2) 1.9525(16) 
Cu(1)-N(1) 2.1981(19) 
Cu(1)-N(2) 2.0710(18) 
Cu(1)-N(3) 2.0075(18) 
Cu(2)-O(1) 2.2567(15) 
Cu(2)-O(3) 1.9378(16) 
Cu(2)-O(5) 1.9316(17) 
Cu(2)-N(4) 2.581(2) 
Cu(2)-N(5) 2.0665(18) 
Cu(2)-N(6) 1.9354(17) 
Cu(1)-O(1)-Cu(2) 118.24(7) 
O(1)-Cu(1)-N(1) 95.56(7) 
O(1)-Cu(1)-N(2) 93.05(6) 
O(1)-Cu(1)-N(3) 161.08(6) 
O(1)-Cu(1)-O(2) 95.09(6) 
O(1)-Cu(2)-N(4) 161.42 
O(1)-Cu(2)-N(5) 90.42(7) 
O(1)-Cu(2)-N(6) 91.13(7) 
O(1)-Cu(2)-O(3) 91.21(6) 
O(1)-Cu(2)-O(5) 101.64(7) 
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The structure of [CuII2(HSIM1)(µ-OAc)]+ contrasts with the previously published structure of the 
dicopper(II) complex of the symmetric ligand HL1, [CuII2(L1)(OAc)2]ClO4, which bears two square 
pyramidal coordinated CuII centers.169 Consequently, the asymmetrically substituted ligand 
H3SIM1 provides two different coordination sites for the CuII ions. This asymmetry is additionally 
visible in the bond length between the CuII centers and the phenolate oxygen atom; while this 
value measures 2.173 Å for both CuII centers in [CuII2(L1)(OAc)2]+,169 in [CuII2(HSIM1)(µ-OAc)]+ this 
value is shortened in the case of the square pyramidal Cu(1) (1.9061(16) Å) and elongated in the 
case of the octahedral Cu(2) (2.2567(15) Å). Interestingly, the Cu···Cu separation in 
[CuII2(HSIM1)(µ-OAc)]+ (3.577 Å) is much shorter than in [CuII2(L1)(OAc)2]+ (3.916 Å),169 probably 
due to the bridging acetate co-ligand, as [CuII2(L1)(OAc)2]+ comprises two terminally coordinated 
acetate co-ligands.  
Magnetic Susceptibility Measurement 
The molar magnetic susceptibtibility (χM) describes the degree of the magnetization of a material 
and characterizes the way in which an applied magnetic field H interacts with the angular 
momenta associated with the thermally populated states of a molecule.172, 173 When a sample is 
perturbed by an external magnetic field H, its magnetization is related to its energy variation by 
Equation 1 which defines the microscopic magnetizations µn for each energy level En (n = 1, 2, …).  
Equation 1 µn = −
δEn
δH
 
The macroscopic molar magnetization M is then obtained by summing the microscopic 
magnetizations weighted according to the Boltzmann distribution (Equation 2). The molar 
magnetic susceptibility is deduced from the molar magnetization by Equation 3.  
Equation 2 M =
N ∑ (−
δEn
δH
)e
−
En
kTn
∑ e
−
En
kTn
 
Equation 3 χ =
δM
δH
 
The function of a magnetometer is to measure the induced or remnant magnetic moment in a 
sample, usually as a function of applied field and temperature.174 A graph of χMT vs. temperature 
(T) is commonly used for the analysis of the magnetic behavior of a substance, whereby a 
constant χMT value is characteristic for a paramagnetic species. Antiferromagnetism leads to the 
deviation of χMT to lower values by decreasing T (J < 0), while the deviation to higher χMT values 
by decreasing T reveals ferromagnetism (J > 0). The effective magnetic moment may be 
calculated from the susceptibility measurements with Equation 4. 
Equation 4 µeff = 2.828√χMT 
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The experimentally obtained value for µeff can be compared with the expected spin-only value 
for a dinuclear system calculated with Equation 5 (for two strongly interacting spins with the 
resulting total spin quantum number Stot) or Equation 6 (for two non-interacting spins S1 and S2). 
Equation 6 simplifies for two non-interacting spins of the same value (S1 = S2 = S) resulting in 
Equation 7. 
Equation 5 µeff = 2√Stot(Stot + 1)  
Equation 6 µeff = 2√S1(S1 + 1) + S2(S2 + 1) 
Equation 7 µeff = 2√S(S + 1) ∗ √2 
In order to understand the magnetic property variable temperature dc magnetic susceptibility 
studies in solid state were performed with ground crystals of complex [CuII2(H2SIM1)(µ-OAc)2]PF6 
in the temperature range from 2 to 300 K. The data for χMT vs. T are shown in Figure 15. The 
strong peak between 50 K and 100 K was attributed to oxygen present in the instrument. 
 
Figure 15: Temperature dependence of χMT for [CuII2(HSIM1)(µ-OAc)]PF6 recorded in a magnetic field of 1000 Oe 
and the respective fit curve (orange line). 
The χMT vs. T plot shows the typical process of a ferromagnetically coupled system. The value of 
χMT increases from a value of 0.8818 cm3mol-1K at 2.25 K to 0.9331 cm3mol-1K at 4.75 K, and then 
decreases at higher temperatures. The χMT value tends to 1 cm3mol-1K at low temperature which 
is the expected value for two interacting S1,2 = ½ metal centers (Stot = 1). The value of 
0.7406 cm3mol-1K at 300 K is close to the expected value for two non-coupled electrons 
(0.75 cm3mol-1K).  
The data were fitted by the following spin Hamiltonian (Equation 8), where J is the isotropic 
exchange coupling constant, Si denotes the spin states (S = ½), and Di and Ei are the axial and 
rhombic zero-field splitting parameters. 
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  Equation 8  
H = −2JS1S2 + ∑ [Di (Szi
2 −
1
3
Si(Si + 1)) + Ei(Sxi
2 − Syi
2) + βSigiH]
2
i=1
 
This model reproduced reasonably well the experimental data when the data points between 
50 K and 100 K were excluded. The final parameter set of the best fit were found to be J = 5.0 cm-1, 
g1 = g2 = 2.0, and the D- and E-values to be 0, considering 5% of a paramagnetic impurity derived 
from the monocopper(II) complex. 
The majority of dicopper(II) compounds have an antiferromagnetically coupled ground state with 
S = 0.173 Therefore, [CuII2(HSIM1)(µ-OAc)]PF6 is a rare example for a dicopper(II) system with weak 
ferromagnetic coupling and an S = 1 ground state. This observation contrasts to previously 
published phenolate-bridged dicopper(II) complexes, which usually show antiferromagnetic 
coupling, i.e. the symmetric complex [CuII2(L1)(OAc)2]ClO4 (J = -0.6 cm-1; ∢(Cu-O-Cu) = 128.65°)169 
and the asymmetric complexes [CuII2(L13)Cl3] (J = -168 cm-1; ∢(Cu-O-Cu) = 111.52°),175 
[CuII2(H4L14)(µ-OH)](ClO4)2 (J = -238.1 cm-1; ∢(Cu-O-Cu) = 95.3°),176 and 
[CuII2(H2L15)(µ-OH)(ClO4)]ClO4 (J = -100.5 cm-1; ∢(Cu-O-Cu) = 91.9°).176 It must be pointed out here 
that the determination of J from the magnetic data is much more accurate for J < 0 than for 
J > 0.173 A comparison of key structural parameters and exchange integrals for 
bis(µ-phenoxido)dicopper(II) complexes reveals the dependence of J on (i) the Cu-OPh-Cu angle, 
(ii) the Cu···Cu distance, (iii) the pyramidal geometry around the phenolate oxygen atom, and (iv) 
the deviation of the copper(II) coordination geometry from square pyramidal.177 Similarly, the 
structural requirements for a strongly coupled hydroxido-bridged dicopper(II) system was 
investigated by Ruiz et al. theoretically, and it was found that (i) small Cu-O-Cu angles, (ii) short 
Cu-O distances, (iii) large out of plane shifts of the hydrogen atoms on the bridge, and (iv) hinge-
distorted Cu2O2 rings lead to strong exchange coupling.178 The major factor controlling the 
exchange coupling is the bridging Cu-O-Cu angle, and a linear variation of 2J with this parameter 
was observed for hydroxido-bridged and alkoxido-bridged dicopper(II) complexes.178, 179 For 
hydroxido-bridged dicopper(II) complexes the crossover point, below which the magnetic 
behavior changes from antiferromagnetic to ferromagnetic coupling, is characterized by a 
Cu-O(H)-Cu angle of 97.5°.177 In the case of bis(µ-phenoxido)dicopper(II) complexes only five 
compounds revealing weak ferromagnetic coupling were observed, in which the Cu-OPh-Cu angle 
lies in the range of 85.9 – 96.1°.177 The Cu(1)-O(1)-Cu(2) angle of [CuII2(HSIM1)(µ-OAc)]PF6 is 
comparably large with a value of 118.24(7) Å when compared to other ferromagnetically coupled 
diphenoxido-bridged complexes, and in the medium range of antiferromagnetically coupled 
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phenoxido-bridged dicopper(II) complexes [CuII2(L1)(OAc)2]ClO4,169 [CuII2(L13)Cl3],175 
[CuII2(H4L14)(µ-OH)](ClO4)2,176 and [CuII2(H2L15)(µ-OH)(ClO4)]ClO4.176  
Interestingly, Chaudhuri et al. developed two bis(µ-phenoxido)dicopper(II) complexes, which 
contain the same ONO donor atoms but reveal opposite exchange interactions, [CuII2(L16)2] the 
usual antiferromagnetic exchange coupling and [CuII2(L17)2] ferromagnetic exchange coupling 
(Chart 9).177 Several structural parameters were discussed to contribute to this contrasting 
magnetic behavior, the smaller Cu-O-Cu angle of [CuII2(L17)2] (86.34° and 85.92° vs. 97.0° and 
99.4° in [CuII2(L16)2]), the shorter Cu···Cu separation of [CuII2(L17)2] (2.697 Å vs. 2.967 Å in 
[CuII2(L16)2]), and the more severe deviation from square planarity of the CuII centers in 
[CuII2(L17)2]. However, the parallel spin coupling of [CuII2(L17)2] was mainly ascribed to the folded 
Cu2(L17)2 structure, in which the two copper(II) planes make an angle of 75.4°.  
 
Chart 9: Bis(phenolate)-bridged dicopper(II) complexes with antiferromagnetic interaction ([CuII2(L16)2]) and 
ferromagnetic interaction ([CuII2(L17)2]).177  
Similarly, in [CuII2(HSIM1)(µ-OAc)]PF6 the Cu(1)-O(1)-O(2)-N2-N4 plane forms an angle of 42.09° 
with the Cu(2)-O(1)-O(3)-N(4)-N(6) plane, which is rather small compared to the 
antiferromangetically coupled complex [CuII2(L1)(OAc)2]ClO4 with an angle of 57.65°. Thus, the 
stronger folding in [CuII2(L1)(OAc)2]ClO4 lowers the magnitude of the antiferromagnetic 
interaction, which dominates exchange coupling between two CuII centers due to loss of orbital 
overlap. Similar diminution of antiferromagnetic coupling due to a folded Cu2O2 and a Cr2O2 core 
has been observed previously.177, 180 Moreover, the distortion of the OPh-CPh bond with respect 
to the Cu-OPh-Cu plane is also known to affect the magnetic behavior.181 In fact, the O(1)-CPh bond 
in [CuII2(HSIM1)(µ-OAc)]PF6 is placed out of the Cu-O(1)-Cu plane which is not the case in 
[CuII2(L1)(OAc)2]ClO4.169 Therefore, it is apparent that the major magnetic exchange interaction 
pathway between the two CuII centers is the oxygen atom of the bridging phenolate ligand. 
However, Horn et al. detected an impact of bridging acetate co-ligands on the coupling of a 
diiron(III) complex suggesting it to be a secondary pathway for the mediation of interaction.102 
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3.2.5 COMPLEXATION STUDIES WITH FEIII 
 
In addition to the investigations with GaIII, used to mimic the FeIII center in native PAPs, the 
coordination behavior of H3SIM1 towards FeIII was examined. Similar to CuII, FeIII is paramagnetic 
with a (Ar)3d5 configuration. Therefore, the coordination chemistry towards FeIII was studied by 
electronic and NMR spectroscopic techniques, suitable for paramagnetic substances.  
UV-vis-NIR Titration 
Recording a UV-vis-NIR spectroscopic time scan with mixtures of H3SIM1 and iron(III) perchlorate 
in methanol both with and without base for about ten hours, the change in the number and 
intensity of absorption bands was monitored during the first 1.5 hours; afterwards no change in 
the spectra was detected. Therefore, all samples were allowed to react at room temperature for 
14 hours before the UV-vis-NIR spectroscopic analysis was undertaken in order to assure that the 
reactions were completed. The spectrum of a mixture of H3SIM1 and iron(III) perchlorate in a 
ratio of 1:1 showed two bands at 348 nm and 552 nm. The relatively broad band at 552 nm 
(ε = 1238 M-1cm-1) originates from the charge transfer (CT) transition from filled pπ orbitals of the 
phenolate oxygen to the empty dπ* orbitals of the FeIII metal center. All phenoxido-FeIII complexes 
display this characteristic phenolate-to-iron(III) CT transition,81 for example the complex 
[FeIIIMn(L1)(µ-OAc)2]+ in acetone at 596 nm (ε = 980 M-1cm-1)182 and the complex 
[FeIII2(L18)2(µ-O)(µ-OBz)]+ in acetonitrile at 522 nm (ε = 2700 M-1cm-1)183. The additional band at 
348 nm (ε = 3838 M-1cm-1) arises from pπ-dσ* type transitions. 
Comparison of the UV-vis-NIR spectra, recorded with methanolic solutions of H3SIM1 and iron(III) 
perchlorate up to a ratio of 1:2 (Figure 16a), illustrates the coordination of one equivalent FeIII 
ions by ligand H3SIM1 resulting in a green solution. Complexation of a second FeIII ion is unlikely 
due to the detection of a plateau of the absorbance at 552 nm vs. FeIII content plot (insert in 
Figure 16a) for mixtures with excess FeIII. The increase of the absorbance at 348 nm at FeIII 
contents higher than one equivalent with respect to the ligand possibly arises from non-
coordinated free FeIII in solution and the resulting hexaaqua complex.  
Addition of one equivalent of triethylamine as a base led to a shift of the CT band from 552 nm 
to 488 nm (ε = 1718 M-1cm-1), directly visible in the change of the solution color to blue and 
possibly due to deprotonation of the phenol moiety. A further increase of the base concentration 
did not result in additional changes. The pπ-dσ* band at 342 nm (ε = 5132 M-1cm-1) experienced 
almost no change during the addition of base. Similarly to the experiments undertaken without 
addition of base, the absorbance vs. equivalence of FeIII plot for the mixtures of H3SIM1, treated 
with one equivalent of triethylamine and iron(III) perchlorate, shows the increase in intensity of 
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the bands at 342 nm and 488 nm up to a 1:1.25 mixture (Figure 16b). At higher FeIII 
concentrations the curve (inset) shows a plateau, suggesting that H3SIM1 is able to bind only one 
FeIII ion, independently of the presence of base. 
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Figure 16: UV-vis-NIR spectroscopic titration of H3SIM1 (0.4 mM) with FeIII(ClO4)3 in methanol a) without NEt3 
and b) with 1 eq of NEt3. 
These results are in contrast to the observation gained during a similar UV-vis-NIR spectroscopic 
titration of ligand H3L2 with [FeCl4](NEt4) in methanol, because a progressive shift of the CT 
transitions from 533 nm to 629 nm was monitored by addition up to one equivalent of FeIII and 
a constant increase in intensity of the band with further addition of FeIII. These findings were 
explained by the simultaneous formation of mono- and dinuclear iron(III) complexes at low FeIII 
content in solution and the shift of the equilibrium in favor of the diiron(III) complex with raising 
FeIII concentrations.109 Considering these observations, the positioning of two bulky pivaloyl-
amide residues proximal to one binding site seems to hinder the coordination of FeIII in 
coordination site C, which was still possible when only one pivaloyl-amide moiety was adjacent 
to the coordination sites as in H3L2.  
NMR Studies  
A mixture of H3SIM1 with 0.5 equivalents of iron(II) tetrafluoroborate in deuterated acetonitrile 
was treated with 4Å molecular sieves and left to react under air for 12 hours. The recorded 1H 
NMR spectrum (-60 ppm to 260 ppm) of the blue solution shows broad resonances in the 
aromatic region associated with the uncomplexed ligand. However, resonances with chemical 
shifts higher than 10 ppm were not detected in contrast to the spectrum of 
[FeII2(H2SIM1)(µ-OAc)2]+, which will be discussed in Chapter 5.3, supporting the proposal of the 
full oxidation of FeII to FeIII during the reaction under aerobic conditions. Unfortunately, 
differences in the integrals assigned to protons of binding site B and binding site C could not be 
detected due to broadening of the signals.  
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The measurement of the magnetic susceptibility of the mixture by the Evans method resulted in 
a value of µeff = 4.79 B.M. Based on a comparison with the calculated spin-only values for a low-
spin FeIII complex (S = 1⁄2) of 1.73 B.M. and for a high-spin FeIII complex (S = 5⁄2) of 5.92 B.M., 
H3SIM1 is proposed to form a mononuclear high-spin FeIII complex.  
It is apparent from the results of the NMR and UV-vis-NIR spectroscopic examinations of mixtures 
with H3SIM1 and iron salts that H3SIM1 is capable of coordinating one FeIII ion, generating a high-
spin FeIII complex. The coordination of the FeIII ion most likely takes place in the more accessible 
binding site B. This proposal is made on the basis of the observations from the 1H NMR titration 
with GaIII, used as FeIII mimic, and a crystal structure obtained with ligand H4SIM3, which bears 
also binding site B, and iron(III) perchlorate. In this way, the second coordination site C of H3SIM1 
stays vacant for other, preferably divalent, metal ions to form heterodinuclear complexes and 
thereby form a more accurate model for PAPs.  
3.3 COMPLEXATION BEHAVIOR OF LIGAND H4SIM3 
 
In addition to the asymmetry in the second coordination sphere H4SIM3 provides also asymmetry 
in the donor sets, in contrast to H3SIM1. The two compartments in H4SIM3 are built up by different 
donors, forming a N3O coordination site (binding site C, Chart 10) and a harder N2O2 coordination 
site, containing a terminal phenolate moiety (binding site A, Chart 10).  
 
Chart 10: Assignment of the binding sites provided by ligand H4SIM3 and the numbering of its atoms. 
However, the positions of the two pivaloyl-amide residues, mimicking the hydrogen bond donors 
in the active site of PAP, are comparable to H3SIM1. Therefore, the comparison of the 
coordination behavior of H3SIM1 and H4SIM3 provides the opportunity to investigate the impact 
of the exchange of one pyridine by a phenolate residue at preserved positions of the hydrogen 
bond donors.   
COORDINATION BEHAVIOR OF ASYMMETRIC LIGANDS 
56 
3.3.1 COMPLEXATION STUDIES WITH ZNII 
 
Similar to the investigation of the ZnII complexation behavior of H3SIM1, the coordination 
chemistry of H4SIM3 with ZnII ions was studied applying the above introduced NMR titration 
technique (Chapter 3.2.1).  
NMR Studies 
Comparable to the analogous experiments undertaken with H3SIM1, the generation of a 
monozinc(II) complex could be followed during addition of zinc(II) perchlorate by 1H NMR 
spectra, measured after each addition step of 0.25 eq to H4SIM3, dissolved in acetonitrile. 
However, after addition of one equivalent, further increase of the ZnII concentration did not 
result in a second set of resonances, suggesting that the generation of a dizinc(II) complex of 
H4SIM3 does not occur. In the monozinc(II) complex spectrum the resonances assigned to binding 
site C are shifted compared to those in the spectrum of the free ligand. This observation was 
duplicated during the complexation of ZnII in binding site C of ligand H3SIM1, suggesting the ZnII 
ion to be bound by the two amidated pyridine residues in binding site C of H4SIM3 (see Figures 2 
and Figure 17).  
 
Figure 17: Comparison of the aromatic regions in the 1H NMR of a) H4SIM3 in CD3OD with b) H4SIM3 with 1.0 eq 
ZnII(ClO4)2 in CD3OD, c) H4SIM3 with 1.0 eq ZnII(ClO4)2 in CD3CN/D2O, and d) H4SIM3 in CD3CN. 
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Moreover, the methylene resonance assigned to H27 was split into two doublets upon addition 
of zinc(II) perchlorate, confirming the coordination of ZnII to binding site C. A similar behavior was 
found when the experiment was performed in methanol. However, the chemical shifts of the 
resonances assigned to the pyridine residue in binding site A differ in the two different solvents 
used (Figure 17).  
When the experiment was undertaken in methanol the resonance of H1 was only slightly affected 
(shifting by 0.05 ppm), but when acetonitrile was used as solvent and zinc(II) perchlorate was 
dissolved in deuterium oxide, this resonance was shifted by 0.3 ppm upon formation of a 
monozinc(II) complex (which is not completely an effect of the change in polarity of the solvent 
as (i) further addition of zinc(II) perchlorate in deuterium oxide did not influence the chemical 
shift of this resonance, and (ii) the H1 resonance assigned to the monozinc(II) complex was also 
detected at the same position after addition of only 0.5 eq of zinc(II) perchlorate and therefore 
less deuterium oxide). For the resonance assigned to H3 the opposite behavior was observed; a 
larger shift in acetonitrile/deuterium oxide than in methanol. The resonances allocated to the 
terminal phenol residue in binding site A did not change to this extent in both solvents used. 
Based on these findings the proposal of two differing complexes in the different solvents used 
with variation orientation of the pyridine residue in binding site A was made. Possibly, the 
orientation of the pyridine nitrogen atom in the direction of the ZnII center in 
acetonitrile/deuterium oxide are assisted by hydrogen bonding via deuterium oxide solvent 
molecules.  
Interestingly, addition of a methanolic solution of zinc(II) acetate to ligand H4SIM3 in methanol 
led directly to a dizinc(II) complex. This was proposed due to the fact that the concentration of 
the new formed species only increased by half of the factor the concentration of ZnII was raised. 
The addition of 0.25 eq of ZnII resulted in an ~ 0.125:0.875 mixture of new species and remaining 
free ligand. Although the resonances broadened during addition of two equivalents of ZnII, it is 
recognizable that the resonances of the terminal phenolate are shifted by the coordination of 
ZnII (Figure 18). The ability of ligand H4SIM3 to form a dizinc(II) complex by reaction with zinc(II) 
acetate is additionally supported by the obtained crystal structure, which will be discussed in 
Chapter 4.3.  
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Figure 18: Comparison of the aromatic regions in the 1H NMR of H4SIM3 in CD3OD with a) 2.0 eq ZnII(ClO4)2 and 
b) 2.0 eq ZnII(OAc)2. 
Mass Spectrometry 
In order to further investigate the composition of the species formed during the addition of 
zinc(II) salts to H4SIM3 containing solution samples were taken during the NMR titration at several 
addition steps and ESI+ mass spectra were recorded. The main peaks detected in the spectra of 
mixtures up to a 1:1 ratio of H4SIM3 and zinc(II) perchlorate were found at m/z 744.4, which 
match the mass of metal-free ligand H4SIM3, and at m/z 806.2 assigned to the [ZnII(H3SIM3)]+ 
complex. Further addition of zinc(II) perchlorate led to an additional signal at m/z 868.1 assigned 
to the dizinc(II) complex [ZnII2(HSIM3)]+, as well as to the signals at m/z 403.7 ([ZnII(H3SIM3)]2+) 
and m/z 434.7 ([ZnII2(HSIM3)]2+). For the latter two signals the mass to charge ratio between the 
peaks in the isotopic pattern was decreased two fold, in accord with the formation of doubly 
charged species.  
 
Figure 19: ESI+ mass spectra of H4SIM3 with a) 2.0 eq ZnII(ClO4)2 and b) 2.0 eq ZnII(OAc)2 (asterisks mark signals 
with monozinc isotopic pattern, crosses mark signals with dizinc isotopic pattern). 
The contribution of the species accountable for the signals detected was identified by their 
isotopic patterns, which were characteristic either for monozinc(II) or for dizinc(II) species, as 
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explained in Chapter 3.2.1 (Figure 3a and 3b). During mass spectrometric investigations there is 
often the debate about the presence of dizinc(II) complexes already present in the sample 
solution, since the generation is also possible during the mass spectrometric measurement from 
the monozinc(II) complex in presence of ZnII ions. However, the constant detection of 
monozinc(II) complexes in mixtures with 2.0 eq (Figure 19a), and even 2.15 eq of zinc(II) 
perchlorate imply that the dizinc(II) complexes are generated during the mass spectrometric 
measurement. Based on this consideration, and taking into account the result from the 1H NMR 
titration, the sole formation of a monozinc(II) complex without presence of a dizinc(II) complex 
by the addition of zinc(II) perchlorate to H4SIM3 is proposed. 
In contrast, after addition of two equivalents of zinc(II) acetate to H4SIM3 an ESI+ mass spectrum 
(Figure 19b) was recorded with one main peak at m/z 966.2 with an isotopic pattern 
characteristic for a dizinc(II) complex, assigned to [ZnII2(H2SIM3)(OAc)(H2O)(D2O)]+, in the absence 
of signals corresponding to a monozinc(II) species. Therfore, it is apparent that the presence of 
acetate anions in solution favors the complexation of two ZnII ions by ligand H4SIM3. This 
observation is in agreement with the preparation of [ZnII2(H2SIM3)(µ-OAc)(OH)] in high yield 
which will be discussed in Chapter 4.2. 
3.3.2 COMPLEXATION STUDIES WITH GAIII 
 
Comparable to the GaIII coordination studies of H3SIM1, the GaIII complexation by H4SIM3 was 
examined by NMR titration as well as mass spectrometric measurements.  
NMR Studies 
Gallium(III) perchlorate and gallium(III) nitrate were used as GaIII source for the 1H NMR titration 
experiment. The coordination of GaIII ions by H4SIM3 was found to be less kinetically favored than 
ZnII coordination, as the mixtures of H4SIM3 and GaIII needed to be heated for an hour at 50°C 
before the reaction was completed. Addition of one equivalent of gallium(III) perchlorate to 
H4SIM3 in methanol led to a new species, in which especially the resonances corresponding to 
binding site A are shifted (Figure 20b) compared to the metal-free ligand. 
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Figure 20: Comparison of the aromatic regions in the 1H NMR of a) H4SIM3 in CD3OD with b) 2.0 eq GaIII(ClO4)3. 
Addition of two equivalents of gallium(III) nitrate in deuterium oxide to H4SIM3 in acetonitrile 
resulted in a very similar spectrum, suggesting that the formation of a digallium(III) complex of 
H4SIM3 is not possible and that the GaIII ions are selectively bound to binding site A, independent 
of the gallium(III) salt and solvent used. This is in accordence with the results derived from the 
reaction of GaIII with H3SIM1, providing the identical binding site C (Chapter 3.2.2), suggesting 
that in this binding site GaIII ions are unlikely to be bound. 
Mass Spectrometry 
The inability of H4SIM3 to form a digallium(III) complex was also confirmed in the mass spectrum 
obtained with a 1:2 mixture of H4SIM3 with gallium(III) nitrate. The only major peak was detected 
at m/z 810.2 with a characteristic monogallium isotopic pattern corresponding to the 
[GaIII(H2SIM3)]+ complex. 
3.3.3 COMPLEXATION STUDIES WITH FEIII 
 
The investigations with GaIII as FeIII mimic showed that GaIII ions are only bound in binding site A 
of ligand H4SIM3, leaving binding site C vacant, as already observed with H3SIM1. In order to verify 
this proposal, the coordination of FeIII ions by ligand H4SIM3 was examined by X-ray diffraction 
and mass spectrometric analysis.  
  
SB8702.001.001.1r.esp
8.4 8.3 8.2 8.1 8.0 7.9 7.8 7.7 7.6 7.5 7.4 7.3 7.2 7.1 7.0 6.9 6.8 6.7 6.6 6.5 6.4 6.3 6.2
Chemical Shift (ppm)
0
0.005
0.010
0.015
0.020
0.025
0.030
0.035
0.040
0.045
0.050
0.055
0.060
0.065
0.070
0.075
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
SB8702h.003.001.1r.esp
8.4 8.3 8.2 8.1 8.0 7.9 7.8 7.7 7.6 7.5 7.4 7.3 7.2 7.1 7.0 6.9 6.8 6.7 6.6 6.5 6.4 6.3 6.2
Chemical Shift (ppm)
0
0.005
0.010
0.015
0.020
0.025
0.030
0.035
0.040
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
H10
H1
H23
H24
H3 H2
H25
H4 H8
H18
H15 H7
H9
a)
H1
H23 H24
H3
H2
H4
H25
H8
H10H18
H15/
H7
H9
H18
H15/
b)
8.4 8.2 8.0 7.8 7.6 7.4 7.2 7.0 6.8 ppm6.6 6.4
COORDINATION BEHAVIOR OF ASYMMETRIC LIGANDS 
61 
X-ray Diffraction 
Treatment of H4SIM3 in methanol (27 mM) with iron(III) perchlorate (2.0 eq) and heating for 
15 min at 50°C resulted in a purple solution. Following addition of sodium tetrafluoroborate 
(4.0 eq) and diethylether diffusion yielded small black crystals, suitable for X-ray data collection. 
Figure 21 shows a plot of the molecular structure and Table 6 gives selected structural 
parameters.  
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Figure 21: Structure of a) {Na[FeIII(H2SIM3)]2(µ-OAc)(µ-OH2)}+ and b) its monomeric section (counter ions, non-
coordinated solvent molecules, and hydrogen atoms, not involved in hydrogen bonding, have been omitted for 
clarity; crystallographic data and ORTEP plots with 50% probability level of thermal ellipsoids appear in the 
Appendix, Table 31 and Figure 73). 
Table 6: Selected bond lengths (Å) and angles (°) for {Na[FeIII(H2SIM3)]2(µ-OAc)(µ-OH2)}(BF4)2. 
 {Na[FeIII(H2SIM3)]2(µ-OAc)(µ-OH2)}2+ 
 Fe(1) Fe(1`)a 
Fe(1)···Fe(1`)                        3.567 
Fe(1)-O(1) 1.918(6) 1.936(5) 
Fe(1)-O(1A) 1.971(5) 1.870(6) 
Fe(1)-O(2) 2.019(5) 2.063(6) 
Fe(1)-N(1) 2.152(7) 2.137(7) 
Fe(1)-N(2) 2.201(7) 2.206(6) 
Fe(1)-O(6) 1.943(6) 1.933(5) 
Fe(1)-O(6)-Fe(1`)                       134.0(3) 
O(1)-Fe(1)-N(1) 163.6(3) 86.4(2) 
O(1)-Fe(1)-N(2) 86.1(3) 88.7(2) 
O(1)-Fe(1)-O(1A) 95.3(2) 95.5(2) 
O(1)-Fe(1)-O(2) 94.4(2) 170.8(2) 
O(1)-Fe(2)-O(6) 100.5(2) 91.9(2) 
 
The structure reveals a diiron(III) core bridged by an aqua and an acetate co-ligand. Both FeIII 
centers are additionally coordinated by a pyridine and two phenolate moieties provided by two 
deprotonated H4SIM3 ligand molecules. Furthermore, the crystal cell of 
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{Na[FeIII(H2SIM3)]2(µ-OAc)(µ-OH2)}(BF4)2 includes a sodium ion and a tetrafluoroborate 
counterion. A similar dimeric structure of an FeIII complex was published by Que et al., obtained 
with the mononucleating ligand N-(o-hydroxybenzyl)-N,N-bis(2-pyridylmethyl)amine (HDP, 
HL18). This published structure of [FeIII2(L18)2(µ-O)(µ-OBz)]BPh4 is formed by a 
(µ-oxo)(µ-benzoate)diiron(III) core.183 
The two FeIII ions in {Na[FeIII(H2SIM3)]2(µ-OAc)(µ-OH2)}(BF4)2, separated by 3.567 Å, are 
coordinated in the harder binding site A of the dinucleating ligand H4SIM3 and reveal short Fe-O 
distances (average 1.957 Å), comparable to those of published complexes of H2L4, in which FeIII 
is also coordinated in binding site A. Examples are [FeIIIFeII(L4)(µ-OAc)2]+ (1.967 Å),140 
[FeIIICuII(L4)(µ-OAc)2]+ (1.978 Å),92 [FeIIIMnII(L4)(µ-OAc)2]+ (1.976 Å),96 [FeIIINiII(L4)(µ-OAc)2]+ 
(1.967 Å),141 [FeIIINiII(L4)(µ-OAc)(OH2)2]2+ (1.990 Å),142 [FeIIIZnII(L4)(OH2)(µ-OH)]2+ (1.985 Å),90, 144 
[FeIIICdII(L4)(µ-OAc)2]+ (1.978 Å),145 [[FeIIIHgII(L4)(µ-OH)]2]2+ (1.985 Å),145 and [FeIIICoII(L4)(µ-OAc)2]+ 
(1.971 Å).146 However, it should be mentioned that the metal ion coordinated in the second 
coordination site may have an effect on the average FeIII-O distance. 
The structure of {Na[FeIII(H2SIM3)]2(µ-OAc)(µ-OH2)}(BF4)2 demonstrates that the FeIII ion is 
preferably coordinated in the harder binding site A, which is in agreement with the NMR titration 
experiments performed with GaIII as an FeIII mimic. Moreover, although an excess of iron(III) 
perchlorate was present in solution, binding site C was left vacant during the crystallization. The 
structure of [NaFeIII(H2SIM1)(µ-OAc)2]PF6, which will be discussed in Chapter 5.3 in more detail, 
also carries the FeIII ion only in the non-amidated binding site of H3SIM1, while binding site C was 
occupied by a Na+ ion. Therefore, the coordination of FeIII in binding site C seems to be unfavored.  
Mass Spectrometry 
A methanolic solution of H4SIM3 (6.86 mM) was treated with two equivalents of sodium 
hydroxide and one equivalent of iron(II) tetrafluoroborate and the mixture was stirred for 14 
hours under aerobic conditions (investigations with UV-vis-NIR spectroscopy and NMR 
spectroscopy revealed the completed oxidation of FeII to FeIII after this period of time). The 
recorded ESI+ mass spectrum of this mixture (Figure 22a) shows one main signal at m/z 797.3, 
which matches the mass of the [FeIII(H2SIM3)]+ complex and shows the characteristic pattern for 
a monoiron complex (Figure 23a). The detection of a monoiron complex supports the finding 
obtained from the 1H NMR titration with GaIII as an FeIII mimic as well as from the X-ray diffraction 
analysis, that GaIII ions can only be bound in one coordination site, namely in binding site A. This 
proposal is supported by the UV-vis-NIR spectroscopic titration of H3SIM1, which contains also 
binding site C, with iron(III) perchlorate as well as the 1H NMR titration and the X-ray structural 
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analysis of H3SIM1 with GaIII as an FeIII mimic, which revealed that FeIII and GaIII cannot be bound 
in the hindered binding site C.  
 
Figure 22: ESI+ mass spectra of H4SIM3 with a) 1.0 eq FeII(BF4)2 after 14 hours exposure to air and b) 1.0 eq 
FeII(BF4)2 after 14 hours of exposure to air and addition of 1.0 eq ZnII(OMe)2 in methanol. 
 
Figure 23: Characteristic isotopic pattern found in ESI+ mass spectra (experimental (top) and calculated 
(bottom)) of H4SIM3 with a) 1 eq of FeII(BF4)2 (after 14 hours of exposure to air) ([FeIII(H2SIM3)]+) and b) 1 eq of 
FeII(BF4)2 (after 14 hours of exposure to air) and 1 eq of ZnII(OMe)2 ([FeIIIZnII(HSIM3)F]+) in methanol. 
Moreover, one equivalent of zinc(II) methoxide was added after 14 hours to the mixture of 
H4SIM3 and one equivalent of iron(II) tetrafluoroborate under aerobic conditions. The resulting 
ESI+ mass spectrum (Figure 21b) contains signals with a characteristic FeZn isotopic pattern 
(Figure 22b), besides the small signal at m/z 797.3 stemming from residues of the monoiron 
complex. The FeZn signals at m/z 430.1, m/z 859.2 and m/z 879.3 were assigned to 
[FeIIIZnII(HSIM3)]2+, [FeIIIZnII(SIM3)]+ and [FeIIIZnII(HSIM3)F]+. This indicates that ZnII ions are 
selectively coordinated in the softer vacant binding site C, while the harder binding site A is 
occupied by the harder FeIII ion, generating an accurate model for the FeZn active site of PAPs.  
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3.3.4 FORMATION OF A HETERODINUCLEAR GAIIIZNII COMPLEX 
 
As discussed in Chapters 3.3.1 and 3.3.2, H4SIM3 was found to bind (i) ZnII selectively in binding 
site C, and (ii) GaIII in the harder binding site A. These findings are in agreement with the observed 
crystal structure of [GaIIIZnII(L4)(µ-OAc)2]+.66 This ligand lacks the pivaloyl-amide residues at the 
6-position of the pyridine residues compared to H4SIM3, but provides a similar primary 
coordination sphere. In [GaIIIZnII(L4)(µ-OAc)2]+, GaIII is bound in the harder binding N2O4-binding 
site and ZnII is coordinated in the softer N3O3-binding site.66 The possibility to generate a GaIIIZnII 
complex with H4SIM3, in which the two different metal ions are bound in distinct binding sites, 
was investigated via NMR spectroscopy and mass spectrometry. 
NMR Studies 
Ligand H4SIM3, dissolved in acetonitrile, was treated with one equivalent of zinc(II) perchlorate 
dissolved in deuterium oxide and the formation of the monozinc(II) complex was confirmed by 
the measurement of a 1H NMR spectrum (Figure 24b). Afterwards, gallium(III) nitrate, dissolved 
in deuterium oxide, was added stepwise and the changes were followed using NMR 
spectroscopy. After addition of one equivalent of gallium(III) nitrate to the monozinc(II) complex 
of H4SIM3 one new main species is visible in the 1H NMR spectrum, in addition to at least three 
other new species (Figure 24c).  
 
Figure 24 Comparison of the aromatic regions in the 1H NMR of a) H4SIM3 in CD3CN, b) H4SIM3 with 1.0 eq of 
ZnII(ClO4)2 in CD3CN/D2O, and c) H4SIM3 with 1.0 eq of ZnII(ClO4)2 and 1.0 eq of GaIII(ClO4)3 in CD3CN/D2O. 
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The resonances of H9 and H10 are shifted upfield similar as found in the monogallium(III) 
complex spectrum. Furthermore, the resonances assigned to H23, H24 and H25 have also a 
similar chemical shift in the monogallium(III) complex. Therefore, the formation of the 
monogallium(III) complex, lacking the ZnII ion in the second coordination site, is proposed during 
this experiment.  
Interestingly, the analogous experiment undertaken in methanol gave a different result. 
Although the addition of gallium(III) perchlorate to the monozinc(II) complex also resulted in the 
formation of three species the chemical shifts of the resonances assigned to H23, H24 and H25 
did not result in the identical chemical shifts of those measured in the monogallium(III) complex. 
Moreover, when the experimental procedure was changed, i.e. when zinc(II) perchlorate was 
added to the monogallium(III) complex, which had been generated in methanol prior to the 
addition of the zinc(II) ion (Figure 25a) only one new species was detected (Figure 25c, d). In 
order to preserve complete conversion to the GaIIIZnII complex treatment with one equivalent of 
base (NaOD in D2O) was necessary (Figure 25d). To confirm that the base was responsible for the 
complexation in the latter experiment, the addition of D2O was tested in a separate experiment. 
Addition of D2O was found to have no influence on the species distribution.  
 
Figure 25: Comparison of the aromatic regions in the 1H NMR of a) H4SIM3 with 1.1 eq of GaIII(ClO4)3 in CD3OD, 
b) H4SIM3 with 1.1 eq of GaIII(ClO4)3 and 0.5 eq of ZnII(ClO4)2 in CD3OD, c) H4SIM3 with 1.1 eq of GaIII(ClO4)3 and 
1.0 eq of ZnII(ClO4)2 heated to 60°C for 8h, and d) H4SIM3 with 1.1 eq of GaIII(ClO4)3, 1.0 eq of ZnII(ClO4)2 and 
1.0 eq of NaOD in CD3OD/D2O. 
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Mass Spectrometry 
The mass spectrometric investigation of H4SIM3 treated with zinc(II) perchlorate and gallium(III) 
nitrate showed three main peaks in the spectrum at m/z 437.6, m/z 446.6 and m/z 992.1, all 
three displaying a GaZn isotopic pattern. The peaks were assigned to the complexes 
[GaIIIZnII(HSIM3)]2+, [GaIIIZnII(HSIM3)(H2O)]2+, and [GaIIIZnII(H2SIM3)(CH3CN)(OH)2]+. 
3.4 COMPLEXATION BEHAVIOR OF LIGAND H4SIM4 
 
H4SIM4 bears two chemically distinct coordination sites and the primary coordination sphere is 
comparable to H4SIM3. However, the second coordination sphere in H4SIM4 provides hydrogen 
bonding proximal both binding sites, while H4SIM4 only introduced hydrogen bonding adjacent 
to the softer coordination site.  
 
Chart 11: Assignment of the binding sites provided by ligand H4SIM4 and the numbering of its atoms. 
In fact, the two sterically demanding pivaloyl-amide moieties are attached to both side-arms in 
H4SIM4 leading to two rather equally accessible binding sites, contrary to H4SIM3. 
3.4.1 COMPLEXATION STUDIES WITH ZNII 
 
The binding behavior of ligand H4SIM4 with ZnII ions was investigated by NMR titration and mass 
spectrometric measurements, as with H3SIM1 and H4SIM3 (Chapter 3.2.1 and 3.3.1). 
NMR Studies 
The formation of a monozinc(II) complex was monitored during the addition of zinc(II) 
perchlorate to a solution of H4SIM4 in methanol. Next to the resonances assigned to the metal-
free ligand, resonances of a new species appeared in mixtures with low ZnII ion concentration. 
Finally, in the 1H NMR spectrum obtained with the 1:1 mixture of zinc(II) perchlorate and H4SIM4 
the resonances corresponding to the monozinc(II) complex of H4SIM4 were the only resonances 
left, while the resonances of the metal-free ligand disappeared. The resonances assigned to the 
non-amidated pyridine residue and one of the two amidated-pyridine residues revealed shifts in 
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the spectrum of the monozinc(II) complex of H4SIM4 compared to the metal-free ligand, while 
the resonances of the other two side-arm moieties did not show pronounced changes (Figure 26). 
This suggests the coordination of ZnII ions in binding site D of H4SIM4. Increase of the ZnII 
concentration to a ratio higher than 1:1 did not lead to changes in the recorded 1H NMR spectrum 
indicating the selective formation of the monozinc(II) complex. However, when the NMR titration 
experiment was conducted in acetonitrile as solvent the formation of the monozinc(II) complex 
could also be detected, but addition of further zinc(II) perchlorate to the monozinc(II) complex 
resulted in a mixture with a second species, most likely the dizinc(II) complex, but complete 
conversion could not be detected.  
 
Figure 26: Comparison of the aromatic regions in the 1H NMR of a) H4SIM4 in CD3OD with b) 1.0 eq of ZnII(ClO4)2. 
Mass Spectrometry 
ESI+ mass spectrometric measurements were conducted in parallel to the 1H NMR spectroscopic 
investigations regarding the ZnII coordination behavior of H4SIM4 by taking samples throughout 
the experiments. The spectrum recorded after addition of one equivalent of ZnII ions in 
acetonitrile showed a main peak at m/z 806.4 associated with the monozinc(II) complex 
[ZnII(H3SIM4)]+ with the characteristic isotopic pattern for monozinc species. Further addition of 
zinc(II) perchlorate led to a spectrum with a main peak at m/z 436.7 exhibiting the isotopic 
pattern characteristic for a dizinc species and corresponding to a complex containing two zinc(II) 
centers, [ZnII2(H2SIM4)]2+. These findings support the observation of the selective formation of a 
monozinc(II) complex by addition of one equivalent of ZnII to H4SIM4 in agreement with the 
results acquired from the NMR spectroscopic measurements.   
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3.4.2 COMPLEXATION STUDIES WITH GAIII 
 
Similar to the complexation of H4SIM4 with ZnII, the capacity of H4SIM4 to form gallium(III) 
complexes was examined by NMR titration and mass spectrometric measurements. 
NMR Studies 
The 1H NMR spectrum recorded with a mixture of one equivalent of gallium(III) perchlorate with 
ligand H4SIM4 in acetonitrile after heating for 12 hours shows mainly 16 resonances in the 
aromatic region. These resonances are accountable for the 16 inequivalent protons of a 
selectively formed species. The shift of the resonances assigned to the protons of the terminal 
phenol residue indicates the coordination of the GaIII ion in binding site E in the resulting 
monogallium(III) complex of H4SIM4.  
 
Figure 27: Comparison of the aromatic regions in the 1H NMR of a) H4SIM4 in CD3CN with b) 1.0 eq of GaIII(ClO4)3 
heated at 60°C for 12h. 
Mass Spectrometry 
The ESI+ mass spectrum recorded with a solution of H4SIM4 treated with one equivalent of 
gallium(III) perchlorate revealed main signals with the pattern characteristic for monogallium 
compounds. The signals were found at m/z 405.7, m/z 810.3, and m/z 912.3 corresponding to 
the species [GaIII(H3SIM4)]2+, [GaIII(H2SIM4)]+, and [GaIII(H3SIM4)(ClO4)]+, respectively. The mass 
spectrometric investigation of a solution of H4SIM4 with one equivalent of zinc(II) perchlorate and 
one equivalent of gallium(III) perchlorate heated for 12 hours at 60°C resulted in a spectrum with 
signals associated with GaZn species due to their characteristic pattern (besides the signals 
assigned to remnants of the monogallium(III) complex). The GaZn species found had the mass to 
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charge ratio of m/z 436.62 and m/z 912.28 and match the mass of [GaIIIZnII(HSIM4)]2+ and 
[GaIIIZnII(SIM4)]+. 
3.5 SUMMARY 
 
The coordination behavior towards ZnII, CuII, GaIII, and FeIII of the asymmetric ligands H3SIM1, 
H4SIM3, and H4SIM4 was examined with various techniques, including NMR spectroscopy, X-ray 
diffraction, mass spectrometry, UV-vis-NIR and EPR spectroscopy. In this way, the selective 
formation of specific complexes due to the asymmetry of the ligands was established. 
Ligand H3SIM1 was shown to coordinate ZnII stepwise, i.e. H3SIM1 generates selectively the 
monozinc(II) complex in presence of ZnII with the ZnII ion bound in binding site B, prior to 
coordination of a second ZnII ion in binding site C. A similar behavior of H3SIM1 with CuII ions was 
detected since the selective formation of a monocopper(II) complex was revealed after addition 
of one equivalent of CuII. In presence of two equivalents of CuII, H3SIM1 generates a dicopper(II) 
complex, which could be structurally characterized as [CuII2(HSIM1)(µ-OAc)]+. In this structure, 
the asymmetry of the complex is visible due to the presence of two unequal CuII centers, one in 
a trigonal bipyramidal and one in a distorted octahedral coordination geometry. Interestingly, 
the additional coordination site in the octahedral CuII center is occupied by the pivaloyl-amide 
oxygen atom of coordination site C, stabilized by hydrogen bond formation by the second 
adjacent pivaloyl-amide residue. In contrast to the observations gained with ZnII and CuII salts, 
H3SIM1 achieved only the coordination of one trivalent metal ion when GaIII or FeIII salts were 
used as metal source. The coordination of the trivalent metal ion takes place in the less hindered 
binding site B, as shown in the X-ray structure of [GaIII(H2SIM1)(µ-OH)]2(ClO4)2. The selectivity of 
the two different binding sites of the asymmetric ligand H3SIM1 was particularly demonstrated 
in the generation of a heterodinuclear GaIIIZnII complex, independent of the order of addition of 
the two metal salts or an excess of one of the two metal salts. The X-ray structure of 
[GaIIIZnII(H2SIM1)(OAc)2(µ-OH)]2(PF6)2 verifies the coordination of GaIII in the less hindered binding 
site B and of ZnII in the amidated binding site C. 
Contrary to H3SIM1, H4SIM3, and H4SIM4 provide two chemically different binding sites with 
regards to the primary coordination sphere, i.e. a softer nitrogen-rich binding site and a harder 
binding site with a terminal phenolate residue. By means of NMR titration and mass 
spectrometric experiments it could be shown that the softer ZnII ion favors the softer binding 
site, while the harder trivalent GaIII ion selectively coordinates to the harder binding site. In case 
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of H4SIM3 the coordination of FeIII in the harder binding site was also verified by X-ray diffraction 
of the dimeric iron(III) complex {Na[FeIII(H2SIM3)]2(µ-OAc)(µ-OH2)}(BF4)2. 
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Chapter 4  
Dizinc Model Complexesd
                                                          
d Main parts of this chapter are published in “Dinuclear Zinc(II) Complexes with Hydrogen Bond Donors as 
Structural and Functional Phosphatase Models”; Simone Bosch, Peter Comba, Lawrence R. Gahan, Gerhard 
Schenk, Inorg. Chem. 2014, 53, 9036-9051. 
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4.1 INTRODUCTION 
 
Due to its geometric flexibility and high ionization potential/Lewis acidity the zinc(II) ion is one of 
the most frequently incorporated metal ions in hydrolases. These features facilitate zinc(II) 
containing enzymes to polarize P-O bonds in phosphate ester substrates and simultaneously to 
activate the phosphorus center towards nucleophilic attack.11 A water molecule coordinated to 
ZnII is highly activated by polarization and ionization. The generation of a hydroxide ion at neutral 
pH can then act as a nucleophile.184 A key property, therefore, in the function of the catalytic 
sites is the acidity (pKa value) of a metal-bound water molecule.185 It is known that the number 
and the nature of the zinc(II) coordinating ligands play a critical role in the polarization 
capacity.186 Studying the zinc(II) complexes [ZnII(H3L19)(OH2)]2+ and [ZnII(H4L20)(OH2)]2+ (Chart 12) 
it was found that, as the coordination number decreases from five to four, the pKa value of the 
ZnII-bound water molecule decreases from 8.0 to 7.3.187-189 In general, as the coordination 
number increases the charge on the ZnII center is reduced and, consequently, the capacity to 
polarize the ZnII-bound water molecule is decreased.184 
 
Chart 12: Zinc(II) complexes used to study the impact of the primary coordination sphere of the ZnII center 
towards the pKa of ZnII-bound water.190 
A similar effect was found by changing coordinating ligands in the primary coordination sphere 
of the ZnII center. The change of one neutral pyridine ligand in [ZnII(L21)(OH2)]2+ (Chart 12) by one 
anionic carboxylate results in a decrease of the Lewis acidity of the ZnII ion and consequently in 
a lowered capacity to polarize the bound water molecule (pKa 8.0 for [ZnII(L21)(OH2)]2+ and pKa 
9.1 for [ZnII(L22)(OH2)]+).191 This was confirmed by ab initio calculations and site-directed 
mutagenesis studies with carbonic anhydrase, and demonstrates the importance of the first 
coordination sphere on the ZnII-water acidity.186, 192 However, the microenvironment of the active 
site in phosphatases is also known to influence the function of metalloproteins by non-covalent 
interactions such as hydrogen bonding.25, 82, 83  
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Mareque-Rivas et al. investigated the impact of hydrogen bond donors adjacent to the ZnII center 
towards the pKa value of the ZnII-bound water using derivatives of [ZnII(L21)(OH2)]2+ (Chart 12) the 
model complexes (Chart 13).190  
 
Chart 13: Zinc(II) complexes used to study the impact of hydrogen bond donors and hydrophobic groups in 
proximity to the ZnII center towards the pKa of ZnII-bound water.190 
Since amino groups are electron donating, the pKa values of the zinc(II)-bound water molecule is 
expected to increase when more zinc(II) coordinating pyridyl groups are exchanged by 
aminopyridyl residues. The fact that the inverse was observed can be rationalized as being due 
to intramolecular hydrogen bonding as the N-H hydrogen bond donors, when close to the ZnII 
center, can polarize the water O-H bond. Moreover, the better hydrogen bond accepting 
properties of the anionic zinc(II)-bound hydroxide relative to water leads to a greater stabilization 
of the zinc(II)-hydroxide by the amino hydrogen bonding groups. In comparison to 
[ZnII(L24)(OH2)]2+, introduction of two neopentylamino group as in [ZnII(H2L27)(OH2)]2+ (Chart 13), 
which simultaneously create a hydrophobic and hydrogen bonding microenvironment in 
proximity to the metal site, resulted in an even lower pKa value of the ZnII-bound water (pKa is 
6.7 for [ZnII(L24)(OH2)]2+and 6.4 for [ZnII(H2L27)(OH2)]2+). Remarkably, these observations suggest 
that the second coordination sphere, which cooperates with the Lewis acidic ZnII center, can be 
of similar importance as the first coordination sphere in enhancing the ZnII-bound water 
acidity.184  
In general, model systems that contain two metal centers were found to cleave various 
substrates at faster rates than the corresponding mononuclear analogues.11 When the two metal 
centers are brought in close distance to each other cooperation is facilitated either by double 
Lewis acid activation of the substrate or Lewis acid activation of the substrate, coupled with the 
provision of a metal bound hydroxide nucleophile. However, recently it was shown that the 
introduction of non-coordinated pyridyl residues in a mononuclear zinc(II) complex is as effective 
as the introduction of a second ZnII ion for enhancing its acidity towards the transesterification 
of phosphodiesters. This was accounted for hydrogen bonding of the vacant coordination site 
(Chart 14).111 
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Chart 14: Introduction of metal-metal cooperation and metal-second sphere cooperation in zinc(II) model 
complexes for hydrolases.193 
Combining both strategies, i.e. metal-metal cooperation, and metal-hydrogen bonding 
cooperation, accomplished in complex [ZnII2(L7)] (Chart 14), resulted in tighter binding of 
phosphate derivatives such as pyrophosphate, RNA fragments and dimethyl phosphate, than 
with dizinc(II) complexes lacking second coordination sphere models or monozinc(II) complexes 
with hydrogen bond donors.112, 113, 194  
Therefore, a variety of ligands were developed in this work, which differ in the type and 
geometric position of hydrogen bond donors and acceptors, more precisely pivaloyl-amide and 
amine moieties. The ligands were synthesized as described in Chapter 2. Using these ligands the 
corresponding dizinc(II) complexes, shown in Chart 15, were prepared and investigated. 
Experimental procedures including ligand and complex syntheses are given in detail in 
Chapter 11. 
 
Chart 15: Dizinc(II) complexes employed to mimic the active site of phosphoesterases. 
These dizinc(II) model complexes were structurally characterized in the solid state and also in 
solution, using X-ray crystallography, NMR spectroscopy, mass spectrometry and UV-vis 
spectroscopy. Moreover, kinetic assays were employed in order to investigate the effect of the 
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introduced moieties into the reference complex [ZnII2(L1)(µ-OAc)2]PF6 (Chart 15). These 
introduced functionalities are able to form hydrogen bonds, responsible for the positioning of 
the substrate and release of the product molecules.  
4.2 SYNTHESIS OF DIZINC(II) COMPLEXES 
 
The dinuclear zinc(II) complexes of HL1, H3L2, H3SIM1, HSIM2 and H4SIM3 were prepared by 
reaction with two equivalents of zinc(II) acetate dihydrate in methanol at 50°C for ten minutes. 
After addition of sodium hexafluorophosphate to the hot solution X-ray quality crystals were 
obtained upon standing. In this way the complexes [ZnII2(L1)(µ-OAc)2]PF6, 
[ZnII2(H2L2)(µ-OAc)2]PF6, [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6, and [ZnII2(SIM2)(µ-OAc)2]PF6 were 
isolated as white crystals. In the case of H4SIM3, the ligand containing solution was treated with 
aqueous sodium hydroxide before addition of zinc(II) acetate dihydrate, in order to ensure 
deprotonation of both phenol residues. Slow evaporation of the solvent led to the complex 
[ZnII2(H2SIM3)(µ-OAc)(OH)] in the form of crystals, suitable for X-ray diffraction, irrespective 
of the presence of sodium hexafluorophosphate. All five dizinc(II) complexes were characterized 
and studied in the solid state and in solution (acetonitrile was chosen as solvent since it is the 
common organic solvent used for hydrolysis activity studies with this type of model complexes). 
Bearing amino and amide residues adjacent the ZnII centers, these complexes offer the potential 
for the investigation of the effect of hydrogen bonding on the phosphoester hydrolytic activity. 
4.3 STRUCTURAL CHARACTERIZATION OF DIZINC(II) 
COMPLEXES 
Solid State Structures 
The colorless single crystals of [ZnII2(L1)(µ-OAc)2]PF6, [ZnII2(H2L2)(µ-OAc)2]PF6, 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6, [ZnII2(SIM2)(µ-OAc)2]PF6 and [ZnII2(H2SIM3)(µ-OAc)(OH)] were 
used for X-ray diffraction data collection. Crystallographic data obtained for the structures 
are displayed in Table 33 (see Appendix).  
The structures obtained show that the dizinc(II) complexes formed with the ligands HL1, H3L2 
and HSIM2 have the common formation for this type of phenolate-based complexes, 
composed of the corresponding ligand monoanion, resulting from the deprotonation of the 
phenol backbone, two ZnII ions, two bridging acetato anions, with a hexafluorophosphate 
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counter ion.100, 195, 196 In accordance with the structure of [ZnII2(L1)(µ-OAc)2]BF4, published by 
Adams et al.,196 both ZnII ions in [ZnII2(L1)(µ-OAc)2]PF6, [ZnII2(H2L2)(µ-OAc)2]PF6 and 
[ZnII2(SIM2)(µ-OAc)2]PF6 are coordinated in a six coordinate arrangement and are bridged by 
the ligand backbone phenoxido group and two acetate co-ligands. The remaining 
coordination sites are occupied by the nitrogen donors of two pyridine ligands and the 
tertiary amines. The structures are shown in Figure 28 and selected distances and valence 
angles are summarized in Table 7. Nordlander et al. recently reported a structure for the 
complex [ZnII2(L1)(µ-OAc)(CH3OH)]ClO4, obtained when HL1 was reacted with zinc(II) acetate, but 
using sodium perchlorate, instead of sodium hexafluorophosphate as source for the 
counterion.197 The crude product was initially treated with water before the complex was 
crystallized by slow diffusion of diethyl ether. In [ZnII2(L1)(µ-OAc)(CH3OH)]ClO4 one ZnII ion is 
coordinated in a slightly distorted octahedral geometry, while the second ZnII ion is the center of 
an distorted square pyramidal coordination geometry.197 
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Figure 28: Structures of a) [ZnII2(L1)(µ-OAc)2]PF6, b) [ZnII2(SIM2)(µ-OAc)2]PF6, and c) [ZnII2(H2L2)(µ-OAc)2]PF6 
showing hydrogen bonding (green dotted lines; counter ions, non-coordinated solvent molecules, and 
hydrogen atoms, not involved in hydrogen bonding, have been omitted for clarity; crystallographic data and 
ORTEP plots with 50% probability level of thermal ellipsoids appear in the Appendix, Table 33 and Figure 74). 
DIZINC MODEL COMPLEXES 
77 
Table 7: Selected bond lengths (Å) and angles (°) for [ZnII2(L1)(µ-OAc)2]PF6, [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6, 
[ZnII2(H2L2)(µ-OAc)2]PF6, [ZnII2(SIM2)(µ-OAc)2]PF6 and [ZnII2(H2SIM3)(µ-OAc)(OH)]. 
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Zn(1)···Zn(2) 3.3714(4) 3.3992(6) 3.5422(7) 3.3948(10) 3.5892(6) 
Zn(1)-O(1) 2.0135(14) 2.025(3) 1.954(3) 1.994(4) 1.9904(19) 
Zn(1)-O(2A) 2.1825(16) 2.092(3) 2.003(3) 2.112(4) 2.065(2) 
Zn(1)-O(2B) 2.0088(15) 2.056(3) - 2.008(4) - 
Zn(1)-N(1) 2.2346(19) 2.169(3) 2.057(3) 2.216(5) 2.096(2) 
Zn(1)-N(2) 2.2306(19) 2.214(3) 2.233(2) 2.206(5) 2.213(2) 
Zn(1)-N(3)* 2.1443(19) 2.284(3) 2.102(3) 2.132(5) 1.934(2) 
Zn(2)-O(1) 2.0342(14) 2.000(3) 2.120(2) 1.995(4) 2.1380(19) 
Zn(2)-O(3A)** 2.0198(17) 2.039(3) 2.133(3) 2.008(4) 2.102(2) 
Zn(2)-O(3B) 2.0849(16) 2.077(3) - 2.114(4) - 
Zn(2)-N(4) 2.223(2) 2.155(3) 2.322(3) 2.239(5) 2.295(2) 
Zn(2)-N(5) 2.247(2) 2.199(3) 2.136(3) 2.165(5) 2.148(2) 
Zn(2)-N(6) 2.1764(19) 2.289(3) 2.336(3) 2.123(5) 2.473(2) 
Zn(2)-O(6) - - 1.945(2) - 1.9571(19) 
Zn(1)-O(1)-Zn(2) 112.80(7) 115.23(13) 120.75(12) 116.65(18) 120.73(9) 
O(1)-Zn(1)-N(1) 87.65(6) 89.95(12) 118.71(12) 88.63(18) 130.04(9) 
O(1)-Zn(1)-N(2) 88.88(7) 87.20(11) 91.48(11) 88.12(17) 91.80(8) 
O(1)-Zn(1)-N(3)* 163.19(7) 160.92(12) 124.82(11) 161.07(18) 109.92(9) 
O(1)-Zn(1)-O(2A)** 87.91(6) 89.64(11) 99.48(12) 89.65(16) 90.21(8) 
O(1)-Zn(1)-O(2B) 100.20(6) 100.55(11) - 101.16(17) - 
O(1)-Zn(2)-N(4) 86.73(7) 93.20(12) 88.66(10) 91.46(16) 86.80(8) 
O(1)-Zn(2)-N(5) 87.53(6) 88.29(12) 90.65(11) 89.20(17) 91.44(9) 
O(1)-Zn(2)-N(6) 163.04(7) 159.77(12) 161.27(10) 162.28(16) 161.12(8) 
O(1)-Zn(2)-O(3A)** 100.51(6) 101.25(11) 87.91(11) 98.04(17) 91.27(8) 
O(1)-Zn(2)-O(3B) 92.43(6) 90.00(11) - 88.12(15) - 
O(1)-Zn(2)-O(6) - - 102.84(10) - 107.30(8) 
* in the case of [ZnII2(H2SIM3)(µ-OAc)(OH)] N(3) is O(1A). 
** in the case of [ZnII2(H2SIM1)(µ-OAc)(OH)]+ and [ZnII2(H2SIM1)(µ-O3POC6H4NO2)]+ O(2A) is O(2) and O(3A) is O(3). 
 
In [ZnII2(H2L2)(µ-OAc)2]+ the ligands in the trans position to the bridging phenolate are the 
pivaloyl-substituted pyridine residues at both ZnII centers and its Zn-Nax distances (2.289(3) Å 
and 2.284(3) Å) are elongated compared to the Zn-Neq distances (2.155(3) Å and 2.169(3) Å) 
of the non-substituted pyridine residues. This contrasts with distances measured in 
[ZnII2(L1)(µ-OAc)2]+, in which the Zn-Nax distances (2.1443(19) Å and 2.1764(19) Å) are shorter 
than the Zn-Neq distances (2.2346(19) Å and 2.223(2) Å), presumably due to the electron 
withdrawing effect of the pivaloyl-amide residues. In agreement with the electron donating 
effect of the amino substituent, the Zn-Nax distance to the amino substituted pyridine moiety 
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(2.123(5) Å) is slightly shorter than to the unsubstituted pyridine ligand (2.132(5) Å) in 
[ZnII(SIM2)(µ-OAc)2]+.  
Reaction of H3SIM1 and H4SIM3 with zinc(II) acetate dihydrate resulted in the complexes 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 and [ZnII2(H2SIM3)(OAc)(µ-OH)] (Figure 29), in which the two 
ZnII ions are only doubly bridged by the phenoxido group of the dinucleating ligand and one 
acetato co-ligand. Zn(1), the ZnII ion in the amide-free binding site, adopts a five-coordinate 
geometry. Applying the method of Addison et al.,171 which evaluates the degree of trigonality 
by means of the structural parameter τ (τ = (β - α)/60, where α and β are the two largest 
angles around the central atom with β > α) and assigns a value of τ = 0 to a regular square 
pyramidal geometry and τ = 1 to a trigonal bipyramidal geometry, the coordination 
environment of Zn(1) in [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 with τ = 0.94 is a trigonal bipyramidal 
with the trigonal plane formed by two pyridines and the backbone phenolate. 
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Figure 29: Structures of [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 (left) and [ZnII2(H2SIM3)(µ-OAc)(OH)] (right) showing 
hydrogen bonding (green dotted lines; counter ions and hydrogen atoms, not involved in hydrogen bonding, 
have been omitted for clarity; crystallographic data and ORTEP plots with 50% probability level of thermal 
ellipsoids appear in the Appendix, Table 34 and Figure 74).  
The five donors around Zn(1) in [ZnII2(H2SIM3)(µ-OAc)(OH)] are arranged in a coordination 
geometry with a τ-value of 0.58, in between trigonal bipyramidal and square pyramidal. 
Assuming trigonal bipyramidal, the trigonal plane is defined by one pyridine and two phenolate 
residues. The axial positions are occupied by the tertiary amine and an acetato oxygen atom in 
both structures, [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 and [ZnII2(H2SIM3)(µ-OAc)(OH)]. The variation of 
the coordination geometry in these two complexes is proposed to be due to the larger phenolate 
moiety in H4SIM3 compared to the pyridine residue in H3SIM1. For [ZnII2(H2SIM3)(µ-OAc)(OH)], the 
angle (O(1)-Zn(1)-O(1a)) is reduced, with respect to the angle (O(1)-Zn(1)-N(3)) in 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6, and the bridging acetate ligand is twisted relative to the 
Zn(1)-O(1)-Zn(2) plane (torsion angles O(1)-Zn(1)-O(2)-C(1a) and O(1)-Zn(2)-O(3)-C(1a) are 6.75° 
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and 29.46° in [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 as well as 50.57° and 64.53° in 
[ZnII2(H2SIM3)(µ-OAc)(OH)]). 
Similar to the zinc(II) sites in [ZnII2(L1)(µ-OAc)2]PF6, [ZnII2(H2L2)(µ-OAc)2]PF6 and 
[ZnII2(SIM2)(µ-OAc)2]PF6, the second ZnII ion in [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 and 
[ZnII2(H2SIM3)(µ-OAc)(OH)], bound to the amide containing binding site (Zn(2)), is six-coordinate. 
The coordination environment of Zn(2) is formed by two pyridine donors, a tertiary amine, the 
bridging phenolate group and the bridging acetate co-ligand and completed by a hydroxido 
group.  
In comparison to [ZnII2(L1)(µ-OAc)2]PF6, [ZnII2(H2L2)(µ-OAc)2]PF6 and [ZnII2(SIM2)(µ-OAc)2]PF6, the 
distances between Zn(1), the ZnII atom coordinated in a trigonal bipyramidal geometry, and the 
coordinating ligands of the primary coordination sphere are shorter. Furthermore, the length of 
the bonds between Zn(2) and its six donors are elongated compared to the complexes 
[ZnII2(L1)(µ-OAc)2]PF6, [ZnII2(H2L2)(µ-OAc)2]PF6, and [ZnII2(SIM2)(µ-OAc)2]PF6, presumably due to 
the electron-rich hydroxido co-ligand. 
The presence of the unusual hydroxido co-ligand was confirmed by comparison of the Zn-O 
distance with the respective value in structures of previously published zinc(II) complexes with 
aqua, μ-hydroxido and terminal hydroxido donor groups. For example, for the dizinc(II) complex 
of HL1, [ZnII2(L1)(OH2)2](ClO4)3, Zn-OH2 distances are of the order of 2.04 Å and the distances to 
bridging hydroxido ligands are reduced to 1.99 Å, as in [ZnII2(L1)(µ-OH)](ClO4)2 (see Figure 30).198  
   
 
Figure 30: [ZnII2(L1)(OH2)2](ClO4)3 and [ZnII2(L1)(µ-OH)](ClO4)2 and the respective zinc(II)–aqua and 
zinc(II)-(µ-hydroxido) distances.198  
Similar Zn-(μ-OH) distances have been found for a variety of dizinc(II) complexes: 
[[ZnII(L30)]2(μ-OH)2](ClO4)2 (1.983(3) Å); [[ZnII(L31)]2(μ-OH)2](ClO4)2 · 0.5 CH3CN (2.070(3) Å); 
[ZnII2(L32)(μ-OH)(py)2](ClO4)2 (1.946(3) Å); [ZnII2(L33)(μ-OH)(py)3](ClO4)2 (1.951(4) Å) and 
[ZnII2(L1)(μ-OH)](ClO4)2 (1.943(3) Å) (structures of the respective ligands are given in the Table of 
Molecules).198-200 These metrics compare with the Zn-O distances in [ZnII2(H2SIM3)(µ-OAc)(OH)] 
(1.9575(19) Å) and [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 (1.943(3) Å), which are significantly shorter 
than in complexes reported with a terminal aqua ligand and in the range of complexes containing 
bridging hydroxido ligands. This supports the notion of the presence of a terminal hydroxido co-
2.043(5) 1.987(3) 
 
Zn-OH(2) distance 
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ligand. Moreover, the long Zn(1)∙∙∙OH distances of 3.936 Å in [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 and 
4.199 Å in [ZnII2(H2SIM3)(µ-OAc)(OH)] support the assignment of the OH¯ group in question as a 
terminal hydroxido co-ligand.  
The fact that a terminal hydroxido co-ligand has not been observed previously in dinuclear zinc(II) 
complexes with similar phenolate-based ligands, but lacking the hydrogen-bond donors, is 
consistent with the proposition that the hydrogen-bond donors, i.e. the two adjacent amide 
residues at the binding site of one ZnII center in [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 and 
[ZnII2(H2SIM3)(µ-OAc)(OH)], stabilize this unusual hydroxido co-ligand. Moreover, the hydrogen 
bond formation within the structure of [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 is confirmed by the 
observed arrangement of the amide hydrogen atoms with respect to the free electron pairs 
of the hydroxido oxygen atom (hydrogen bonds are depicted as green dotted lines in 
Figure 28 and Figure 29). This is in accordance with the previous observation that the 
incorporation of two H-bond donors, i.e. neopentylamino groups, in tripodal N4 ligands lead 
to the generation of a stable ZnII-OH complex [ZnII(H2L27)(OH)]ClO4 due to H-bonding 
(Figure 31).190  
 
Figure 31: Previously published ZnII-hydroxido complex [ZnII(H2L27)(OH)]ClO4, stabilized by hydrogen bond 
formation.190 
Furthermore, hydrogen bond formation was detected in [ZnII(H2L27)(OH)]ClO4 proposed from 
the short distances between the amino nitrogen and hydroxido oxygen atom (2.741 Å and 
2.727 Å)190; the corresponding distances for [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 and 
[ZnII2(H2SIM3)(µ-OAc)(OH)] are listed in Table 8. This table also contains the corresponding 
distances for [ZnII2(H2L2)(µ-OAc)2]PF6 and [ZnII2(SIM2)(µ-OAc)2]PF6, and those between the 
amine or amide nitrogen atom and the nearby acetate oxygen atoms are in the range 
2.750(8) Å and 2.982(4) Å. These short distances demonstrate that the desired hydrogen 
bond formation is also present in these complexes. Importantly, the protons of the amine or 
amide moieties also point towards oxygen atoms of the bridging acetate groups in 
[ZnII2(H2L2)(µ-OAc)2]PF6 and [ZnII2(SIM2)(µ-OAc)2]PF6.   
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Table 8: Selected distances (Å) for [ZnII2(H2L2)(µ-OAc)2]PF6, [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6, 
[ZnII2(SIM2)(µ-OAc)2]PF6, and [ZnII2(H2SIM3)(µ-OAc)(OH)] corresponding to H-bond formation. 
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N(7)-O(2B) 2.982(4) - -  
N(7)-O(3A) - - 2.802(9)  
N(7)-O(6) - 2.809(4) - 2.764(3) 
N(8)-O(3A) 2.976(4) - 2.750(8)  
N(8)-O(6) - 2.874(4) - 2.870(3) 
 
Moreover, the hydrogen bonding appears to direct the position of the pivaloyl-amide groups 
resulting in an enlarged angle between the pyridine planes and the plane containing the 
amide group (N(7)C(34)O(4) and N(8)C(37)O(5)) (28.3° and 17.8° for [ZnII2(H2L2)(µ-OAc)2]+; 
12.0° and 19.2° for [ZnII2(H2SIM1)(µ-OAc)(OH)]+; 9.2° and 19.1° for 
[ZnII2(H2SIM3)(µ-OAc)(OH)]). This angle was found to be small in the structure of the 
6-(pivaloylamido)pyridine containing ligand HL34 with a value of 11.4° due to a C-H···O=C 
interaction between the carbonyl oxygen and the nearby hydrogen atom in 5-position of the 
pyridine ring.168 Interestingly, in the asymmetric complexes [ZnII2(H2SIM1)(µ-OAc)(OH)]+ and 
[ZnII2(H2SIM3)(µ-OAc)(OH)] only the angle at the 6-(pivaloylamido)pyridine moiety, which is 
coordinated opposite of the bridging acetate group, is expanded, presumably due to steric 
hindrance within the cavity.  
In all five complexes discussed in this chapter, the ZnII ions are coordinated in the anti-
configuration with respect to the phenoxide ring. The resulting ZnII∙∙∙ZnII distances (see 
Table 7) are at the short end of the range reported for similar dizinc(II) complexes. The 
variation of ligand symmetry and substituents in the range of five ligands discussed here only 
leads to a relatively small variation of the ZnII∙∙∙ZnII distance (3.37 Å to 3.59 Å). Importantly, 
the ZnII∙∙∙ZnII distances are slightly elongated in the asymmetric complexes 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 and [ZnII2(H2SIM3)(µ-OAc)(OH)] to 3.54 Å and 3.59 Å. 
Consequently, the ZnII-O-ZnII angle is increased in those two complexes to about 120°, close 
to a highly symmetrical trigonal angle with respect to the phenoxide bridge, and this 
compares with ZnII-O-ZnII angles in the range 112.8° to 116.1° in the more symmetric 
derivatives [ZnII2(L1)(µ-OAc)2]PF6, [ZnII2(H2L2)(µ-OAc)2]PF6, and [ZnII2(SIM2)(µ-OAc)2]PF6.  
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The X-ray crystallographic results for the acetate-bridged dizinc(II) complexes give rise to the 
conclusions that (i) ZnII ions bound in phenoxido-based ligands with pyridine donors (e.g. the less 
hindered ligands HL1, H3L2 and HSIM2) favor a six-coordinate geometry (by binding to two 
bridging acetate ligands) over the trigonal bipyramidal geometry with only one bridging acetate 
co-ligand, which was only observed in the case of H3SIM1 and H4SIM3 due to the sterically 
demanding tert-butyl groups, and (ii) the two bulky pivaloyl-amide residues of H3L2 are positioned 
on opposite sides of the phenolate backbone upon coordination of two zinc(II) ions. Moreover, 
the asymmetric ligands H3SIM1 and H4SIM3 enforce a cavity that leads to the complexation 
of two ZnII ions in different coordination geometries: one zinc(II) site is octahedral, the other 
site is trigonal bipyramidal, the coordination geometry found for both ZnII ions in the active 
site of Phospholipase C 201 and for one ZnII ion in Ser/Thr Phosphatase-1,202 which is 
accompanied by a zinc(II) in a square-pyramidal geometry.202 The biomimetic systems 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6, [ZnII2(H2L2)(µ-OAc)2]PF6, [ZnII2(SIM2)(µ-OAc)2]PF6, and 
[ZnII2(H2SIM3)(µ-OAc)(OH)] demonstrate the formation of a hydrogen-bond network similar 
to that found in the active site of the native enzymes.  
Infrared Spectroscopy  
Examination of solid state FT-IR spectra of the dizinc(II) complexes and comparison among each 
other as well as to the free ligands provide a good method for assigning the different infrared 
vibrations and investigating the symmetry of the complexes and the strength of the hydrogen 
bonds formed (Figure 32).203  
 
Figure 32: Comparison of IR spectra of a) [ZnII2(H2SIM3)(µ-OAc)(OH)], b) [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6, c) 
[ZnII2(H2L2)(µ-OAc)2]PF6, d) H2SIM1, e) [ZnII2(SIM2)(µ-OAc)2]PF6, f) [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 and g) 
[ZnII2(L1)(µ-OAc)2]PF6.  
The very similar IR spectra of H3SIM1 and H3L2 show the N-H vibration band at around 3440 cm-1 
(Figure 32d); this is lowered by 145 cm-1 (1.73 kJ∙mol-1) in the spectrum of 
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[ZnII2(H2L2)(µ-OAc)2]PF6 (Figure 32c). This can be explained by hydrogen bonding, which results 
in N-H bond elongation and therefore in a lowering of the vibrational frequency and a broadening 
of the corresponding bands. Thus, the detection of only a very broad N-H vibration band for 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 around 3120 cm-1 (Δν = 220 cm-1, 2.63 kJ∙mol-1) suggests that 
the hydrogen bonds are even stronger in this complex (Figure 32b).204, 205 Moreover, the 
terminal hydroxido-ligand in [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 results in a sharp O-H stretch with 
a frequency of 3385 cm-1. The small energy value of 3385 cm-1 (40.5 kJ∙mol-1) for the 
excitation of the O-H stretch additionally reflects the strength of the hydrogen bonding 
within this complex. Unfortunately, for [ZnII2(H2SIM3)(µ-OAc)(OH)] both bands, associated 
with hydrogen bonding, are very broad (Figure 32a). 
The spectrum of the reference complex [ZnII2(L1)(µ-OAc)2]PF6 lacks bands in the region 
between 3100 cm-1 to 3600 cm-1 (Figure 32g), whereas its amino derivative, 
[ZnII2(SIM2)(µ-OAc)2]PF6, has three transitions in this region, assigned to N-H stretching 
vibrations (Figure 32e). Additionally, the separation of the asymmetric and symmetric 
acetate stretches at around 1400 cm-1 and 1550 cm-1 confirms bidentate binding in the solid 
state of all dizinc(II) complexes, discussed herein.205, 206 Interestingly, for the asymmetric 
complexes [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 and [ZnII2(H2SIM3)(µ-OAc)(OH)] the intensity of the 
band assigned to the asymmetric acetate stretching vibration is lower (~ 1580 cm-1) than for 
the symmetric counterpart, in contrast to the symmetric complexes [ZnII2(L1)(µ-OAc)2]PF6, 
[ZnII2(H2L2)(µ-OAc)2]PF6 and [ZnII2(SIM2)(µ-OAc)2]PF6 (~ 1600 cm-1), suggesting a slightly 
different coordination geometry. In the cases in which hexafluorophosphate was present as 
the counter ion stretching and deformation bands were detected around 830 cm-1 and 
555 cm-1. 
Mass Spectrometry 
In order to investigate the complex structure of the dizinc(II) complexes in solution, mass 
spectrometric data were obtained in dichloromethane as well as in acetonitrile; Table 9 
summarizes the highest mass peaks detected. All highest mass peaks showed the distinctive 
isotopic pattern of dizinc(II) complexes (Figure 33). As expected, the separation of the peaks for 
the doubly charged species was 0.5 m/z units.  
The mass spectrometric measurement showed solvent dependency in the case of the doubly 
acetate-bridged complexes [ZnII2(L1)(µ-OAc)2]PF6, [ZnII2(H2L2)(µ-OAc)2]PF6, and 
[ZnII2(SIM2)(µ-OAc)2]PF6. Thus, the highest mass peaks obtained by ESI+ mass spectrometric 
measurements in dichloromethane were assigned to the intact cation, but similar measurements 
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in acetonitrile resulted in highest mass peaks that imply ligand exchange within the complex 
cationic structure. In contrast, the complexes [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 and 
[ZnII2(H2SIM3)(µ-OAc)(OH)], containing only one bridging acetate co-ligand and an additional 
hydroxido co-ligand led in both solvents to highest mass peaks that could be assigned to species 
missing the acetate bridge. These findings imply ligand exchange by solvent or water molecules 
in acetonitrile (rather than dichloromethane) for all complexes discussed in this chapter.  
 
Figure 33: Recorded (top) and calculated (bottom) isotopic pattern for a) [ZnII2(H2L2)(OH)(H2O)]2+ and b) 
[ZnII2(L2)]2+ detected in the mass spectrum of [ZnII2(H2L2)(µ-OAc)2]PF6 in acetonitrile. 
Table 9: Highest mass peaks in ESI+ mass spectrometric measurements of [ZnII2(L1)(µ-OAc)2]PF6, 
[ZnII2(H2L2)(µ-OAc)2]PF6, [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6, [ZnII2(SIM2)(µ-OAc)2]PF6, and [ZnII2(H2SIM3)(µ-OAc)(OH)] 
in dichloromethane and acetonitrile. 
complex 
highest ESI+ mass peaks 
          in dichloromethane               in acetonitrile 
 peak found 
(m/z) 
assigned to 
(calcd m/z) 
peak found 
(m/z) 
assigned to  
(calcd m/z) 
[ZnII2(L1)(µ-OAc)2]PF6 779.1537 [ZnII2(L1)(OAc)2]+  
779.1517 
360.0704 [ZnII2(L1)(OAc)]2+ 
360.0689 
   779.1507 [ZnII2(L1)(OAc)2]+ 
779.1517 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 921.2715 [ZnII2(H2SIM1)(OH)2(CH2O)]+ 
921.2791* 
429.1298 [ZnII2(HSIM1)]2+ 
429.1268 
   917.2757 [ZnII2(HSIM1)(OAc)]+ 
917.2674 
[ZnII2(H2L2)(µ-OAc)2]PF6 977.2952 [ZnII2(H2L2)(OAc)2]+ 
977.2886 
429.1283 [ZnII2(HL2)]2+ 
429.1268 
[ZnII2(SIM2)(µ-OAc)2]PF6 809.1766 [ZnII2(SIM2)(OAc)2]+ 
809.1735 
344.0730 [ZnII2(SIM2)]2+  
344.0701 
[ZnII2(H2SIM3)(µ-OAc)(OH)] 872.2469 [ZnII2(HSIM3)]+  
872.2459 
435.6 [ZnII2(SIM3)]2+ 
435.6272 
   908.3 [ZnII2(HSIM3)(H2O)2]+ 
908.2682 
* Best fit found for this pattern.  
853.2527
855.2501
857.2499
858.2507
860.2497
853.2505
855.2483
857.2463
858.2494
860.2465
a) b)
427.1307
427.6315
428.1299
428.6301
429.1294
429.6294
430.1277
430.6279
431.6276
432.1277
431.1269
427.1289
427.6306
428.1278
428.6290
429.1268
429.6283
430.1253
430.6269
432.1277
431.1246
431.6263
DIZINC MODEL COMPLEXES 
85 
NMR Studies 
In order to probe the symmetry of the complexes in solution, 1H and 13C NMR measurements of 
the dizinc(II) complexes were carried out in deuterated acetonitrile. Two-dimensional methods 
(NOESY, COSY, HSQC and HMBC) were used to assign the signals to the explicit hydrogen or 
carbon atoms in the manner described in Chapter 3.2.1. The number, chemical shifts and splitting 
of the resonances detected illustrate the symmetry of the coordination compounds in solution.  
[ZnII2(L1)(µ-OAc)2]PF6 and [ZnII2(H2L2)(µ-OAc)2]PF6 
The equivalence of the two binding sites within [ZnII2(H2L2)(µ-OAc)2]PF6, found by X-ray 
diffractometric investigation, was confirmed as the 16 aromatic protons resulted in eight 
resonances in the aromatic region of the 1H NMR spectrum, with each of the multiplet 
resonances integrating for two protons (Figure 34, top). Comparison with the 1H NMR 
spectrum of the free ligand H3L2 (Figure 34, bottom) shows a downfield shift of protons of 
the amidated pyridine residues and an upfield shift of protons of the unsubstituted pyridines 
upon the binding of ZnII ions. As expected, [ZnII2(L1)(µ-OAc)2]PF6 showed the same behavior, 
leading to a 1H NMR spectrum corresponding to a pair of two equal pyridine groups within 
the complex. Moreover, due to the same surroundings the two bridging acetate groups in 
[ZnII2(L1)(µ-OAc)2]PF6 and [ZnII2(H2L2)(µ-OAc)2]PF6, and the tert-butyl residues in 
[ZnII2(H2L2)(µ-OAc)2]PF6 lead to a single resonance. This supports the symmetry appearance 
of [ZnII2(L1)(µ-OAc)2]PF6 and [ZnII2(H2L2)(µ-OAc)2]PF6, also when dissolved in acetonitrile.  
 
Figure 34: Aromatic region of the 1H-NMR spectra of a) ligand H3L2 and b) complex [ZnII2(H2L2)(µ-OAc)2]PF6 in 
CD3CN. 
Additional experiments were undertaken to study the stability of complex 
[ZnII2(H2L2)(µ-OAc)2]PF6 in water/acetonitrile mixtures, as well as under basic conditions 
(conditions comparable to the activity assays which will be discussed in Chapter 7). 
Therefore, [ZnII2(H2L2)(µ-OAc)2]PF6 was dissolved in CD3CN, and D2O was added stepwise. 
Figure 35 shows the spectra of [ZnII2(H2L2)(µ-OAc)2]PF6 in pure CD3CN and CD3CN/D2O 
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mixtures (8:1, 2:1, 1:1). The addition of D2O led to no variation in the chemical shifts but 
induced a broadening of the detected resonances. Further addition of NaOD in D2O resulted 
in no change in the 1H NMR spectrum as shown in Figure 35e. This implies that no 
decoordination of ZnII takes place under basic conditions. 
 
Figure 35: Aromatic region of the 1H NMR spectra of a) complex [ZnII2(H2L2)(µ-OAc)2]PF6 in CD3CN and in 
CD3CN/D2O mixtures (b) 8:1 , c) 2:1, d) 1:1) as well as e) in CD3CN/D2O mixture with pH 10.4. 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 
The asymmetry of [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6, observed in the solid state by X-ray 
diffraction, also emerges from the 1H NMR spectrum, where the aromatic region exhibits 16 
resonances (Figure 36, top). In this complex, every hydrogen atom has a different electronic 
environment leading to the difference in the spectrum, when compared to the metal-free ligand 
(Figure 36, bottom). The resonances from the protons proximal to the ZnII centers show a 
downfield shift while protons, that are distant from the metal centers, especially those pointing 
to the opposite site of the phenolate backbone, show an upfield shift. Similarly, the proton signals 
of each methylene group are separated, which gives rise to a set of 12 doublets in the region 
between 3.3 and 4.5 ppm (Figure 37, top). This implies that the electronic environment of 
protons bound to the same methylene carbon are not identical, in contrast to the spectrum of 
the free ligand (Figure 37, bottom), and this again is consistent with the observed X-ray structure. 
The coupling to the other hydrogen atom at the same carbon atom leads to the appearance of 
doublets. As a result of the asymmetry in this structure, the two tert-butyl groups in 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+ give rise to two resonances in the 1H NMR spectrum.  
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Figure 36: Aromatic region of 1H NMR spectra of a) ligand H3SIM1 and b) complex [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 
in CD3CN. 
 
Figure 37: Methylene resonances in the 1H NMR spectra of a) ligand H3SIM1 and b) complex 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 in CD3CN. 
[ZnII2(SIM2)(µ-OAc)2]PF6 
Although the crystal structure of [ZnII2(SIM2)(µ-OAc)2]PF6 suggests that, in the solid state, the 
complex is symmetrical, the 1H NMR spectrum exhibits 16 resonances in the aromatic region 
(Figure 38, top). Similar to the spectrum of [ZnII2(H2SIM1)(µ-OAc)(OH)]+, 12 resonances in the 
form of doublets are detected for the methylene protons in [ZnII2(SIM2)(µ-OAc)2]+. In contrast 
to [ZnII2(L1)(µ-OAc)2]+ and [ZnII2(H2L2)(µ-OAc)2]+, the two bridging acetate co-ligands in 
[ZnII2(SIM2)(µ-OAc)2]+ produce two resonances in the 1H NMR spectrum. Therefore, the 
substitution of two pyridine groups in one of the binding sites of HL1 creates two different 
coordination environments in HSIM2, which induce the formation of an asymmetric dizinc(II) 
complex in solution, in contrast to the symmetric structure observed in the solid state by X-ray 
crystallography.  
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Figure 38: Aromatic region of the 1H NMR spectra of a) ligand HSIM2 and b) complex [ZnII2(SIM2)(µ-OAc)2]PF6 in 
CD3CN. 
[ZnII2(H2SIM3)(µ-OAc)(OH)] 
Unfortunately, the poor solubility of [ZnII2(H2SIM3)(µ-OAc)(OH)] made it impossible to conduct 
a comparable set of 1H NMR measurements for this complex, because addition of perchloric 
acid was necessary to achieve solubility. Figure 39 illustrates the 1H NMR spectra obtained 
for the ligand H4SIM3 and [ZnII2(H2SIM3)(µ-OAc)(OH)] in deuterated acetonitrile after addition 
of four volume percent perchloric acid.  
Comparison of the spectra exhibits two essential findings. Firstly, resonances for protons of 
the two amidated pyridine residues in binding site A (defined in Chart 7, Chapter 3) as well 
as resonances for protons of the unsubstituted pyridine moiety in binding site B are shifted 
in the complex spectrum compared to the free ligand. Secondly, the resonances of only one 
methylene proton pair is split into two doublets. Therefore, the addition of perchloric acid 
appears to lead to loss of the phenolate side-arm from the metal ion, since the proton 
resonances exhibit the same chemical shifts as those for this phenolate in the free ligand. 
The shift of the resonances assigned to the amidated pyridine residues in addition to the 
splitting of the methylene group assigned to the same side-arms implies sustained binding of 
a ZnII ion in binding site A. Whether the pyridine residue of binding site B is still bound to a 
ZnII center remains unclear, since on the one side the aromatic resonances of this side-arm 
are shifted, but on the other side the methylene group transformed in a singlet. The ESI+ mass 
spectrometric measurement of [ZnII2(H2SIM3)(µ-OAc)(OH)] in deuterated acetonitrile after 
addition of hydrochloric acid resulted in a spectrum showing the main peak with a pattern typical 
for a dizinc(II) species (m/z 870.2 assigned to [Zn2(HSIM3)]+), but also a peak with a typical 
monozinc(II) pattern with a similar intensity was detected (m/z 806.2 assigned to [Zn(H3SIM3)]+).  
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Figure 39: Aromatic region (a) and methylen proton resonances (b) in the 1H NMR spectra of H4SIM3 (bottom) 
and [ZnII2(H2SIM3)(µ-OAc)(OH)] (top) in CD3CN with 4 vol% HClO4. 
The results obtained by NMR spectroscopic techniques demonstrate that only the two complexes 
[ZnII2(L1)(µ-OAc)2]+ and [ZnII2(H2L2)(µ-OAc)2]+ contain two metal centers in identical geometry, 
when dissolved in acetonitrile. [ZnII2(H2SIM1)(µ-OAc)(OH)]+ and [ZnII2(SIM2)(µ-OAc)2]+, the 
complexes formed with the asymmetrically substituted ligands H3SIM1 and HSIM2, contain two 
ZnII ions in different surroundings. This suggests that the asymmetry of the amide-based complex 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 is not only the result of the two different coordination 
geometries of the two ZnII centers but is also due to the hydrogen bond donating groups in 
proximity to one of the coordination sites.  
UV-vis Spectroscopic Studies 
Electronic spectra of the complexes [ZnII2(L1)(µ-OAc)2]PF6, [ZnII2(H2L2)(µ-OAc)2]PF6, 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6, and [ZnII2(SIM2)(µ-OAc)2]PF6 were recorded in acetonitrile as 
well as in acetonitrile/aqueous buffer mixtures (1:1). The aqueous buffer solutions were 
50 mM in HEPES, 50 mM in MES, 50 mM in CHES, 50 mM in CAPS and 250 mM in lithium 
perchlorate and were adjusted to a specific pH value by addition of aqueous sodium hydroxide 
solution. These buffer solutions were also used for the hydrolytic activity assays discussed in 
Chapter 6.3.  
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All four dizinc(II) complexes show two bands in the regions at 230 - 260 nm and 280 - 320 nm 
attributed to pπ→pπ* ligand internal transitions (see Figure 40 and Table 10).  
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Figure 40: UV-vis absorption spectra of dizinc(II) complexes (5 µM solution in CH3CN). 
Table 10: UV-vis spectral properties of the dizinc(II) complexes (5 µM in CH3CN). 
complex  UV-vis 
[nm] 
ε 
[M-1 cm-1] 
transitions 
[ZnII2(L1)(µ-OAc)2]PF6 260 113168 pπ → pπ* 
 311 37161 pπ → pπ* 
[ZnII2(H2L2)(µ-OAc)2]PF6 238 249438 pπ → pπ* 
 289 177075 pπ → pπ* 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 239 198843 pπ → pπ* 
 290 151351 pπ → pπ* 
[ZnII2(SIM2)(µ-OAc)2]PF6 237 213347 pπ → pπ* 
 305 120667 pπ → pπ* 
 
The substitution with a pivaloyl-amide group in position six of two pyridine residues in 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+ and [ZnII2(H2L2)(µ-OAc)2]+ leads to a hypsochromic shift in the UV-
vis spectroscopic measurements, compared with the spectra of the unsubstituted compound 
[ZnII2(L1)(µ-OAc)2]+. The substitution by amino moieties, as in [ZnII2(SIM2)(µ-OAc)2]+, has a 
similar but less pronounced effect.  
pH Behavior 
In order to examine the behavior of the complexes [ZnII2(L1)(µ-OAc)2]+, [ZnII2(H2L2)(µ-OAc)2]+, 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+ and [ZnII2(SIM2)(µ-OAc)2]+ under basic conditions, UV-vis 
spectroscopic measurements were also conducted in acetonitrile-aqueous buffer mixtures 
(1:1); the pH values recorded refer to the aqueous component. With increasing basicity, the 
band in the absorbance spectrum of [ZnII2(H2L2)(µ-OAc)2]+ at 287 nm experiences a shift to 
294 nm. Also, the band at 233 nm decreases in intensity, while new bands at 259 nm and 
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326 nm arise (Figure 41a). Figure 41b shows the change of absorbance at different 
wavelengths as a function of rising pH value. The overlay of the spectra at different pH values 
indicates the presence of three isosbestic points at 246 nm, 270 nm and 297 nm. The 
observation of isosbestic points indicates that the dizinc(II) complex is stable in the 
investigated pH range and undergoes a single deprotonation step. Therefore, the curves can 
be analyzed by the Henderson-Hasselbalch Equation 9, where [HA] and [A¯] are the 
concentrations of the protonated and deprotonated complex species, respectively, in the 
equilibrium (Ka: equilibrium constant). 
Equation 9 pH = pKa + log
[A−]
[HA]
 
[HA] and [A¯] follow the correlation given in Equation 10 with the initial complex 
concentration [HA]0. 
Equation 10 [A−] = [HA]0 − [HA] 
Therefore, the concentration of protonated species in solution can be described as given in 
Equation 11. 
Equation 11 [HA] =
[HA]0
10pH−pKs+1
 
The Beer-Lambert Law assuming two species in solution is given in Equation 12, where ε1 and 
ε2 are the extinction coefficients of the protonated (HA) and deprotonated complex species 
(A¯) and d is the path length. 
Equation 12 Abs = ε1 ∗ d ∗ [HA] + ε2 ∗ d ∗ [A
−] 
Consideration of Equation 10, leads to Equation 13. 
Equation 13 Abs = (ε1 − ε2) ∗ d ∗ [HA] + ε2 ∗ d ∗ [HA]0  
Substituting [HA] in Equation 13, as defined in Equation 11, provides Equation 14. 
Equation 14 Abs = (ε1 − ε2) ∗
[HA]0∗d
10pH−pKa+1
+ ε2 ∗ [HA]0 ∗ d  
Here, the absorbance depends on the extinction coefficients, ε1 and ε2, and the pKa value. 
Fitting of the pH-dependent spectroscopic data to Equation 14 results in an estimate of the 
pKa value of [ZnII2(H2L2)(µ-OAc)2]+ of 8.14 ± 0.25. pH-dependent UV-vis spectroscopic 
measurements of [ZnII2(H2SIM1)(µ-OAc)(OH)]+ show similar effects (Figure 41c, d), and from 
fitting of these data to Equation 14, the pKa value of [ZnII2(H2SIM1)(µ-OAc)(OH)]+ is: 
pKa = 7.27 ± 0.65. The variation of the pH value from 5 to 11 did not result in any change of 
the UV-vis spectra of [ZnII2(L1)(µ-OAc)2]PF6 and [ZnII2(SIM2)(µ-OAc)2]PF6.  
DIZINC MODEL COMPLEXES 
92 
 
Figure 41: UV-vis spectroscopic titration spectra (5 µM in acetonitrile/buffer between pH 5 and 11) for a) 
[ZnII2(H2L2)(µ-OAc)2]PF6 and c) [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 as well as absorbance vs. pH plots for b) 
[ZnII2(H2L2)(µ-OAc)2]PF6 and d) [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6. 
The spectrophotometrically determined pKa values of [ZnII2(H2SIM1)(µ-OAc)(OH)]+ and 
[ZnII2(H2L2)(µ-OAc)2]+ can be compared to the corresponding data obtained from the analysis 
of the kinetic data of the phosphoester hydrolysis, and this supports the mechanistic 
interpretation (see Chapter 7). Importantly, the data described here also support the solution 
structural analysis, i.e. the observation of isosbestic points in the pH range of 5 to 11 indicates 
that the dizinc(II) complexes are stable (and the only species of relevance) in these solutions, 
and this emerges also from the NMR studies, specifically in mixed CD3CN/D2O solutions at 
varying pH values (see above).   
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4.4 SUMMARY 
 
The five ligands HL1, with no substituents, H3SIM1, H4SIM3, with two asymmetrically disposed 
amide residues, H3L2, with two symmetrically disposed amide residues, and HSIM2, with two 
asymmetrically disposed amine anchor groups, lead to strikingly different structures of the 
dizinc(II) complexes [ZnII2(L1)(µ-OAc)2]+, [ZnII2(H2L2)(µ-OAc)2]+, [ZnII2(H2SIM1)(µ-OAc)(OH)]+, 
[ZnII2(SIM2)(µ-OAc)2]+, and [ZnII2(H2SIM3)(µ-OAc)(OH)]. While the three complexes 
[ZnII2(L1)(µ-OAc)2]+, [ZnII2(H2L2)(µ-OAc)2]+, and [ZnII2(SIM2)(µ-OAc)2]+ show the common 
structure of phenoxido-bridged phosphatase models with two bridging acetate co-ligands, 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+ and [ZnII2(H2SIM3)(µ-OAc)(OH)] possess two strikingly different 
ZnII sites, one being five- and one six-coordinate, with rare example of a ZnII-OH bond. The 
appearance of a terminal hydroxido co-ligand is ascribed to the steric hindrance caused by 
the asymmetric pivaloyl-substituted ligand backbone and the emerging incapacity of the 
resulting dizinc(II) complexes to bind two acetate co-ligands. Stabilization of this hydroxido 
co-ligand by hydrogen bond formation is supported by X-ray structures and the IR spectra of 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+ and [ZnII2(H2SIM3)(µ-OAc)(OH)]. Hydrogen bond formation was 
also seen in the structure of the complexes [ZnII2(H2L2)(µ-OAc)2]+ and [ZnII2(SIM2)(µ-OAc)2]+ 
to the acetate co-ligands. 
The structures of the dizinc(II) complexes in solution were studied via NMR spectroscopy. 
The asymmetry of [ZnII2(H2SIM1)(µ-OAc)(OH)]+ in solution was verified. Furthermore, the 
solution structure of [ZnII2(SIM2)(µ-OAc)2]+, which is also built up by an asymmetric ligand 
backbone, was found to contain two unequal ZnII centers due to the two amino residues 
adjacent one of the two ZnII centers. In conclusion these three asymmetric complexes 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+, [ZnII2(SIM2)(µ-OAc)2]+ and [ZnII2(H2SIM3)(µ-OAc)(OH)] can be 
considered as accurate model complexes for phosphoesters type metalloenzymes as they 
bear the two ZnII centers in different coordination environments and have the capacity to 
form a hydrogen bond network as exhibited for the native enzymes. 
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Chapter 5  
Diiron Model Complexese 
                                                          
e Main parts of this chapter will be published in “An Approach to More Accurate Model Systems for Purple 
Acid Phosphatases (PAPs)”; Paul V. Bernhardt, Simone Bosch, Peter Comba, Lawrence R. Gahan, Graeme R. 
Hanson, Valeriu Mereacre, Christopher J. Noble, Gerhard Schenk, Hubert Wadepohl; manuscript in 
preparation. 
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5.1 INTRODUCTION 
 
Iron is one of the most versatile of the biochemically active metals and, therefore, the role of 
iron in its various oxidation states in the active sites of metalloenzymes has been widely 
studied.207-211 Even considering only non-haem diiron proteins, the diiron core takes part in a 
multitude of functions including oxygen transport (Hemerythrin), methane oxidation (Methane 
Monooxygenase, MMO), conversion of ribonucleotides to deoxyribonucleotides (Ribonucleotide 
Reductase, RNR), detoxification of NO (Flavodiiron Nitric Oxide Reductase, FNOR) and hydrolysis 
of phosphate esters (Purple Acid Phosphatase, PAP).210-218 In these enzymes the diiron sites, in 
all of their accessible oxidation states, are typically bridged by at least one carboxylate moiety.183 
Most of the iron-containing non-haem diiron proteins function through interaction of their 
diiron(II) form with dioxgen. In contrast, PAPs perform a hydrolytic function, at least in vitro, via 
their heterovalent diiron(III/II) form and in this way are involved in the regulation of phosphate 
and phosphorylated metabolite levels in a wide range of organisms.102 More precisely, PAPs 
catalyze the hydrolysis of phosphomonoesters at acidic to neutral pH. The active sites of the 
mammalian PAPs isolated from bovine spleen (bsPAP) and porcine uterus (ufPAP) were 
determined to contain a dinuclear iron center in two accessible oxidation states: the FeIII2 form, 
which is characterized by typical visible absorption maxima between 550 nm and 570 nm 
(ε ~ 4000 M-1cm-1), and the reduced FeIIIFeII form, which exhibits blue shifted absorption maxima 
between 505 nm and 510 nm (ε ~ 4000 M-1cm-1).69, 138, 217, 219, 220 Interestingly, the FeIII2 form of 
ufPAP was found to have an upper limit of less than 1% of the activity of the heterovalent FeIIIFeII 
form.21, 218, 221 The redox potential for the FeIII2/FeIIIFeII couple of ufPAP was found to be 0.367 V 
at pH 5 and 0.306 V at pH 6 vs. NHE. Therefore, the enzyme is easily and reversibly oxidized to 
the FeIII2 form owing to the low redox potential of the FeII center.222, 223 This observation led to 
the suggestion that PAPs may regulate their catalytic activity in vivo by reversible 
oxidation/reduction of the active site.222 
PAPs further differ from other non-heme diiron proteins having a tyrosinate ligand leading to the 
characteristic absorption bands and consequently to the characteristic purple color. The 
absorption bands have been assigned by resonance Raman studies to tyrosinate-to-FeIII CT 
transitions.219 With Mössbauer spectroscopy the iron centers of ufPAP and bsPAP were revealed 
to have distinct coordination environments, and this was confirmed by X-ray crystallographic 
studies of ufPAP.219, 224, 225 Magnetic susceptibility studies indicate that the FeIII and FeII centers 
are weakly antiferromagnetically coupled with J values ranging from -5 cm-1 to -11 cm-1 
(H = -2JS1S2).219, 226 Similarly, weak antiferromagnetic coupling was emerged from magnetic 
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susceptibility studies for the oxidized FeIII2 form of ufPAP (J > -15 cm-1).227 Moreover, the reduced 
form of ufPAP exhibits rhombic EPR signals at g = 1.94, 1.73 and 1.58, consistent with antiferro-
magnetically coupled high-spin FeII and FeIII centers.217, 228 
In recent years, a number of structural models for the active site of PAPs have been developed 
using phenoxido-containing multidentate ligands.81 FeIII2 complexes, which were reported for 
symmetrical ligands such as H3L3, H3L35, HL36, and H3L37, were used to model the oxidized form of 
PAPs.101, 125, 229, 230 Moreover, heterovalent diiron complexes were also generated using 
symmetric ligands such as HL1, HL11, HL38, and HL10 and have been examined as structural models 
for PAPs.99, 138, 139, 231, 232 From the separation of their one-electron redox processes assigned to 
the FeII2/FeIIIFeII and FeIIIFeII/FeIII2 couples the stability of the FeIIIFeII form over the corresponding 
homovalent FeII2 or FeIII2 complexes was investigated. The comproportionation constant (Kcom) 
for this equilibrium was found to be in the order of 1010 - 1012 and therefore confirms the 
substantial stability of the mixed-valent FeIIIFeII form.81 
Perhaps the most widely employed FeIIIFeII model complex mimicking the mixed-valent diiron 
active site of PAP is [FeIIIFeII(L4)(µ-OAc)2]ClO4. This acetate-bridged FeIIIFeII complex of the 
asymmetric ligand H2L4 revealed significant similarities in the physical properties compared to 
the native enzyme ufPAP. In particular, [FeIIIFeII(L4)(µ-OAc)2]ClO4 exhibits (i) a comparable 
metal···metal distance (3.483(2) Å vs. 3.31 Å in ufPAP), (ii) a phenolate-to-FeIII charge transfer 
band at 550 nm (vs. the tyrosinate-to-FeIII charge transfer band at ~ 510 nm in ufPAP), (iii) weakly 
antiferromagnetically coupled high spin FeIII and FeII ions (J = -7.4 cm-1 vs. -5 to -11 cm-1 for ufPAP), 
(iv) localized iron valences in the solid state, and (v) a reversible FeIIIFeII/FeIII2 redox couple at a 
similar potential (380 mV vs. NHE vs. 344 mV at pH 4.1 / 367 mV at pH 5 for ufPAP).94, 96, 106, 140, 
141 
Although [FeIIIFeII(L4)(µ-OAc)2]ClO4 mimics accurately the first coordination sphere in the active 
site of PAP, the important structural features derived from the second coordination sphere of 
PAPs have not been addressed. The PAPs active site includes non-coordinated histidine groups 
proximal to the iron centers, which may help to position the substrate, as proposed from 
crystallographic data as well as from mechanistic studies.74 These amino acid residues have been 
considered in the diiron(III) complexes, depicted in Chart 16, in form of basic groups proximal to 
the metal centers, in order to mimic the hydrogen bonding network within the active site of 
PAPs.108, 114 Moreover, the generation of a FeIIIFeII form by bulk electrolysis with 
[FeIII2(L8)(µ-OH)(OH2)2]2+ was achieved.109, 114 
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Chart 16: Previously reported diiron(III) complexes containing hydrogen bond donors.108, 114 
Examination and comparison of the phosphoester hydrolysis, accomplished with the complexes 
possesing the capacity for hydrogen bonding, as well as the FeIII2 complex of HL1, lacking 
hydrogen bond donors, gave further insights on the impact of hydrogen bond donors proximal 
to the diiron core on the catalytic activity. The results emerging from this progress are discussed 
in more detail in Chapter 8.  
In this work, the role of the hydrogen bond donor position is probed, based on the hypothesis 
that hydrogen bonding in an asymmetrical manner favors monodentate or asymmetrical bridging 
phosphate binding and therefore helps to release the product formed after hydrolysis. Hence, 
the ligands H3SIM1 and H4SIM3 were designed and synthesized. In this chapter the synthesis and 
characterization of three FeII2 complexes, shown in Chart 17, are discussed. All three complexes 
bear two pivaloyl-amide residues that are able to form hydrogen bonds to substrate molecules. 
The two hydrogen bond donors in [FeII2(H2SIM1)(µ-OAc)2]PF6 and [FeII2(H2L2)(µ-OAc)2]PF6 are 
positioned in two different fashions, (i) both pivaloyl-amide moieties adjacent to one binding 
site, or (ii) one pivaloyl-amide moiety adjacent to each binding site. Similar to 
[FeII2(H2SIM1)(µ-OAc)2]PF6, [FeII2(H2SIM3)(µ-OAc)2] contains both pivaloyl-amide residues in one 
binding site but the second binding site has one phenolate instead of a pyridine residue. 
Among other investigations, the stability of the FeIIIFeII complex of the asymmetric ligand H3SIM1 
over the corresponding homovalent FeII2 and FeIII2 complexes was studied by examination of the 
comproportionation constant Kcom. 
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Chart 17: Diiron(II) complexes discussed in this chapter. 
As discussed in Chapter 3.2.5 the coordination of two FeIII ions in a single H3SIM1 ligand molecule 
could not be detected. Therefore, the preparation of a FeIII2 complex and the subsequent 
generation of the FeIIIFeII complex by bulk electrolysis as it was done with 
[FeIII2(L8)(µ-OH)(OH2)2](ClO4)4 is not feasible and alternative synthetic pathways were tested. For 
example, Suzuki et al. and Maeda et al. prepared first the FeII2 complex of HL1 and, subsequently, 
generated the heterovalent diiron form by selective oxidation in the presence of oxygen.231, 233 
With this knowledge, the stability of [FeII2(H2SIM1)(µ-OAc)2]PF6 under aerobic conditions was 
tested. Moreover, the generation of an FeIIIFeII complex of H3SIM1 was studied with 
electrochemical methods as well as by the use of the oxidant ferrocenium hexafluorophosphate.  
5.2 SYNTHESIS OF DIIRON(II) MODEL COMPLEXES 
 
The dinuclear iron(II) complexes of H3SIM1 and H3L2 were prepared under an inert atmosphere in 
the glovebox by reaction with two equivalents of iron(II) acetate in degassed methanol. After the 
yellow solution was stirred for 12 hours at room temperature, sodium hexafluorophosphate was 
added. The mixture was filtered through a syringe filter and subsequent diffusion of degassed 
diethylether into the solution yielded X-ray quality crystals. In this way, the complexes 
[FeII2(H2SIM1)(µ-OAc)2]PF6 and [FeII2(H2L2)(µ-OAc)2]PF6 were isolated as green crystals. 
Applying this procedure to H4SIM3, the ligand containing solution was treated with one 
equivalent of sodium hydroxide before addition of iron(II) acetate and sodium 
hexafluorophosphate. Diffusion of degassed diethylether into the claret-colored solution 
resulted in the formation of only a few crystals of the complex {Na[FeII2(H2SIM3)(µ-OAc)2]2}PF6, 
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suitable for X-ray diffraction but insufficient for further investigations. 
[FeII2(H2SIM1)(µ-OAc)2]PF6 and [FeII2(H2L2)(µ-OAc)2]PF6 were characterized and studied in the 
solid state and also in solution. Furthermore, the possibility of obtaining an FeIIIFeII complex with 
the asymmetric complex [FeII2(H2SIM1)(µ-OAc)2]PF6 was examined. Bearing two amide residues 
adjacent to one iron(II) center in [FeII2(H2SIM1)(µ-OAc)2]PF6 or one amide residue adjacent to 
each iron(II) center in [FeII2(H2L2)(µ-OAc)2]PF6, these complexes offer the potential for the 
investigation of the positioning effect of hydrogen bonding on the phosphoester hydrolytic 
activity.  
5.3 STRUCTURAL CHARACTERIZATION OF DIIRON(II) 
COMPLEXES 
 
The three diiron(II) complexes were structurally characterized in the solid state and 
[FeII2(H2SIM1)(µ-OAc)2]PF6 and [FeII2(H2L2)(µ-OAc)2]PF6 also in solution. Due to the air 
sensitivity of the samples, especially in solution, analyses were undertaken strictly anaerobically. 
The solid state structures were investigated by X-ray diffraction analysis and SQUID experiments. 
Furthermore, the structure as well as the electronic, magnetic, and electrochemical properties 
in solution of [FeII2(H2SIM1)(µ-OAc)2]PF6 and [FeII2(H2L2)(µ-OAc)2]PF6 were studied with UV-
vis-NIR spectroscopy, NMR spectroscopy, and cyclic voltammetry. In addition, the oxidation 
of the diiron(II) complexes under aerobic conditions was investigated. 
Solid State Structure under Anaerobic Conditions 
The yellow crystals of [FeII2(H2SIM1)(µ-OAc)2]PF6 and [FeII2(H2L2)(µ-OAc)2]PF6 and the black 
crystals of {Na[FeII2(H2SIM3)(µ-OAc)2]2}PF6 were used for X-ray diffraction data collection. 
Crystallographic data obtained are displayed in Table 35 (see Appendix).  
The structures of [FeII2(H2SIM1)(µ-OAc)2]+ and [FeII2(H2L2)(µ-OAc)2]+ were solved including a 
complex cation and a hexafluorophosphate counterion. With H4SIM3 as ligand in the complex 
preparation, the X-ray crystal structure revealed a dimeric structure in which the 
[FeII2(H2SIM3)(µ-OAc)2] monomers are bridged by a sodium cation between the Fe(1) ions 
(separated by 6.119 Å) coordinated in the amide-free binding sites. The charge is neutralized by 
the hexafluorophosphate counterion present in the crystal cell. The structures of the complex 
cations are shown in Figure 42 and selected distances and valence angles are summarized in 
Table 11. 
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In contrast to the corresponding ZnII2 complexes discussed in Chapter 4.3, all three FeII2 
complexes, are bridged threefold by two acetate co-ligands and the phenolate-linker of the 
respective ligand. In addition to the three bridging ligands, the two FeII ions in 
[FeII2(H2SIM1)(µ-OAc)2]+ and [FeII2(H2L2)(µ-OAc)2]+ are coordinated by two pyridine moieties and 
a tertiary amine, forming an octahedral coordination environment.  
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Figure 42: Structures of a) [FeII2(H2SIM1)(µ-OAc)2]+, b) [FeII2(H2L2)(µ-OAc)2]+, c) {Na[FeII2(H2SIM3)(µ-OAc)2]2}+ and 
d) the monomeric section of the latter complex, showing hydrogen bonding (green dotted lines; counter ions, 
non-coordinated solvent molecules, and hydrogen atoms, not involved in hydrogen bonding, have been 
omitted for clarity; crystallographic data and ORTEP plots with 50% probability level of thermal ellipsoids appear 
in the Appendix, Table 35 and Figure 75). 
While the FeII-NPy distances for the pyridine residues lacking the amide substituents are in the 
range of 2.159 Å to 2.178 Å, the distance between the FeII center and the amidated pyridine 
moieties are elongated with bond distances from 2.290 Å to 2.364 Å as expected because of the 
electron withdrawing effect of the pivaloyl-amide residues. This finding accords with the results 
obtained from a FeII2 complex [FeII2(H4L39)(µ-OBz)2]+ of the fourfold pivaloyl-amide substituted 
ligand H5L39 in which the FeII-NPy distances to the amidated pyridines are in the range of 2.250 Å 
to 2.265 Å.234 The FeII-Namine distances of [FeII2(H2SIM1)(µ-OAc)2]+ and [FeII2(H2L2)(µ-OAc)2]+, 
ranging from 2.188 Å to 2.270 Å, are in the medium range compared with the Fe-NPy distances, 
While this parameter is similar in the two binding sites of [FeII2(H2L2)(µ-OAc)2]+ containing an 
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amide-substituted pyridine in each binding site (2.2311(15) Å and 2.2270(16) Å), the FeII-Namine 
distance in the amide-free binding site in [FeII2(H2L2)(µ-OAc)2]+ is elongated (2.270(5) Å) and 
shortened to 2.188(6) Å in the amide-containing binding site. An explanation for this finding may 
be the hydrogen bond formation of the amide residues to the bridging acetate co-ligands, 
distorting the other coordination bonds. Moreover, comparison to the pivaloyl-amide-free 
complex [FeII2(L1)(µ-OPr)2]+ (2.250(2) Å and 2.259(2) Å)235 both FeII-Namine distances in 
[FeII2(H2L2)(µ-OAc)2]+ are shortened as in both binding sites hydrogen bond formation takes place. 
In contrast, in [FeII2(H2SIM1)(µ-OAc)2]+ only the amide-containing coordination sites contains a 
shorter FeII-Namine distance, while the other FeII-Namine distance in the amide-free binding site is 
elongated compared to the found values in [FeII2(L1)(µ-OPr)2]+,235 as the hydrogen bonding 
network is only created in the amidated binding site. 
Table 11: Selected bond lengths (Å) and angles (°) for [FeII2(H2SIM1)(µ-OAc)2]PF6, [FeII2(H2L2)(µ-OAc)2]PF6 and 
{Na[FeII2(H2SIM3)(µ-OAc)2]2}PF6. 
 [FeII2(H2SIM1)(µ-OAc)2]+ [FeII2(H2L2)(µ-OAc)2]+ {Na[FeII2(H2SIM3)(µ-OAc)2]2}+ 
   Fe(1) Fe(1`) 
Fe(1)···Fe(1`) - - 6.118 
Fe(1)···Fe(2) 3.430 3.4457(3) 3.536 3.541 
Fe(1)-O(1) 2.039(4) 2.0746(13) 2.046(3) 2.053(3) 
Fe(1)-O(1A) - - 2.005(3) 2.001(3) 
Fe(1)-O(2A) 2.024(4) 2.0930(13) 2.131(3) 2.142(3) 
Fe(1)-O(2B) 2.185(4) 2.0712(13) 2.287(3) 2.249(3) 
Fe(1)-N(1) 2.167(5) 2.1753(16) 2.178(3) 2.168(3) 
Fe(1)-N(2) 2.270(5) 2.2311(15) 2.256(3) 2.277(3) 
Fe(1)-N(3) 2.159(5) 2.3638(15) - - 
Fe(2)-O(1) 2.040(4) 2.0378(13) 2.046(3) 2.040(3) 
Fe(2)-O(3A) 2.204(4) 2.1184(14) 2.117(3) 2.114(3) 
Fe(2)-O(3B) 2.079(4) 2.1020(14) 2.093(3) 2.105(3) 
Fe(2)-N(4) 2.290(6) 2.1703(16) 2.299(3) 2.299(3) 
Fe(2)-N(5) 2.188(6) 2.2270(16) 2.207(3) 2.212(4) 
Fe(2)-N(6) 2.311(5) 2.2786(15) 2.315(3) 2.325(3) 
Fe(1)-O(1)-Fe(2) 114.45(18) 113.83(6) 119.60(12) 119.82(12) 
O(1)-Fe(1)-N(1) 91.16(18) 87.69(6) 90.25(11) 90.55(11) 
O(1)-Fe(1)-N(2) 86.17(17) 86.53(5) 86.94(10) 86.82(11) 
O(1)-Fe(1)-N(3) 156.49(19) 160.48(5) - - 
O(1)-Fe(1)-O(1A) - - 165.10(11) 165.81(11) 
O(1)-Fe(1)-O(2A) 104.69(17) 102.08(5) 94.75(10) 94.82(10) 
O(1)-Fe(1)-O(2B) 87.79(17) 90.73(5) 85.79(10) 84.94(10) 
O(1)-Fe(2)-N(4) 87.09(18) 90.36(5) 87.46(10) 87.72(11) 
O(1)-Fe(2)-N(5) 87.69(18) 88.88(6) 87.83(11) 87.96(12) 
O(1)-Fe(2)-N(6) 162.03(18) 160.55(6) 160.81(12) 161.05(12) 
O(1)-Fe(2)-O(3A) 93.65(16) 89.27(6) 89.89(10) 91.04(11) 
O(1)-Fe(2)-O(3B) 103.30(16) 97.90(5) 105.74(10) 104.19(10) 
 
The FeII···FeII distance is the shortest in [FeII2(H2SIM1)(µ-OAc)2]+ formed with the asymmetric 
pyridine-rich ligand H3SIM1 but still longer than that found in [FeII2(L1)(µ-OPr)2]+ (3.348(2) Å).235 
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Although the first coordination sphere in [FeII2(H2L2)(µ-OAc)2]+ is comparable to that in 
[FeII2(H2SIM1)(µ-OAc)2]+ the FeII···FeII separation is 0.015 Å shorter in the latter. From the 
elongation of the FeII···FeII separation results a widening of the Fe(1)-O(1)-Fe(2) angle 
(114.45(18) Å for [FeII2(H2SIM1)(µ-OAc)2]+ and 113.83(6) Å for [FeII2(H2L2)(µ-OAc)2]+), compared to 
[FeII2(L1)(µ-OPr)2]+ (108.93(6)°). In the respective ZnII2 complexes the behavior is reversed, that is, 
the [ZnII2(H2L2)(µ-OAc)2]+ exhibits a 0.143 Å shorter ZnII···ZnII distance, possibly due to the doubly 
acetate-bridged arrangement, which was not found in [ZnII2(H2SIM1)(µ-OAc)(OH)]+. Comparison 
of the FeII2 and ZnII2 complexes of H3L2, which are both doubly acetate-bridged, shows a longer 
FeII···FeII than ZnII···ZnII distance (3.4457(3) Å for [FeII2(H2L2)(µ-OAc)2]+ vs. 3.3992(6) Å for 
[ZnII2(H2L2)(µ-OAc)2]+). In the case of the complexes derived from ligand H3SIM1 the observation 
is opposite, most likely to the lack of the second bridging acetate co-ligand in 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+ (3.5422(7) Å vs. 3.430 Å in [FeII2(H2SIM1)(µ-OAc)2]+). Similar to the 
ZnII2 complex, the FeII2 complex of ligand H4SIM3 with two phenol moieties in contrast to H3SIM1 
and H3L2, the metal···metal distance is the longest by about 0.1 Å. In [FeII2(H2SIM3)(µ-OAc)2] the 
Fe(1) ion is surrounded by the bridging phenolate, two bridging acetate co-ligands, a tertiary 
amine, only one pyridine and one terminal phenolate residue. The distance between the FeII 
center and the terminal phenolate, Fe(1)-O(1A) (2.007(4) Å/2.003(4) Å), is shorter than the 
Fe(1)-N(3) distances found in [FeII2(H2SIM1)(µ-OAc)2]+ (2.159(5) Å) and [FeII2(H2L2)(µ-OAc)2]+ 
(2.3638(15) Å), due to the higher electron density of the anionic coordinating ligand. As a result, 
the Fe(1) center is forced away from the Fe(2) center, explaining the elongated FeII···FeII 
separation. In [FeII2(H2SIM3)(µ-OAc)2] the impact of the sodium ion between the Fe(1) ions of the 
monomer subunits should not be neglected. The sodium ion is surrounded by six oxygen atoms 
deriving from the terminal phenolate and both acetate co-ligands of both monomer subunits. 
This arrangement results in an asymmetrically chelating acetate co-ligand, while the bridging 
acetate is coordinated in a more symmetric fashion; more precisely, the FeII-O distances of the 
asymmetric acetate differ by 0.204 Å/0.143 Å and by 0.022 Å/0.023 Å for the symmetric acetate. 
However, this can also be attributed to the asymmetry of the complex, induced by the 
asymmetric ligand backbone, as both acetate co-ligands are also coordinated in an asymmetric 
fashion in [FeII2(H2SIM1)(µ-OAc)2]+. Therefore, each iron center in [FeII2(H2SIM1)(µ-OAc)2]+ 
develops a short and a long bond to the acetate oxygen atoms, although the differences in the 
bond lengths are not as pronounced as in [FeII2(H2SIM3)(µ-OAc)2]. In contrast, in 
[FeII2(H2L2)(µ-OAc)2]+ the two bridging acetate co-ligands are bound in a symmetric manner with 
differences in the FeII-O distances of the same acetate anion of 0.0254 Å and 0.0308 Å. 
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As mentioned above, a hydrogen bond network was present in the structures of 
[FeII2(H2SIM1)(µ-OAc)2]+, [FeII2(H2L2)(µ-OAc)2]+, and [FeII2(H2SIM3)(µ-OAc)2] and the presence of 
this network is proposed based on (i) the short distances between the amido nitrogen and 
acetate oxygen atoms, listed in Table 12, and (ii) the orientation of the pivaloyl-amide 
substituents with respect to the acetate co-ligands and the pyridine rings.  
Table 12: Selected distance (Å) for [FeII2(H2SIM1)(µ-OAc)2]+, [FeII2(H2L2)(µ-OAc)2]+, and [FeII2(H2SIM3)(µ-OAc)2] 
corresponding to H-bond formation. 
 [FeII2(H2SIM1)(µ-OAc)2]+ [FeII2(H2L2)(µ-OAc)2]+ [FeII2(H2SIM3)(µ-OAc)2] 
N(7)-O(2A) - 3.032(2)  
N(7)-O(3B) 3.057 - 3.124/3.076 
N(8)-O(3B) 2.969 3.006(2) 2.936/2.997 
 
The formation of hydrogen bonds with the acetate oxygen atoms appears to direct the position 
of the pivaloyl-amide groups. This results in enlarged angles between the pyridine planes and the 
plane containing the amide group (N-C-O) in some cases. This angle was found to be 12.09° and 
30.14° for [FeII2(H2SIM1)(µ-OAc)2]+, 18.51° and 30.72° for [FeII2(H2L2)(µ-OAc)2]+ and 30.38°/34.58° 
and 38.10°/35.12° for [FeII2(H2SIM1)(µ-OAc)2], but differs from 0.86° to 23.02° in uncoordinated 
pivaloyl-amide substituted pyridines in the mononuclear structures discussed in Chapter 3. 
Solid State Structure under Aerobic Conditions 
Treatment of H3SIM1, dissolved in methanol, with two equivalents of iron(II) acetate and one 
equivalent of sodium hexafluorophosphate under an inert atmosphere for 12 hours resulted in a 
yellow solution. Following diffusion of diethylether, green crystals of the complex 
[FeII2(H2SIM1)(µ-OAc)2]PF6 formed, as discussed above. When the yellow solution was exposed to 
air the color turned purple immediately. Diffusion of diethylether into this purple solution yielded 
black crystals of [FeIIINa(H2SIM1)(µ-OAc)2]PF6, suitable for X-ray diffraction data collection. 
Crystallographic data obtained are displayed in Table 36 (see Appendix).  
The structure was solved including the cationic complex [FeIIINa(H2SIM1)(µ-OAc)2]+ and a 
hexafluorophosphate counterion in the crystal cell. The structure is depicted in Figure 43, and 
selected distances and valence angles are summarized in Table 13. The complex cation contains 
the deprotonated phenolate backbone, an FeIII ion in the amide-free binding site, a Na+ ion in the 
amidated binding site and two bridging acetate co-ligands. The two metal ions are bridged 
threefold, comparable to [FeII2(H2SIM1)(µ-OAc)2]+. Repetition of the experiment showed that the 
synthesis of [FeIIINa(H2SIM1)(µ-OAc)2]+ is reproducible and proved the unusual coordination of a 
Na+ ion by the phenolate-based ligand H3SIM1.  
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Figure 43: Structure of [FeIIINa(H2SIM1)(µ-OAc)2]+ showing hydrogen bonding (green dotted lines; counter ions 
and hydrogen atoms, not involved in hydrogen bonding, have been omitted for clarity; crystallographic data 
and ORTEP plots with 50% probability level of thermal ellipsoids appear in the Appendix, Table 36 and 
Figure 76). 
Table 13: Selected bond lengths (Å) and angles (°) for [FeIIINa(H2SIM1)(µ-OAc)2]PF6 and 
[FeII2(H2SIM1)(µ-OAc)2]PF6. 
 [FeIIINa(H2SIM1)(µ-OAc)2]+ [FeII2(H2SIM1)(µ-OAc)2]+ 
Fe···M a 3.4802(6) 3.430 
Fe-O(1) b 1.8906(11) 2.039(4) 
Fe-O(2A) b 1.9620(11) 2.024(4) 
Fe-O(2B) b 1.9556(11) 2.185(4) 
Fe-N(1) b 2.1702(13) 2.167(5) 
Fe-N(2) b 2.2130(13) 2.270(5) 
Fe-N(3) b 2.1767(13) 2.159(5) 
M-O(1) a 2.3710(12) 2.040(4) 
M-O(3A) a 2.3578(13) 2.204(4) 
M-O(3B) a 2.3575(13) 2.079(4) 
M-N(4) a 2.5819(14) 2.290(6) 
M-N(5) a 2.4845(14) 2.188(6) 
M-N(6) a 2.5862(15) 2.311(5) 
Fe-O(1)-M a, b 108.98(5) 114.45(18) 
O(1)-Fe-N(1) b 87.54(5) 91.16(18) 
O(1)-Fe-N(2) b 91.54(5) 86.17(17) 
O(1)-Fe-N(3) b 166.43(5) 156.49(19) 
O(1)-Fe-O(2A) b 98.85(5) 104.69(17) 
O(1)-Fe-O(2B) b 101.88(5) 87.79(17) 
O(1)-M-N(4) a 121.84(5) 87.09(18) 
O(1)-M-N(5) a 79.69(4) 87.69(18) 
O(1)-M-N(6) a 133.73(5) 162.03(18) 
O(1)-M-O(3A) a 85.18(4) 93.65(16) 
O(1)-M-O(3B) a 91.86(4) 103.30(16) 
a M is Na in [FeIIINa(H2SIM1)(µ-OAc)2]+ and Fe(2) in [FeII2(H2SIM1)(µ-OAc)2]+. 
b Fe is called Fe(1) in [FeII2(H2SIM1)(µ-OAc)2]+. 
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The FeIII center in [FeIIINa(H2SIM1)(µ-OAc)2]+ is coordinated in a similar manner to the FeII centers 
in [FeII2(H2SIM1)(µ-OAc)2]+, forming a distorted octahedral coordination geometry with two 
pyridines, a tertiary amine, the bridging phenolate linker, and two bridging acetate co-ligands. 
The distances of the Fe center to the pyridine nitrogen atoms in [FeIIINa(H2SIM1)(µ-OAc)2]+ are 
slightly elongated compared to those in [FeII2(H2SIM1)(µ-OAc)2]+, while the coordination bond 
between the Fe ion and the amine nitrogen is slightly shortened by 0.057 Å. The oxidation of the 
FeII center to FeIII by exposure to air is manifested in the significant differences of the FeII-O and 
FeIII-O distances. In [FeIIINa(H2SIM1)(µ-OAc)2]+ the FeIII-O bonds are all shorter than the FeII-O 
bonds in [FeII2(H2SIM1)(µ-OAc)2]+, as expected due to the higher Lewis acidity of FeIII compared to 
FeII. The differences in the Fe-O bonds are comparable to those in the hexaaqua ions [FeII(H2O)6]2+ 
and [FeIII(H2O)6]3+, where FeII-OH2 is 2.13 Å and FeIII-OH2 is 2.00 Å.166 A similar observation was 
found for the complexes {Na[FeIII(H2SIM3)]2(µ-OAc)(µ-OH2)}(BF4)2 and 
{Na[FeII2(H2SIM3)(µ-OAc)2]2}+ as the FeIII complex exhibits an average FeII-OPh distance of 1.957 Å 
and this value is 2.103 Å for the FeII complex. Furthermore, the average FeIII-O bond length of 
[FeIIINa(H2SIM1)(µ-OAc)2]+ (1.9361 Å) is comparable to that found for the FeIII center in 
[FeIIIFeII(L1)(µ-OPr)2]+ with a value of 1.96 Å, while the average of the FeII-O bond lengths was 
2.09 Å, close to that found for [FeII2(H2SIM1)(µ-OAc)2]+ (2.083 Å and 2.108 Å).139 However, it 
should be mentioned that both acetate co-ligands are bound in an asymmetric fashion in 
[FeII2(H2SIM1)(µ-OAc)2]+ and [FeIIINa(H2SIM1)(µ-OAc)2]+, but in the FeIIINa complex both form a 
short bond to the FeIII ion and a longer bond to the Na+ ion. This different arrangement of the 
bridging acetate co-ligands in the complexes also influences the average of the FeII-O and FeIII-O 
distances. 
The sodium ion in [FeIIINa(H2SIM1)(µ-OAc)2]+ is surrounded by the same primary coordination 
sphere as the FeIII center, but in a trigonal prismatic geometry. The distances of the coordinating 
atoms to the Na+ ion are without exceptions longer compared to the corresponding distances in 
[FeII2(H2SIM1)(µ-OAc)2]+ by at least 0.15 Å, due to the decreased charge and the larger ionic radius 
of the metal center. Consequently, the separation between the two coordination centers in 
[FeIIINa(H2SIM1)(µ-OAc)2]+ is increased (3.4802 Å vs. 3.430 Å in [FeII2(H2SIM1)(µ-OAc)2]+).  
The two oxygen atoms coordinating the Na+ ion in the amidated binding site are part of a 
hydrogen bond formed by the pivaloyl-amide substituents. Such a hydrogen bonding network is 
also visible in the previously discussed complexes containing pivaloyl-amide residues. Table 14 
compares the corresponding N-O distances of the different complexes derived from ligand 
H3SIM1.   
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Table 14: Selected distances (Å) for [FeIIINa(H2SIM1)(µ-OAc)2]+, [FeII2(H2SIM1)(µ-OAc)2]+, and 
[ZnII2(H2SIM1)(µ-OAc)2]+, corresponding to H-bond formation. 
 [FeIIINa(H2SIM1)(µ-OAc)2]+ [FeII2(H2SIM1)(µ-OAc)2]+ [ZnII2(H2SIM1)(µ-OAc)(OH)]+ 
N(7)-O(3A) 3.153 - - 
N(7)-O(3B) - 3.057 - 
N(8)-O(3B) 3.087 2.969 - 
N(7)-O(6) - - 2.809(4) 
N(8)-O(6) - - 2.874(4) 
 
However, in contrast to the complexes [ZnII2(H2SIM1)(µ-OAc)(OH)]+ and [FeII2(H2SIM1)(µ-OAc)2]+, 
the two pivaloyl-amide nitrogen atoms, N(7) and N(8), in [FeIIINa(H2SIM1)(µ-OAc)2]+ do not point 
in the direction of the same oxygen atom, but to two different oxygen atoms, each part of an 
acetate co-ligand.  
The structure of [FeIIINa(H2SIM1)(µ-OAc)2]PF6 suggests that the crystallization of the FeIIINa form 
of the complex is more likely than of the FeIII2 complex of the respective ligand H3SIM1. It seems 
that, when the two FeII ions of [FeII2(H2SIM1)(µ-OAc)2]+ are oxidized by exposure to air, the 
resulting diiron(III) complex is unstable. Thus, only the iron(III) center in the less sterically 
demanding binding site remains bound, while in the more sterically hindered binding site a metal 
exchange from FeIII to Na+ takes place prior crystallization.  
Elemental Analysis 
The unusual presence of a Na+ ion in a phenolate-based complex was also confirmed by 
elemental analysis. Table 15 compares the experimentally obtained values for two separately 
prepared samples of [FeIIINa(H2SIM1)(µ-OAc)2]PF6 with the expected values.  
Table 15: Elemental analytical results obtained with two samples of [FeIIINa(H2SIM1)(µ-OAc)2]PF6 and the 
corresponding calculated values.  
 C [%] H [%] N [%] F [%] Fe [%] Na [%] 
sample 1 51.11 4.62 9.96 10.17 5.84 2.27 
sample 2 51.88 5.58 10.20 n.a. n.a. n.a. 
calc. for [FeIIINa(H2SIM1)(µ-OAc)2]PF6 52.77 5.37 10.47 10.66 5.22 2.15 
 
The calculation of the molecular formula derived from the analytical data is C48H49N8F6FeNa, 
which compares well with the required molecular formula C47H57N8O7F6FeNa for 
[FeIIINa(H2SIM1)(µ-OAc)2]PF6 and proves the ratio of Fe:Na = 1:1.  
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Solid State Susceptibility Measurements  
In order to understand the magnetic properties of [FeII2(H2SIM1)(µ-OAc)2]PF6 and 
[FeIIINa(H2SIM1)(µ-OAc)2]PF6, variable temperature dc SQUID magnetic susceptibility studies 
were performed with ground crystals in the temperature range from 2 - 300 K.  
The χMT vs. T curve obtained with the powdered sample of [FeII2(H2SIM1)(µ-OAc)2]PF6 is 
reproduced in Figure 44. At 300 K, the χMT value of [FeII2(H2SIM1)(µ-OAc)2]PF6 is 6.47 cm3mol-1K 
(µeff = 7.19 B.M.). This value is slightly above 6.00 cm3mol-1K (µeff = 6.92 B.M.), the value expected 
for two non-interacting high-spin FeII ions. The continuous decrease of the χMT product upon 
decrease in temperature suggests an antiferromagnetic interaction between the two FeII centers 
in [FeII2(H2SIM1)(µ-OAc)2]PF6. This conclusion is confirmed by the fact that χMT reaches 
0.35 cm3mol-1K (µeff = 1.35 B.M.) below 2 K, indicating an S = 0 ground state for 
[FeII2(H2SIM1)(µ-OAc)2]PF6. An impurity of paramagnetic monoiron(III) complex is suggested 
accountable for the higher experimental χMT values compared to the expected ones.  
 
Figure 44: Temperature dependence of χMT for [FeII2(H2SIM1)(µ-OAc)2]PF6, recorded in a magnetic field of 
1000 Oe and the respective fit curve (green line). 
The data were fitted according to the simplified van Vleck formula for two interacting S = 2 spins, 
including paramagnetic impurities (imp) (Equation 16), derived from the Heisenberg Hamiltonian 
formulated in Equation 15.236 
Equation 15 H = −2JS1S2 
Equation 16 χM =
NAg
2µB
2
3kT
S(S + 1) + χimp 
The best fit was obtained with J = -5.05 cm-1 and a fixed g factor at g = 2.15, which is in agreement 
with the antiferromagnetism. 5.8% monoiron(III) complex as paramagnetic impurity (S = 5⁄2) was 
determined. The weak antiferromagnetism is similar to the observed magnetism for native PAPs, 
with J values between -5 cm-1 and -11 cm-1.  
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Studying FeII2 complexes of HL1, Hendrich et al. found that replacing two bridging carboxylate co-
ligands as in [FeII2(L1)(µ-OPr)2]+ with bridging phosphate co-ligands, as in [FeII2(L1)(µ-O2P(OPh)2)2]+, 
results in the change of the magnetic behavior from ferromagnetic to antiferromagnetic.237 This 
was attributed to the change in the FeII-OPh-FeII angle (108.93(6)° for [FeII2(L1)(µ-OPr)2]+ and 
122.7(2)° for [FeII2(L1)(µ-O2P(OPh)2)2]+) and the simultaneous modification of the metal-metal 
interaction.237 The FeII-OPh-FeII angle in [FeII2(H2SIM1)(µ-OAc)2]PF6 is 114.45(18)° and falls 
between those two values. Moreover, the magnitude of the antiferromagnetic exchange 
constant for [FeII2(H2SIM1)(µ-OAc)2]PF6 is in the range of those reported for other oxygen-bridged 
diiron(II) complexes (Table 16).  
Table 16: Selected structural parameters for diiron(II) complexes proposed to correlate with the magnetic 
exchange constant J. 
complex ∢(FeII-O-FeII) [°] d(FeII-µ-O) [Å] Ø(d(FeII-µ-O)) [Å] J [cm-1] 
[FeII(L40)2(O2CH)3(O2CH)]a 238 113.0(1) 
2.172(2) 
2.113(2) 
2.143 -0.16 
[FeII2(H2SIM1)(µ-OAc)2]PF6 
114.5 
2.039(4) 
2.024(4) 
2.032 -5.0 
[FeII2(L41)(µ-OBz)](BF4)2 239 
125.7(6) 
2.028(13) 
1.968(10) 
1.998 -5.5 
[FeII2(L42)(µ-OBz)(H2O)]BF4 240 
131.2 
2.060(2) 
1.984(2) 
2.022 -8.6 
[FeII2(L43)(µ-OBz)](BF4)2 241 
124.0 
1.960(6) 
1.973(7) 
1.967 -10.5 
a the two FeII centers are formaldehyde-bridged. 
However, comparing the antiferromagnetic exchange constant J in relation with the FeII-O-FeII 
angle, there is not a direct correlation detectable (Pearson`s correlation coefficient: -0.75), but 
the critical value of the FeII-O-FeII angle regarding the change from ferromagnetic to 
antiferromagnetic interaction seems to be between 108.9° and 113.2°.237, 238 A potential 
influence of the FeII-(µ-O) distance was also suggested to be accountable for the magnetic 
behavior of diiron(II) complexes and it appears that this parameter shows a correlation with the 
antiferromagnetic exchange interaction (Pearson`s correlation coefficient: 0.90).181, 237 Thus, the 
weakened metal-metal interaction manifested by the longer FeII-(µ-O) bond leads to the 
decrease or elimination of antiferromagnetic coupling between the two FeII centers. However, it 
should be mentioned that due to the limited number of examples of alkoxido/phenoxido-bridged 
diiron(II) complexes this proposal should be considered as speculative.  
For the monoiron(III) complex [FeIIINa(H2SIM1)(µ-OAc)2]PF6 χMT = 4.29 cm3mol-1K (µeff = 5.84 B.M.) 
at 300 K was obtained. This value is close to the expected value for five unpaired electrons of 
χMT = 4.39 cm3mol-1K (µeff = 5.92 B.M.).   
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NMR Studies 
Susceptibility Measurements with the Evans Method under Anaerobic Conditions 
The magnetic properties of [FeII2(H2SIM1)(µ-OAc)2]+ and [FeII2(H2L2)(µ-OAc)2]+ were also 
investigated in solution, applying the methodology described by Evans.242 In this method the 
frequency shift in the NMR spectrum between two solutions, the pure solvent and a known 
concentration of the paramagnetic material in the same solvent, is measured. The frequency shift 
is proportional to the paramagnetic susceptibility of the compound (Equation 17).  
Equation 17 χpara,subst =
3
4πc
(
Δν
ν
) + χdia,solv + χdia,subst 
The effective magnetic moment µeff is calculated with Equation 18.  
Equation 18 µeff = 2.828√χpara,substT  
The magnetic moments of the complexes were evaluated with Equations 17 and 18, after taking 
appropriate corrections for diamagnetism of the solvent and the complex into account. In 
solution, the complexes exhibit effective magnetic moments of 6.10 B.M. for 
[FeII2(H2SIM1)(µ-OAc)2]+ and 5.35 B.M. for [FeII2(H2L2)(µ-OAc)2]+. The experimentally derived 
values for these complexes were lower than the calculated value for two non-interacting high-
spin FeII centers (µeff = 6.93 B.M.) indicate the presence of exchange coupling between the two 
metal centers. 
Susceptibility Measurements with the Evans Method under Aerobic Conditions 
The magnetic susceptibility of [FeII2(H2SIM1)(µ-OAc)2]+ dissolved in deuterated acetonitrile was 
found to reduce from µeff = 6.10 B.M. to µeff = 4.55 B.M. within the first hour after the solution 
was exposed to air, and subsequently to µeff = 3.82 B.M. within 24 hours. The decrease of µeff can 
be explained by the formation of relatively strongly coupled complexes, but the composition is 
not entirely clear. It has to be mentioned that µeff = 1.73 B.M. for a strongly coupled 
(hs)FeIII-(hs)FeII system and µeff = 0 for a strongly coupled (hs)FeIII-(hs)FeIII system is only expected 
at low temperature. On the basis of published work on similar systems, only moderate coupling 
through the phenoxide bridge is expected.114, 125, 230 Interestingly, slightly increased µeff values 
were observed when the solutions were measured after several weeks again (µeff = 4.85 B.M.). 
This might be the result of a slow decomposition of initially formed FeIII2 species, i.e. formation 
of a monoiron(III) complex and ligand-free FeIII. This is in agreement with the observed X-ray 
structures under aerobic and anaerobic conditions.   
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1H NMR Spectroscopy under Anaerobic Conditions 
1H NMR spectroscopy was used to investigate the symmetry of the diiron(II) complexes in 
solution. The paramagnetic 1H NMR spectra of [FeII2(H2SIM1)(µ-OAc)2]PF6 and 
[FeII2(H2L2)(µ-OAc)2]PF6, dissolved in deuterated acetonitrile, were recorded (Figure 45). The 1H 
NMR spectra of the diiron(II) complexes display well-resolved and relatively narrow resonances, 
consistent with the fast electronic relaxation of the high-spin FeII centers and their energetically 
low excited levels.243 The chemical shifts of the resonances extend over 230 ppm, from -30 ppm 
to 200 ppm. Overall, the spectrum is highly similar to that of the FeIIMnII complex of HL1 and 
HL44.244, 245  
 
Figure 45: 1H NMR spectrum of a) [FeII2(H2SIM1)(µ-OAc)2]PF6 and b) [FeII2(H2L2)(µ-OAc)2]PF6 in CD3CN.  
Unfortunately, connectivity in the complexes could not be resolved sufficiently with COSY 
experiments to assign the protons. However, in the spectrum recorded with 
[FeII2(H2L2)(µ-OAc)2]+, 13 resonances were detected, while in the spectrum of 
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[FeII2(H2SIM1)(µ-OAc)2]+, 26 resonances were observed, i.e. one resonance for each proton. In the 
case of [FeII2(H2L2)(µ-OAc)2]+, due to a rotation axis two protons resonate at similar fields and, 
therefore, a single resonance for two protons was detected. Moreover, the spectrum of 
[FeII2(H2SIM1)(µ-OAc)2]+ exhibits two equally intense sharp resonances at 3.86 ppm and 4.08 ppm, 
which are assigned to the two tert-butyl groups of the pivaloyl-amide residues due to their 
integration for nine protons. Interestingly, the spectrum of [FeII2(H2L2)(µ-OAc)2]+ shows a signal 
integrating for 18 protons at 5.40 ppm. The comparison of the spectra obtained of 
[FeII2(H2SIM1)(µ-OAc)2]PF6, bearing a symmetric ligand backbone, and [FeII2(H2SIM1)(µ-OAc)2]PF6, 
bearing an asymmetric ligand backbone, suggest that the symmetry provided by the ligands is 
still present in the respective diiron(II) complexes. 
1H NMR Spectroscopy under Aerobic Conditions 
The green solution of [FeII2(H2SIM1)(µ-OAc)2]+, dissolved in deuterated acetonitrile, turned rapidly 
purple when exposed to air. The 1H NMR spectrum obtained with this purple solution exhibited 
only one sharp downfield shifted resonance in the region between 20 ppm and 200 ppm, as 
opposed to the original spectrum of the complex measured under anaerobic conditions 
(Figure 46).  
 
Figure 46: 1H NMR spectra of [FeII2(H2SIM1)(µ-OAc)2]PF6 in CD3CN under a) and c) anaerobic conditions and b) 
and d) after exposure to air. 
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In [FeII2(H2SIM1)(µ-OAc)2]+ the short electronic relaxation time of the FeII ion makes the overall 
system relax fast enough so that sharp NMR resonances are observed. After exposure to air, the 
antiferromagnetic interactions are not strong enough to quench the electronic spin at room 
temperature. Therefore, the FeIII complex formed presents only very broad unresolved 
resonances. Interestingly, reaction with air results in four broad resonances in the region 
between 6 ppm and 8 ppm, while there was only one single resonance visible in the intact 
[FeII2(H2SIM1)(µ-OAc)2]+ complex. This can be due to (i) one binding site being metal-free with 
non-coordinating pyridine residues, or (ii) some protons in the resulting diiron(III) complex are 
only slightly affected by the paramagnetic metal ions exhibiting resonances with chemical shifts 
similar to the metal-free ligand.  
Mass Spectrometry 
ESI+ mass spectrometric investigations of [FeII2(H2SIM1)(µ-OAc)2]PF6 in dichloromethane resulted 
in a spectrum with a main peak at m/z 924.4 and two smaller peaks at m/z  889.2 and m/z 957.3 
with isotopic patterns characteristic for diiron complexes (Figure 47). The signals are assigned to 
[FeII2Na(HSIM1)(CH3O)2]+, [FeII2(HSIM1)(CH3OH)F]+ and the intact complex [FeII2(H2SIM1)(OAc)2]+, 
respectively. When the solution of [FeII2(H2SIM1)(µ-OAc)2]PF6 in acetonitrile was exposed to air 
for about ten minutes prior to the measurement, one main signal was detected at m/z 782.3 
consisting to the monoiron(III) complex [FeIII(HSIM1)]+. 
 
Figure 47: Characteristic isotopic pattern found in ESI+ mass spectra (experimental (top) and calculated 
(bottom)) of [FeII2(H2SIM1)(µ-OAc)2]PF6 a) measured directly after solvation in dichloromethane 
([FeII2(H2SIM1)(OAc)2]+) and b) in acetonitrile after exposure to air for 5 min ([FeIII(HSIM1)]+). 
Unfortunately, the solubility of [FeII2(H2L2)(µ-OAc)2]PF6 in dichloromethane was lower compared 
to [FeII2(H2SIM1)(µ-OAc)2]PF6 and made the addition of methanol necessary, in order to obtain a 
spectrum. This resulted in a main signal at m/z 729.4, matching the protonated ligand [H4L2]+ and 
a rather intense signal at m/z 782.3, matching the oxidation product [FeIII(HL2)]+. Therefore, the 
mass spectrometric investigation of the FeII2 complex in solution is hampered due to fast 
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oxidation. However, signals with the characteristic diiron isotopic pattern were detected at 
m/z 929.3, m/z 943.3, and m/z 957.3, and these are assigned to the diiron species 
[FeII2(H2L2)(OAc)(CH3O)]+, [FeII2(H2L2)(OAc)(CH3CH2O)]+, and the intact complex 
[FeII2(H2L2)(OAc)2]+. 
The ESI+ mass spectrometric investigations undertaken with the purple solid 
[FeIIINa(H2SIM1)(µ-OAc)2]PF6, dissolved in methanol resulted in a spectrum with a main peak at 
m/z 872.4, assigned to [FeIII(H2SIM1)(CH3OH)(OAc)]+. The softer ionization method conducted 
with MALDI experiments resulted in a spectrum with two main peaks at m/z 821.3 and m/z 839.3, 
which both show the pattern characteristic for an iron complex similar to the one depicted in 
Figure 47b). These signals match the species of [FeIIINa(SIM1)(H2O)]+ and [FeIIINa(SIM1)(H2O)2]+. 
Mössbauer Spectroscopy 
57Fe Mössbauer spectroscopy is a very sensitive technique, which has been very useful for 
ascertaining the oxidation and spin states of iron centers. This technique is based on the 
Mössbauer effect, consisting of recoil-free, resonant absorption and emission of gamma rays.246 
Mössbauer experiments involve the determination of the energy difference between the ground 
state and the excited states by exposure of the sample to a beam of gamma radiation. The energy 
difference between the ground and the excited states depends on the interaction of the nucleus 
and electric (and magnetic) fields at the nucleus (Scheme 11).247 Thus, 57Fe Mössbauer spectra 
reflect chemical information of the iron centers in the Mössbauer parameters, i.e. isomer shift 
and quadrupole splitting. The isomer shift results from the Coulomb interaction of the nuclear 
charge distribution and the s-electron charge cloud, penetrating the nucleus (electric monopole 
interaction) and depends, therefore, most strongly on the ionization of the iron center.246 The 
quadrupole splitting originates from the interaction between the electric quadrupole moment 
eQ of the nucleus itself and the Electron Field Gradient (EFG) at the nucleus (electric quadrupole 
interaction).246 The EFG arises from an aspherical distribution of electrons in the valence orbitals 
and/or aspherical charge distribution in the ligand sphere. Thus, the quadrupole splitting 
depends on the symmetry of the environment of the iron center.246 
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Scheme 11: Origin of the isomer shift δ (electric monopol ineraction) and the quadrupol splitting ΔEQ (electric 
quadrupol interaction) in 57Fe Mössbauer spectra.246, 247  
Mössbauer Spectroscopy under Anaerobic Conditions 
In order to investigate the coordination chemistry of the two FeII centers in 
[FeII2(H2SIM1)(µ-OAc)2]PF6, a 57Fe enriched sample was prepared and a 57Fe Mössbauer spectrum 
was measured in frozen acetonitrile solution at 170 K (Figure 48a). The spectrum obtained shows 
a single quadrupole doublet, indicating similar electronic environments for both FeII centers. The 
parameters determined by fitting the spectrum, using the NORMOS Mössbauer Fitting 
Program248, δ = 1.13(1) mm/s and ΔEQ = 2.66(1) mm/s (Γ = 0.45(1) mm/s), are consistent with FeII 
in the high-spin configuration and in agreement with values reported for other dinuclear high-
spin FeII complexes, i.e. [FeII2(L42)(µ-O2CCF3)(H2O)2](BF4)2 (δ = 1.05 mm/s and ΔEQ = 2.69 mm/s).240 
The δ shift of [FeII2(H2SIM1)(µ-OAc)2]PF6 to more positive values compared to 
[FeII2(L42)(µ-O2CCF3)(H2O)2](BF4)2 is attributed to the increased electronegativity of the 
coordinating ligands in the former complex. 
Mössbauer Spectroscopy under Aerobic Conditions 
The Mössbauer spectrum of a sample of [FeII2(H2SIM1)(µ-OAc)2]PF6, dissolved in acetonitrile and 
exposed to air for 24 hours, was collected at 170 K and showed a slightly asymmetric doublet 
(Figure 48b). The 57Fe Mössbauer spectrum obtained after exposure to air for further 24 hours 
was essentially the same (Figure 48c). Least-squares fitting determined two doublets of equal 
intensity with the isomer shifts of δ(I) = 0.42(1) mm/s and δ(II) = 0.42(1) mm/s and the 
quadrupole splitting of ΔEQ(I) = 0.77(2) mm/s (Γ = 0.44(1) mm/s) and ΔEQ(II) = 1.31 mm/s 
(Γ = 0.40(1) mm/s), respectively. The Mössbauer parameters are in agreement with two high-spin 
FeIII ions in similar electronic environments and are comparable with those previously reported 
for phenolate-bridged diiron(III) complexes, i.e. [FeIII2(H2L2)(µ-OH)]4+ (δ = 0.47 mm/s, 
ΔEQ = 0.84 mm/s),114 [FeIII2(µ-O)(L45)2(OH)(H2O)]ClO4 (δ = 0.45 mm/s, ΔEQ(I) = 1.63 mm/s, 
ΔEQ(II) = 1.11 mm/s),249 and [FeIII2(L46)2(µ-OAc)]ClO4 (δ = 0.39 mm/s, ΔEQ = 0.93 mm/s).102 The 
fitting with two quadupole doublets is consistent with two different FeIII centers and, therefore, 
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the formation of the complex [FeIII2(H2SIM1)(µ-OAc)2]3+. In contrast to [FeII2(H2SIM1)(µ-OAc)2]PF6, 
the asymmetry of electron density distribution around the two FeIII centers in 
[FeIII2(H2SIM1)(µ-OAc)2]3+ is larger and therefore large enough to afford two distinct quadrupole 
doublets. 
     
Figure 48: Comparison of the 57Fe Mössbauer spectra obtained from frozen acetonitrile solution (except 
spectrum g)) of a) [FeII2(H2SIM1)(µ-OAc)2]PF6, b) [FeII2(H2SIM1)(µ-OAc)2]PF6 after exposure to air for 24 h c) 
[FeII2(H2SIM1)(µ-OAc)2]PF6 after exposure to air for 48 h, d) [FeII2(H2SIM1)(µ-OAc)2]PF6 treated with NaPF6 after 
exposure to air for 72 h, e) [FeIIINa(H2SIM1)(µ-OAc)2]PF6 after exposure to air for 24 h, f) 
[FeIIINa(H2SIM1)(µ-OAc)2]PF6 after exposure to air for 2 h and g) [FeIIINa(H2SIM1)(µ-OAc)2]PF6 as a solid. 
The purple solid [FeIIINa(H2SIM1)(µ-OAc)2]PF6 exhibits a broad singlet in the 57Fe Mössbauer 
spectrum, ascribed to a relaxing high-spin FeIII mononuclear species (Figure 48g) and a small 
signal indicating a FeII species. The spectrum obtained of [FeIIINa(H2SIM1)(µ-OAc)2]PF6, dissolved 
in acetonitrile (Figure 48f), is essentially the same as the one obtained of the solid, except for an 
intensity decrease of the FeII species. The FeII species found in these spectra is assigned to 
impurities of [FeIIIFeII(H2SIM1)(µ-OAc)2]2+ and the corresponding fitting curves are shown in Figure 
49c. This interpretation derives from comparison with the corresponding 57Fe Mössbauer 
spectrum of [FeIIIFeII(H2SIM1)(µ-OAc)2]2+ (Figure 54b), generated by chemical oxidation of 
[FeII2(H2SIM1)(µ-OAc)2]+ and will be discussed later in this chapter. During further exposure to air, 
the spectrum becomes more narrow (Figure 48e) and exhibits features similar to the spectrum 
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of [FeIII2(H2SIM1)(µ-OAc)2]3+ (Figure 48d), suggesting the formation of the diiron(III) complex in 
acetonitrile solution under aerobic conditions. Coordination of two FeII ions in the corresponding 
ligand H3SIM1 and subsequent oxidation of the iron centers appears to be the preferred way to 
form [FeIII2(H2SIM1)(µ-OAc)2]3+ compared to direct coordination of two FeIII ions (discussed in 
Chapter 3.2.5). Moreover, the crystallization of [FeIII2(H2SIM1)(µ-OAc)2]3+ from methanol solution 
seems to be less likely than crystallization of [FeIIINa(H2SIM1)(µ-OAc)2]PF6, because only the latter 
compound was isolated via diethylether diffusion.  
Treatment of [FeIII2(H2SIM1)(µ-OAc)2]3+ with perchloric acid results in decomposition of the 
complex apparent by its loss of color in solution. Interestingly, a solution of 
[FeIIINa(H2SIM1)(µ-OAc)2]PF6, which was exposed to air for 72 hours (generating the mixture of 
[FeIII2(H2SIM1)(µ-OAc)2]3+ and metal-free ligand H3SIM1), and subsequent treatment with 
perchloric acid resulted in a 57Fe Mössbauer spectrum with a single quadrupole doublet, 
characteristic for a high-spin FeII species (Figure 49b). This indicates the reduction of the FeIII ion 
by the phenol-based ligand H3SIM1 in acidic solution. 
 
Figure 49: Comparison of the 57Fe Mössbauer spectra obtained from frozen acetonitrile solution of a) 
[FeII2(H2SIM1)(µ-OAc)2]PF6 after exposure to air for 72 h and addition of HClO4, b) [FeIIINa(H2SIM1)(µ-OAc)2]PF6 
after exposure to air for 72 h and addition of HClO4, and c) [FeIIINa(H2SIM1)(µ-OAc)2]PF6. 
Mayer et al. used phenols with pendant substituted pyridines to study the concerted proton-
electron transfer in hydrogen-bonded pyridine-phenols.250, 251 In this process, the electron is 
removed by an outer-sphere one-electron oxidant such as [FeIII(L47)3]3+ and [FeIII(L48)3]3+ and 
derivatives thereof, and the phenolic proton is transferred concomitantly to the pendant basic 
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pyridyl residue to give a distonic radical cation (Scheme 12).250, 251 Another task which the basic 
sites fulfill is the stabilization of the oxidized product.251 
 
Scheme 12: CPET reactivity of phenols with pendant basic moieties.251 
The addition of perchloric acid to [FeIIINa(H2SIM1)(µ-OAc)2]PF6 in acetonitrile solution results in 
the protonation of the bridging phenolate, apparent in the color change to blue, forming most 
likely [FeIII(H3SIM1)(solv)2]3+ (Scheme 13). The unexpected appearance of a FeII species in the 57Fe 
Mössbauer spectrum, recorded with the colorless solution obtained after ultrasonication, is 
proposed to be due to a CPET mechanism similar to the one shown in Scheme 12. The FeIII 
complex is proposed to act as a one-electron oxidant generating a phenol radical and the 
corresponding FeII complex. The proximal pyridine residues may act as pendant basic site 
(Scheme 13). It is not clear if the oxidant needed for the oxidation of the phenol-based ligand is 
an FeIII ion coordinated to the same ligand or the FeIII center of another complex molecule.  
 
Scheme 13: Proposed mechanism for the CPET in [FeIII(H3SIM1)(solv)2]2+. 
Similar to the observation obtained from the acidified solution of [FeIIINa(H2SIM1)(µ-OAc)2]PF6, 
the [FeIII2(H2SIM1)(µ-OAc)2]3+ compound (formed via oxidation under aerobic conditions of a 
solution of [FeII2(H2SIM1)(µ-OAc)2]+ in acetonitrile) showed also an FeII species in the 57Fe 
Mössbauer spectrum, measured after treatment with perchloric acid (Figure 49a). Besides the 
quadrupole doublet, assigned to ligand-free FeII ions, a broad signal was determined in the 
spectrum, indicating the presence of a FeIII species in the mixture. This finding is consistent with 
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the 2:1 ratio of FeIII ions and phenol-based ligand in the initial mixture, which enables only the 
reduction of half of the FeIII ions, as no more phenol-based species are available in solution.  
Electrochemical Studies using Cyclic Voltammetry 
The electrochemical behavior of [FeII2(H2SIM1)(µ-OAc)2]+ and [FeII2(H2L2)(µ-OAc)2]+ was 
investigated by cyclic voltammetry (CV). The CV experiments were conducted in degassed 
acetonitrile solution (0.1 M NBu4ClO4, 0.5 mM complex) at room temperature and the results are 
presented in Figure 50. Ferrocene was used as internal standard.252 Multiple CV scans were 
essentially identical when the experiments were undertaken under anaerobic conditions, 
indicating that decomposition in solution does not occur.  
The CV of [FeII2(H2SIM1)(µ-OAc)2]PF6 shows two sequential reductions, a reversible one-electron 
transfer at 0.16 V vs. SCE (ΔEP = 88 mV) and a quasi-reversible one-electron transfer at 0.56 V vs. 
SCE (ΔEP = 153 mV) (Figure 50a) which can be assigned to the FeII2/FeIIIFeII and FeIIIFeII/FeIII2 
couples, respectively. Interestingly, the potential at 0.16 V (vs. SCE) is similar to the redox couple 
examined for the native ufPAP enzyme at ~ 0.34 V vs. NHE (0.10 V vs. SCE).222 
In the case of [FeII2(H2L2)(µ-OAc)2]PF6 a more complex CV was observed, with two anodic and two 
cathodic waves (Figure 50b). Thus, several species appear to coexist in both redox states in 
solution and these complicate the redox behavior. While the FeIIIFeII/FeIII2 couples are in the same 
region as in the case of [FeII2(H2SIM1)(µ-OAc)2]PF6, the FeII2/FeIIIFeII couples are shifted to more 
positive redox potentials around 0.8 V vs. SCE. The redox potential of the FeIII2 complex of ligand 
H2L2 was detected at 0.40 V vs. SCE.114  
Table 17 compares these values with the redox potentials found for similar complexes but lacking 
the pivaloyl-amide residues. Interestingly, the redox potentials found for [FeII2(H2L2)(µ-OAc)2]PF6 
are all shifted to more positive potentials, while in the case of [FeII2(H2SIM1)(µ-OAc)2]PF6 E1 is 
shifted to more positive and E2 to more negative potentials, compared to the unsubstituted 
complexes derived from HL1. 
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Figure 50: Cyclic voltammograms of a) [FeII2(H2SIM1)(µ-OAc)2]PF6, b) [FeII2(H2L2)(µ-OAc)2]PF6, c) 
[FeII2(H2SIM1)(µ-OAc)2]PF6 after exposure to air and d) [FeII2(H2L2)(µ-OAc)2]PF6 after exposure to air, recorded in 
degassed acetonitrile (0.5 mM complex, 0.1 M NBu4ClO4) at rt under Ar (glassy carbon working electrode, 
platinum wire counter electrode, Ag/Ag+ (0.1 mM in NaCl) reference electrode). 
Table 17: Cyclic voltammetric data of phenoxido-bridged diiron complexes in acetonitrile. 
complex  E1 [V vs. SCE] E2 [V vs. SCE] ΔE [V] Kcoma 
[FeII2(H2SIM1)(µ-OAc)2]PF6 b 0.16 0.56 0.41 8.5·106 
[FeII2(H2L2)(µ-OAc)2]PF6 b 0.18/0.34 0.79/0.92 ~ 0.60 ~ 1.4·1010 
[FeIIIFeII(L1)(µ-OAc)2](BF4)2 c 231 -0.03 0.68 0.71 1.6·1012 
[FeIIIFeII(L1)(µ-OPr)2](BPh4)2 d 139 -0.01 0.69 0.70 7.5·1011 
[FeIIIFeII(L1)(µ-OBz)2](PF6)2 d 139 0.06 0.75 0.69 4.7·1011 
[FeIIIFeII(L1)(µ-OBz)2](BF4)2 c 231 0.05 0.73 0.68 5.0·1011 
[FeIIIFeII(L1)(µ-OBz)2](BF4)2 e 253 -0.02 0.67 0.69 6.8·1011 
[FeIIIFeII(L11)(µ-OAc)2](BPh4)2 f 232 -0.09 0.66 0.75 3.3·1012 
a see Equation 19. 
b 0.1 M NBu4ClO4, glassy carbon working electrode, platinum wire counter electrode, Ag/Ag+ (0.1 mM in NaCl) 
reference electrode. 
c Bu4NClO4, glassy carbon working electrode, auxiliary electrode, saturated calomel reference electrode. 
d 0.1 M NBu4BF4, platinum disk working electrode, platinum wire auxiliary electrode, saturated calomel 
reference electrode. 
e 0.1 M NBu4ClO4, glassy carbon working electrode, platinum counter electrode, saturated Ag/AgCl reference 
electrode. 
f 0.1 M NBu4ClO4, platinum net working electrode, platinum wire auxiliary electrode, Ag/Ag+ or calomel working 
electrode. 
 
The trend to more positive potentials by an increase of the number of pivaloyl-amide 
substituents was already observed with pivaloyl-amide substituted CoII and CuII complexes.254, 255 
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The hydrogen bond donors implemented in the complexes induce a shift to less negative values 
for EP (Chart 18). More precisely, the complex [CoIII(L21)(acetohydroximate)]Cl was found to have 
a CoII/CoIII couple at -0.99 V vs. SCE, while the 6-pivaloylamide substituted derivative showed this 
potential at -0.72 V vs. SCE. It was proposed that the easier CoII/CoIII reduction is due to the 
decreased charge of the hydroximate oxygen because of hydrogen bonding with the pivaloyl-
amide residue.254 Similarly, the CuII complexes of the tripodal ligand L21 show a reduction wave 
in the CV at more positive redox potentials with an increasing number of 6-pivaloyl-amide 
substitution of the pyridine moieties.255 Therefore, the two pivaloyl-amide residues in 
[FeII2(H2L2)(µ-OAc)2]PF6, one at each iron center, seem to influence the redox potentials of the 
FeII2/FeIIIFeII and FeIIIFeII/FeIII2 couples in the same way, probably due to hydrogen bond 
formation. 
 
Chart 18: CoII and CuII complexes used to study the impact of pivaloyl-amide substituents in proximity to the 
metal center on the redox potential.254, 255 
Table 17 also compares the methyl-substituted complex [FeIIIFeII(L11)(µ-OAc)2](BPh4)2 232 with the 
heterovalent diiron complexes of HL1. The more negative potentials of the redox couples for 
[FeIIIFeII(L11)(OAc)2](BPh4)2,232 compared to [FeIIIFeII(L1)(µ-OAc)2](BPh4)2,231 was explained by the 
effect of the electron-donating ability of methyl substituents of the 6-methylpyridine rings.231, 232 
Therefore, the cathodic shift of the redox potentials of [FeII2(H2SIM1)(µ-OAc)2]PF6 and 
[FeII2(H2L2)(µ-OAc)2]PF6 compared to [FeIIIFeII(L1)(µ-OAc)2](BF4)2 may result from the electron 
withdrawing effect of the pivaloyl-amide residues.  
The contrasting effect of lowering the redox potential by about 500 mV by incorporation of 
pivaloyl-amide residues into a diiron(II) complex was reported by Arii et al. and proposed to be 
caused by an increase in the energy level of the HOMO of the iron centers due to coordination 
of pivaloyl-amide oxygen atoms.256 Therefore, the lower redox potential of the FeII2/FeIIIFeII 
couple of [FeII2(H2SIM1)(µ-OAc)2]PF6 by 0.12 V compared to [FeIIIFeII(L1)(µ-OAc)2](BF4)2 is probably 
induced by the two pivaloyl-amide residues adjacent to one of the two iron centers. Moreover, 
a diiron(II) complex of a HL1 derivative with pivaloyl-amide residues at each pyridine moiety 
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(H5L39) resulted in a CV with a strong wave at 0.39 V vs. SCE and shoulders at -0.20 V and -0.36 V 
vs. SCE.234  
The formation of an FeIIIFeII complex is important to obtain a more accurate model for the active 
form of PAP. The thermodynamic stability of the FeIIIFeII complex of the asymmetric ligand H3SIM1 
was estimated by examining the following comproportionation equilibrium.  
 
From the separation of the redox potentials ΔE, the comproportionation constant Kcom can be 
calculated from Equation 19 and is listed in combination with the values reported for 
pivaloylamide-free diiron complexes in Table 7.139, 231, 232, 253 
Equation 19 ∆E = (
RT
nF
) lnKcom 
The small value of ΔE for [FeII2(H2SIM1)(µ-OAc)2]PF6 (0.41 V) yielded Kcom = 8.5·106, which indicates 
a substantial stability of the FeIIIFeII complex over the corresponding FeII2 and FeIII2 complexes. 
However, the value is rather small compared to those of other phenoxido-bridged diiron 
complexes (Table 17). However, the corresponding heterovalent diiron complex of ligand H3SIM1 
would take the asymmetry and the hydrogen bonding network present in the active site of the 
native PAP enzyme into consideration. Therefore, a suitable method for oxidation of 
[FeII2(H2SIM1)(µ-OAc)2]PF6 was explored and will be discussed in Chapter 5.4. 
The green solutions of [FeII2(H2SIM1)(µ-OAc)2]PF6 and [FeII2(H2L2)(µ-OAc)2]PF6 in acetonitrile were 
exposed to air, subsequently degassed and CVs recorded. These data are also shown in Figure 50. 
The purple solution derived from [FeII2(H2SIM1)(µ-OAc)2]PF6 resulted in a CV with an irreversible 
redox wave around 0.5 V vs. SCE and two quasi-reversible redox waves at 0.02 V and -0.16 V vs. 
SCE. The corresponding CV derived from [FeII2(H2L2)(µ-OAc)2]PF6 has two irreversible redox 
couples at 0.54 V and 0.04 V vs. SCE. The irreversibility of the redox processes indicates structural 
changes associated with the oxidation. Moreover, consecutive CV scans were not identical, and 
this is attributed to (partial) decomposition after oxidation.  
UV-vis-NIR Spectroscopy  
Electronic Properties under Anaerobic Conditions 
In addition to the intense absorptions below 300 nm (π-π* transitions of the ligand backbone), 
the electronic spectra of [FeII2(H2SIM1)(µ-OAc)2]+ and [FeII2(H2L2)(µ-OAc)2]+ dissolved in 
acetonitrile show only one band in the region of 400 - 450 nm. [FeII2(H2SIM1)(µ-OAc)2]+ has a 
transition at 416 nm (ε = 1446 M-1cm-1) and [FeII2(H2L2)(µ-OAc)2]+ has a band at 409 nm 
(ε = 1315 M-1cm-1), ascribed to MLCT transitions of FeII to the pyridine donors. This is in 
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accordance with previously published FeII2 complexes.234, 235, 257, 258 The lack of low-energy 
absorption bands indicates that [FeII2(H2SIM1)(µ-OAc)2]+ and [FeII2(H2L2)(µ-OAc)2]+ are high-spin 
FeII complexes.258 
Electronic Properties under Aerobic Conditions 
The UV-vis-NIR spectrum of [FeIIINa(H2SIM1)(µ-OAc)2]PF6 in acetonitrile shows one broad 
transition at 568 nm (ε = 2499 M-1cm-1) and a shoulder at 335 nm (ε = 5049 M-1cm-1), in addition 
to the intense absorptions below 300 nm. The band at 568 nm is associated with the phenolate-
to-iron(III) charge transfer transition from the oxygen pπ orbital to the FeIII dπ* orbitals and is 
energetically close to the tyrosinate-to-iron(III) charge transfer observed for PAPs. 69, 138, 217, 219, 
220 The majority of synthetic FeIII-phenolate complexes exhibit CT bands with molar extinction 
coefficients in the order of 1000 - 2000 M-1cm-1 per FeIII-phenolate bond.259, 260 The molar 
extinction coefficient of 2499 M-1cm-1 for [FeIIINa(H2SIM1)(µ-OAc)2]PF6 is slightly outside this 
range but does still not approach the value found in the native enzymes. 69, 138, 217, 219, 220 A 
comparison of a variety of similar doubly acetate-bridged FeIIIMII complexes of H2L4 reveals that 
the molar extinction coefficient strongly depends on the nature of the MII ion, i.e. 
[FeIIIMnII(L4)(µ-OAc)2]ClO4 (544 nm, 2680 M-1cm-1),96 [FeIIICuII(L4)(µ-OAc)2]ClO4 (546 nm, 
3400 M-1cm-1),92 [FeIIIZnII(L4)(µ-OAc)2]ClO4 (540 nm, 3700 M-1cm-1),95 [FeIIIFeII(L4)(µ-OAc)2]BF4 
(556 nm, 4560 M-1cm-1),94 and [FeIIINiII(L4)(µ-OAc)2]ClO4 (538 nm, 4813 M-1cm-1).81, 141  
pH Behavior 
In order to examine the behavior of [FeII2(H2SIM1)(µ-OAc)2]+ and [FeII2(H2L2)(µ-OAc)2]+ under 
basic condition UV-vis-NIR spectroscopic measurement were also conducted in acetonitrile-
aqueous buffer mixtures (1:1). The pH of the aqueous buffer was varied from pH 6 to pH 11; the 
pH recorded refers to the aqueous component. With increasing basicity the absorbance of 
[FeII2(H2L2)(µ-OAc)2]+ (Figure 51c) shows a decrease in intensity of the two bands at 235 nm and 
286 nm, while two new bands at 261 nm and 314 nm arise. Moreover, the band at 414 nm 
experiences a shift to 440 nm with increasing basicity. Figure 51d shows the change of 
absorbance at different wavelengths as a function of pH value. The overlay of the spectra at 
different pH values indicates the presence of three isosbestic points at 245 nm, 274 nm, and 
395 nm. This implies that the diiron(II) complex is stable in the investigated pH range and 
undergoes a single deprotonation step. Therefore, the curves can be analyzed by the 
Equation 6, as discussed in Chapter 4.3.  
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Figure 51: UV-vis spectroscopic titration (50 µM in acetonitrile/buffer between pH 6 and 11) for a) 
[FeII2(H2SIM1)(µ-OAc)2]PF6 and c) [FeII2(H2L2)(µ-OAc)2]PF6 as well as absorbance vs. pH plots for b) 
[FeII2(H2SIM1)(µ-OAc)2]PF6 and d) [FeII2(H2L2)(µ-OAc)2]PF6. 
Fitting of the pH-dependent spectroscopic data as described Chapter 4.3, leads to the pKa 
value of 9.58 ± 0.65 for [FeII2(H2L2)(µ-OAc)2]+. This is about 1.5 pH units higher than that 
observed with the corresponding dizinc(II) complex [ZnII2(H2L2)(µ-OAc)2]+ and follows the 
same trend as the corresponding metal aqua complexes.165 
The pH-dependent UV-vis-NIR spectra of [FeII2(H2SIM1)(µ-OAc)2]+ show a similar shifting of the 
band at 399 nm to 426 nm (Figure 51a). In contrast to [FeII2(H2L2)(µ-OAc)2]+, both bands 
between 200 nm and 300 nm in the spectrum of [FeII2(H2SIM1)(µ-OAc)2]+ increase in intensity 
with increasing basicity. The absorbance vs. pH plot (Figure 51b) exhibits changes in the pH 
regions around 7 and around 10.5, indicating two deprotonation steps with pKa values 
around 7 and 10.5.  
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5.4 STUDIES TOWARD THE FORMATION OF A 
HETEROVALENT FEIIIFEII COMPLEX  
 
As explained before the presence of a heterovalent diiron core and the hydrogen bonding 
network that arises from the peptide backbone are essential features of the active site of 
PAPs. Therefore, the generation of a FeIIIFeII complex of H3SIM1 creates an accurate model 
system for PAP. In order to test the generation of [FeIIIFeII(H2SIM1)(solv)x]4+, the chemical 
oxidation was analyzed by UV-vis, EPR, and 57Fe Mössbauer spectroscopy. 
UV-vis-NIR Spectroscopy  
Due to the fact that the two redox waves in the CV of [FeII2(H2SIM1)(µ-OAc)2]+ are well separated 
and that the redox potential of ferrocene is in between the two waves, the chemical oxidation of 
[FeII2(H2SIM1)(µ-OAc)2]+ was tested using ferrocenium hexafluorophosphate as oxidant. The 
solution of [FeII2(H2SIM1)(µ-OAc)2]+ in acetonitrile was therefore treated stepwise with a solution 
of ferrocenium hexafluorophosphate under anaerobic conditions. After addition of one and after 
the two equivalents of oxidant the mixture was allowed to react for 12 hours.  
It is apparent that the oxidant reacts with the diiron(II) complex in a ratio of 
[FeII2(H2SIM1)(µ-OAc)2]+ to ferrocenium of 1:1. UV-vis bands arise at 362 nm (ε = 6357 M-1cm-1) 
and 500 nm (ε = 1271 M-1cm-1), while the bands at 283 nm and 654 nm decrease (Figure 52c). 
Addition of a second equivalent of ferrocenium hexafluorophosphate does not significantly 
change the UV-vis spectrum (362 nm, ε = 7460 M-1cm-1 and 500 nm, ε = 1471 M-1cm-1), but a 
shoulder at 619 nm appears. This transition at 619 nm arises from unreacted ferrocenium 
hexafluorophosphate and indicates the incapacity of the oxidant to oxidize the second FeII ion in 
the initial [FeII2(H2SIM1)(µ-OAc)2]+ complex. This indicates a selective formation of the 
heterovalent complex [FeIIIFeII(H2SIM1)(solv)x]4+.  
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Figure 52: UV-vis-NIR spectra after addition of ferrocenium hexafluorophosphate to a) 
[FeII2(H2SIM1)(µ-OAc)2]PF6 and b) [FeII2(H2L2)(µ-OAc)2]PF6 (green lines: without FeCp2PF6; red lines: 1 eq 
FeCp2PF6; black lines: 2 eq FeCp2PF6; blue line: FeCp2PF6) and time-dependent experiments of c) 
[FeII2(H2SIM1)(µ-OAc)2]PF6 with 1 eq FeCp2PF6 and d) [FeII2(H2L2)(µ-OAc)2]PF6 with 1 eq FeCp2PF6 (a spectrum 
every 20 min for a period of 12 h). 
For the purpose of comparison the oxidation of the symmetric complex [FeII2(H2L2)(µ-OAc)2]PF6 
with ferrocenium hexafluorophosphate was also examined. The reaction with one equivalent of 
oxidant lead to transitions at 373 nm (ε = 7688 M-1cm-1) and 515 nm (ε = 2114 M-1cm-1). In 
contrast to the experiments with [FeII2(H2SIM1)(µ-OAc)2]+, addition of a second equivalent of 
ferrocenium hexafluorophosphate lead to further changes in the spectrum, i.e. a shift of the band 
at 515 nm to 540 nm (ε = 2415 M-1cm-1) (Figure 52b and d). Thus, the oxidant seems to be capable 
to oxidize both FeII centers in [FeII2(H2L2)(µ-OAc)2]PF6. However, it does not emerge whether the 
two FeII centers are oxidized stepwise or simultaneously. However, the steady rise of the 
absorbance band at 515 nm during the stepwise addition of up to one equivalent of ferrocenium 
hexafluorophosphate and the following shift with further addition of oxidant as well as the Kcom 
value of ~1.4·1010 (see Table 17) indicate a substantial stability of the heterovalent complex 
[FeIIIFeII(H2L2)(solv)x]4+.  
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EPR Spectroscopy 
EPR spectroscopy has been shown to be a useful technique for the characterization of the FeIIIFeII 
core in heterovalent diiron model complexes and proteins.261 At low temperature FeIIIFeII sites 
exhibit a broad EPR signal at gav < 2, indicative for antiferromagnetically coupled high-spin FeIII 
(S1 = 5⁄2, 6A state) and high-spin FeII (S2 = 2, 5T state), resulting in a spin ground state of Stotal = ½. 
These signals are only observed near liquid helium temperature and disappear above 30 K.262 
Such a behavior is very similar to that of the heterovalent diiron proteins.262 
EPR spectra in frozen acetonitrile solution with one or two equivalents of oxidant added were 
recorded at temperatures below 5 K to investigate the oxidation state of [FeII2(H2SIM1)(µ-OAc)2]+ 
after reaction with one and two equivalents of ferrocenium hexafluorophosphate for 12 hours 
at room temperature. The resulting spectra are presented in Figure 53. Both spectra show a 
broad intense signal centered near g = 1.6 (g1 = 1.43, g2 = 1.67, g3 = 1.82, derived from fitting the 
spectrum assuming as an S = ½ FeIII core), in addition to a strong signal near g = 4.3. These spectra 
are similar to that obtained from the electrochemically generated heterovalent complex 
[FeIIIFeII(H2L2)(µ-OH)]3+.114 
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Figure 53: EPR spectra (9.4 GHz) of mixtures of [FeII2(H2SIM1)(µ-OAc)2]+ with a) 1 eq FeCp2PF6 (T = 5 K) and b) 
2 eq of FeCp2PF6 (T = 1.7 K, 1 mM in acetonitrile-toluene solution (1:1), experimental spectra in black, spectrum 
after subtraction of the copper impurity in grey, simulated spectrum in red. The signals at g = 2.04 is an artefact 
due to a copper(II) impurity in the cavity of the spectrometer). 
The signal at g ~ 1.6 is attributed to a strongly antiferromagnetically coupled FeIIIFeII core. Similar 
broad signals in this region have previously been reported for [FeIIIFeII(L1)(µ-OPr)2]+, 
[FeIIIFeII(L11)(µ-OAc)2]2+, [FeIIIFeII(L51)(µ-OAc)2]2+, and [FeIIIFeII(L4)(µ-OAc)2]+.139, 140, 232, 235, 262 
Similarly, bsPAP exhibits a rhombic spectrum with apparent g values of 1.58, 1.73 and 1.85 at 
DIIRON MODEL COMPLEXES 
128 
pH > 5.219 The fact that both mixtures show similar EPR spectra with features typical for an FeIIIFeII 
species supports the prediction (CV) and observation (UV-vis) that ferrocenium can only oxidize 
one of the two FeII centers of [FeII2(H2SIM1)(µ-OAc)2]+. 
Both frozen solution spectra exhibit a sharp signal at g ~ 4.3 (g1 = 4.28, g2 = 5.57, g3 = 9.44). This 
could arise from a mononuclear rhombic high-spin FeIII complex present as impurity, most likely 
formed by decomposition of [FeIIIFeII(H2SIM1)(µ-OAc)2]2+ in solution, or a decomposition product 
of ferrocenium hexafluorophosphate. The detection of a similar signal from a ferrocenium 
hexafluorophosphate solution which was left under aerobic conditions for two days indicates 
that the latter is the case. This is also supported by the fact that the spectrum of a powder of 
[FeIIIFeII(L51)(OBz)2(OH)]BF4 did not exhibit such signal.262 The intense signals near g ~ 4.3 originate 
from the FeIII center with almost axial symmetry (g = 8.56, 5.45) and rhombic symmetry (g = 4.30). 
However, such an impurity was often detected with solution EPR spectra of FeIIIFeII complexes, 
but the intensity was not as strong as in the spectra obtained with the mixtures of 
[FeII2(H2SIM1)(µ-OAc)2]+ with ferrocenium hexafluorophosphate. Therefore, it is not clear if the 
generated FeIIIFeII complex is stable enough to exist in solution, since the intense signal at g ~ 4.3 
could arise from at least partial decomposition.  
It should be noted that in the spectra recorded with heterovalent complexes of ligand HL51 in 
solution there is, besides the signal at g ~ 1.7, a broad signal at g ~ 5-6 which is absent in the iron 
proteins and HL1 complexes. This signal shows also temperature dependence which is similar to 
that of the signal at g ~ 1.7. Therefore, the signals at g ~ 5-6 may be ascribed to the mononuclear 
complex in S = 3⁄2 spin state.262 Those features were not detected in the spectra recorded with 
the mixture of [FeII2(H2SIM1)(µ-OAc)2]+ with ferrocenium hexafluorophosphate indicating that the 
intense signal at g ~ 1.7 arises from the decomposition of ferrocenium. 
Mössbauer Spectroscopy 
The heterovlalent form of [FeIIIFeII(H2SIM1)(solv)x]4+, generated by oxidation of 
[FeII2(H2SIM1)(µ-OAc)2]+ with ferrocenium hexafluorophosphate was also studied by 57Fe 
Mössbauer spectroscopy. A mixture of 57Fe enriched [FeII2(H2SIM1)(µ-OAc)2]+ with one equivalent 
of ferrocenium hexafluorophosphate (as 56Fe) as oxidant clearly showed after 12 hours at room 
temperature signals for both FeIII and FeII (Figure 54b). Moreover, the presence of FeIII and FeII in 
equimolar ratio emerges from the fact that the ratio of areas of the two sets of quadrupole 
doublets is nearly unity. Thus, [FeIIIFeII(H2SIM1)(solv)x]4+ appears to be stable in solution. In 
addition, the Mössbauer parameters of the characteristic high-spin FeIII quadrupole doublet, 
δ(I) = 0.41(1) mm/s and ΔEQ(I) = 0.36(2) mm/s (Γ(I) = 0.38(1) mm/s), and the characteristic high-
spin FeII quadrupole doublet, δ(II) = 1.17(1) mm/s and ΔEQ(II) = 2.78(1) mm/s 
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(Γ(II) = 0.53(2) mm/s), are comparable to these of previously reported phenolate-bridged FeIIIFeII 
complexes, i.e. [FeIIIFeII(L1)(µ-OPr)2](BPh4)2 (δ(I) = 0.48 mm/s and ΔEQ(I) = 0.50 mm/s; 
δ(II) = 1.13 mm/s and ΔEQ(II) = 2.69 mm/s),235 [FeIIIFeII(L1)(µ-ppa)2](BF4)2 (δ(I) = 0.48 mm/s and 
ΔEQ(I) = 0.56 mm/s; δ(II) = 1.14 mm/s and ΔEQ(II) = 2.75 mm/s),233 [FeIIIFeII(L4)(µ-OAc)2]ClO4 
(δ(I) = 0.52 mm/s and ΔEQ(I) = 1.10 mm/s; δ(II) = 1.13 mm/s and ΔEQ(II) = 2.54 mm/s),94 and 
[FeIIIFeII(L51)(µ-OAc)2](BF4)2 (δ(I) = 0.58 mm/s and ΔEQ(I) = 0.40 mm/s; δ(II) = 1.29 mm/s and 
ΔEQ(II) = 2.81 mm/s).262 The 57Fe Mössbauer spectrum of the asymmetric complex 
[FeIIIFeII(H2SIM1)(solv)x]4+ shows distinct, i.e. valence trapped, FeIII and FeII centers, indicating that 
each of the two metal ions is bound specifically in one of the two binding sites. 
 
Figure 54: Comparison of 57Fe Mössbauer spectra of [FeII2(H2SIM1)(µ-OAc)2]PF6 a) in acetonitrile, b) with 1 eq of 
FeCp2PF6 and c) with 2 eq of FeCp2PF6. 
Addition of two equivalents of ferrocenium hexafluorophosphate to the solution of 57Fe enriched 
[FeII2(H2SIM1)(µ-OAc)2]+ in acetonitrile resulted in a comparable 57Fe Mössbauer spectrum. The 
fitted parameters are δ(I) = 0.40(1) mm/s and ΔEQ(I) = 0.41(1) mm/s (Γ(I) = 0.43(1) mm/s) for FeIII 
and δ(II) = 1.15(1) mm/s and ΔEQ(II) = 2.65(1) mm/s (Γ(II) = 0.46(2) mm/s) for FeII. This supports 
the proposed incapacity of the oxidant to oxidize both FeII centers of [FeII2(H2SIM1)(µ-OAc)2]+ and 
the selective formation of the heterovalent [FeIIIFeII(H2SIM1)(solv)x]4+ form.  
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5.5 SUMMARY 
 
The two ligands H3SIM1 and H3L2 with two asymmetrically and two symmetrically disposed 
pivaloyl-amide moieties, respectively, lead to [FeII2(H2SIM1)(µ-OAc)2]PF6 and 
[FeII2(H2L2)(µ-OAc)2]PF6, after treatment with iron(II) acetate and hexafluorophosphate 
under anaerobic conditions. These complexes revealed the common structure for 
phenoxido-bridged phosphatase models bearing two bridging acetate co-ligands. NMR 
spectroscopy demonstrates that the symmetry provided by the ligands is still present in the 
diiron(II) complexes, [FeII2(H2SIM1)(µ-OAc)2]+ and [FeII2(H2L2)(µ-OAc)2]+, in solution. Under 
aerobic conditions only [FeIIINa(H2SIM1)(µ-OAc)2]PF6 could be isolated. However, with 57Fe 
Mössbauer spectroscopy the formation of the corresponding FeIII2 complex was monitored 
in solutions of [FeII2(H2SIM1)(µ-OAc)2]PF6 and [FeIIINa(H2SIM1)(µ-OAc)2]PF6 under aerobic 
conditions. This diiron(III) complex is unstable under acidic conditions, reacting possibly via 
a concerted proton-electron transfer to generate an FeII species and a ligand-phenol radical.  
SQUID susceptibility measurements indicate that [FeII2(H2SIM1)(µ-OAc)2]PF6 consists of two 
weakly antiferromagnetically coupled high-spin FeII ions. This also emerges from solution 
magnetic susceptibility measurements, UV-vis and Mössbauer spectroscopy. The CV of 
[FeII2(H2SIM1)(µ-OAc)2]+ exhibits two reasonably well separated redox waves for the redox 
couples FeII2/FeIIIFeII and FeIIIFeII/FeIII2, and the Kcom value indicates an appreciable stability of the 
mixed-valent FeIIIFeII species. Therefore, the generation of the heterovalent diiron complex of 
H3SIM1 was probed. The successful formation of complex [FeIIIFeII(H2SIM1)(solv)x]4+ by chemical 
oxidation of [FeII2(H2SIM1)(µ-OAc)2]+ with ferrocenium hexafluorophosphate under anaerobic 
conditions was verified by 57Fe Mössbauer, UV-vis and EPR spectroscopy. As a result of these 
studies an accurate model complex [FeIIIFeII(H2SIM1)(solv)x]4+ for the active form of 
mammalian PAPs became available with a heterovalent diiron core in a asymmetric 
coordination environment with the capacity to form a hydrogen bond network as exhibited 
for the native enzymes.  
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Chapter 6  
Studies of the 
Phosphatase Mechanism
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6.1 ENZYMATIC MECHANISMS OF PHOSPHOESTER 
CLEAVAGE 
 
Phosphatases are amongst the most efficient enzymes known with their ability to drastically 
reduce the activation energies associated with the hydrolytic cleavage of phosphoester bonds.11 
Acid Phosphatases, e.g. PAPs, which are most active at low pH, and Alkaline Phosphatases (APs), 
which exhibit their highest activity under basic conditions, are two particularly important 
classes.11  
Hydrolysis Mechanism Proposed for AP 
In the active site of AP the phosphoester substrate is activated by interaction with both ZnII 
centers (Scheme 14).11, 263, 264 A proximal arginine residue is proposed to be involved in the 
substrate binding and the simultaneous activation of the substrate. The nucleophilic attack of 
the phosphoester substrate is accomplished by an alcohol group of a serine residue adjacent the 
dizinc(II) active core. The resulting transition state is also stabilized by the arginine residue 
adjacent to the dizinc(II) core. The release of the alcoholate leaving group is supported by the 
interaction with one ZnII center. Subsequently, alcohol/water ligand exchange provides the 
nucleophilic water molecule necessary for the hydrolysis and this nucleophile attacks the 
bridging phosphate and thereby initiates the dissociation of the phosphate product, and the 
regeneration of the resting state.11, 263, 264 
 
Scheme 14: Proposed catalytic cycle for the AP of E. coli.11, 263, 264  
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Catalytic Mechanisms Proposed for PAP 
Recently, an eight step mechanism for the phosphoester hydrolysis by the heterodinuclear active 
site of PAPs was proposed (Scheme 15).25, 29 This catalytic cycle is based on X-ray structures, 
spectroscopic studies of different enzyme-inhibitor complexes and kinetic data for phosphoester 
hydrolysis. Prior to nucleophilic attack it was suggested that the phosphoester substrate is 
precoordinated in the second coordination sphere and stabilized via an extensive hydrogen 
bonding network, involving the µ-hydroxido ligand, the ZnII coordinated asparagine residue and 
adjacent histidine residues. This proposal derives from stopped-flow kinetic measurements and 
a crystal structure of a kbPAP-sulfate complex in which a sulfate anion is coordinated in this 
fashion.25, 265, 266 Following this, the preorientation of the phosphoester leads to a monodentate 
and subsequently bridging coordination mode of the phosphoester substrate. The attacking 
nucleophile is proposed to be the asymmetrically bound µ-hydroxido ligand, although the nature 
of the nucleophile is still a matter of debate, and different proposals are discussed later in this 
chapter.25, 67, 69, 82, 85, 267, 268 After the esterolysis, the phosphate remains bound to the active site 
either in a tripodal or a µ-1,3-bridging coordination fashion, proposed on basis of crystal 
structures of different types of PAPs.26, 83, 85 The least understood step of the catalytic cycle is the 
regeneration of the resting state of the enzyme, which requires the removal of the phosphate 
group. The authors suggested a plausible sequence depicted in Scheme 15.29  
 
Scheme 15: Proposed reaction mechanism for PAP-catalyzed phosphoester hydrolysis based on X-ray 
structures.25, 29 
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Various other suggestions regarding the catalytic mechanism of dinuclear phosphoesterases 
have been proposed, and these are summarized in Scheme 16.269 Early publications proposed 
the activation of the phosphoester substrate via monodentate coordination to the metal in 
binding site β and the subsequent attack of a Mα-bound terminal hydroxide (Mα = FeIII in PAP), 
generating a pentacoordinated, associative-type phosphorus intermediate or transition state 
(Scheme 16, pathway a).83, 228  
 
Scheme 16: Possible pathways for phosphoesterase catalyzed hydrolysis (Mα = FeIII, Mβ = FeII, ZnII, MnII for PAP; 
Mα = Mβ = ZnII for AP).269 
However, stopped-flow kinetic studies with ufPAP in its native FeIIIFeII form and the artificial 
FeIIIMnII form revealed that the hydrolysis of the phosphoester substrate occurs faster than the 
perturbation of the FeIII-OTyr charge transfer transition.82 This supports a monodentate substrate 
binding but also indicates the hydroxide nucleophile not being directly bound to the FeIII center. 
In addition, EPR spectroscopic results showed that the FeIII in bsPAP is only slowly affected during 
the catalytic cycle of phosphoester hydrolysis, therefore, a ‘general-base’ mechanism has been 
proposed.267 Here, the Mα-bound hydroxide functions as base and activates a non-coordinated 
water molecule, which subsequently attacks the terminal phosphoester in binding site β 
(Scheme 16, pathway b); the phosphate product remains monodentately coordinated after the 
hydrolysis.269 A third pathway has been suggested, derived from the crystallographic data, where 
the phosphoester coordinates in a bridging fashion before being attacked by the bridging 
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hydroxido ligand (Scheme 16, pathway c). However, the low nucleophilicity of a µ-hydroxido 
makes pathway a and pathway b more plausible.25, 270 These three different mechanisms were 
similarly discussed for AP consisting of two ZnII centers in the active site.65, 271 Similarly, different 
inhibition processes are discussed that all include formation of catalyst-substrate or catalyst-
inhibitor (hydrolysis product) adducts, containing the phosphates in a bridging coordination 
mode (Scheme 16, pathway d and e).83, 228 The presence of these equilibria was supported by 
labeling studies with 18O-phosphate, which demonstrated successive oxygen exchange between 
enzyme bound phosphate and water.272 
It is likely that, depending on the metal composition in the active site and the substrate used, 
different mechanisms operate.66 However, there is an ongoing debate about (i) the substrate 
coordination mode (monodentate (Scheme 16, species A) vs. bridging (Scheme 16, species B)), 
(ii) the type of the attacking nucleophile, and (iii) the reaction type (concerted vs. stepwise). 
Moreover, the impact of the second coordination sphere with respect to the catalytic mechanism 
is still not fully understood, although it is apparent that the histidine residues proximal to the 
dimetallic core play an important role in the phosphoester hydrolysis activity of PAPs.25, 82, 83 
Klabunde et al. proposed a reaction mechanism (Scheme 17) where these histidine residues, 
essential for catalysis, were involved in the active site of kbPAP.83  
 
Scheme 17: Proposed reaction mechanism for PAP-catalyzed phosphoester hydrolysis, considering the second 
coordination sphere of the enzyme.83 
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Interaction with the protonated histidine residues promote (i) binding and activation of the 
substrate, (ii) transition state stabilization, and (iii) release of the leaving group, thus explaining 
the enhanced activity at low pH. This mechanism was supported by DFT studies, undertaken to 
understand the importance of hydrogen bonds within the reaction mechanism and to identify 
the reasons that enable the model system [FeIII2(L6)(µ-O)Cl4](Cl)2 to hydrolyze not only the 
phosphodiester model substrate BDNPP but also the phosphomonoester model substrate DNPP 
(Scheme 18).108, 109 Relative energies of this model complex, binding the substrates either in a 
monodentate or in a bridging mode, were calculated and compared. While the phosphodiester 
BDNPP is more likely bound in a monodentate fashion, stabilized by the formation of hydrogen 
bonds to the protonated cyclam ring, the phosphomonoester DNPP is proposed to interchange 
between the monodentate and the bridging mode due to a relatively small activation barrier. 
Once the phosphomonoester substrate is coordinated to one of the FeIII ions two reaction 
pathways are possible: either the phosphoester-bridged complex is formed, leading to the 
deactivation of the catalyst (Scheme 18, pathway b), or the nucleophilic attack via the hydroxido 
ligand bound to the second FeIII ion takes place (Scheme 18, pathway a), resulting in the 
hydrolysis of the substrate. These competitive reactions were compared by relaxed potential 
energy surface scans conducted by stepwise decrease of the distance between the non-
coordinated FeIII ion and the oxygen atom of DNPP in the case of inhibition (Scheme 18, pathway 
b) or the hydroxido ligand oxygen atom and the phosphorus atom of DNPP in the case of 
hydrolysis (Scheme 18, pathway a).108, 109  
 
Scheme 18: Proposed catalytic cycle for the hydrolysis of BDNPP and DNPP with the use of the FeIII2 complex of 
H2L6.108, 109 
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With these DFT studies it was elucidated that (i) the activation barrier of the deactivation is higher 
than of the cleavage of the phosphoester bond and (ii) the lack of hydrogen bond formation 
capacity (using a deprotonated cyclam backbone) leads to a smaller energy difference between 
the two possible reaction pathways.108, 109 Thus, the capacity of this model complex 
[FeIII2(L6)(µ-O)Cl4](Cl)2 for cleaving a phosphomonoester was ascribed to the involvement of a 
hydrogen bond network in the reaction mechanism. 
Although the two catalytic mechanisms of PAP and AP differ in the interaction that places the 
phoshoester substrate in the ideal position for the nucleophilic attack and, more importantly, in 
the nature of the attacking nucleophile, there are some common features, i.e. (i) the activation 
of the substrate by Lewis acid metal ion coordination and hydrogen bonding interactions with 
side-chains of adjacent residues, (ii) promotion of the transition state formation by the metal 
ions and hydrogen bonding residues, and (iii) the assistance of the release of the alkoxide leaving 
groups via stabilizing interaction with the extensive hydrogen bonding network in the active 
site.11 
However, it should not be underestimated that in addition to specific chemical features, the 
remarkable catalytic activity of phosphatase enzymes may also derive from the polarity and the 
steric demand of the environment of the active site.273 It has been suggested that the catalysis 
of enzymes is promoted by binding of the substrate in hydrophobic pockets with an apparent 
dielectric constant much lower than the surrounding water. In this way, both the equilibrium for 
proton transfer reactions is shifted and the strengths of hydrogen bonds, involving the substrate 
binding and the transition state stabilization, are changed.274 Bond cleavage in enzymes is also 
known to be promoted by straining of the substrate in order to support the formation of the 
transition state.11 
In the following chapters kinetic studies with the complexes developed in this work (Chapter 3, 
4, and 5) will be discussed. The emphasis was on a correlation of the position of the hydrogen 
bonding residues in the active site of the model complexes with the catalytic efficiencies. 
However, the influence of sterically demanding residues as well as the impact of a more electron-
rich primary coordination site was also studied. 
6.2 PHOSPHOESTER SUBSTRATES EMPLOYED IN CLEAVAGE 
STUDIES 
 
In order to access the cleavage activity of phosphatase model complexes a number of non-
natural substrate models have been used as mimics of natural phosphate linkages. The model 
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substrates employed to study the phosphoester binding with the model complexes 
developed in this work are 4-nitrophenylphosphate (PNPP) (as its disodium salt), bis(4-nitro-
phenyl)phosphate (BPNPP), 2,4-dinitrophenylphosphate (DNPP) (as its 2,6-lutidinium salt) 
and bis(2,4-dinitrophenyl)phosphate (BDNPP) (as its pyridinium salt); these are shown in 
Chart 19. PNPP and BPNPP are commercially available, BDNPP and DNPP were prepared 
following reported procedures as described in detail in Chapter 11.14. 
 
Chart 19: Phosphoester model substrates employed in this work. 
The phosphoester hydrolysis reactivity of the catalysts developed in this work was probed with 
a spectrophotometric assay using BDNPP (phosphodiester) and DNPP (phosphomonoester) as 
model substrates. These phosphoester compounds were chosen because of their well-
demonstrated and -documented use with various catalysts.11, 81 They also serve as an 
appropriate comparison of the results obtained with those from past works since these 
substrates are commonly used. In Scheme 19 the hydrolysis of the phosphodiester BDNPP 
under basic conditions is shown. Cleavage of BDNPP forms DNPP by release of 2,4-dinitro-
phenolate. The phosphomonoester product DNPP can be further hydrolyzed in a second 
step.  
 
Scheme 19: Hydrolysis of BDNPP and DNPP under basic conditions releasing 2,4-dinitrophenolate. 
Cleavage of the phosphorous-oxygen bond of BDNPP or DNPP was followed, for approximately 
three minutes, at 25°C by monitoring the generated product 2,4-dinitrophenolate by its strong 
absorption at 400 nm (ε = 12,100 M-1cm-1). The initial hydrolysis rate v0 was calculated from the 
initial rate of the increase of the absorbance at 400 nm.  
It is important to note, that the model substrates BDNPP and DNPP are activated towards 
cleavage as the resulting product is strongly stabilized via resonance. Moreover, spontaneous 
hydrolysis of the model substrate takes place in basic solution. Therefore, all experiments 
were conducted in triplicate and the average data were subsequently corrected from the 
autohydrolysis by subtraction of the v0 value obtained with measurements in the absence of 
a catalyst.  
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6.3 GENERAL PROCEDURES 
 
Before the results of the kinetic investigations are discussed in the following chapters the general 
procedure applied will be introduced. 
6.3.1 PH DEPENDENCE ASSAYS 
 
By varying the pH of the multicomponent buffer, the pH dependence of the activity was studied 
in the pH range from 5 to 11. The pH values refer to the aqueous component, and it should be 
noted that the pH of an aqueous solution of the buffer is the same within error as in a 1:1 mixture 
of buffer and acetonitrile.275, 276 The resulting data were fitted either to Equation 20 describing a 
monoprotic system or to Equation 21 which is based on a model for a diprotic system with two 
active species En and En-1 (Scheme 20).277 
  Equation 20 v0 =
vmax
1+
[H+]
𝐾𝑎
 
  Equation 21 v0 =
vmax(1+
γKa2
[H+]
)
(1+
[H+]
Ka1
+
Ka2
[H+]
)
 
Here, v0 is the initial reaction rate and vmax is the maximum reaction rate that is reached under 
given conditions. The factor γ is related to the relative activity of the two active species in 
equilibrium (EnS and En-1S); a value of γ less than unity corresponds to a more active EnS adduct 
and a value higher than 1 considers the deprotonated adduct En-1S as more active.277, 278 The Ka 
values obtained are the protonation equilibrium constants between the two relevant active 
species. 
 
Scheme 20: Model of a diprotic system with two active species on which Equation 21 is based on.277 
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6.3.2 SUBSTRATE CONCENTRATION DEPENDENCE ASSAYS 
 
The measurements of the dependence of the BDNPP hydrolysis rate on the substrate 
concentration were determined at a range of pH values to assess the catalytic behavior of 
different protonation states. Due to the poor solubility of BDNPP in acetonitrile, assays with 
a starting concentration of the substrate higher than 11.5 mM could not be investigated. If 
the dependence of the rate of hydrolysis on the BDNPP concentration showed Michaelis-
Menten saturation behavior, the experimental data were fitted to Equation 22 in order to 
determine the kinetic parameter values for the Michaelis-Menten constant KM and the 
maximum reaction rate vmax.279, 280 KM describes the substrate concentration required for the 
enzyme/catalyst to reach one-half of its maximum cleavage reaction rate. 
Equation 22 v0 =
vmax[BDNPP]0
KM+[BDNPP]0
 
Applying Equation 23 the catalytic rate kcat, which describes the number of substrate 
molecules cleaved by one active site per second, was evaluated. The efficiency of the catalyst 
is expressed as kcat/KM. 
Equation 23 kcat =
vmax
[complex]0
 
 
6.3.3 TURN OVER NUMBERS 
 
Long-term studies regarding the catalytic activity of the catalysts developed in this thesis 
were conducted preparing assays with an excess of phosphoester substrate and leaving them 
to react at room temperature for up to two weeks. During the experiment, samples were 
taken at various intervals, diluted with solvent (mixture acetonitrile:MilliQ-water (1:1)), and 
their UV-vis spectra were recorded to determine the amount of phosphoester hydrolysis. 
The increase in the absorbance at 400 nm, assigned to the hydrolysis product, 2,4-
dinitrophenolate, was monitored over time and turn over numbers calculated using the Beer-
Lambert Law.
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Chapter 7  
Phosphatase Activity of 
Dizinc Complexesf
                                                          
f Main parts of this chapter are published in “Dinuclear Zinc(II) Complexes with Hydrogen Bond Donors as 
Structural and Functional Phosphatase Models”; Simone Bosch, Peter Comba, Lawrence R. Gahan, Gerhard 
Schenk, Inorg. Chem. 2014, 53, 9036-9051. 
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7.1 INTRODUCTION 
 
The facile catalyzed cleavage of phosphoesters is a crucial reaction for living organisms, for 
example in processing RNA replication and bone metabolism, and it is of ecological importance 
in the detoxification of pesticides. Natural phosphatases, which accomplish this hydrolysis, 
commonly contain ZnII ions in their active sites. Therefore, dizinc(II) complexes have been widely 
used as artificial models to expand our understanding of the hydrolysis mechanism in the native 
enzymes and to promote the development into new therapeutic agents.  
Attention in the design of model complexes has been mainly focused on the influence of (i) the 
ZnII···ZnII distance, (ii) the moieties bridging the two ZnII centers, and (iii) the ZnII coordinating 
residues in the primary coordination sphere.28, 65, 271, 281, 282 Whilst many zinc(II) complexes of 
simple chelating ligands were reported to be effective in hydrolyzing phosphoesters, the catalytic 
rates generally were found to be modest compared to the native nucleases and phosphatases. 
Thus, in recent years emphasis has been put in the secondary coordination sphere of the ZnII 
center(s) of model complexes, because many metalloenzymes that catalyze the cleavage of 
phosphoesters also use amino acid side chains to preorientate the substrate molecule and to 
stabilize the transition state.80, 84 The development of complexes incorporating functionalities, 
imitating the environment proximal to the dimetallic core of nucleases and phosphatases, 
resulted in complexes with increased acceleration capacity compared to their non-functionalized 
counterparts. 
Before introducing examples of zinc(II) model complexes considering the secondary interactions 
within the active site of phosphatases, it should be noted that the kinetic studies of those 
complexes were often undertaken using the RNA model substrate HPNPP (2-hydroxypropyl-4-
nitrophenylphosphate). In the case of HPNPP the P-O bond cleavage is introduced by the 
nucleophilic attack of an alkoxide (in contrast to a hydroxide nucleophile for the hydrolysis of 
BNPP, BDNPP and DNPP (Scheme 21, bottom)), followed by the release of an alkoxide group 
(Scheme 21, top). Therefore, the process is termed transesterification, while the attack by a 
hydroxide is known as hydrolysis.11 
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Scheme 21: Transesterification of HPNPP (top) and hydrolysis of BNPP (bottom).  
Although the processes differ in the type of nucleophile initiating the cleavage reaction, they 
have commonalities in (i) the activation of the phosphoester by coordination to a ZnII center and 
(ii) the proposed formation of a five-coordinate trigonal bipyramidal phosphorus atom in the 
transition state.  
Breslow et al. were the first to explore the effect of functional groups within simple metal 
complexes, their intention being to emulate secondary enzyme active site features that are either 
known or postulated to contribute to the phosphoester cleavage activity. The incorporation of 
basic groups such as thiophenolate or imidazole as in [ZnII(HL53)]2+ and [ZnII(HL54)]2+ were shown 
to accelerate HPNPP cleavage 9-fold and 20-fold, respectively, compared to the reference 
complex [ZnII(HL52)]2+ (Chart 20).283 
 
Chart 20: Zinc(II) complexes employed by Breslow et al. studying the impact of basic residues proximal to the 
ZnII center.283 
Subsequently Kövári and Krämer reported a significant increase in BPNPP cleavage activity by 
incorporation of amine groups at the end of rigid alkyne pendants of ZnII-bpy complexes.157 While 
the BPNPP hydrolysis activity for [ZnII(L55)(OH2)3]2+ (Chart 21) was found to be similar to that of 
the parent complex [ZnII(bpy)(OH2)3]2+, a significantly higher hydrolysis rate was observed with 
complex [ZnII(L56)(OH2)3]2+ (Chart 21), ascribed to the hydrogen bonding capacity of the amino 
residues.157 
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Chart 21: Zinc(II) complexes used by Kövári, Krämer and He et al. to study the effect of hydrogen bonding 
towards the phosphoester cleavage.157, 284 
With a similar model system the effect of guanidinium residues, mimicking the secondary 
coordination sphere of phosphatases at different positions with respect to the ZnII center, was 
investigated by He et al.284 The kinetic data revealed that [ZnII(L57)(OH2)3]2+ and [ZnII(L58)(OH2)3]2+ 
(Chart 21) accelerated BPNPP hydrolysis nearly 300-fold and 600-fold, compared to their 
analoguous [ZnII(bpy)(OH2)3]2+ complex, missing guanidinium groups (Table 18).284  
Table 18: Kinetic data (kcat in [10-3 s-1], KM in [mM] and kcat/KM in [s-1M-1]) of BPNPP hydrolysis reported for 
[ZnII(bpy)(OH2)3]2+, [ZnII(L58)(OH2)3]2+, and [ZnII(L57)(OH2)3]2+ (all kinetic studies were undertaken in aqueous 
solution).284 
complex kcat KM kcat/KM pHMM 
[ZnII(bpy)(OH2)3]2+ 0.57·10-3 6.82 8.35·10-5 7.2 
[ZnII(L57)(OH2)3]2+ 0.14 2.08 0.07 7.2 
[ZnII(L58)(OH2)3]2+ 0.37 0.70 0.53 7.2 
 
Due to the fact that the KM values for [ZnII(L57)(OH2)3]2+ and [ZnII(L58)(OH2)3]2+, both bearing 
guanidinium groups, were lower than for the reference complex [ZnII(bpy)(OH2)3]2+, the hydrogen 
bond donors in the ligands were proposed to facilitate phosphodiester cleavage by interaction 
with the substrate. Furthermore, the guanidinium arms were postulated (i) to assist the binding 
of the phosphate substrate to the ZnII ion, (ii) to act as additional Lewis acid, which polarizes the 
phosphate substrate, and (iii) potentially to protonate the leaving group.284 
Similarly, the positive contribution of non-coordinating amines in ZnII complexes of tris(pyridyl-
methyl)amine towards the HPNPP cleavage efficiency was exhibited with the complexes 
[ZnII(L21)(OH2)]2+ (kcat/KM = 1.0·10-3 M-1s-1) and [ZnII(L25)(OH2)]2+ (kcat/KM = 7.9·10-2 M-1s-1) 
(Chart 22), ascribed to the capacity of the amino groups to activate the bound substrate towards 
intramolecular nucleophilic attack via hydrogen bonding.11, 110 Such interactions were confirmed 
by a crystal structure of [ZnII(L24)(NO3)]+ derived from a similar ligand with two amino residues, 
forming hydrogen bonds to the coordinating oxygen atom of a NO3¯ anion.285 On the basis of DFT 
calculations a general base catalysis mechanism for the phosphodiester cleavage by complex 
[ZnII(L25)(OH2)]2+ was proposed, in which hydrogen-bonding interactions serve to stabilize the key 
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five-coordinate phosphorus intermediate as well as lower the energy barrier of proton transfer 
reactions by enhancing solvation.11, 286 
 
Chart 22: Zinc(II) complexes employed to study the impact of amino residues towards the cleavage of 
phosphodiesters.110, 112, 285 
Recently the approach to incorporate hydrogen bond donors into zinc(II) model complexes has 
been extended to the synthesis of dinuclear metal-ion complexes with hydrogen bond donors in 
proximity to the metal centers. In this way, the dizinc(II) system [ZnII2(L7)(OH2)2]4+ was developed 
to be capable of forming four hydrogen bonds with a phosphate ester substrate as demonstrated 
by a X-ray structure of [ZnII2(L7)(PNPP)]3+.112 [ZnII2(L7)(OH2)2]4+ is currently one of the most active 
synthetic cleavage agents, accelerating the cleavage of HPNPP by a factor of almost a million 
(kcat = 0.017 s-1, KM = 0.32 mM at pH = 7.4), ascribed to the cooperation of double Lewis activation 
by two ZnII ions within the complex and the hydrogen bonding environment provided by the 
ligand backbone.112 
Studying the phosphoester cleavage activity of m-xylyl based dizinc(II) complexes substituted 
with alkyl, amino or acetamido residues (Chart 23) an increased activity towards HPNPP 
transesterification while all functionalized dizinc(II) complexes [ZnII(L60)(OH2)2]2+, 
[ZnII(L61)(OH2)2]2+ and [ZnII(L62)(OH2)2]2+ exhibited greater activity than the parent complex 
[ZnII(L59)(OH2)2]2+.287 
 
Chart 23: Dizinc(II) complexes used to study the impact of methyl, amino and acetamido functionalities proximal 
to the ZnII centers.287 
Closer inspection of the kinetic data revealed that the differences in the H-bond donating abilities 
of the amino and acetamido residues are only subtly manifested in the strength of substrate 
binding by [ZnII(L61)(OH2)2]2+ and [ZnII(L62)(OH2)2]2+ (KM differs by ~ 3.5) and the catalytic rate 
constant (factor of 2).287  
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Table 19: Kinetic data (kcat in [s-1], KM in [mM] and kcat/KM in [103 s-1M-1]) of HPNPP transesterification reported 
for [ZnII2(L59)(OH2)2]4+, [ZnII2(L60)(OH2)2]4+, [ZnII2(L61)(OH2)2]4+, and [ZnII2(L62)(OH2)2]4+ (all kinetic studies were 
undertaken in methanol under optimal pH conditions).287 
complex kcat KM kcat/KM 
[ZnII2(L59)(OH2)2]4+ 0.13 0.08 1.6 
[ZnII2(L60)(OH2)2]4+ 6.2 0.21 29.8 
[ZnII2(L61)(OH2)2]4+ 3.89 0.24 16 
[ZnII2(L62)(OH2)2]4+ 7.2 0.07 109 
 
However, comparison of the KM values reveals that (i) the acetamide derivative [ZnII2(L62)(OH2)2]4+ 
and the unsubstituted complex [ZnII2(L59)(OH2)2]4+ have comparable substrate affinity, and (ii) 
both the methyl derivative [ZnII2(L60)(OH2)2]4+ and the amino derivative [ZnII2(L61)(OH2)2]4+ bind 
the phosphoester substrate slightly more weakly than does [ZnII2(L59)(OH2)2]4+, missing those 
functionalities. Moreover, the hydrolysis rates are in the same range for all substituted 
complexes suggesting that the different functionalities (alkyl, amino, acetamido) are all equally 
capable of stabilizing the transition state. In conclusion, the effect of the functionalization of the 
dizinc(II) catalyst with hydrophobic and sterically demanding CH3 groups seems comparable 
afforded by amino and acetamido substituents.287 Therefore, other effects such as steric and 
local polarity seem to be as important in such systems as hydrogen-bond formation and should 
be considered in order to generate more active model complexes. 
The function of the ZnII ions during transesterification is the activation of the substrate, and a 
positive effect of adjacent hydrogen bond donors on the substrate activation was discovered 
studying mono- and dinuclear model complexes, providing hydrogen bond donors proximal to 
the ZnII center(s). In the case of the phosphoester hydrolysis the task of the metal ions in the 
model complexes is not only the phosphoester activation but also the generation of the 
hydroxide nucleophile. Although a positive effect of the presence of two ZnII ions in close distance 
has been reported to have an accelerating effect on the hydrolysis of phosphoester,86-89, 288 the 
impact of hydrogen bond donors has only been studied with a few monozinc(II) complexes 
providing hydrogen bonding capacity. In this work, the two strategies of (i) a dinuclear core and 
(ii) the provision of hydrogen bonding ability was combined to develop more accurate dizinc(II) 
model complexes for phosphatases. More precisely, dizinc(II) complexes have been prepared 
with amino and pivaloyl-amide residues in the 2-position of two of the four coordinating pyridine 
moieties (Chart 24). The synthesis and characterization of these dizinc(II) complexes has been 
discussed in Chapter 4.  
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Chart 24: Dizinc(II) complexes employed in this chapter. 
Comparison of the functionalized complexes [ZnII2(H2L2)(µ-OAc)2]+, 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+, and [ZnII2(SIM2)(µ-OAc)2]+ to the unsubstituted complex 
[ZnII2(L1)(µ-OAc)2]+ enables the study of the impact of hydrogen bond donors proximal the 
dizinc(II) center towards the hydrolysis of phosphoesters. Moreover, an insight in the effect 
of the position of hydrogen bond donors could be achieved via comparison of the two 
complexes [ZnII2(H2SIM1)(µ-OAc)(OH)]+ and [ZnII2(H2L2)(µ-OAc)2]+, both bearing pivaloyl-
amide residues, but at different positions with regard to the dizinc(II) core. Similarly, 
comparison of the asymmetric complexes [ZnII2(SIM2)(µ-OAc)2]+, bearing amino residues and 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+, bearing sterically demanding pivaloyl-amide residues revealed 
information on the effect of a hindered ZnII center in a dizinc(II) complex. Furthermore, the 
two complexes [ZnII2(H2SIM1)(µ-OAc)(OH)]+ and [ZnII2(H2SIM3)(µ-OAc)(OH)], which are 
identical with regard to the secondary coordination sphere, but differ in one of the 
coordinating ligands in the primary coordination sphere, enables the investigation of 
combining an asymmetric primary coordination sphere with an asymmetric secondary 
coordination sphere within a dizinc(II) complex.  
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7.2 PHOSPHOESTER HYDROLYSIS STUDIES OF DIZINC(II) 
COMPLEXES 
 
The phosphoester hydrolysis reactivity of [ZnII2(L1)(µ-OAc)2]+, [ZnII2(H2L2)(µ-OAc)2]+, 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+, [ZnII2(SIM2)(µ-OAc)2]+, and [ZnII2(H2SIM3)(µ-OAc)(OH)] was 
probed with a spectrophotometric assay using BDNPP as model substrate. The general 
experimental procedure explained in Chapter 6.3 was applied. 
pH and Concentration Dependence 
The rate vs. pH profiles for three of the dizinc(II) complexes show a nearly sigmoidal shape, 
whereas the corresponding profile for [ZnII2(H2SIM1)(µ-OAc)(OH)]+ appears to be bell-shaped. 
This bell-shaped profile indicates that the catalyst-substrate complex (EnS) is most active in 
its mixed protonation state, where both protonation and deprotonation lead to a decrease 
of activity. Based on a fit adopting the equation for a monoprotic system, the assumed two 
active species in the case of [ZnII2(L1)(µ-OAc)2]+ and [ZnII2(SIM2)(µ-OAc)2]+ have the same 
activity. In contrast, the deprotonated active species of [ZnII2(H2L2)(µ-OAc)2]+ appears to play 
an important role in the catalytic cycle as the rate vs. pH profile rises steadily as the pH 
increases, leading to a γ value of 4.19. Comparison of the profiles leads to the conclusion that 
the presence of two amine groups near one ZnII center in [ZnII2(SIM2)(µ-OAc)2]+ lowers the 
kinetically relevant pKa value by 1.3 pKa units, in agreement with previously published results 
(introduced in Chapter 4).184 The influence of two amide groups at one ZnII center in 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+ is comparatively small; in contrast the symmetric incorporation 
of two amide moieties in [ZnII2(H2L2)(µ-OAc)2]+ causes a significant effect, both in the profile 
shape (highest reactivity at high pH; Figure 55a) and the pKa values.  
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Figure 55: a) pH dependence of BDNPP hydrolysis activity for [ZnII2(L1)(µ-OAc)2]+ (black triangles), 
[ZnII2(H2L2)(µ-OAc)2]+ (blue diamonds), [ZnII2(H2SIM1)(µ-OAc)(OH)]+ (red squares), and [ZnII2(SIM2)(µ-OAc)2]+ 
(green circles) and substrate concentration dependence b) at pH = 7, c) at pH = 9.5 and d) at pH = 11. 
The measurements of the dependence of the BDNPP hydrolysis rate on the complex 
concentration were determined at pH 9.5. The results show that for each complex the 
hydrolysis rates are linearly dependent on the complex concentration.  
The dependence of the rate of hydrolysis on the BDNPP concentration were examined at 
three pH values (i.e. pH = 7.0, 9.5 and 11) to assess the catalytic behavior of different 
protonation states (Figure 55b, c, d). [ZnII2(SIM2)(µ-OAc)2]+ was not tested at pH = 11 as no 
difference in the hydrolysis rate, compared to pH = 9.5, was detected during the previous pH 
dependence experiments. Due to the poor solubility of BDNPP in acetonitrile, assays with a 
starting concentration of the substrate higher than 11.5 mM could not be investigated. The 
experimental data showed Michaelis-Menten saturation behavior for all complexes and were 
fitted to Equation 22. The derived parameter values kcat, KM and kcat/KM are listed in Table 20.   
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Table 20. Kinetic data (kcat in [10-3 s-1], KM in [mM] and kcat/KM in [s-1M-1]) of BDNPP hydrolysis for 
[ZnII2(L1)(µ-OAc)2]+, [ZnII2(H2L2)(µ-OAc)2]+, [ZnII2(H2SIM1)(µ-OAc)(OH)]+, [ZnII2(SIM2)(µ-OAc)2]+, and 
[ZnII2(H2SIM3)(µ-OAc)(OH)]. 
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pKa(I)  6.53 ± 0.05 7.67 ± 0.16 6.96 ± 0.06 5.19 ± 0.02 7.33 ± 0.16 
pKa(II)  10.33 ± 0.83 9.45 ± 0.19 10.72 ± 0.28 10.02 ± 0.78 10.01 ± 0.40 
γ  1.26 ± 0.08 4.19 ± 0.67 0.45 ± 0.14 1.05 ± 0.03 2.01 ± 0.32 
kcat 7 7.18 ± 4.39 0.09 ± 0.01 0.57 ± 0.04 3.49 ± 0.25  
KM 7 123 ± 79 2 ± 1 4 ± 1 18 ± 2  
kcat/KM 7 0.06 0.04 0.14 0.20  
kcat 9.5 5.08 ± 0.85 3.20 ± 0.21 2.70 ± 0.21 9.58 ± 0.70 8.67 ± 0.89 
KM 9.5 80 ± 14 9 ± 1 18 ± 2 52 ± 4 37 ± 5 
kcat/KM 9.5 0.06 0.34 0.15 0.18 0.23 
kcat 11 2.07 ± 0.29 10.83 ± 0.62 3.68 ± 0.25 -  
KM 11 27 ± 5 26 ± 2 28 ± 2 -  
kcat/KM 11 0.08 0.42 0.13 -  
TON  
(after 8 d) 
9.5 109 ± 5 158 ± 8 101 ± 4 121 ± 6  
 
While at pH = 7 [ZnII2(L1)(µ-OAc)2]+, without hydrogen bond donors, exhibits the highest rate of 
hydrolysis, [ZnII2(SIM2)(µ-OAc)2]+ is the most efficient catalyst due to its smaller KM value. 
Moreover, the Michaelis-Menten constants KM are lower for all complexes providing a 
hydrogen bond network, compared to [ZnII2(L1)(µ-OAc)2]+, both at pH = 7 and pH = 9.5. The 
net interpretation of this observation is that complexes that facilitate hydrogen bonding 
exhibit higher affinities towards the phosphodiester substrate and therefore reveal higher 
catalytic efficiencies than [ZnII2(L1)(µ-OAc)2]+ (except for [ZnII2(H2L2)(µ-OAc)2]+ at pH = 7). 
Furthermore, the measurements at pH = 11 resulted in significantly higher kcat values for the 
complexes that support hydrogen bond formation, compared to the reference complex 
[ZnII2(L1)(µ-OAc)2]+. The Michaelis-Menten constants obtained under these more basic 
conditions are comparable for all three complexes. Therefore, the complexes 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+ and [ZnII2(H2L2)(µ-OAc)2]+ have twice and five times higher 
catalytic efficiencies than [ZnII2(L1)(µ-OAc)2]+.  
Due to the insolubility of the neutral complex [ZnII2(H2SIM3)(µ-OAc)(OH)], 0.2 vol% perchloric acid 
needed to be added in order to dissolve the complex in acetonitrile. The exact appearance of the 
complex in slight acidic solution is not fully clarified, as discussed in Chapter 4.3. However, the 
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pH profile of [ZnII2(H2SIM3)(µ-OAc)(OH)], depicted in Figure 56a, exhibited two deprotonation 
steps in the region between 5 and 11 similar to [ZnII2(H2SIM1)(µ-OAc)(OH)]+. Compared to 
complex [ZnII2(H2SIM1)(µ-OAc)(OH)]+, bearing only pyridine coordinating ligands besides the 
bridging phenolate residue, the pKa(I) value of [ZnII2(H2SIM3)(µ-OAc)(OH)] is shifted to a higher 
value as expected due to the electron-rich terminal phenolate ligand. In contrast, the second pKa 
value of [ZnII2(H2SIM3)(µ-OAc)(OH)], pKa(II), is shifted to lower pH values compared to 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+. Whilst in the case of [ZnII2(H2SIM1)(µ-OAc)(OH)]+ the singly 
deprotonated form was found to be the most active species, [ZnII2(H2SIM3)(µ-OAc)(OH)] exhibited 
the most active form after two deprotonation steps with a γ-value of 2. 
 
Figure 56: a) pH dependence of BDNPP hydrolysis activity and b) substrate concentration dependence at 
pH = 9.5 for [ZnII2(H2SIM3)(µ-OAc)(OH)]. 
The dependence of the BDNPP hydrolysis rate on the substrate concentration for 
[ZnII2(H2SIM3)(µ-OAc)(OH)] was investigated at pH 9.5 and the results are depicted in Figure 
56b. The experimental data were fitted to Equation 22 and the parameter values kcat, KM, and 
kcat/KM are listed in Table 20. Comparison of the kinetic parameters of 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+ and [ZnII2(H2SIM3)(µ-OAc)(OH)], both with two pivaloyl-amide 
residues in an asymmetric manner with respect to the dizinc(II) core, but differing in the primary 
coordination sphere, allows statements regarding the impact of an electron-rich coordinating 
ligand. The respective KM values show that [ZnII2(H2SIM3)(µ-OAc)(OH)] exhibits lower substrate 
affinity than [ZnII2(H2SIM1)(µ-OAc)(OH)]+, ascribed to the more electron-rich primary 
coordination sphere. However, [ZnII2(H2SIM3)(µ-OAc)(OH)] revealed a three-fold increased 
hydrolysis rate compared to [ZnII2(H2SIM1)(µ-OAc)(OH)]+ and following a higher catalytic 
efficiency.  
Comparing the kinetic parameters of [ZnII2(H2SIM3)(µ-OAc)(OH)] with all of the dizinc(II) 
complexes studied in this work reveals that the hydrolysis rate of [ZnII2(H2SIM3)(µ-OAc)(OH)] lies 
in the range of the hydrolysis rate determined for [ZnII2(SIM2)(µ-OAc)2]+, bearing two amino 
residues, and is significantly higher than the one of the reference complex [ZnII2(L1)(µ-OAc)2]+, 
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missing hydrogen bonding capacity. Interestingly, the latter was not the case for 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+, which deviates only in the primary coordination sphere from 
[ZnII2(H2SIM3)(µ-OAc)(OH)]. This suggests that the acceleration of the BDNPP hydrolysis by a more 
electron-rich primary coordination sphere is more pronounced than the deceleration by two 
pivaloyl-amide residues adjacent one ZnII center. 
Turn Over Numbers  
Studies of the turn over number (TON) were conducted at pH = 9.5 and 25°C with 
[complex]0 = 15 nM and [BDNPP]0 = 5.25 µM. Samples were taken at various intervals during the 
experiment, diluted with solvent, and their UV-vis spectra were recorded to determine the 
amount of phosphoester hydrolysis. The increase in the absorbance at 400 nm, assigned to the 
hydrolysis product 2,4-dinitrophenolate, was monitored over time and TON values after eight 
days were calculated using the Beer-Lambert Law. The resulting data are given in Figure 57 and 
Table 20. 
 
Figure 57: a) UV-vis spectra of the BDNPP hydrolysis assay with [ZnII2(H2L2)(µ-OAc)2]+, taken at different time 
points after substrate addition and b) time dependence of the absorbance band of 2,4-nitrophenolate (400nm) 
with [ZnII2(L1)(µ-OAc)2]+ (black triangles), [ZnII2(H2L2)(µ-OAc)2]+ (blue diamonds), [ZnII2(H2SIM1)(µ-OAc)(OH)]+ (red 
squares) and [ZnII2(SIM2)(µ-OAc)2]+ (green circles). 
Complexes generated from ligands which engender asymmetry exhibit a lower TON than the 
symmetric complex [ZnII2(H2L2)(µ-OAc)2]+. This implies that the presence of an amide moiety on 
each coordination site has a beneficial impact on the hydrolytic activity. The comparison of the 
time-dependent traces for the two asymmetric catalysts, [ZnII2(H2SIM1)(µ-OAc)(OH)]+ and 
[ZnII2(SIM2)(µ-OAc)2]+, indicate that there is also a decrease of the TON as a result of the bulky 
nature of the pivaloyl group in the former complex. Therefore, the hydrolysis rate of 
[ZnII2(SIM2)(µ-OAc)2]+ is in the first 70 hours significantly higher. Furthermore, the data obtained 
with [ZnII2(H2SIM1)(µ-OAc)(OH)]+ are similar to those of the reference system [ZnII2(L1)(µ-OAc)2]+ 
during the first 150 hours after BDNPP addition. However, the difference in the traces after 150 
hours reveal earlier inhibition in presence of two amide moieties at adjacent zinc(II) centers. It is 
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proposed that an increased affinity for the hydrolysis product DNPP is the reason for this, 
resulting in the inhibition of the complex at an earlier point in time. The experiments 
demonstrate that the phosphoester hydrolysis rate of dizinc(II) complexes is influenced by (i) the 
availability of the catalytic center, and (ii) the possibility to interact with amine or amido 
hydrogen bond donors, whereas the opportunity for the formation of hydrogen bonds on both 
metal centers appears to have a beneficial effect for the hydrolytic activity.  
Studies with a variety of complexes of bis[bis(2-substituted-pyridinyl-6-methyl)]amine type 
ligands have illustrated the impact of (i) enhanced H-bonding effects in the second coordination 
sphere, (ii) the steric hindrance in the active site and beyond, and (iii) the polarity of the 
substituents, on the intramolecular hydrolysis of the substrate, for example the RNA model 
HPNPP.287 Moreover, an impaired BDNPP affinity was found for the dizinc(II) complex of a bulky 
phenolate-based ligand HL63 (kcat = (0.97 ± 0.21)·10-3 s-1; KM = (7.01 ± 2.57) mM; 
kcat/KM = 0.14 s-1M-1) compared to its unconcealed counterpart H2L64 (kcat = (2.45 ± 0.27)·10-3 s-1; 
KM = (9.48 ± 1.74) mM; kcat/KM = 0.26 s-1M-1), which was proposed to be a steric effect attributed 
to the bulky vinylbenzyl group.276  
Therefore, the exact origin of the acceleration of the BDNPP hydrolysis with the dizinc(II) 
complexes studied in this work may be attributed in part to the enhanced H-bonding effects, but 
the effects of other parameters in combination with H-bonding, needs further investigation. 
Product Inhibition at the Active Site 
Studies of the hydrolysis of phosphomonoesters using DNPP as model substrate in the substrate 
concentration dependence assays as well as in the TON assays revealed no acceleration of 
phosphoester hydrolysis compared to the autohydrolysis assay for the dizinc(II) complexes 
[ZnII2(L1)(µ-OAc)2]+, [ZnII2(H2L2)(µ-OAc)2]+, [ZnII2(H2SIM1)(µ-OAc)(OH)]+, and 
[ZnII2(SIM2)(µ-OAc)2]+. 
Similar to the phosphate inhibition of phosphatases,289, 290 the formation of an adduct with a 
bridging phosphomonoester between the two ZnII sites is known to lead to inhibition of 
phosphoester hydrolysis in model complexes.291 Therefore, the influence of addition of DNPP to 
the reaction mixtures was explored. The presence of DNPP (1 mM) in the kinetic assays was 
shown to decrease the hydrolytic rate, independently of whether the phosphomonoester was 
added before or simultaneously with the substrate BDNPP (Figure 58).  
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Figure 58: Initial rate vs. substrate concentration for the hydrolysis of BDNPP of [ZnII2(H2L2)(µ-OAc)2]PF6 with 
(unfilled symbols) and without (filled symbols) addition of DNPP. 
The inhibited hydrolysis rates obtained in the presence of catalyst are, within the relatively large 
errors of these measurements, indistinguishable from the autohydrolysis rates under the same 
conditions (autohydrolysis experiments contain only phosphomono- and phosphodiester). These 
results demonstrate not only product inhibition but also that the hydrolysis product DNPP is 
more strongly bound to the complex than the phosphodiester substrate BDNPP.  
Crystal Structure of an Asymmetric Dizinc(II) Complex with the Phospho-
monoester PNPP 
In order to explore the nature of product inhibition, the asymmetric complex 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+ was treated with an excess of the phosphomonoester PNPP in 
acetonitrile. PNPP was chosen as phosphomonoester substrate mimic due to its higher stability 
towards autohydrolysis compared to DNPP. After the solvent was removed and the remaining oil 
dissolved in methanol, colorless crystals suitable for X-ray crystallography were obtained by slow 
evaporation. The structure reveals that the inhibited complex contains one μ-PNPP molecule, 
which forms a bridge between the two ZnII centers of the same dizinc(II) complex (Figure 59; 
selected structural parameters are listed in Table 21), in contrast to a previously published 
complex [ZnII4(L65)2(µ-O3POC6H4NO2)(H2O)2](PF6)2, in which the PNPP molecule forms not only an 
intramolecular bridge between the two ZnII ions but also a intermolecular bridge between two 
ZnII centers of adjacent dizinc(II) complexes.195 In [ZnII2(H2SIM1)(µ-O3POC6H4NO2)]PF6, both ZnII 
ions are bound to the bridging phenoxido residue, to the nitrogen atoms of two pyridine ligands, 
to a tertiary amine and additionally to an oxygen atom of the bridging PNPP molecule. 
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Figure 59: Structure of [ZnII2(H2SIM1)(µ-O3POC6H4NO2)]PF6 showing hydrogen bond formation (green dotted 
lines; counter ions, non-coordinated solvent molecules, and hydrogen atoms, not involved in hydrogen 
bonding, have been omitted for clarity; crystallographic data and ORTEP plots with 50% probability level of 
thermal ellipsoids appear in the Appendix, Table 34 and Figure 74). 
Table 21: Selected bond lengths (Å) and angles (°) for [ZnII2(H2SIM1)(µ-O3POC6H4NO2)]PF6 compared to 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6. 
 [ZnII2(H2SIM1)(µ-O3POC6H4NO2)]+ [ZnII2(H2SIM1)(µ-OAc)(OH)]+ 
Zn(1)...Zn(2) 3.6971(8) 3.5422(7) 
Zn(1)-O(1) 1.987(3) 1.954(3) 
Zn(1)-O(2) 2.011(3) 2.003(3) 
Zn(1)-N(1) 2.074(4) 2.057(3) 
Zn(1)-N(2) 2.269(4) 2.233(2) 
Zn(1)-N(3) 2.062(4) 2.102(3) 
Zn(2)-O(1) 2.140(3) 2.120(2) 
Zn(2)-O(3) 1.941(3) 2.133(3) 
Zn(2)-N(4) 2.443(4) 2.322(3) 
Zn(2)-N(5) 2.133(4) 2.136(3) 
Zn(2)-N(6) 2.107(4) 2.336(3) 
Zn(2)-O(6) - 1.945(2) 
Zn(2)-O(5) 2.122(3) - 
Zn(1)-O(1)-Zn(2) 127.16(17) 120.75(12) 
O(1)-Zn(1)-N(1) 136.52(16) 118.71(12) 
O(1)-Zn(1)-N(2) 89.85(14) 91.48(11) 
O(1)-Zn(1)-N(3) 100.53(16) 124.82(11) 
O(1)-Zn(1)-O(2) 98.94(13) 99.48(12) 
O(1)-Zn(2)-N(4) 162.62(14) 88.66(10) 
O(1)-Zn(2)-N(5) 91.55(14) 90.65(11) 
O(1)-Zn(2)-N(6) 87.68(14) 161.27(10) 
O(1)-Zn(2)-O(3) 93.42(13) 87.91(11) 
O(1)-Zn(2)-O(6) - 102.84(10) 
O(5)-Zn(2)-O(1) 100.35(13) - 
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Comparison with the structure of the corresponding acetate-bridged complex 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 (discussed in detail in Chapter 4.3), used as the starting material 
for the synthesis of [ZnII2(H2SIM1)(µ-O3POC6H4NO2)]PF6, illustrates important similarities: the 
ZnII ions in both structures are on different sides of the phenoxido plane and exhibit different 
coordination geometries. In the catalyst-inhibitor adduct [ZnII2(H2SIM1)(µ-O3POC6H4NO2)]PF6, 
Zn(1) is also coordinated in a trigonal bipyramidal geometry (τ-value of 0.88), while Zn(2) is at the 
center of a six-coordinate site. In contrast to the catalyst complex, the remaining coordination 
site of Zn(2) is no longer completed by a terminal hydroxido group, but by the neighboring amide 
oxygen atom of the supporting dinucleating ligand. The coordination of the bulky PNPP inhibitor 
in [ZnII2(H2SIM1)(µ-O3POC6H4NO2)]PF6, compared to the acetate co-ligand in 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 leads to an increase of the ZnII∙∙∙ZnII distance by 0.16 Å, 
accompanied by the widening of the Zn(1)-O(1)-Zn(2) angle by 6.4º. The structural differences in 
the dizinc(II) complexes of H3SIM1, [ZnII2(H2SIM1)(µ-O3POC6H4NO2)]PF6 and 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6, are mainly in the angles within the triangular plane of the 
trigonal bipyramidal site. Due to the bulkier 4-nitrophenolate residue of PNPP in 
[ZnII2(H2SIM1)(µ-O3POC6H4NO2)]PF6, compared to the acetate co-ligand in 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6, the O(1)-Zn(1)-N(1) angle is widened (136.53(16)º vs. 
118.77(16)º), and the O(1)-Zn(1)-N(3) angle is contracted (100.50(16)º vs. 124.76(15)º). However, 
the primary coordination sphere of the two complexes is similar. 
Further investigation of the second coordination sphere in the amide-based complexes 
[ZnII2(H2L2)(µ-OAc)2]PF6, [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6, [ZnII2(H2SIM3)(µ-OAc)(OH)] 
(discussed in detail in Chapter 4.3), and [ZnII2(H2SIM1)(µ-O3POC6H4NO2)]PF6 indicates that, 
while the symmetric ligand H3L2 forms two hydrogen bonds to the two bridging acetate co-
ligands – one hydrogen bond to each acetate – the symmetric complexes, 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 and [ZnII2(H2SIM3)(µ-OAc)(OH)], form two hydrogen bonds to 
the hydroxido ligand, stabilizing this unusual structure. However, the introduction of the 
monophosphate PNPP, replacing the bridging acetate, leads to the coordination of one of 
the amide groups, stabilized by hydrogen bonding to the second amide function. The 
distance between these nitrogen and oxygen atoms of 3.210(6) Å is long compared to the 
corresponding distances in [ZnII2(H2L2)(µ-OAc)2]PF6 (2.982(4) Å and 2.977(5) Å), 
[ZnII2(H2SIM1)(µ-OAc)(OH)]PF6 (2.810(4) Å and 2.875(4) Å), and [ZnII2(H2SIM3)(µ-OAc)(OH)] 
(2.764(3) Å and 2.870(3) Å). It is assumed that steric hindrance by the tert-butyl groups 
causes this elongation. Interestingly, no hydrogen bonding to the bridging phosphate, as 
previously observed with the amino group-containing complex [ZnII2(L7)(µ-PNPP)]+, occurs.112  
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31P NMR Studies of Phosphoester Binding 
Phosphomonoester Binding 
In order to gain further insight into the catalytic mechanism, substrate binding was studied 
by 31P NMR spectroscopy. 31P NMR spectra of the hexafluorophosphate salts of the dizinc(II) 
complexes were measured with 85% H3PO4 as an external standard, and the 31P resonance of 
PF6¯ anion was then used as internal standard for the phosphoester binding experiments. First 
the spectra of the phosphoester substrates were measured to study the influence of the ester 
groups on the 31P chemical shifts (Figure 60a; NaPF6 referenced to -144.30 ppm). Comparison of 
the 31P shifts in phosphoric acid, PNPP, BPNPP, DNPP, BDNPP, diphenyl phosphate and triphenyl 
phosphate show a linear correlation with the number of protons substituted by phenyl groups in 
H3PO4. Importantly, a comparison of the resonances of the phosphodiesters, BDNPP and BPNPP, 
as well as of the phosphomonoesters, DNPP and PNPP, indicates that the impact of an additional 
nitro substituent at the phenyl groups is rather small. 
The 31P NMR spectrum of the crystallographically investigated complex 
[ZnII2(H2SIM1)(µ-O3POC6H4NO2)]+ in acetonitrile has a single resonance at 0.62 ppm compared 
to -5.05 ppm for the uncoordinated phosphoester. This effect was also studied using the 
phosphomonoester DNPP for the four dizinc(II) complexes, in order to gain deeper 
understanding on the product inhibited structure during the BDNPP hydrolysis; the detected 
resonances are summarized in Table 22. 
 
Figure 60: a) Chemical shifts of 31P NMR resonances for phosphoester substrates (OP(OH)3-x(OR)x) in water 
containing CD3CN vs. extent of substitution (x) of phosphoric acid with 2,4-dinitrophenyl, 4-nitrophenyl and 
phenyl residues; Comparison of 31P NMR spectra in CD3CN after addition of DNPP to b) 
[ZnII2(H2SIM1)(OAc)(OH)]+, c) [ZnII2(H2L2)(OAc)2]+, d) [ZnII2(SIM2)(OAc)2]+ directly after addition, and e) 
[ZnII2(SIM2)(OAc)2]+ after 48 hours. 
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Table 22: Phosphoester 31P NMR resonances obtained before and after addition of dizinc(II) complexes 
[ZnII2(H2L2)(µ-OAc)2]+, [ZnII2(H2SIM1)(µ-OAc)(OH)]+, and [ZnII2(SIM2)(µ-OAc)2]+. 
ligand 
backbone in 
ZnII2 complex p
h
o
sp
h
o
- 
es
te
r 
resonances arising from phosphoesters [ppm] 
metal-
free                                      treated with the ZnII2 complexes 
H3SIM1 PNPP -5.05 0.62        
H3SIM1 DNPP -5.76 -6.85 -5.01 -2.89      
after 98 d DNPP  -6.85 -5.01       
H3L2 DNPP -5.76 -6.80 -4.25       
after 98 d DNPP  -6.80 -4.25 -2.93      
HSIM2 DNPP -5.76 -3.90 -3.37 -2.81 -2.50 -0.64 -0.40 -0.16 -0.09 
after 48 h DNPP      -0.63   -0.08 
H3L2 BDNPP -14.10         
 0.25eq    -10.25       
 0.5eq    -10.20       
 0.75eq   (-11.46) -10.22 (-6.88) (-4.58)     
after 24 h 0.75eq    -10.21 -6.95 -4.54 -1.40    
 1.0eq   -11.40 -10.20 -7.01 -4.48 -1.41    
after 21 d 1.0eq     -7.26 -4.45 -1.42    
 
The spectra recorded after the addition of DNPP to the amine-based complex 
[ZnII2(SIM2)(µ-OAc)2]+ in deuterated acetonitrile (~20 vol% water content) show eight 
resonances shortly after addition (-3.90 ppm, -3.37 ppm, -2.81 ppm, -2.50 ppm, -0.64 ppm, 
-0.40 ppm, -0.16 ppm and -0.09 ppm) (Figure 60d). Over 48 hours further reaction results in the 
observation of only two resonances at -0.61 ppm and -0.08 ppm (Figure 60e). More detailed 
analysis of the spectrum obtained immediately after addition revealed a pattern of two sets of 
four resonances, in which always two resonances of the four are separated by about 0.3 ppm 
(50 Hz) or 0.5 ppm (78 Hz and 85 Hz). 31P NMR studies performed with a series of cyclic 
phosphates disclosed that besides the electronegativity effect, the chemical shifts of 31P NMR 
resonances are also significantly influenced by (i) the O-P-O angle, and (ii) the torsional angle 
R-O-P-O(R) of the phosphate.292 Therefore, the eight resonances were attributed to four 
different species (-3.64 ppm, -2.66 ppm, -0.41 ppm and -0.25 ppm), each of them present in two 
conformers with varied positions of the 2,4-dinitrophenyl residue of the phosphoester. After 
48 hours only the ‘doublet’ at -0.25 ppm remains. The chemical shift difference of 5.51 ppm 
between the resonances of DNPP in its free form and bound to complex [ZnII2(SIM2)(solv)x]n+ is 
in the same range as found by comparison of free PNPP and [ZnII2(H2SIM1)(µ-O3POC6H4NO2)]+. 
Therefore, a similar bridging coordination mode of DNPP to complex [ZnII2(SIM2)(solv)x]n+ as 
found in [ZnII2(H2SIM1)(µ-O3POC6H4NO2)]+ is proposed. Once more it should be emphasized 
that until this most stable phosphoester-bridged dizinc(II) complex was formed three different 
intermediate stages were detectable.  
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In contrast, when the amido-based complexes [ZnII2(H2SIM1)(µ-OAc)(OH)]+ and 
[ZnII2(H2L2)(µ-OAc)2]+ and solved in deuterated acetonitrile (~3.0 vol% water content for 
[ZnII2(H2L2)(µ-OAc)2]+ and ~1.2 vol% water content for [ZnII2(H2SIM1)(µ-OAc)(OH)]+) were 
treated with one equivalent of DNPP, two major resonances with similar chemical shifts 
appeared in the 31P NMR spectra (-6.85 ppm, -5.01 ppm and -6.80 ppm, -4.25 ppm) 
(Figure 60b, c). Therefore, similar coordination modes of DNPP to [ZnII2(H2L2)(solv)x]n+ and 
[ZnII2(H2SIM1)(solv)x]n+ are assumed. Moreover, the resonances detected were downfield and 
upfield shifted, respectively, compared to the free phosphomonoester. The extent of the 
shifts (0.75 ppm to 1.51 ppm) are small compared to the cases discussed above. This suggests 
a rather different coordination mode of DNPP to [ZnII2(H2SIM1)(solv)x]n+ and 
[ZnII2(H2L2)(solv)x]n+ than observed in the X-ray structure of [ZnII2(H2SIM1)(µ-O3POC6H4NO2)]+. 
Studies with cyclic phosphoesters have shown that the O-P-O angle has a significant impact on 
the 31P NMR chemical shift.292 For example, an increase in the bond angle of phosphotriesters 
results in the better shielding of the phosphorus atom and therefore in an upfield shift of the 
31P NMR resonance.292 Assuming the same binding mode for DNPP and PNPP, an upfield shift 
due to a larger O-P-O angle in the case of DNPP competes with a downfield shift due to 
coordination to two ZnII ions, and this could explain the smaller extent of the downfield shifts 
in the cases of DNPP with [ZnII2(H2L2)(µ-OAc)2]+ and [ZnII2(H2SIM1)(µ-OAc)(OH)]+. The major 
resonances at around -6.8 ppm and -4 to -5 ppm can be attributed either to a complex 
structure with two DNPP ligands in two different electronic environments or to two different 
complex structures, each of them containing only one bound DNPP. Although the detection 
of the two major resonances upon binding DNPP by the amide-based complexes, 
[ZnII2(H2L2)(solv)x]n+ and [ZnII2(H2SIM1)(solv)x]n+, are similar, their 31P NMR spectra are 
different: while the third resonance at -2.89 ppm was detected immediately after addition 
of DNPP to [ZnII2(H2SIM1)(µ-OAc)(OH)]+ and disappears after 14 weeks, a species with a 
similar signal was not observed with [ZnII2(H2L2)(µ-OAc)2]+, but, when a spectrum was 
measured after 14 weeks (-2.93 ppm). This implies that both complexes form different 
species with DNPP in different coordination modes, however, the equilibrium constants are 
dependent on the symmetry of the complex backbone. This could explain the different 
catalytic activity of the complexes [ZnII2(H2L2)(µ-OAc)2]+ and [ZnII2(H2SIM1)(µ-OAc)(OH)]+. 
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Phosphodiester Binding 
The binding of BDNPP was investigated for the most active complex [ZnII2(H2L2)(µ-OAc)2]+ by 
stepwise addition of 0.25 equivalents of BDNPP and recording the 31P NMR spectra at each 
step (~1.0 vol% water content) (Figure 61). Addition up to 0.5 equivalents BDNPP to a 
solution of the complex in CD3CN resulted in the formation of only one phosphorus-
containing species with a 31P NMR resonance at -10.22 ppm (Figure 61b,c), in addition to free 
BDNPP with a resonance at -14.43 ppm (Figure 61a). After further addition of BDNPP two 
additional signals at -6.86 ppm and -4.58 ppm occurred in the 31P NMR spectrum, and the 
signal integration increases upon increase of BDNPP concentration. Further reaction led to 
the disappearance of the initially detected species and formation of a new species with a 
resonance at -1.41 ppm.  
 
Figure 61: 31P NMR measurements upon addition of BDNPP to [ZnII2(H2L2)(OAc)2]+ in CD3CN a) BDNPP reference, 
b) 0.25 eq BDNPP, c) 0.5 eq BDNPP, d) 0.75 eq BDNPP, e) 0.75 eq BDNPP after 24h, f) 1.0 eq BDNPP, g) 1.0 eq 
BDNPP after 16 days, and h) DNPP reference (* unreacted BDNPP). 
Comparison to the spectra monitored after addition of the phosphomonoester DNPP to 
[ZnII2(H2L2)(µ-OAc)2]+ (Figure 61c), assigns the resonances at -6.86 ppm and -4.58 ppm to species 
containing DNPP. The increase of the integrals of these two species is accompanied by the 
decrease of the initially detected resonance at -10.22 ppm. Therefore, the resonance 
at -10.22 ppm is suggested to originate from a BDNPP-complex adduct. It follows that the binding 
of the phosphodiester to the ZnII ion leads to a downfield shift by 4.2 ppm compared to free 
BDNPP, accompanied by the activation of the phosphodiester BDNPP. The following hydrolysis 
of BDNPP provides the phosphomonoester DNPP, which binds in the same way as by direct 
addition of DNPP to the complex. The decrease of the signal assigned to the BDNPP-complex 
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adduct is accompanied with an increase of a signal at -1.41 ppm. Although the structure of the 
corresponding species remains unclear, we speculate that this complex adduct is able to release 
the DNPP product and therefore continues to catalyze the BDNPP hydrolysis. 
Mass Spectrometric Investigation of Phosphoester Binding 
Phosphomonoester Binding 
ESI+ mass spectrometric investigations were carried out with mixtures of the different dizinc(II) 
complexes with either the phosphomonoester DNPP or the phosphodiester BDNPP. Treatment 
of [ZnII2(H2SIM1)(µ-OAc)(OH)]+ in acetonitrile with the phosphomonoester DNPP resulted in a 
mass spectrum with the main peak at m/z 1201.2 corresponding to the species 
[ZnII2(HSIM1)(DNPP)(HOAc)(HF)]+. This peak at m/z 1201.2 was also apparent in the spectrum 
recorded with the mixture of complex [ZnII2(H2L2)(µ-OAc)2]+ with DNPP ascribed to the species 
[ZnII2(HL2)(DNPP)(HOAc)(HF)]+, respectively. An additional signal was found in this spectrum at 
m/z 1121.2 matching the mass of [ZnII2(HL2)(DNPP)]+. Interestingly, treatment of complex 
[ZnII2(SIM2)(µ-OAc)2]+ with the phosphomonoester DNPP resulted in a variety of signals in the 
region around m/z 1200, but those could not been ascribed to specific species due to overlapping 
of the signals. This finding is in agreement with the above discussed 31P NMR spectroscopic 
investigations supporting the various coordination modes of the phosphomonoester to the 
complex [ZnII2(SIM2)(µ-OAc)2]+. 
Phosphodiester Binding 
Samples taken during the 31P NMR spectroscopic titration of BDNPP to the complex 
[ZnII2(H2L2)(µ-OAc)2]+ resulted in ESI+ mass spectra showing peaks at m/z 1121.2 and m/z 1201.2. 
These two species have also been detected in the mixture of the same dizinc(II) complex with the 
phosphomonoester DNPP and were ascribed to the species [ZnII2(HL2)(DNPP)]+ and 
[ZnII2(HL2)(DNPP)(HOAc)(HF)]+. Therefore, the coordination of the hydrolysis product has also 
been seen in the mass spectrometric investigations and supports the assignment during the 31P 
NMR spectroscopic investigations.  
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7.3 SUMMARY 
 
Studying the phosphoester hydrolysis activity of a variety of model complexes with hydrogen 
bonding functionalities adjacent to the dizinc(II) core, but differing in (i) the type of the 
hydrogen bond donor, (ii) the position of the hydrogen bond donor, and (iii) the coordinating 
ligands in the primary coordination sphere, resulted in deeper insights in the impact of the 
second coordination sphere of phosphatases. 
The impact of the hydrogen bond donors of the catalysts on their hydrolytic activity was 
clearly found to be pH dependent. Amino substitution of the two pyridine residues 
coordinated to one of the two ZnII centers as in [ZnII2(SIM2)(µ-OAc)2]+ leads to a lower pH 
maximum of the phosphoester hydrolysis activity, whilst substitution with pivaloyl-amide 
residues at the same positions as in [ZnII2(H2SIM1)(µ-OAc)(OH)]+ has not a significant effect. 
However, positioning of one pivaloyl-amide residue adjacent to each ZnII center as in 
[ZnII2(H2L2)(µ-OAc)2]+ enables activity only under strong basic conditions.  
The main impact of the secondary interactions was shown to be the increased substrate 
affinity, and this obviously depends on the hydrogen bonding sites and the type of the 
hydrogen bonding groups. At pH 7 the diamino derivative [ZnII2(SIM2)(µ-OAc)2]+ is the most 
effective catalyst, possibly due to the flexibility in the binding mode of the 
phosphomonoester product, as seen in the 31P NMR spectroscopic investigations. While at 
pH 7 the positioning of both pivaloyl-amide residues proximal to one ZnII center in 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+ has a more positive effect towards the BDNPP hydrolysis than 
positioning one pivaloyl-amide adjacent to each ZnII center in [ZnII2(H2L2)(µ-OAc)2]+; the 
finding at more basic condition is inversed. Moreover, the impact of a more electron-rich 
primary coordination sphere in [ZnII2(H2SIM3)(µ-OAc)(OH)] is found to surpass the effect of 
the hydrogen bonding effect of the secondary coordination sphere. However, at strong basic 
conditions the hydrolysis rate of the hydrogen bonding capable complexes 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+, [ZnII2(H2L2)(µ-OAc)2]+ and [ZnII2(SIM2)(µ-OAc)2]+ are significantly 
higher than for the parent complex [ZnII2(L1)(µ-OAc)2]+ missing hydrogen bond donors. 
Long-term catalytic studies revealed that at pH 9.5 the symmetrical, sterically hindered, 
amide-based system [Zn2(H2L2)(µ-OAc)2]+ is the most efficient dizinc(II) complex employed in 
this work, and this is primarily due to less stable catalyst-inhibitor complexes. In contrast, 
incorporation of two pivaloyl-amide residues in an asymmetrical fashion as in 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+ leads to the generation of a stable catalyst-inhibitor (hydrolysis 
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product) adduct. The reason for this behavior was found in the crystal structure of the 
corresponding complex with a bridging phosphomonoester co-ligand, which reveals one of 
the two pivaloyl-amide moieties to function as co-ligand for the remaining vacant 
coordination site of the proximal ZnII center, stabilized by hydrogen bond formation to the 
second pivaloyl-amide residue.  
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Chapter 8  
Phosphatase Activity  
of Diiron Complexesg
                                                          
g Main parts of this chapter will be published in “An Approach to More Accurate Model Systems for Purple 
Acid Phosphatases (PAPs)”; Paul V. Bernhardt, Simone Bosch, Peter Comba, Lawrence R. Gahan, Graeme R. 
Hanson, Valeriu Mereacre, Christopher J. Noble, Gerhard Schenk, Hubert Wadepohl; manuscript in 
preparation. 
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8.1 INTRODUCTION 
 
The hydrolysis of phosphoesters in mammals is catalyzed by phosphatases with two iron centers 
in the active site, i.e. PAP. The oxidation state of the two iron centers in the active site of PAP 
was shown to be significant, with the homovalent FeIII2 form of ufPAP exhibiting phosphoester 
hydrolysis activity of less than 1% of that of the heterovalent FeIIIFeII form.221 Although 
phosphodiester hydrolysis was observed with a wide range of model complexes, the biological 
relevant hydrolysis of phosphomonoesters with model systems has rarely been reported. 
Recently two dinuclear PAP model compounds were reported for which the hydrolysis of the 
phosphomonoester model substrate DNPP was achieved.108, 114 The two complexes, 
[FeIII2(L8)(µ-OH)(OH2)2](ClO4)4 and [FeIII2(L6)(µ-O)Cl4](Cl)2, depicted in Chart 25, differ from 
previously studied model systems in their ability to form hydrogen bonds to the putative 
substrate molecule bound to the metal centers; this was accomplished by incorporation of basic 
residues adjacent the dimetal core. At the same time a third complex, [FeIII2(L2)(µ-OH)](ClO4)4, 
was reported, and this complex included pivaloyl-amide moieties as mimics for the non-bonding 
histidine residues in the active site of PAPs.114 Investigations of the BDNPP hydrolysis with the 
FeIII2 complex of HL1, missing hydrogen bond donors, as well as its derivatives 
[FeIII2(L8)(µ-OH)(OH2)2](ClO4)4 and [FeIII2(L2)(µ-OH)](ClO4)4 showed that the two complexes 
providing hydrogen bond donors exhibited faster hydrolysis rates than the FeIII2 complex formed 
with HL1. However, it should be mentioned that the complexes [FeIII2(L8)(µ-OH)(OH2)2](ClO4)4 and 
[FeIII2(H2L2)(µ-OH)](ClO4)4 exhibited similar catalytic efficiencies (kcat/KM) to the reference 
complex lacking a hydrogen bond donor; the differences were due to the higher substrate affinity 
of the complexes [FeIII2(L8)(µ-OH)(OH2)2](ClO4)4 and [FeIII2(H2L2)(µ-OH)](ClO4)4 and subsequent 
larger substrate binding constants KM, ascribed to hydrogen bond formation.114 In contrast, the 
complex [FeIII2(L6)(µ-O)Cl4](Cl)2 shows the highest catalytic efficiency kcat/KM reported so far, with 
a similar substrate affinity compared to [FeIII2(L1)(solv)x]5+, but a ten-fold higher hydrolysis rate.108 
Table 23 (page 170) lists kinetic data reported for different diiron complexes.  
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Chart 25: Previously reported diiron(III) complexes containing hydrogen bond donors.108, 114 
In order to understand the impact of the hydrogen bond donors the phosphoester binding of 
[FeIII2(L8)(µ-OH)(OH2)2](ClO4)4, [FeIII2(H2L2)(µ-OH)](ClO4)4, and [FeIII2(L6)(µ-O)Cl4](Cl)2 was studied. 
These investigations revealed that (i) [FeIII2(L6)(µ-O)Cl4](Cl)2 and [FeIII2(L8)(µ-OH)(OH2)2](ClO4)4 
bind phosphomonoester DNPP in a bridging coordination mode, (ii) while the phosphodiester 
BDNPP was bound in a terminal fashion, and (iii) [FeIII2(H2L2)(µ-OH)](ClO4)4 did not indicate 
terminal coordination of phosphodiesters.109 The difference in the coordination of phospho-
esters of the phenolate-based complexes is reflected in their hydrolysis activity by a significantly 
larger activity of [FeIII2(L8)(µ-OH)(OH2)2](ClO4)4 compared to [FeIII2(H2L2)(µ-OH)](ClO4)4.109, 114 The 
terminal coordination is rather unusual as many crystal structures show phenolate-based 
dinuclear complexes binding phosphodiesters in a bridging mode.293, 294 This unusual 
coordination mode of phosphoesters was attributed to the hydrogen bonding network provided 
by the ligand backbones 108, 109, 114 supported by computational studies with 
[FeIII2(L6)(µ-O)Cl4](Cl)2. Commencing with a phosphomonoester molecule monodentately 
coordinated to complex [FeIII2(L6)(µ-O)(solv)3]4+, the activation barrier for bridging coordination 
was calculated to be considerably larger than for the hydrolysis reaction, especially in case the 
cyclam nitrogen atoms are protonated, thus illustrating the important role of the second 
coordination sphere on PAP like reactivity.108, 109 
With the complex [FeIII2(L8)(solv)x]5+ the generation of its reduced FeIIIFeII form was achieved by 
bulk electrolysis. Kinetic studies revealed that the heterovalent diiron complex of ligand HL8 
exhibited a five-fold increased catalytic efficiency with respect to its corresponding homovalent 
FeIII2 counterpart.109, 114 [FeIIIFeII(L8)(solv)x]4+ revealed a lower substrate binding constant KM and 
a faster hydrolysis rate than [FeIII2(L8)(solv)x]5+.114 As discussed above, the trend of a higher 
activity of the heterovalent diiron form compared to the homovalent FeIII2 form was also 
detected for the native PAP enzyme and ascribed to an increased ligand exchange rate of FeII 
compared to FeIII.278 The release of the reaction product was proposed to be most likely the rate-
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limiting step in the catalytic mechanism,21, 66, 266, 295 and this proposal is supported by the water 
exchange rates of FeIII and FeII (102 s-1 and 106 s-1, respectively).278, 296-298 
Although the complex [FeIII2(H2L2)(µ-OH)](ClO4)4 provides two hydrogen bond donors similar to 
[FeIII2(L8)(µ-OH)(OH2)2](ClO4)4 and [FeIII2(L6)(µ-O)Cl4](Cl)2, this complex exhibited no phospho-
monoester hydrolysis capacity and revealed no monodetate coordination of phosphodiesters. 109 
The latter was rather unexpected due to the sterically demanding pivaloyl-amide residues. In 
order to favor terminal coordination of phosphoesters an asymmetric ligand H3SIM1 was 
designed in this work bearing two pivaloyl-amide residues similar to H3L2, but both proximal to 
one of the two binding sites. In Chapter 2.4 the syntheses and characterization of the respective 
FeII2 complexes, [FeII2(H2SIM1)(µ-OAc)2]PF6 and [FeII2(H2L2)(µ-OAc)2]PF6, depicted in Chart 26, has 
been described as well as the generation of the FeIIIFeII complex of ligand H3SIM1. 
 
Chart 26: Diiron(II) complexes discussed in this chapter. 
Comparison of those two FeII2 complexes facilitates the study of the impact of the hydrogen bond 
donor position. Moreover, comparison of the FeII2 complex and the reported FeIII2 complex of the 
ligand H3L2 will give an insight in the effect of the oxidation states of complexes providing 
hydrogen bonding capacity. Furthermore, the homovalent complexes [FeII2(H2SIM1)(µ-OAc)2]PF6 
and [FeII2(H2L2)(µ-OAc)2]PF6 and their corresponding heterovalent complexes generated by 
oxidation with ferrocenium hexafluorophosphate will enable to probe the effect of (i) the mixed 
oxidation state of the diiron core, and (ii) one or two hydrogen bond donors proximal to the FeII 
center. Therefore, kinetic studies with the substrate models BDNPP and DNPP have been 
conducted and the obtained results are presented in the following chapter. 
8.2 PHOSPHOESTER HYDROLYSIS STUDIES OF DIIRON 
COMPLEXES 
 
The sensitivity of the FeII2 complexes to oxidation made it necessary to undertake the studies of 
the catalytic activity of the complexes [FeII2(H2SIM1)(µ-OAc)2]+ and [FeII2(H2L2)(µ-OAc)2]+ under 
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inert atmosphere and therefore the experiments were carried out in a glovebox. It should be 
noted that the number of data points is smaller as well as the variance within the data points is 
significantly larger, compared to the investigations undertaken with the ZnII2 complexes owing to 
the more difficult procedures necessitated by manipulating the samples in the glovebox. The 
plots obtained for the dependence of the initial hydrolysis rate on the pH and on the initial 
substrate concentration are depicted in Figure 62. Unfortunately, the v0 vs. pH curves could not 
been fitted following the procedures employed to model the analogous ZnII2 complexes and 
therefore only qualitative comparison is possible. 
pH Dependence 
The initial rate vs. pH profiles for [FeII2(H2SIM1)(µ-OAc)2]+ and [FeII2(H2L2)(µ-OAc)2]+ exhibited a 
similar shape. This finding is in contrast to the corresponding ZnII2 complexes of the ligands 
H3SIM1 and H3L2 (discussed in Chapter 7.2), which showed significantly different curve shapes. 
The [FeII2(H2L2)(µ-OAc)2]+ complex exhibited lower hydrolysis rates compared to 
[FeII2(H2SIM1)(µ-OAc)2]+ under the same condition. The curve shapes indicate that three active 
species are present in the pH range between pH 7 and pH 10. The first deprotonation step around 
pH 7 generates an active species; deprotonation of this species around pH 8.6 lowers its activity, 
while a third deprotonation at pH > 9.5 leads again to an increase of activity. This behavior is 
significantly different to the ZnII2 complexes [ZnII2(H2SIM1)(µ-OAc)(OH)]+ and 
[ZnII2(H2L2)(µ-OAc)2]+, which showed a bell-shaped and a sigmoidal profile, respectively 
(Chapter 7.2).  
 
Figure 62: a) pH dependence and b) substrate concentration dependence at pH = 9.5 of BDNPP hydrolysis 
activity for [FeII2(H2SIM1)(OAc)2]+ (black squares) and [FeII2(H2L2)(OAc)2]+ (blue triangles). 
In contrast to [FeII2(H2L2)(µ-OAc)2]+, the FeIII2 complex of ligand H3L2 exhibited an initial rate vs. 
pH profile with a relatively sharp activity maximum at pH 6.5.109 The activity maximum in the 
region between pH 7 and pH 9 for [FeII2(H2L2)(µ-OAc)2]+ is at higher pH compared to 
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[FeIII2(H2L2)(solv)x]5+. This activity shift to higher pH values is in agreement with the pKa values of 
iron-bound water molecules (pKa = 9.5 for FeII and pKa = 2.2 for FeIII) ascribed to the lower Lewis 
acidity of FeII compared to FeIII.165  
Substrate Concentration Dependence 
The dependence of the BDNPP hydrolysis rate on the substrate concentration was determined 
at pH = 9.5 to access a catalytic active species of the FeII2 complexes and to allow comparison to 
the studies conducted with the respective ZnII2 complexes. The measurements with complex 
[FeII2(H2L2)(µ-OAc)2]+, in which the two hydrogen bonding pivaloyl-amide residues are positioned 
in a symmetric manner, exhibited similar hydrolysis rates to [FeII2(H2SIM1)(µ-OAc)2]+, the latter 
bearing the hydrogen bond donors in an asymmetric fashion. Therefore, the activity of these 
complexes within the first minutes of catalysis appears to be independent on the position of the 
hydrogen bond donors. The data obtained are depicted in Figure 62b and show Michaelis-
Menten saturation behavior. Fitting the data of [FeII2(H2SIM1)(µ-OAc)2]+ with the well-known 
Michaelis-Menten equation (Equation 22) provided values for the parameters kcat, KM, and 
kcat/KM. Table 23 lists these values and compares them to data for other diiron complexes.  
Table 23: Kinetic data (kcat in [10-3 s-1], KM in [mM] and kcat/KM in [s-1M-1]) of BDNPP hydrolysis for 
[FeII2(H2SIM1)(µ-OAc)2]+ and reported diiron complexes (all kinetic studies were undertaken in a mixture of 
acetonitrile:aqueous buffer solution (1:1)). 
complex pKa(I) pKa(II) kcat KM kcat/KM pHMMa 
[FeII2(H2SIM1)(µ-OAc)2]+  n.a. n.a. 2.37 ± 0.29 3.53 ± 0.68 0.67 9.5 
[FeIII2(L1)(solv)x]5+ 114 5.00 7.15 0.17 ± 0.01 1.74 ± 0.35 0.10 6.35 
[FeIII4(L66)2(µ-OAc)2(µ-O)(µ-OH)(OH2)2]+ 278 5.42 8.41 1.6 ± 0.2 7.4 ± 0.6 0.22 6.5 
[FeIII2(H2L2)(solv)x]5+ 114 5.16 7.43 0.47 ± 0.03 5.92 ± 0.62 0.08 6.45 
[FeIII2(L67)(solv)x]5+ 114 5.39 9.38 0.65 ± 0.03 7.38 ± 0.69 0.09 7.44 
[FeIII2(H2L6)(µ-O)Cl2]2+ 108 5.0 7.3 1.33 ± 0.08 1.94 ± 0.37 0.68 6.17 
[FeIIIFeII(L4)(µ-OAc)2]+ 140 5.03 6.93 1.88 4.63 0.41 5.6 
[FeIIIFeII(L67)(solv)x]4+ 114 5.30 8.02 1.14 ± 0.04 2.30 ± 0.24 0.50 6.69 
a pH of aqueous buffer solution used for substrate dependence assays. 
Compared to other examples of phenolate-bridged diiron complexes, [FeII2(H2SIM1)(µ-OAc)2]+ 
exhibits the highest hydrolysis rate reported to date. In addition, the catalytic efficiency is the 
second highest reported for diiron(III) complexes after [FeIII2(H2L6)(µ-O)Cl2]2+. Although the latter 
complex exhibits a lower hydrolysis rate, it has a higher catalytic efficiency to 
[FeII2(H2SIM1)(µ-OAc)2]+ due to higher substrate affinity. The Michaelis-Menten constant KM and 
subsequently the substrate affinity of complex [FeII2(H2SIM1)(µ-OAc)2]+ is in the medium range 
compared to the listed diiron complexes.  
Comparison of the two complexes [FeIII2(H2L2)(solv)x]5+ and [FeII2(H2L2)(µ-OAc)2]+ with the same 
ligand backbone allows the identification of the impact of the oxidation state of the two iron 
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centers. The reduced form exhibits a higher hydrolysis rate, a higher substrate affinity and 
consequently a higher catalytic efficiency, but with the cost of the maximum activity at more 
basic conditions. Therefore, the higher activity of the two FeII2 complexes studied in this work 
compared to the reference complexes listed in Table 23 can be attributed to an interplay of 
hydrogen bonding ability and the lower Lewis acidity of the two FeII centers (compared to the 
FeIII centers in the reference complexes). However, it should be noted that the FeII2 complexes 
are less reactive at physiological pH than under basic conditions used for these investigations. 
The substrate concentration dependence measurements conducted with the ZnII2 complexes 
[ZnII2(H2L2)(µ-OAc)2]+ and [ZnII2(H2SIM1)(µ-OAc)(OH)]+ also under basic conditions (pH 9.5) 
resulted for both complexes in lower hydrolysis rates and higher Michaelis-Menten constants 
than the FeII2 complex [FeII2(H2SIM1)(µ-OAc)2]+. Consequently, the catalytic efficiencies of 
[ZnII2(H2L2)(µ-OAc)2]+ and [ZnII2(H2SIM1)(µ-OAc)(OH)]+ are lowered compared to 
[FeII2(H2SIM1)(µ-OAc)2]+; two-fold in the case of [ZnII2(H2L2)(µ-OAc)2]+ and four-fold in the case of 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+.  
Turn Over Numbers  
In order to probe the long-term catalytic behavior of the diiron complexes of ligand H3SIM1 and 
H3L2 studies of the TONs were conducted at 25°C with [complex]0 = 10 µM and [BDNPP]0 = 3.0 mM 
at different pH. The assays were prepared in the glovebox using 0.5 mM solutions of 
[FeII2(H2SIM1)(µ-OAc)2]+ and [FeII2(H2L2)(µ-OAc)2]+ as well as 0.5 mM mixtures of 
[FeII2(H2SIM1)(µ-OAc)2]+ and [FeII2(H2L2)(µ-OAc)2]+ with ferrocenium hexafluorophosphate (1:1), 
prepared 24 hours prior to the TON studies. Samples were taken from these assays at various 
intervals during the experiment, diluted with solvent, and their UV-vis spectra were recorded to 
determine the amount of phosphoester hydrolysis. The increase in the absorbance at 400 nm, 
assigned to the hydrolysis product 2,4-dinitrophenolate, was monitored over time and TON 
values were calculated after nine days using the Beer-Lambert Law. The resulting data obtained 
at pH 9.5 and pH 11 are given in Figure 63 and Table 24. [ZnII2(L1)(µ-OAc)2]PF6 was also included 
in the process to ensure that there is no effect given by undertaking the experiments under inert 
atmosphere. In fact, this ZnII2 complex exhibit comparable TONs to those obtained under aerobic 
conditions (Chapter 7.2). Furthermore, the ZnII2 complex lacking hydrogen bond donors exhibited 
the highest TONs throughout the study. 
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Figure 63: Time dependence of the absorbance band of 2,4-nitrophenolate (400 nm) a) at pH 9.5 and b) at pH 11 
with [ZnII2(L1)(µ-OAc)2]+ (red), [FeII2(H2SIM1)(µ-OAc)2]+ (green), and [FeII2(H2L2)(µ-OAc)2]+ (blue) with addition of 
1 eq FeCp2PF6 (triangles) and without (squares). 
The TONs for the diiron complexes increase with increasing pH, but it should be mentioned that 
all four iron containing assays show similar TONs when the experiments are conducted at pH < 9. 
However, under more basic condition the structural variations in the diiron complexes were 
reflected in the differences of their determined TONs. At basic conditions (pH > 9) the asymmetric 
diiron complex [FeII2(H2SIM1)(µ-OAc)2]+ (depicted in green in Figure 63) showed higher TONs than 
the symmetric counterpart [FeII2(H2L2)(µ-OAc)2]+ (depicted in blue in Figure 63). This 
development seems independent on the oxidation state of the iron centers as the mixtures of 
the respective complexes with one equivalent of ferrocenium hexafluorophosphate followed the 
same trend. These findings lead to the conclusion that two hydrogen bond donors proximal to 
one FeII center in the FeII2 model complex help to prevent more efficiently the complex being 
inhibited than one hydrogen bond donor proximal to each FeII center. Interestingly, the impact 
of the hydrogen bond donors was found to be reversed for the ZnII2 complexes: one hydrogen 
bond donor adjacent to each ZnII center is more efficient in preventing complex inhibition than 
two hydrogen bond donors proximal to one of the two ZnII centers. 
Table 24: Turn over numbers (TONs) of BDNPP hydrolysis for [FeII2(H2SIM1)(µ-OAc)2]+ and [FeII2(H2L2)(µ-OAc)2]+ 
as well as mixtures of those complexes with 1 eq FeCp2PF6. 
complex TON after 9 h 
 pH 9 pH 9.5 pH 11 
[FeII2(H2SIM1)(µ-OAc)2]+ 11 ± 2 61 ± 4 86 ± 4 
[FeII2(H2SIM1)(µ-OAc)2]+ + 1 eq FeCp2+ 6 ± 6 39 ± 1 107 ± 7 
[FeII2(H2L2)(µ-OAc)2]+ 2 ± 2 26 ± 3 37 ± 5 
[FeII2(H2L2)(µ-OAc)2]+ + 1 eq FeCp2+ 2 ± 2 28 ± 2 39 ± 6 
 
Comparison of the TONs obtained with assays containing the same FeII2 complex but differing in 
the presence of ferrocenium hexafluorophosphate enables to study the impact of the oxidation 
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states of the bound iron ions. The TON of the symmetric diiron complex bearing the H3L2 ligand 
backbone was found to be independent on the presence of ferrocenium hexafluorophosphate. 
This was different when the asymmetric complex [FeII2(H2SIM1)(µ-OAc)2]+ was used as catalyst. 
The long-term measurements at pH 9 and pH 9.5 resulted in higher TON values in the absence of 
ferrocenium hexafluorophosphate indicating that the heterovalent complex 
[FeIIIFeII(H2SIM1)(solv)x]4+ is favored for bridging phosphate inhibition for the corresponding 
homovalent FeII2 complex. This finding is in agreement with the higher water exchange rate of 
FeII compared to FeIII (106 s-1 and 102 s-1).278, 296-298 However, at strongly basic conditions (pH 11) 
the trend was reversed, i.e. the FeIIIFeII complex revealed a higher TON than the FeII2 complex of 
H3SIM1.  
Studies of the hydrolysis of phosphomonoesters using DNPP as model substrate in the TON 
assays revealed no acceleration of phosphoester hydrolysis compared to the autohydrolysis 
assay independent on (i) the symmetry, and (ii) the oxidation state of the diiron complexes. 
8.3 SUMMARY 
 
The investigation of the phosphoester hydrolysis undertaken with the FeII2 complexes 
[FeII2(H2SIM1)(µ-OAc)2]+ and [FeII2(H2L2)(µ-OAc)2]+ and comparison with the corresponding ZnII2 
and FeIIIFeII complexes gave insights on the impact of (i) the secondary coordination sphere, and 
(ii) the Lewis acidity of the metal ion bound to the ligand backbone. The hydrolysis rate was found 
to be similar for both complexes [FeII2(H2SIM1)(µ-OAc)2]+ and [FeII2(H2L2)(µ-OAc)2]+; thus, the 
activity in the first minutes of catalysis seems to be independent on the hydrogen bond donor 
position. However, significant differences in long-term activity studies, i.e. the TONs, of 
[FeII2(H2SIM1)(µ-OAc)2]+ and [FeII2(H2L2)(µ-OAc)2]+ indicate that the steric hindrance of two 
pivaloyl-amide residues adjacent to one FeII center prevents inhibition by a bridging phospho-
monoester molecule more efficiently than positioning one sterically demanding hydrogen bond 
donor proximal to each FeII center. Interestingly, the effect of the position of the pivaloyl-amide 
residues is found to be the opposite for the respective ZnII2 complexes (discussed in Chapter 7.2). 
Of the two influences of the pivaloyl-amide residues towards the bridging phosphoester 
coordination, (i) the hindered access to the metal ion, and (ii) the stabilization by hydrogen bond 
formation, the first appears more important for the FeII2 complexes while the latter seems more 
important for the ZnII2 complexes. But it should be mentioned that both FeII2 complexes exhibit 
lower TONs than the corresponding ZnII2 complexes, as expected due to the lower Lewis acidity 
and the faster water exchange rate of ZnII compared to FeII. However, the FeII2 complexes 
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revealed higher hydrolysis rates and catalytic efficiencies than the ZnII2 complexes. Therefore, 
the higher Lewis acidity of FeII compared to ZnII appears to enhance not only the hydrolysis 
acceleration but also the binding of inhibiting phosphomonoesters. Similarly, the oxidation of 
one of the two FeII centers in [FeII2(H2SIM1)(µ-OAc)2]+ forming a more accurate FeIIIFeII model 
system for PAP, lead to a lower TON. This is in agreement with the decreased water exchange 
rate and the higher Lewis acidity of FeIII compared to FeII.164, 166 However, the FeII2 complex of 
H2L2 reveales a more basic pH maximum of the hydrolysis activity than the respective FeIII2 
complex supporting the presumption that the role of the FeIII center in the active site of PAP is 
the provision of a nucleophilic hydroxide at low pH. 
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Chapter 9  
Phosphatase Activity of 
Heterovalent 
Heterodinuclear Complexesh
                                                          
h Main parts of this chapter will be published in “Asymmetric Mono- and Dinuclear GaIII and ZnII complexes as 
Models for Purple Acid Phosphatases (PAPs)”; Simone Bosch, Peter Comba, Lawrence R. Gahan and Gerhard 
Schenk; manuscript in preparation. 
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9.1 INTRODUCTION 
 
As a prototype of dinuclear metallohydrolases, PAPs catalyze the hydrolysis of phospho-
monoesters containing two metal ions in close proximity in the active site of PAPs. More 
precisely, PAPs are the only dinuclear metallohydrolases which require a mixed-valent dinuclear 
site for their activity.21 While mammalian PAPs consist of a FeIIIFeII center,49 the metal ion 
composition in PAPs isolated from plants was found to be either FeIIIZnII or FeIIIMnII.23, 24, 67, 68 It 
has been shown, however, that replacement of the FeIII center in pig PAP and bovine spleen PAP 
by a GaIII ion generates GaIIIFeII and GaIIIZnII derivatives that exhibit similar activities to the native 
enzymes,66, 142, 167, 299, 300 and showing that the diamagnetic GaIII ion was able to act as a functional 
analog of paramagnetic FeIII in PAPs.146 
Small heterodinuclear mixed-valent compounds modeling the structural and functional 
properties of metallohydrolases have been shown to be useful tools to study the roles of 
structural features within the active site of the corresponding enzymes. For example, the 
complex [FeIIIZnII(L4)(µ-OAc)2]+ has shown that (i) the model substrate BDNPP only interacts with 
the ZnII ion, and (ii) the bridging hydroxide is a much weaker nucleophile than the terminal 
FeIII-bound hydroxide in the active species [(HO)FeIII(µ-OH)MII(OH2)].90 The respective 
isostructural complex [GaIIIZnII(L4)(µ-OAc)2]+ was also studied and exhibited a higher TON than 
the analogous FeIIIZnII complex.66 A similar result was observed from kinetic studies of the 
complexes [FeIIICoII(L4)(µ-OAc)2]+ and [GaIIICoII(L4)(µ-OAc)2]+, and Table 25 summarizes the 
reported kinetic data.146 As in the case of the biomimetics, the GaIII derivative of ufPAP revealed 
modest increased reactivity consistent with the increased nucleophilic character of the 
GaIII-bound hydroxide compared to the FeIII-bound hydroxide.146 Moreover potentiometric 
titrations with [FeIIICoII(L4)(µ-OAc)2]+ and [GaIIICoII(L4)(µ-OAc)2]+ supports the terminal hydroxide 
being the reaction initiating nucleophile, as assumed previously for [GaIIIZnII(L4)(µ-OAc)2]+ and 
[FeIIIZnII(L4)(µ-OAc)2]+.146, 66 Hence, the mechanism that emerges for biomimetics involves the 
initial monodentate coordination of the substrate to the divalent metal ion, followed by a 
nucleophilic attack by the terminal MIII-bound hydroxide. This was supported by kinetic isotope 
effect and UV-vis spectroscopic substrate binding studies with [FeIIICoII(L4)(µ-OAc)2]+ and 
[GaIIICoII(L4)(µ-OAc)2]+.146 
Kinetic studies with a FeIIIZnII complex anchored to 3-aminopropyl-functionalized silica (Si3AP) 
resulted in increased substrate affinities compared to the free catalyst.153 This effect was 
proposed to be caused by stabilization via hydrogen bonds with the residual amino-groups of the 
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surface, supporting the role of the non-coordinating histidines in the active site of PAPs to bring 
the substrate in position suitable for hydrolysis. 
Table 25: Kinetic data (kcat in [10-3 s-1], KM in [mM] and kcat/KM in [s-1 M-1]) of BDNPP hydrolysis (all kinetic studies 
were undertaken in a mixture of acetonitrile:aqueous buffer solution (1:1)). 
complex pKa(I) pKa(II) kcat KM kcat/KM pHMMa 
[FeIIIZnII(L4)(µ-OAc)2]+ 95 4.8 7.5 0.73 8.10 0.09 6.1 
[FeIIIZnII(L4)(µ-OH)2]+ 90 5.3 8.1 0.91 4.20 0.22 6.5 
[GaIIIZnII(L4)(µ-OAc)2]+ 66 5.4 8.6 1.41 7.15 0.20 6.8 
[FeIIICoII(L4)(µ-OAc)2]+ 146 5.2 8.8 1.42 92.7 0.02 7.0 
[GaIIICoII(L4)(µ-OAc)2]+ 146 5.7 8.9 1.87 88.1 0.02 7.5 
[FeIIIZnII(HL68)(µ-OH)(H2O)]2+ 153 - - 0.90 3.55 0.25 7.0 
[FeIIIZnII(Si3AP-L68)(µ-OH)(H2O)]2+ 153 - - 0.14 1.54 0.09 7.0 
a pH of aqueous buffer solution used for substrate dependence assays. 
Using monogallium(III) complexes of tripodal ligands, H2L69, H3L70, H3L71, and H3L72 among others 
(Scheme 22), the influence of the nature of the ligand donor sites on the reactivity of GaIII 
(mimicking the FeIII ion in PAPs) has been evaluated.70 Thereby, the attack of the coordinated 
substrate by a GaIII-bound hydroxide (Scheme 22, path a) was shown to be the catalytic 
mechanism rather than the alternative, where the metal-bound hydroxide acts as a general base 
deprotonating incoming water, which subsequently attacks the phosphoester substrate 
(Scheme 22, path b).70 
 
Scheme 22: Substrate activation and the two possibilities for the nucleophilic attack on the phosphorus atom 
during phosphoester hydrolysis by monogallium(III) model compounds and ligands H2L69, H3L70, H3L71, and H3L72 
employed studying the influence of the nature of the ligand donor sites on the phosphoester hydrolysis activity 
of GaIII complexes.70 
During the studies, it emerged that the reactivity of the monogallium(III) complexes was 
enhanced by replacement of neutral nitrogen donor atoms and carboxylate groups by phenolate 
groups. Specifically it was proposed that the presence of strongly electron-donating phenolate 
groups (H3L72 > H3L71 > H3L70 > H2L69) in the coordination sphere of GaIII weakens the metal-
hydroxide bond, thus giving rise to an enhanced nucleophilicity and higher activity of the 
corresponding GaIII complexes.70 Table 26 lists the reported kinetic data.70   
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Table 26: Kinetic data (kcat in [10-3 s-1], KM in [mM] and kcat/KM in [s-1M-1]) of BDNPP hydrolysis (all kinetic studies 
were undertaken in a mixture of methanol-aqueous buffer solution (1:5) at 37°C).70 
complex pKa(I) pKa(II) kcat KM kcat/KM pHMMa 
[GaIII(L69)(µ-OH)]2 5.69 7.12 3.61 1.34 2.69 6.4 
[GaIII(L70)(H2O)2] 5.43 8.59 21.2 541 0.04 7.0 
[GaIII(L71)(H2O)2] 5.90 8.99 30.5 10.3 2.96 7.5 
[GaIII(L72)(H2O)2] 7.26 9.72 46.4 7850 0.01 8.5 
a pH of aqueous buffer solution used for substrate dependence assays. 
Comparison of the different monogallium(III) complexes emphasizes that the two most reactive 
complexes [GaIII(L71)(H2O)2] and [GaIII(L72)(H2O)2] have (i) the lowest Lewis acidities, thus providing 
the lowest substrate activation, and (ii) the strongest hydroxide nucleophile.70 Apparently, this 
reveals that of the two effects of the metal ion in the hydrolysis of phosphoesters, (i) Lewis acid 
activation of the substrate and (ii) nucleophile activation, the latter is more important in 
determining the intrinsic reactivity.70 
In order to stabilize the heterovalent dinuclear core, the peptide backbone of the active site in 
PAPs forms two chemically distinct environments for the metal centers. In Chapter 3 the selective 
formation of the heterodinuclear heterovalent complexes [GaIIIZnII(H2SIM1)(solv)x]4+ and 
[GaIIIZnII(H2SIM4)(solv)x]3+, depicted in Chart 27, has been illustrated. These complexes combine 
the three essential structural features within the active site of PAPs: (i) the distinct coordination 
environment in the two binding sites, (ii) the mixed-valent dinuclear metal core, and (iii) the 
hydrogen bonding network provided by the second coordination sphere. With hydrogen bond 
donors proximal to the metal centers, mimicking the non-coordinating histidine residues in the 
active site of PAPs, the impact of hydrogen bonding capacity on the reactivity has been examined 
by comparison to each other and the reported complex [GaIIIZnII(L4)(µ-OAc)2]+; the results are 
presented in the following chapter. 
 
Chart 27: GaIIIZnII complexes employed in this chapter. 
Moreover, the ligands H3SIM1 and H4SIM4 have been shown to selectively form mononuclear GaIII 
and ZnII complexes (see Chapter 3). Therefore, the role of the specific structural aspect were 
investigated not only in their GaIIIZnII complexes but also in their mononuclear GaIII and ZnII 
complexes as well as in their dizinc(II) complexes, depicted in Chart 28.  
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Chart 28: ZnII, GaIII and ZnII2 complexes referred to in this chapter.  
Prior to the kinetic investigations the catalysts were prepared in solution. Separate 5 mM 
acetonitrile solutions of H3SIM1, H4SIM4, zinc(II) perchlorate, and gallium(III) perchlorate were 
prepared. One equivalent of ligand solution was treated with either (i) one equivalent of zinc(II) 
perchlorate solution, (ii) two equivalents of zinc(II) perchlorate solution, or (iii) one equivalent of 
gallium(III) perchlorate solution. These mixtures were then heated at 50°C for one hour in the 
case of the zinc(II) containing mixtures and for six hours in the case of the gallium(III) containing 
mixtures in order to completely form the complexes [ZnII(H2SIM1)(solv)x]+, [ZnII(H3SIM4)(solv)x]+, 
[ZnII2(H2SIM1)(solv)x]3+, [ZnII2(H2SIM4)(solv)x]2+, [GaIII(H2SIM1)(solv)x]2+, and [GaIII(H2SIM4)(solv)x]+. 
The in this way previously prepared gallium(III) complexes of H3SIM1 and H4SIM4, 
[GaIII(H2SIM1)(solv)x]2+ and [GaIII(H2SIM4)(solv)x]+, were treated with one equivalent of zinc(II) 
perchlorate and heated at 50°C for a further one hour to generate the GaIIIZnII complexes 
[GaIIIZnII(H2SIM1)(solv)x]4+ and [GaIIIZnII(H2SIM4)(solv)x]3+. All solutions were diluted with 
acetonitrile in the way that the final complex concentration was 1 mM.  
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9.2 PH BEHAVIOR OF GAIIIZNII COMPLEXES 
 
For determination of the pKa values of metal-bound water deprotonation in the different 
complexes UV-vis spectroscopic titrations were undertaken. The investigations were carried out 
in acetonitrile:aqueous buffer mixtures (1:1) and the reported pH values refer to the pH of the 
buffer solution. Figure 64a depicts as an example the resulted UV-vis spectra for the complex 
[GaIIIZnII(H2SIM1)(solv)x]4+.  
When the spectrum recorded at pH 5.5 is excluded, two isosbestic points are visible at 293 nm 
and 312 nm, indicating an equilibrium of two species. The absorbance vs. pH plots at different 
wavelengths are given in Figure 64b. These plots were fitted according to the procedure for the 
dizinc(II) complexes explained in Chapter 4.3. The pKa values obtained for all complexes studied 
in this Chapter are given in Table 27.  
 
Figure 64: a) UV-vis spectroscopic titration spectra (25 µM in acetonitrile:aqueous buffer between pH 5.5 and 
10.5) and b) absorbance vs. pH plot for [GaIIIZnII(H2SIM1)(solv)x]4+. 
Table 27: pKa values as determined by UV-vis-spectroscopic titration. 
complex pKa complex pKa 
[ZnII(H2SIM1)(solv)x]+ 7.3 ± 0.2 [ZnII(H2SIM4)(solv)x] 8.4 ± 0.5 
[ZnII2(H2SIM1)(solv)x]3+ 6.9 ± 0.6 [ZnII2(H2SIM4)(solv)x]2+ 9.8 ± 0.1 
[GaIII(H2SIM1)(solv)x]2+ 6.7 ± 0.9 
9.1 ± 0.4 
[GaIII(H2SIM4)(solv)x]+ 7.1 ± 0.7 
[GaIIIZnII(H2SIM1)(solv)x]4+ (5.9 ± 0.4)a 
8.4 ± 0.2 
[GaIIIZnII(H2SIM4)(solv)x]3+ 6.7 ± 0.4 
(10.6 ± 0.1)a 
a determined pKa values are close to limits of the examined pH range. 
Fitting the data between pH 5.5 and pH 7.5 with a similar procedure resulted in a second pKa 
value for [GaIIIZnII(H2SIM1)(solv)x]4+. Similarly, a second pKa was found for 
[GaIIIZnII(H2SIM4)(solv)x]3+; these pKa values should, however, be interpreted with care as they are 
close to the limits of the pH range studied. The respective pKa values reported for 
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[GaIIIZnII(L4)(µ-OAc)2]+, pKa(I) = 6.2 and pKa(II) = 8.0, were assigned to the equilibria depicted in 
Scheme 2.66 
 
Scheme 23: Illustration of the protonation equilibria for GaIIIZnII complexes present in basic solution.66 
Comparison of the pKa values obtained for [GaIIIZnII(H2SIM4)(solv)x]3+ and [GaIIIZnII(L4)(OAc)2]+ 
indicate a shift of 0.5 pH units on account of a pivaloyl-amide residue proximal to the GaIII center. 
This trend was also found, but was even more pronounced, for the monozinc(II) complexes 
[ZnII(H2SIM1)(solv)x]+ and [ZnII(H3SIM4)(solv)x]+.  
9.3 PHOSPHOESTER HYDROLYSIS STUDIES WITH GAIIIZNII 
COMPLEXES 
 
The investigation of phosphatase-like activity of the two heterovalent heterodinuclear GaIIIZnII 
complexes of the ligands H3SIM1 and H4SIM4 as well as their monogallium(III), monozinc(II), and 
dizinc(II) complexes were performed following the general procedure described in Chapter 6.3.  
Kinetic Investigations with Complexes Bearing the H3SIM1 Backbone 
pH Dependence 
The pH dependence of the hydrolysis activity towards BDNPP of the complexes described above 
was investigated. Figure 65a shows the resulting v0 vs. pH plot and Table 28 summarizes the pKa 
and γ values obtained by fitting the data, assuming a monoprotic or diprotic system as explained 
in Chapter 6.3.  
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Figure 65: a) pH dependence and b) substrate concentration dependence at pH = 7 of BDNPP hydrolysis activity 
for mixtures of ligand H3SIM1 and with 1 eq of zinc(II) perchlorate (red triangles), 2 eq of zinc(II) perchlorate 
(green diamonds), 1 eq of gallium(III) perchlorate (blue squares), 1 eq zinc(II) perchlorate and 1 eq of gallium(III) 
perchlorate (black circles).  
The examination of the BDNPP hydrolysis by the mono- and dinuclear complexes of H3SIM1 
revealed differing pH dependencies. The monozinc(II) complex of H3SIM1, [ZnII(H2SIM1)(solv)x]+, 
with ZnII in the amide-free binding site B, was only active under basic conditions and showed very 
little activity below pH 7.5. Because the pKa value for the deprotonation step of 
[ZnII(H2SIM1)(solv)x]+ is close or outside of the limits of the pH range examined in this study, the 
pKa and γ values obtained from the fit to Equation 21 need to be interpreted with care. The 
dizinc(II) complex of HL1 with two ZnII centers in similar coordination environments to 
[ZnII(H2SIM1)(solv)x]+ and lacking hydrogen bond donors, revealed pKa values of 6.5 and 10.3 and 
exhibited hydrolysis activity in the pH range between these two pKa values. Therefore, the lack 
of activity at pH < 7.5 in the case of [ZnII(H2SIM1)(solv)x]+ seems to be due to the inability of 
cooperative interaction between two ZnII centers. The pH dependence found for the dizinc(II) 
complex [ZnII2(H2SIM1)(solv)x]3+, with both coordination sites of H3SIM1 occupied by ZnII supports 
this proposal, as it exhibits BDNPP hydrolysis activity below pH 7.5, in contrast to the monozinc(II) 
complex [ZnII(H2SIM1)(solv)x]+. 
In contrast to the mono- and dizinc(II) complexes of H3SIM1, the monogallium(III) complex 
[GaIII(H2SIM1)(solv)x]+ shows a bell-shaped profile in the v0 vs. pH plot. This complex is only 
catalytically active in the pH range between the two pKa values of 6.3 and 8.6, indicating that the 
active species is [GaIII(H2SIM1)(OH)(OH2)]. Both protonation and deprotonation of this active 
species lead to a decrease of activity.  
Interestingly, when the second coordination site of the monogallium(III) complex is occupied by 
ZnII in [GaIIIZnII(H2SIM1)(solv)x]4+, a superposition of the profiles found for [ZnII(H2SIM1)(solv)x]+ 
and [GaIII(H2SIM1)(solv)x]2+ is observed but the initial rate at pH 7 was found to be higher than the 
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sum of the corresponding initial rates of [ZnII(H2SIM1)(solv)x]+ and [GaIII(H2SIM1)(solv)x]2+, 
indicating a cooperative effect of the two metal centers. 
Comparison of the hydrolysis activity of the two mononuclear complexes of H3SIM1, 
[ZnII(H2SIM1)(solv)x]+ and [GaIII(H2SIM1)(solv)x demonstrates the role of the metal. While 
[ZnII(H2SIM1)(solv)x]+ shows only activity at high pH, [GaIII(H2SIM1)(solv)x]+ is active at low pH, 
indicating that in the case of a ZnII in the active site, a high enough concentration of hydroxide is 
essential to ensure phosphoester hydrolysis. The fact that the metal-free ligand as well as the 
ligand-free zinc(II) perchlorate did not show any activity in the entire pH range illustrates the 
requirement for the ZnII ion to be coordinated to the ligand for activation and subsequent 
hydrolysis of the phosphoester substrate. In the case of [GaIII(H2SIM1)(solv)x]+ the substrate 
hydrolysis detected at low pH can be explained by the ability of the GaIII center to activate 
coordinated water and thereby to generate the nucleophilic hydroxide. Here, the nucleophile 
needed for phosphoester hydrolysis is provided even at near neutral pH. Moreover, ligand-free 
gallium(III) perchlorate was also tested for the hydrolysis of BDNPP but did not show any activity. 
The fact that at basic conditions only autohydrolysis is detectable with [GaIII(H2SIM1)(solv)x]+ 
indicates that the GaIII ion in the doubly deprotonated species, most likely [GaIII(H2SIM1)(OH)2] is 
not able to activate the phosphoester substrate. 
Substrate Concentration Dependence 
The substrate concentration dependence was probed for [ZnII(H2SIM1)(solv)x]+, 
[GaIII(H2SIM1)(solv)x]+, and [GaIIIZnII(H2SIM1)(solv)x]4+ at pH 7 (0.5 mM < [BDNPP]0 < 4.14 mM). 
Saturation behavior was achieved for [ZnII(H2SIM1)(solv)x]+ and [GaIIIZnII(H2SIM1)(solv)x]4+ that was 
not the case for [GaIII(H2SIM1)(solv)x]+ (kcat, KM and kcat/KM are listed in Table 28). 
Table 28: Kinetic data (kcat in [10-3 s-1], KM in [mM] and kcat/KM in [s-1M-1]) of BDNPP hydrolysis with mixtures of 
the ligands H3SIM1 or H4SIM4 with 1 eq of zinc(II) perchlorate, 2 eq of zinc(II) perchlorate, 1 eq of gallium(III) 
perchlorate, 1 eq zinc(II) perchlorate and 1 eq of gallium(III) perchlorate (all kinetic studies were undertaken in 
a mixture of acetonitrile-aqueous buffer solution (1:1)). 
complex pKa(I) pKa(II) γ kcata KMa kcat/KMa 
[ZnII(H2SIM1)(solv)x]+ (9.2 ± 0.5)c (10.9 ± 0.5)c (14.94 ± 7.00)c 0.24 ± 0.02 4 ± 1 0.07 
[ZnII2(H2SIM1)(solv)x]3+ 6.9 ± 0.4 9.6 ± 0.3 2.21 ± 0.64 n.a. n.a. n.a. 
[GaIII(H2SIM1)(solv)x]2+ 6.3 ± 0.2 8.6 ± 0.2 0.01 ± 0.07 -b -b -b 
[GaIIIZnII(H2SIM1)(solv)x]4+ 6.5 ± 0.1 10.9 ± 0.1 90.34 ± 13.87 13.03 ± 3.51 12 ± 4 1.07 
[ZnII(H2SIM4)(solv)x] (12.4)c - - 0.12 ± 0.04 1 ± 1 0.10 
[ZnII2(H2SIM4)(solv)x]2+ - - - n.a. n.a. n.a. 
[GaIII(H2SIM4)(solv)x]+ 6.7 ± 0.1 8.7 ± 0.2 0.01 ± 0.05 0.67 ± 0.14 7 ± 2 0.10 
[GaIIIZnII(H2SIM4)(solv)x]3+ 6.5 ± 0.2 10.5 ± 0.3 12.84 ± 3.62 1.83 ± 0.21 7 ± 1 0.25 
a the assays were performed with aqueous buffer solution pH = 7, TONs were determined after 9 days. 
b the kinetic data for [GaIII(H2SIM1)(solv)x]+ could not be determined as Michaelis-Menten behavior was not observed. 
c determined pKa values are close to limits if the examined pH range. 
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Mareque-Rivas et al. reported that a vacant second coordination site besides the coordination 
site occupied by ZnII accelerates phosphoester hydrolysis in a similar way as providing 
metal···metal interaction This effect was not observed for the phenolate-based complexes 
discussed in this chapter since the ZnII2 complexes of both, HL1 and H3SIM1, exhibit higher 
hydrolysis rates than [ZnII(H2SIM1)(solv)x]+.111, 193 The KM values determined for 
[ZnII(H2SIM1)(solv)x]+ (KM = 4 mM) and [ZnII2(H2SIM1)(µ-OAc)(OH)]+ (KM = 4 mM; discussed in 
Chapter 7.2) are, however, in both cases much lower than for [ZnII2(L1)(µ-OAc)2]+ (KM = 123 mM; 
discussed in Chapter 7.2), indicating an enhancement on the substrate affinity by the hydrogen 
bonding network.  
Furthermore, the results obtained with the substrate concentration dependence measurements 
indicate that the exchange of the ZnII ion present in binding site B in [ZnII(H2SIM1)(solv)x]+ by a 
GaIII ion and the subsequent coordination of ZnII in binding site C leads to a 50-fold increase in 
phosphoester hydrolysis rate, but simultaneously the value for KM rises, i.e. the substrate affinity 
decreases. However, the catalytic efficiency of [GaIIIZnII(H2SIM1)(solv)x]4+ is still 15-fold higher 
than the one detected for [ZnII(H2SIM1)(solv)x]+.  
Comparison of the kinetic parameters for the GaIIIZnII complex of H3SIM1 with those obtained for 
[ZnII2(H2SIM1)(µ-OAc)(OH)]+ (kcat = (0.57 ± 0.04)·10-3 s-1; KM = (4 ± 1) mM; kcat/KM = 0.14 s-1M-1;301 
discussed in Chapter 7.2) reveals that the heterodinuclear GaIIIZnII complex hydrolyzes BDNPP 
twenty times faster at neutral pH. Although the substrate affinity of the GaIIIZnII complex is 
significantly lower, the catalytic efficiency of [GaIIIZnII(H2SIM1)(solv)x]4+ is increased six-fold 
compared to its ZnII2 counterpart illustrating the importance of the trivalent metal ion in the 
model complex. 
Kinetic Investigations with Complexes Bearing the H4SIM4 Backbone 
pH Dependence 
The pH dependence experiments of the BDNPP hydrolysis for [ZnII(H3SIM4)(solv)x]+, 
[GaIII(H2SIM4)(solv)x]+ and [GaIIIZnII(H2SIM4)(solv)x]3+ resulted in similar findings as for the 
corresponding complexes bearing the H3SIM1 ligand backbone, i.e. that (i) [ZnII(H3SIM4)(solv)x]+ is 
only active under strong basic conditions, (ii) [GaIII(H2SIM4)(solv)x]+ is active in a defined pH region 
between the two pKa values, 6.74 and 8.68, and (iii) [GaIIIZnII(H2SIM4)(solv)x]3+ exhibits a 
superposition of the behavior found for [ZnII(H3SIM4)(solv)x]+ and [GaIII(H2SIM4)(solv)x]+ (Figure 
66a).  
PHOSPHATASE ACTIVITY OF HETEROVALENT HETERODINUCLEAR COMPLEXES 
185 
 
Figure 66: a) pH dependence and b) substrate concentration dependence at pH = 7 of BDNPP hydrolysis activity 
for mixtures of ligand H4SIM4 and with 1 eq of zinc(II) perchlorate (red triangles), 2 eq of zinc(II) perchlorate 
(green diamonds), 1 eq of gallium(III) perchlorate (blue squares), 1 eq zinc(II) perchlorate and 1 eq of gallium(III) 
perchlorate (black circles). 
Substrate Concentration Dependence 
The substrate concentration dependence measurements of [ZnII(H3SIM4)(solv)x]+, 
[GaIII(H2SIM4)(solv)x]+, and [GaIIIZnII(H2SIM4)(solv)x]3+ revealed that the hydrolysis rate of the 
GaIIIZnII complex is increased three-fold compared to the monogallium(III) complex and increased 
six-fold compared to the monozinc(II) complex. However, the substrate affinity of the GaIIIZnII 
complex is similar to that of the GaIII complex and significantly lower to that of the ZnII complex. 
Due to the much faster hydrolysis rate, the catalytic efficiency of [GaIIIZnII(H2SIM4)(solv)x]3+ is 
2.5-times higher than those of [ZnII(H3SIM4)(solv)x]+ and [GaIII(H2SIM4)(solv)x]+.  
In contrast to the corresponding complexes of H3SIM1, [ZnII(H3SIM4)(solv)x]+ bears the ZnII in the 
same binding site as [GaIIIZnII(H2SIM4)(solv)x]3+, just like [GaIII(H2SIM4)(solv)x]+ contains the GaIII in 
the same binding site as [GaIIIZnII(H2SIM4)(solv)x]3+. Therefore, the fact that the GaIIIZnII complex 
of H4SIM4 complex exhibit a higher catalytic activity than the sum of the hydrolysis rates of the 
monozinc(II) and monogallium(III) complexes can merely be attributed to a cooperative effect. 
Comparison of the ZnII, ZnII2, GaIII, and GaIIIZnII Complexes with the Ligand 
Backbones H3SIM1 and H4SIM4 
Independent on the ligand backbone of H3SIM1 and H4SIM4, the two complexes with the same 
metal ions coordinated show similar pH dependencies of the initial hydrolysis rate. However, the 
initial hydrolysis rate of [ZnII(H2SIM1)(solv)x]+ is higher at pH 10 than that for [ZnII(H3SIM4)(solv)x]+ 
indicating a shift of the pKa to higher pH by the pivaloyl-amide residue adjacent to the ZnII center 
in [ZnII(H2SIM4)(solv)x]. The same is found for the ZnII2 complexes [ZnII2(H2SIM1)(solv)x]3+ and 
[ZnII2(H2SIM4)(solv)x]2+, i.e. [ZnII2(H2SIM4)(solv)x]2+ becomes active at higher pH than 
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[ZnII2(H2SIM1)(solv)x]3+, but the increase of the initial hydrolysis rate with increasing pH from 9 to 
10 for the latter complex is more pronounced. The differences in the catalytic behavior of 
[ZnII2(H2SIM1)(solv)x]3+ and [ZnII2(H2SIM4)(solv)x]2+ could be a result of two structural features, 
(i) the unequal primary coordination sphere, and (ii) the different positioning of the hydrogen 
bond donors in the second coordination sphere. 
Comparison of the ZnII2 complexes of H3L2 and H4SIM4 provides the opportunity to study the 
effect of changes to the first coordination sphere, with the secondary coordination sphere the 
same in both complexes. While H3L2 has two N3O binding sites, H4SIM4 offers one N3O- and one 
N2O2-coordination site. [ZnII2(H2L2)(µ-OAc)2]+ (see Chapter 7.2) and [ZnII2(H2SIM4)(solv)x]2+ exhibit 
similar behavior of their BDNPP hydrolysis activity; with increasing pH the initial hydrolysis rate 
for both increases significantly. However, the value of the initial hydrolysis rate measured at pH 
9 is significantly higher for [ZnII2(H2SIM4)(solv)x]2+ than for [ZnII2(H2L2)(µ-OAc)2]+ and this is 
attributed to the exchange of one pyridine ligand by a more basic terminal phenolate ligand. 
Unfortunately, the absorbance at 400 nm increased to values near device limit when the 
experiments with [ZnII2(H2SIM4)(solv)x]2+ were undertaken at pH > 9. Based on these findings the 
higher initial hydrolysis rate of [ZnII2(H2SIM4)(solv)x]2+ compared to [ZnII2(H2SIM1)(solv)x]3+ is 
ascribed to the more basic phenolate donor in the former complex. 
However, the most pronounced differences with respect to the two ligand backbones was found 
for the GaIII complexes. In the pH profiles of Figure 67 it is clearly demonstrated that the 
complexes [GaIII(H2SIM4)(solv)x]+ and [GaIIIZnII(H2SIM4)(solv)]3+ show higher initial hydrolysis 
velocities than the corresponding H4SIM4 complexes [GaIII(H2SIM1)(solv)x]2+ and 
[GaIIIZnII(H2SIM1)(solv)]4+ in the entire pH range studied (Figure 67a). 
 
Figure 67: Comparison of a) pH dependence and b) substrate concentration dependence at pH = 7 of BDNPP 
hydrolysis activity for mixtures of ligand H3SIM1 (unfilled symbols) and H4SIM4 (filled symbols) with 1 eq of 
gallium(III) perchlorate (blue squares), 1 eq zinc(II) perchlorate and 1 eq of gallium(III) perchlorate (black 
circles). 
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The GaIIIZnII complexes [GaIIIZnII(H2SIM4)(solv)]3+ and [GaIIIZnII(H2SIM1)(solv)]4+ differ in two 
structural features, (i) the primary coordination environment of the GaIII center, and (ii) the 
position of the hydrogen bond donors mimicking the histidine residues in the second 
coordination sphere of the PAP active site. The previously reported complex 
[GaIIIZnII(L4)(µ-OAc)2]+ helps to extract the specific impact of the structural variations.66 The GaIII 
environments in [GaIIIZnII(H2SIM4)(solv)]3+ and [GaIIIZnII(L4)(µ-OAc)2]+ are similar with respect to 
the primary coordination sphere, but differ in the secondary coordination sphere as 
[GaIIIZnII(H2SIM4)(solv)]3+ bears a pivaloyl-amide residue adjacent to the GaIII center while 
[GaIIIZnII(L4)(µ-OAc)2]+ misses a proximal hydrogen bond donor. In contrast, the GaIII center in 
both [GaIIIZnII(H2SIM1)(solv)]4+ and [GaIIIZnII(L4)(µ-OAc)2]+, do not have a hydrogen bond donor in 
close proximity and therefore do not vary in the secondary coordination sphere, but the primary 
coordination sphere of the two complexes is different. Therefore, comparison of 
[GaIIIZnII(H2SIM4)(solv)]3+ with [GaIIIZnII(L4)(µ-OAc)2]+ enables the elucidation of the effect of a 
hydrogen bonding donor adjacent to the GaIII center. Similarly, comparison of 
[GaIIIZnII(H2SIM1)(solv)]4+ and [GaIIIZnII(L4)(µ-OAc)2]+ gives an insight in the impact of the exchange 
of a pyridine by a phenolate residue in the primary coordination environment of the GaIII center.  
In contrast to [GaIIIZnII(H2SIM1)(solv)x]4+ and [GaIIIZnII(H2SIM4)(solv)x]3+, [GaIIIZnII(L4)(µ-OAc)2]+ 
exhibited a sigmoidal v0 vs. pH curve with a relatively sharp activity maximum at pH ~ 6.8.66 The 
differences in the pH profile curve shapes derived for [GaIIIZnII(H2SIM1)(solv)x]4+ and 
[GaIIIZnII(H2SIM4)(solv)x]3+ compared to [GaIIIZnII(L4)(µ-OAc)2]+, more precisely the fact that the 
initial hydrolysis rate rises at pH values higher than nine for [GaIIIZnII(H2SIM1)(solv)x]4+ and 
[GaIIIZnII(H2SIM4)(solv)x]3+, in contrast to that of [GaIIIZnII(L4)(µ-OAc)2]+, is attributed to the 
hydrogen bond donors adjacent to the ZnII site in the former complexes. 
The GaIII coordination environments in both [GaIIIZnII(H2SIM1)(solv)x]4+ and [GaIIIZnII(L4)(µ-OAc)2]+ 
do not provide hydrogen bonding nearby, but they differ in the primary coordination sphere. The 
GaIII center in [GaIIIZnII(H2SIM1)(solv)x]4+ is bound in a N3O-site, while the GaIII ion in 
[GaIIIZnII(L4)(µ-OAc)2]+ is coordinated to a N2O2-site. Therefore, the shift of the pH maximum by 
0.8 pH units with respect to the phosphoester hydrolysis activity in the region between pH 7 and 
pH 9 to more acidic conditions seems to be a result of the electron-rich phenolate coordinating 
ligand. However, it should be noted that this is in contrast to the results obtained with the 
monogallium(III) complexes of the tripodal ligands examined by Erxleben et al. (Scheme 22 and 
Table 26).70 
The GaIII ions in [GaIIIZnII(H2SIM4)(solv)x]3+ and [GaIIIZnII(L4)(µ-OAc)2]+ have both the same primary 
coordination sphere but in [GaIIIZnII(H2SIM4)(solv)x]3+ a pivaloyl-amide residue is positioned 
adjacent to the GaIII ion that is missing in [GaIIIZnII(L4)(µ-OAc)2]+. Interestingly, the pH maximum 
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for the hydrolysis activity in the region between pH 7 and pH 9 is shifted by 0.7 pH units to more 
basic conditions by the incorporation of a hydrogen bond donor proximal to the GaIII center. Thus, 
the capacity of hydrogen bonding has a similar effect as a less electron-rich ligand in the primary 
coordination sphere, resulting in a more basic activity pH maximum.  
Although, the pH maxima of the hydrolysis activity in the region between pH 6 and pH 9 is shifted 
to more basic conditions for the two complexes with hydrogen bond donors proximal to the 
dinuclear core, [GaIIIZnII(H2SIM1)(solv)]4+ and [GaIIIZnII(H2SIM4)(solv)]3+ (see Table 28) exhibit at 
pH 7 (i) higher hydrolysis rates kcat, (ii) higher KM values and subsequently lower substrate affinity, 
and (iii) higher catalytic efficiencies than [GaIIIZnII(L4)(µ-OAc)2]+ (see Table 25), lacking hydrogen 
bonding capacity.66 This is most likely due to hydrogen bond formation. Moreover, the 
positioning of two hydrogen bond donors adjacent to the ZnII binding site has the most 
pronounced effect. 
Turn Over Numbers  
In order to determine the TONs of the ZnII, ZnII2, GaIII, and GaIIIZnII complexes of H3SIM1 and H4SIM4 
a long-term study was conducted following the general procedure explained in Chapter 6.3. The 
assays were prepared with the aqueous-buffer solution of pH 7. TON values after nine days were 
calculated using the Beer-Lambert Law. The resulting data are given in Figure 68 and Table 29. 
 
Figure 68: Time dependence of the absorbance band of 2,4-nitrophenolate (400 nm) at pH = 7 of BDNPP 
hydrolysis activity assays with mixtures of ligand H3SIM1 (unfilled symbols) and H4SIM4 (filled symbols) with 1 eq 
zinc(II) perchlorate (red triangles), 2 eq zinc(II) perchlorate (green diamonds), 1 eq of gallium(III) perchlorate 
(blue squares), 1 eq zinc(II) perchlorate and 1 eq of gallium(III) perchlorate (black circles). 
Comparing the complexes with the same metal content enables the formulation of conclusions 
about the impact of the structural variations given by the two ligand backbones. In the case of 
the monozinc(II) complexes [ZnII(H2SIM1)(solv)x]+ and [ZnII(H3SIM4)(solv)x]+ the hydrolysis 
acceleration appears to be similar in the first 60 hours. But [ZnII(H3SIM4)(solv)x]+, which has a ZnII 
adjacent to a hydrogen bond donor, is, inhibited at lower product concentration than 
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[ZnII(H2SIM1)(solv)x]+ lacking hydrogen bond donors proximal to the ZnII center, an effect possibly 
due to hydrogen bond formation. 
Table 29: TONs of BDNPP hydrolysis with mixtures of the ligands H3SIM1 or H4SIM4 with 1 eq of zinc(II) 
perchlorate, 2 eq of zinc(II) perchlorate, 1 eq of gallium(III) perchlorate, 1 eq zinc(II) perchlorate and 1 eq of 
gallium(III) perchlorate (all kinetic studies were undertaken in a mixture of acetonitrile:aqueous buffer solution 
(1:1)). 
complex TONa 
[ZnII(H2SIM1)(solv)x]+ 10 ± 1 
[ZnII2(H2SIM1)(solv)x]3+ 18 ± 1 
[GaIII(H2SIM1)(solv)x]2+ 35 ± 1 
[GaIIIZnII(H2SIM1)(solv)x]4+ 23 ± 5 
[ZnII(H2SIM4)(solv)x] 6 ± 1 
[ZnII2(H2SIM4)(solv)x]2+ 16 ± 1 
[GaIII(H2SIM4)(solv)x]+ 21 ± 1 
[GaIIIZnII(H2SIM4)(solv)x]3+ 25 ± 2 
a the assays were performed with aqueous buffer solution pH = 7, TONs were determined after 9 days. 
For the GaIII complexes a similar result was observed since [GaIII(H2SIM4)(solv)x]+ with a pivaloyl-
amide residue adjacent to the GaIII center showed higher TONs than [GaIII(H2SIM1)(solv)x]2+, 
lacking a proximal hydrogen bond donor. However, compared to the respective monozinc(II) 
complexes both monogallium(III) complexes exhibited higher TONs as expected from the above 
discussed kinetic studies. Thus, the inhibiting phosphomonoester is bound in mononuclear 
complexes more strongly to a ZnII ion than to a GaIII ion and is stabilized by proximal hydrogen 
bond donors.  
During the investigation of the TONs at pH 9.5 of various dizinc(II) complexes, discussed in 
Chapter 7.2, it was revealed that positioning one pivaloyl-amide residue proximal to each binding 
site prevents inhibition more reliably than with both at one binding site. Such an effect was not 
found comparing the TONs of [ZnII2(H2SIM4)(solv)x]2+ and [ZnII2(H2SIM1)(solv)x]3+; both exhibited 
similar TONs. Compared to [ZnII2(H2L2)(µ-OAc)2]+, discussed in Chapter 7.2, [ZnII2(H2SIM4)(solv)x]2+ 
has a terminal phenolate residue instead of a pyridine in the primary coordination sphere, while 
the secondary coordination sphere is in both complexes arranged in a symmetrical fashion. 
Therefore, the lower TON of [ZnII2(H2SIM4)(solv)x]2+ compared to [ZnII2(H2L2)(µ-OAc)2]+ is ascribed 
to the difference in the primary coordination sphere. Thus, the inhibition of dizinc(II) complexes 
by a phosphomonoester molecule seems to be favored by two hydrogen bond donors proximal 
to one binding site and an electron-rich phenolate residue in the primary coordination sphere.  
Comparing the two GaIIIZnII complexes, [GaIIIZnII(H2SIM1)(solv)x]4+ with two privaloyl-amide 
residues proximal to the ZnII center exhibited a lower TON. This suggests that sterical hindrance 
does not prevent from inhibition. The higher TON of [GaIIIZnII(H2SIM4)(solv)x]3+ compared to 
[GaIIIZnII(H2SIM1)(solv)x]4+ is assumed to be due to the lower product affinity of the GaIII center 
coordinated to the electron-rich terminal phenolate residue. 
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The heterodinuclear complex [GaIIIZnII(H2SIM4)(solv)x]3+ revealed also a higher TON than the 
homodinuclear complex [ZnII2(H2SIM4)(solv)x]2+. It appears that a phosphoester bridge between 
two ZnII centers coordinated in H4SIM4 is more easily formed than between a GaIII and a ZnII 
center, i.e. at lower product concentration. Interestingly, the TON of [GaIIIZnII(H2SIM4)(solv)x]3+ is 
also higher than for the two mononuclear complexes [ZnII(H3SIM4)(solv)x]+ and 
[GaIII(H2SIM4)(solv)x]+, indicating a positive interaction of the two metal ions in the 
heterodinuclear complex.  
Comparing the different complexes of H3SIM1 without a terminal phenolate, the results suggests: 
the heterodinuclear complex [GaIIIZnII(H2SIM1)(solv)x]4+ exhibits a similar TON as the dizinc(II) 
complex [ZnII2(H2SIM1)(solv)x]3+ indicating that the inhibition is independent of the two metal ions 
bound in the two binding sites of H3SIM1. However, [GaIIIZnII(H2SIM1)(solv)x]4+ shows a steeper 
increase of the absorbance at 400 nm with time, especially in the first fourty hours, compared to 
[ZnII2(H2SIM1)(solv)x]3+. Thus, the hydrolysis rate depends strongly on the presence of the trivalent 
metal ion.  
What emerged is that the GaIIIZnII complex with H4SIM4 is the most active catalyst, with H3SIM1 
the monogallium(III) complex is the most active one. Surprisingly, [GaIII(H2SIM1)(solv)x]2+ exhibits 
the highest TON of all complexes studied, with a TON of 35 after nine days. The high TON of 
[GaIII(H2SIM1)(solv)x]2+ is ascribed to (i) the lower product affinity of GaIII compared to ZnII, (ii) the 
lack of a proximal hydrogen bond donor, and (iii) the absence of a second metal ion and the 
resulting incapacity to bind efficiently the phosphomonoester product.  
Phosphomonoester Hydrolysis Studies  
Studies towards the phosphomonoester hydrolysis activity of the zinc(II), dizinc(II), gallium(III) 
and GaIIIZnII complexes of H3SIM1 and H4SIM4 were conducted with the activated model substrate 
DNPP at different pHs (7, 8, 9 and 10). A significant phosphomonoester hydrolysis capacity was 
only observed for [GaIIIZnII(H2SIM1)(solv)x]4+, while a slight increase in the 2,4-phenolate 
concentration in the assays of [GaIII(H2SIM1)(solv)x]4+ at pH 7 and [ZnII2(H2SIM4)(solv)x]2+ at pH 9.5 
compared to autohydrolysis was detected. However, due to the instability of DNPP in the buffer 
solution, the deviations of the initial hydrolysis velocities obtained for [GaIII(H2SIM1)(solv)x]4+ and 
[ZnII2(H2SIM4)(solv)x]2+ are too high to make an explicit statement about their hydrolysis capacity.  
The fact that only the GaIIIZnII and GaIII complex of H3SIM1 showed the ability to hydrolyze the 
phosphomonoester DNPP in contrast to the corresponding complexes of H4SIM4, indicates that 
neither the strong electron-rich terminal phenolate nor the hydrogen bond donor proximal to 
the trivalent metal center cause the capacity of phosphomonoester hydrolysis in PAPs. 
Moreover, the dizinc(II) complex of ligand H3SIM1 did not reveal phosphomonoester hydrolysis. 
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This indicates that the trivalent metal ion is essential for the DNPP hydrolysis. Moreover, the only 
model complexes reported to cleave phosphomonoester bonds contained at least one FeIII 
ion.108, 109, 114 
 
Figure 69: Substrate concentration dependence at pH = 7 of DNPP hydrolysis activity for the mixture of ligand 
H3SIM1 with 1 eq zinc(II) perchlorate and 1 eq of gallium(III) perchlorate. 
The substrate concentration dependence measurements were conducted at pH 7 in order to 
mimic near physiological conditions. [GaIIIZnII(H2SIM1)(solv)x]4+ showed Michaelis-Menten type 
behavior, and fitting the data determined the catalytic parameters kcat = (0.12 ± 0.02)·10-3 s-1, 
KM = (0.94 ± 0.32) mM and kcat/KM = 0.12 s-1M-1. Although the activity of [GaIIIZnII(H2SIM1)(solv)x]4+ 
is lower than those reported for the diiron complexes,108, 109, 114 [GaIIIZnII(H2SIM1)(solv)x]4+ is to 
date the first heterodinuclear model complex able to hydrolyze phosphomonoesters.  
9.4 SUMMARY 
 
The investigations undertaken with the mono- and dinuclear complexes of the two asymmetric 
ligands H3SIM1 and H4SIM4 with differing primary and secondary coordination spheres lead to a 
deeper insight in the reaction mechanism of phosphoester hydrolysis with heterodinuclear 
biomimetics. In the proposed mechanism the phosphoester is activated by the ZnII center and 
the GaIII is responsible for providing the hydroxide nucleophile at near physiological conditions 
(Scheme 24). 
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Scheme 24: Proposed mechanism for the BDNPP hydrolysis catalyzed by [GaIIIZnII(H2SIM1)(solv)x]4+. 
It was shown that the monozinc(II) complexes are not able to hydrolyze phosphoesters at near 
physiological conditions, but coordination of a second ZnII ion in the same ligand enables the 
hydrolysis. A similar cooperative effect was detected for the GaIIIZnII complexes. Although the 
substrate affinity of the complex [GaIIIZnII(H2SIM1)(solv)x]4+ was lower than of the corresponding 
ZnII2 complex, the heterodinuclear complex exhibits a 50-fold faster hydrolysis rate and a six-fold 
increased efficiency. Comparison of the activity of the two different GaIIIZnII complexes revealed 
a shift of the optimum pH to higher values with (i) an electron-poor coordinating ligand in the 
primary coordination sphere, or (ii) provision of hydrogen bonding by the second coordination 
sphere. Furthermore, the capacity of a hydrogen bonding network proximal to the dinuclear core 
results in (i) higher hydrolysis rates, (ii) lower substrate affinities, and (iii) higher efficiencies, 
especially when the two hydrogen bond donors were placed proximal to the ZnII center. 
However, the long-time studies showed that such a sterically demanding complex is not 
prevented from inhibition. During the long-term studies an acceleration effect by the trivalent 
metal ion was detected. Furthermore, a GaIII coordinating phenolate-residue results in a higher 
TON than pyridine for the GaIIIZnII complexes. However, the highest TON was found for the 
monogallium(III) complex without hydrogen bond donors in close distance to the metal center 
but with a vacant second amidated coordination site.  
Investigation of the DNPP hydrolysis of the different complexes showed that only the complex 
[GaIIIZnII(H2SIM1)(solv)x]4+ is able to cleave phosphomonoesters efficiently. Therefore, this 
complex does not only combine the essential structural features of the active site of PAP, but is 
also the first heterodinuclear model complex mimicking the essential function of PAPs, the 
hydrolysis of phosphomonoesters. 
 193 
Chapter 10  
Conclusions and Outlook
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In course of this work the ligands HL1 and H2L4, which have previously been accepted as a suitable 
basis for model complexes of phosphatases, were modified by the introduction of substituents 
capable of hydrogen bonding. In this way, the second coordination sphere of phosphatase 
metalloenzymes was mimicked in order to further improve the accuracy of phosphatase 
biomimetics as enzyme models. For the synthesis of the four asymmetric ligands, a selective 
procedure was evaluated, generating two different coordination sites. These ligands mimic the 
asymmetric peptide backbone that surrounds the dimetallic core in the active site of 
phosphatases.  
The series of ligands studied, with no substituents, two asymmetrically disposed and two 
symmetrically disposed amide or two asymmetrically disposed amine anchor groups for 
hydrogen bonding, led to strikingly different structures of the corresponding dizinc(II) 
complexes. It became apparent that the steric hindrance caused by two pivaloyl-amide 
substitutents adjacent to one coordination site, and the subsequent inability of the 
corresponding dizinc(II) complexes to bind two acetate co-ligands, resulted in a dizinc(II) 
structure similar to the active sites of phosphatases with two different ZnII sites – one 6- and 
the other 5-coordinate. Moreover, these complexes represent rare examples of zinc(II) 
complexes with a hydroxido co-ligand - the potential nucleophile during the phosphoester 
hydrolysis reaction - stabilized by hydrogen bond formation. The desired hydrogen bonding 
network was also observed for the dizinc(II) and diiron(II) complexes studied, which revealed 
the common structure of phenoxido-bridged phosphatase models bearing two bridging 
acetate co-ligands.  
Studying the phosphoester hydrolysis activity of the series of dizinc(II) and diiron(II) model 
complexes with hydrogen bonding functionalities proximal to the dimetal core enabled the 
analysis of the implications of (i) the type of the hydrogen bond donor, (ii) the position of the 
hydrogen bond donor, and (iii) the coordinating ligands in the primary coordination sphere. 
The main impact of the secondary interactions in the dizinc(II) complexes was found to be 
the increased substrate affinity, and this obviously depends on the hydrogen bonding sites 
and the type of the hydrogen bonding groups. In fact, at pH 7 the diamino derivative is the 
most effective catalyst, and positioning of both pivaloyl-amide residues proximal to one ZnII 
center exhibited a more positive effect towards the BDNPP hydrolysis than positioning one 
pivaloyl-amide adjacent to each ZnII center. Long-term catalytic studies showed that at pH 
9.5 the symmetrical, sterically hindered, amide-based system is the most efficient dizinc(II) 
complex studied here, and this is primarily due to less stable catalyst-inhibitor complexes. 
Interestingly, the effect of the position of the pivaloyl-amide residues was shown to be the 
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opposite for the corresponding diiron(II) complexes. In fact, incorporation of two pivaloyl-
amide residues in an asymmetric fashion into a dizinc(II) complex lead to the generation of a 
stable catalyst-inhibitor (hydrolysis product) adduct. Herein, one of the two pivaloyl-amide 
moieties fills the remaining vacant coordination site and is stabilized by hydrogen bond 
formation to the second pivaloyl-amide residue.  
Although this work showed that the incorporation of sterically demanding amide moieties 
into dinuclear model complexes have a beneficial effect on the phosphoester cleavage 
capacity, it is still not completely understood which structural feature is accounted therefore: 
(i) the hydrogen bonding capacity, (ii) the sterical strain, or (iii) the electronic effect caused 
by potential coordination of the amide-oxygen donor. In order to circumvent the latter and 
to preserve the steric strain of the hydrogen bonding substituents, which might promote the 
hydrolysis, the efforts of future work could be put in the reduction of the pivaloyl-amide 
functionalities of the ligands developed in this thesis. For example, reduction of ligand H3SIM1 
with lithium aluminium hydride should generate ligand H4L73 with a sterically demanding 
amine substituent (Chart 29).199 Using H4L73 for the synthesis of a dizinc(II) complex supplies 
a biomimetic which maintains (i) the capacity to form hydrogen bonds as well as (ii) the steric 
strain comparable to H3SIM1, but lacks the ability to stabilize a catalyst-inhibitor complex by 
coordination of an adjacent donor. 
 
Chart 29: Depiction of the desired ligands for the generation of phosphatase biomimetics in future studies. 
The more electron-rich primary coordination sphere and the amino hydrogen bond donors 
have been shown to support the phosphoester hydrolysis. Therefore, biomimetics which 
carry those structural features in tandem would be of considerable interest. The 
development of H3L74 and H3L75 (Chart 29), and complexes thereof, should have the potential 
to mimic the functionality of the native enzymes more accurately. 
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An interesting result during the characterization of the diiron(II) complexes was the reduction 
capacity of FeIII bound to the ligand H3SIM1 under acidic conditions. A concerted proton-
electron transfer mechanism was proposed for this reaction, but a direct proof remains to 
be provided. Therefore, a suitable experiment could be the use of EPR spectroscopy or radical 
scavengers which could support the proposed mechanism via the generation of a radical 
species. 
In order to gain a more accurate model system for the active form of mammalian PAPs the 
formation of a heterovalent diiron core in an asymmetric coordination environment with the 
capacity to form a hydrogen bond network similar to the native enzymes was probed. In fact, 
the successful formation of an FeIIIFeII species via chemical oxidation of the respective diiron(II) 
complex with ferrocenium hexafluorophosphate under anaerobic conditions was achieved. 
Comparison of the catalytic activity of the parent diiron(II) and the heterovalent diiron complex 
supported the presumption that the role of the FeIII center in the active site of PAP is the provision 
of a nucleophilic hydroxide at low pH. Another milestone for the development of sophisticated 
model systems for the active form of mammalian PAPs could be the generation of diiron(II) 
complexes of H4SIM3 and H4SIM4 and the following study of the oxidation, analogous to the 
approach outlined in this thesis. Furthermore, reliable protocols for the isolation of the 
complexes obtained, such as extraction of the generated byproduct ferrocene need to be 
developed. These investigations are promising due to the provision of two chemically distinct 
coordination sites within these ligands. 
The second strategy to generate heterovalent dinuclear model complexes which provide in 
parallel hydrogen bonding donors adjacent to the dimetal core was the selective generation 
of a GaIIIZnII complex. Therefore, the coordination behavior of the three pivaloyl-amide 
containing ligands towards ZnII, CuII, GaIII and FeIII was examined with various techniques. In this 
way, the selective formation of specific complexes was detected assigned to the asymmetry of 
the ligands. The trivalent GaIII ion was shown to coordinate in the less hindered or the more 
electron-rich binding site, while the remaining binding site is selectively filled by the divalent ZnII 
ion. Moreover, the catalytic activity of the monogallium(III), the monozinc(II), and the 
heterodinuclear GaIIIZnII complexes was investigated. In this way, the previously proposed 
mechanism, in which the phosphoester is activated by the ZnII center and the GaIII is accountable 
for providing the hydroxide nucleophile even at near physiological conditions, was supported in 
this study and a cooperative effect was detected for the GaIIIZnII complexes. Although the 
substrate affinity of the GaIIIZnII complex was lower than for the respective ZnII2 complex, a 
50-fold faster hydrolysis rate and a six-fold increased efficiency was detected in one case. 
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Comparing the activity of the two different GaIIIZnII complexes exhibited a shift of the optimum 
pH to higher values with (i) an electron-poor coordinating ligand in the primary coordination 
sphere, or (ii) provision of hydrogen bonding by the second coordination sphere. However, the 
capacity of a hydrogen bonding network proximal to the GaIIIZnII core resulted in (i) higher 
hydrolysis rates, (ii) lower substrate affinities, and (iii) higher efficiencies, especially when the 
two hydrogen bond donors were placed proximal to the ZnII center.  
With the use of long-term studies an acceleration effect by the trivalent metal ion was detected 
and a high TON was supported by the coordination of the GaIII by a terminal phenolate-residue. 
However, the highest TON was found for the monogallium(III) complex bearing no hydrogen 
bond donors at close distance to the metal center but with a vacant second amidated 
coordination site. The lower TON of the respective GaIIIZnII was ascribed to the inhibitory effect 
of a bridging product molecule, stabilized via coordination of the adjacent amide residue, as 
found in a similar dizinc(II) complex. Therefore, the preparation of ligand H3L73 and its derivatives, 
in combination with the generation of a GaIIIZnII complex with the two different metal ions in 
distinct binding sites, may shed light into the coordination capacity of the amide oxygen atom.  
The generation of the GaIIIZnII complex of ligand H3L73 is of particular interest due to the fact that 
the amidated counterpart [GaIIIZnII(H2SIM1)(solv)x]4+ revealed the ability to cleave 
phosphomonoesters. Therefore, this complex does not only combine the essential structural 
features of the active site of PAP, but it is also the first heterodinuclear model complex found to 
mimick the essential function of PAPs, i.e. the hydrolysis of phosphomonoesters. However, the 
results of the phosphoester hydrolysis activity indicate fast inhibition, which makes the GaIIIZnII 
complex of ligand H3L73 a promising candidate for a more accurate structural and functional 
model of the heterovalent heterodinuclear active site of PAP, thus, leading us a step further to 
the well-directed development of more efficient osteoporosis therapeutic agents. 
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Chapter 11  
Experimental Section
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11.1 GENERAL REMARKS 
 
The main part of this thesis is and will be published in several scientific journals. For the NMR 
spectra (1H and 31C) and mass spectra for the synthesized ligands as well as titration experiments 
it can be refered to the Supporting Information of each of the corresponding publications. The 
experimental structures reported in this thesis are deposited at the “Cambridge Crystallographic 
Data Centre”, the experimental data are not included in the Appendix, but can be obtained free 
of charge via www.ccdc.cam.ac.uk/data_request/cif. The corresponding CCDC-reference code of 
each complex is given in the Appendix. 
11.2 MATERIAL AND METHODS 
11.2.1 CHEMICALS 
 
Chemicals and solvents used for synthesis and spectroscopy were purchased from Sigma-Aldrich 
and Acros. 2,4-Dinitrophenol was recrystallized and phosphoryl chloride was distilled before 
usage. All other chemicals were used without prior purification. Solvents for organic synthesis 
were of standard quality. Dry solvents were purchased from Sigma-Aldrich and Acros, stored over 
molecular sieves, and used without further purification. For complex syntheses and spectroscopy 
solvents of p.a. grade were utilized without further purification. In the kinetic assays MilliQ water 
was used. 
11.2.2 PHYSICAL MEASUREMENTS 
NMR Spectroscopy 
Nuclear Magnetic Resonance (NMR) spectra were recorded with Bruker AV200, AV400, AV500 
and AV600 spectrometers, for 13C and 31P NMR spectra with 1H decoupling. Two-dimensional 
correlation spectroscopy (COSY), nuclear Overhauser-effect spectroscopy (NOESY), 
heterodinuclear single quantum correlation (HSQC) and hetereodinuclear multiple bond 
connectivity (HMBC) experiments were used to assign each signal in the spectra. For 1H and 13C 
NMR spectra chemical shifts are reported in δ-units, relative to known solvent peak references: 
δH = 7.27 ppm, δC = 77.00 ppm for CDCl3; δH = 1.94 ppm, δC = 1.39 ppm for CD3CN; δH = 3.30 ppm, 
δC = 49.00 ppm for CD3OD and δH = 2.05 ppm, δC = 29.92 ppm for CD3COCD3. 85 % phosphoric 
acid (0 ppm) was used as external reference for 31P NMR spectra. The following abbreviations 
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were used: s (singlet), bs (broad singlet), d (doublet), t (triplet), dt (doublet of triplets), dd 
(doublet of doublets), ddd (doublet of doublets of doublets), td (triplet of doublets), sep (septet) 
and m (multiplet). The reported coupling constants nJ are for 1H-1H couplings. The software 
package TopSpinTM from BRUKER was used for data processing.302 
Magnetic Susceptibility Measurement by the Evans Method 
Magnetic moments in solution were measured for a solution of known concentration of complex 
in deuterated solvent in a capillary which was in a NMR tube carrying the same solvent. The 
experiments were conducted with Bruker AV200 and AV500 instruments. Magnetic moments 
were evaluated using Equation 24 and Equation 25, whereby appropriate corrections were 
considered. 
Equation 24 χpara,subst =
3
4πc
(
Δν
ν
) + χdia,solv + χdia,subst 
Equation 25 µ = 2.828√χpara,substT  
Solid State Magnetic Susceptibility Measurement with SQUID 
Magnetic susceptibility in solid state were examined with a MPMS-XL 5T superconducting 
quantum interference device (SQUID) from Quantum Design. The powdered samples were 
pressed into a PTFE band to avoid field-induced orientation and incorporated into two plastic 
straws as sample holder. Diamagnetic corrections for the PTFE band and the sample holder were 
applied.  
X-Ray Structure Analyses 
X-ray crystallographic data for the zinc(II) and gallium(III) complexes were collected with an 
Oxford Diffraction Gemini Ultra dual source (Mo or Cu) CCD diffractometer. The structures were 
solved by direct methods (SIR-92) using the SHELXS computer program and refined by the full-
matrix least-squares method based on F2, with the SHELXL 97 computer program.303 These 
programs were accessed by the WINGX 1.70.01 crystallographic collective package.304 
Crystallographic data for the iron complexes were collected with a Bruker AXS Smart 1000 CCD 
and an Agilent Technologies SuperNova-E dual source (Mo or Cu) CCD diffractometer. Using the 
software Olex2,305 the structures were solved with conventional direct methods and refined by 
full-matrix least squares based on F2. All non-hydrogen atoms were given anisotropic 
displacement parameters, unless they were disordered, and were placed at calculated positions. 
Hydrogen atoms were fixed geometrically and were not refined. The counter ion hexafluoro-
phosphate was in some cases resolved into two disordered octahedral anions, which share the 
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same phosphorus central atom. For [ZnII2(H2L2)(µ-OAc)2]PF6, the structure was refined with 
acetone and water solvate, both with an occupancy of 50%. In case of [FeII2(H2L2)(µ-OAc)2]PF6 the 
structure was refined with a diethylether solvate in the elemental cell. For 
[FeII2(H2SIM1)(µ-OAc)2]PF6 and {Na[FeII2(H2SIM3)(µ-OAc)2]2}PF6 electron density attributed to 
disordered solvent molecules was removed from the structure with the BYPASS procedure as 
implemented in PLATON (SQUEEZE).306, 307 Partial structure factors from the solvent masks were 
included in the refinement as separate contributions to Fobs.The X-ray structural data of the 
published structures were deposited at the Cambridge Crystallographic Data Centre. 
IR Spectroscopy 
FT-Infrared spectroscopy was carried out with a Perkin Elmer FT-IR Spectrometer SPECTRUM 
2000 equipped with a Smiths DuraSamplIR II ATR diamond window. 
Mass Spectrometry 
Electron ionization (EI) mass spectra were recorded with a JEOL JMS-700 instrument, Matrix-
assisted laser desorption/ionization (MALDI) mass spectra were recorded with a Bruker ApexQe 
hybrid 9.4 FT-ICR instrument and Electrospray ionization (ESI) mass spectra were measured on a 
Finnigan LCQ spectrometer at the Institute of Organic Chemistry of the University of Heidelberg. 
High resolution mass spectra were collected with a Bruker microTOFQ ESI-MS spectrometer in 
the School of Chemistry and Molecular Biosciences of the University of Queensland and a Bruker 
Apex-Qe hybrid 9.4 T FT-ICR instrument at the Institute of Organic Chemistry at the University of 
Heidelberg. The data were processed with Bruker Compass Data Analysis software.  
Elemental Analyses 
Elemental microanalyses were performed in the analytic laboratories of the Institute of Organic 
Chemistry of the University of Heidelberg with an Elementar Vario Mikro cube machine and the 
Carlo Erba Elemental Analyzer model NA1500 in the School of Chemistry and Molecular 
Biosciences at the University of Queensland. 
Cyclic Voltammetry  
Cyclic voltammetric measurements were performed on a CH Instruments CHI660D 
electrochemical workstation equipped with a Faraday cage using a three-electrode setup 
consisting of a glassy carbon working electrode, a platinum wire as a counter electrode and a 
Ag/Ag+ (0.1 mM in NaCl) reference electrode. The complex solutions were prepared with 
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degassed solvents with 0.1 M (NBu4)ClO4 as electrolyte. The redox potentials of the obtained 
signals were determined by comparison to a ferrocen sample measured at the same conditions 
and referenced vs. SCE (E(Fc/Fc+) = 0.380V vs. SCE).252 
EPR Spectroscopy  
X-band EPR spectra were measured with a Bruker Biospin ELEXSYS E500 spectrometer. The 
microwave frequency and magnetic field were calibrated with a Bruker frequency counter and 
an ER036 TM or an ER035M Tesla meter. Spin-Hamiltonian parameters were determined by 
computer simulations of the experimental spectra using the programs XSophe308 and 
MoSophe.309 The simulated and experimental spectra were visualized with the software suite 
XeprView.  
UV-vis-NIR Spectroscopy 
UV-vis-NIR spectra were recorded at 25°C with a TIDAS II J&M spectrophotometer and a Varian 
Cary50 Bio UV/visible spectrophotometer in 10 mm quartz cuvettes. Time-dependent UV-vis-NIR 
measurements were performed using a TIDAS II J&M spectrophotometer. Time-course 
measurements at fixed wavelengths were monitored by a JASCO V-570 spectrophotometer and 
a Varian Cary50 Bio UV/visible spectrophotometer with a Peltier temperature controller.  
Mössbauer Spectroscopy 
57Fe Mössbauer spectra of frozen solutions were acquired with a conventional spectrometer 
incorporating an Oxford Instruments Mössbauer-Spectromag 4000 Cryostat, equipped with a 
57Co source (3.7 GBq) in a rhodium matrix in the constant-acceleration mode at 170 K. Isomer 
shifts are given relative to α-Fe at 300 K. Spectra were fitted using the NORMOS Mössbauer 
Fitting Program. 
 
11.2.3 PHOSPHOESTER HYDROLYSIS EXPERIMENTS 
General Procedure 
Phosphoester hydrolysis activity of the complexes was probed with a spectrophotometric assay 
using BDNPP as phosphodiester model substrate and DNPP as phosphomonoester model 
substrate. Cleavage of the phosphorous-oxygen bond was followed at 25°C by monitoring the 
generated product, 2,4-dinitrophenolate, by its strong absorption at 400 nm (ε = 12,100 M-1cm-1). 
All measurements were carried out in 1:1 acetonitrile-buffer mixtures and performed in 
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triplicates. The complex was allowed to equilibrate in the acetonitrile-buffer mixture for one 
minute prior addition of substrate. When the substrate was added to the reaction mixture the 
starting hydrolysis activity was monitored in the time between 15 and 195 seconds and analyzed 
by linear regression. For each experiment autohydrolysis assays were conducted by measuring 
the hydrolysis rate under the same conditions, but without complex, and were substracted from 
the derived data.  
Preparation of the Multicomponent Buffer Solutions 
The aqueous buffer consisted of 2-(N-morpholino)ethanesulfonic acid (MES) (50 mM; pH range: 
5.5 – 6.7), 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) (50mM; pH range: 
6.8 – 8.2), 2-(cyclohexylamino)ethanesulfonic acid (CHES) (50 mM; pH range: 8.6 – 10.0), 3-(cyclo-
hexylamino)-1-propanesulfonic acid (CAPS) (50 mM; pH range: 9.7 – 11.1) and lithium 
perchlorate (250 mM) for ionic strength control. The desired pH of the buffers was adjusted by 
addition of aqueous sodium hydroxide solution. Following treatment with Chelex® (Chelex 100 
sodium form) overnight and filtration with 45 µm syringe filters ensured the absence of metal 
ions in the buffer solutions. The pH values reported refer to the aqueous component; however, 
it should be noted that the pH of a 1:1 mixture of buffer and acetonitrile was the same within 
error as of the corresponding buffer solution itself.275, 276 
Phosphodiester Hydrolysis Assays 
The activated model substrate BDNPP was initially prepared as 15 mM solution in acetonitrile 
and the complex solutions were 1 mM in acetonitrile. The pH dependence of the activity was 
studied by varying the pH value of the multicomponent buffer in the pH range of 5 to 11. In this 
process the assays contained the complex 0.04 mM and BDNPP 5 mM in the cuvette. The 
resulting pH profiles were fitted in the Origin (OriginLab) program using Equation 20 and Equation 
21 (Chapter 6.3).277 
Complex concentration dependency assays were 5 µM in BDNPP and 0.01 – 0.09 mM in complex, 
respectively. The data derived were fitted with a linear function using the Origin software. 
Substrate concentration dependence of the catalytic rate was examined with a fixed complex 
concentration of 0.04 mM and the BDNPP concentration varied. The experimental data obtained 
were fitted in the Origin (OriginLab) program to the Michaelis-Menten equation (Equation 22). 
Studies of the turn over number (TON) were conducted 15 nM in complex and 5.25 µM in BDNPP. 
Samples were taken at various intervals during the experiment, diluted with solvent, and their 
UV-vis spectra were recorded to determine the progress of phosphoester hydrolysis. The 
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increase in the absorbance at 400 nm, assigned to the hydrolysis product 2,4-dinitrophenolate, 
was monitored over time and TON values were calculated using the Beer-Lambert Law. 
Phosphomonoester Hydrolysis Assays 
Phosphomonoester hydrolysis activity of the activated substrate DNPP was examined in a similar 
manner to the BDNPP assays, but DNPP was dissolved initially in aqueous buffer solution of the 
required pH. During the pH dependence measurements the final concentrations in the cuvette 
were 0.04 mM of complex and 0.5 mM in DNPP. Complex concentration dependent assays were 
1 mM in DNPP and the complex concentration ranged from 0.03 to 0.09 mM. In order to study 
the substrate concentration dependency the concentration of complex was fixed at 0.04 mM and 
the DNPP concentration was varied between 0.1 and 1.5 mM. Turn-over experiment samples 
contained 0.01 mM complex and 3 mM DNPP.  
11.3 SYNTHESES OF PRECURSORS  
11.3.1 2,6-BIS(CHLOROMETHYL)-4-METHYLPHENOL (22) 
 
2,6-Bis(chloromethyl)-4-methylphenol (22) was prepared according to a known literature 
procedure.310 
2,6-bis(hydroxymethyl)-4-methylphenol (4) (2.5 g, 14.9 mmol) was treated with concentrated 
hydrochloric acid (30 ml) and stirred at room temperature overnight. The product was extracted 
into dichloromethane (3 x 65 ml) and dried over sodium sulfate. Removal of the solvent gave 
2,6-bis(chloromethyl)-4-methylphenol (22) in quantitative yield.  
 
1H NMR (199.92 MHz, CDCl3): δ = 2.29 (s, 3H, H3), 4.67 (s, 4H, H1), 7.10 (s, 2H, H2) ppm. 
 
  
EXPERIMENTAL 
206 
11.3.2 3-(CHLOROMETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE (5)  
2-Hydroxy-3-(hydroxymethyl)-5-methylbenzaldehyde (1) 
 
2-Hydroxy-3-(hydroxymethyl)-5-methylbenzaldehyde (1) was synthesized by modification of 
previously described procedures.120, 121 
To a solution of 2,6-bis(hydroxymethyl)-4-methylphenol (4) (50.0 g, 0.30 mol, 1.0 eq) in 
chloroform (1.6 l) was added activated manganese oxide (191 g, 2.2 mol, 7.3 eq) in portions and 
the resulting suspension was stirred for 2.5 hours at room temperature (progress was monitored 
by TLC (SiO2; CH2Cl2:MeOH = 98:2)). The manganese dioxide was removed via filtration through 
a pad of Celite (Ø = 3 cm, L = 10 cm). The filtrate was concentrated to a brownish solid, which 
contained compound 1 and compound 23. The mixture was separated by column 
chromatography (SiO2; Ø = 5 cm; L = 15 cm; CH2Cl2:MeOH = 98:2) yielding pure 2-hydroxy-3-
(hydroxymethyl)-5-methylbenzaldehyde (1) (23.1 g, 46%) and 2-hydroxy-5-methylisophthal-
aldehyde (23) (12.8 g, 25 %), both as yellowish solids. 
 
MS (EI+, direct): m/z = 166.06 ([C9H10O3], calcd. 166.06). 
1H NMR (600.13 MHz, CDCl3): δ = 2.33 (s, 3H, H9), 2.44 (bs, 1H, H10), 4.72 (s, 2H, H8), 7.28 (s, 
1H, H6), 7.40 (s, 1H, H4), 9.85 (s, 1H, H7), 11.17 (s, 1H, H11) ppm. 
13C NMR (150.90 MHz, CDCl3): δ = 20.2 (C9), 60.5 (C8), 120.0 (C1), 129.0 (C3/C5), 129.1 (C3/C5), 
132.6 (C4), 136.9 (C6), 157.3 (C2), 196.7 (C7) ppm. 
Elemental analysis: Calcd. for C9H10O3:  C  65.05%; H  6.07% 
Found:   C  64.88%; H  6.29%. 
 
MS (EI+, direct): m/z = 164.04 ([C9H8O3], calcd. 164.05). 
1H NMR (200.13 MHz, CDCl3): δ = 2.40 (s, 3H, H5), 7.78 (s, 2H, H3), 10.23 (s, 2H, H6), 11.47 (s, 
1H, H7) ppm. 
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13C NMR (100.55 MHz, CDCl3): δ = 20.0 (C5), 122.9 (C2), 129.5 (C4), 137.9 (C3), 161.7 (C1), 192.1 
(C6) ppm. 
3-(Chloromethyl)-2-hydroxy-5-methylbenzaldehyde (5) 
 
3-(Chloromethyl)-2-hydroxy-5-methylbenzaldehyde (5) was synthesized according to a known 
literature procedure.121 
A solution of compound 1 (2.50 g, 15 mmol) in ethanol (12.5 ml) was added dropwise to warm 
concentrated hydrochloric acid (37.5 ml) and the mixture was then heated at 40°C for two hours. 
The resulting precipitate was filtered and washed with water until a pH value of 8 was reached. 
The yellowish solid, 3-(chloromethyl)-2-hydroxy-5-methylbenzaldehyde (5), was dried under 
vacuum until dryness (1.85 g, 67%). 
 
MS (EI+, direct): m/z = 184.10 ([C9H9O2Cl], calcd. 184.03). 
1H NMR (200.13 MHz, CDCl3): δ = 2.36 (s, 3H, H9), 4.68 (s, 2H, H8), 7.36 (s, 1H, H4), 7.47 (s, 1H, 
H6), 9.87 (s, 1H, H7), 11.26 (s, 1H, H10) ppm. 
13C NMR (50.32 MHz, CDCl3): δ = 20.2 (C9), 39.8 (C8), 120.4 (C3), 125.8 (C1/C6), 129.2 (C1/C6), 
134.0 (C5), 139.0 (C4), 157.3 (C2), 196.4 (C7) ppm. 
Elemental analysis: Calcd. for C9H9O2Cl: C  58.55%; H  4.91% 
Found:   C  58.34%; H  5.18%. 
 
11.3.3 BIS(PYRIDIN-2-YLMETHYL)AMINE (2) 
 
Bis(pyridine-2-ylmethyl)amine (2) was prepared according to known literature procedures.115 
A solution of picolylaldehyde (24) (9.50 ml, 10.7 g, 0.10 mol, 1.0 eq) in methanol (225 ml) was 
cooled with a water-ice bath and 2-(aminomethyl)pyridine (25) (10.3 ml, 10.8 g, 0.10 mol, 1.0 eq) 
was added dropwise. Subsequently, the reaction mixture was allowed to warm up to room 
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temperature. After stirring the solution for two hours the mixture was again cooled with a water-
ice bath before sodium borohydride (7.57 g, 0.20 mol, 2.0 eq) was added in portions. The reaction 
mixture was stirred overnight at room temperature. After the solution was concentrated under 
reduced pressure, the residue was treated with water (250 ml) and neutralized with 2M 
hydrochloric acid. The product was extracted into dichloromethane (3 x 75 ml), washed with 
brine and dried over sodium sulfate. The solvent was removed under reduced pressure to give 
bis(pyridine-2-ylmethyl)amine (2) as a brown oil (12.5 g, 63%).  
 
Molecular Formula: C12H13N3 
1H NMR (200.13 MHz, CDCl3): δ = 3.26 (s, 1H, NH), 4.03 (s, 4H, H6), 7.17 (dd, 3J = 7.45 Hz, 
3J = 4.93 Hz, 2H, H2), 7.39 (d, 3J = 7.83 Hz, 2H, H4), 7.66 (td, 3J = 7.46 Hz, 4J = 1.79 Hz, 2H, H3), 8.59 
(d, 3J = 4.93 Hz, 2H, H1) ppm. 
13C NMR (50.32 MHz, CDCl3): δ = 54.0 (C6), 121.6 (C2/C4), 121.9 (C2/C4), 135.9 (C3), 148.8 (C1), 
158.7 (C5) ppm. 
 
11.3.4 2-(((PYRIDIN-2-YLMETHYL)AMINO)METHYL)PHENOL (16) 
 
2-(((Pyridine-2-ylmethyl)amino)methyl)phenol (16) was prepared according to known literature 
procedures.124, 125 
Salicylaldehyde (26) (12.2 g, 0.10 mol, 1.0 eq) was dissolved in methanol (225.0 ml) and the 
solution was cooled in a water-ice bath. 2-(Aminomethyl)pyridine (25) (10.4 ml, 10.8 g, 0.10 mol, 
1.0 eq) was added dropwise and the mixture was stirred for two hours at room temperature. 
Subsequently, sodium borohydride (7.57 g, 0.20 mol, 2.0 eq) was added in small portions while 
the solution was cooled in a water-ice bath. After completion of the addition, the reaction 
mixture was stirred overnight at room temperature. The solution was concentrated under 
reduced pressure and the residue was treated with water (250 ml) and neutralized with 2M 
hydrochloric acid. The product was extracted into dichloromethane (3 x 75 ml), washed with 
brine and dried over sodium sulfate. Removal of the solvent yielded 2-(((pyridine-2-ylmethyl)-
amino)methyl)phenol (16) as a brown oil (21.2 g, 99%).  
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HRMS (ESI+, CH3OH): m/z = 215.1179 ([C13H15N2O]+, calcd. 215.1179). 
1H NMR (399.89 MHz, CDCl3): δ = 3.92 (s, 2H, H7), 4.00 (s, 2H, H6), 6.78 (t, 3J = 7.40 Hz, 1H, H10), 
6.87 (d, 3J = 8.03 Hz, 1H, H12), 6.98 (d, 3J = 7.28 Hz, 1H, H9), 7.15 - 7.24 (m, 3H, H2, H4, H11), 7.66 
(td, 3J = 7.62 Hz, 4J = 1.19 Hz, 1H, H3), 8.58 (d, 3J = 3.76 Hz, 1H, H1) ppm. 
13C NMR (100.55 MHz, CDCl3): δ = 51.7 (C7), 52.9 (C6), 116.3 (C12), 119.0 (C10), 122.3 (C8), 122.4 
(C2), 122.6 (C4), 128.6 (C11), 128.7 (C9), 136.6 (C3), 149.3 (C1), 157.6 (C13), 158.1 (C5) ppm. 
 
11.3.5 2-(AMINOMETHYL)PHENOL (20) 
 
2-(Aminomethyl)phenol (20) was prepared according to published procedures with minor 
modifications.126 
Salicylamide (27) (2.68 g, 19.5 mmol, 1.0 eq) was treated with 1M borane tetrahydrofuran 
complex solution (100 ml, 100 mmol, 5.1 eq) under argon atmosphere and heated to 75°C for 
two days. After the mixture cooled to room temperature the reaction was quenched via dropwise 
addition of methanol. The solvent was removed under reduced pressure. The remaining 
tetrahydrofuran was stripped by addition of methanol (2 x 25 ml) followed by removal under 
vacuum to obtain 2-(aminomethyl)phenol (20) as a white solid in quantitative yield. 
 
HRMS (EI+, direct): m/z = 123.0697 ([C7H9NO], calcd. 123.0684). 
1H NMR (600.13 MHz, CDCl3): δ = 4.13 (s, 2H, H6), 6.79 (td, 3J = 7.42 Hz, 4J = 1.11 Hz, 1H, H3), 6.86 
(dd, 3J = 8.07 Hz, 4J = 0.91 Hz, 1H, H1), 6.98 (dt, 3J = 7.44 Hz, 4J = 0.62 Hz, 1H, H4), 7.18 (td, 
3J = 7.72 Hz, 4J = 1.61 Hz, 1H, H2) ppm. 
13C NMR (150.90 MHz, CDCl3): δ = 45.4 (C6), 116.7 (C1), 119.0 (C3), 123.9 (C5), 127.9 (C4), 128.7 
(C2), 158.3 (C7) ppm.  
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11.3.6 N-(6-PIVALOYLAMIDO-2-PYRIDYLMETHYL)-N-(2-PYRIDYL-
METHYL)AMIN (18) 
N-(6-methylpyridin-2-yl)pivalamide (9) 
 
N-(6-methylpyridin-2-yl)pivalamide (9) was prepared by slight modification of a previously 
described procedure.116 
A solution of 2-amino-6-methylpyridine (8) (54.1 g, 0.50 mol, 1.0 eq) in dry dichloromethane 
(500 ml) was treated with triethylamine (90.1 ml, 65.8 g, 0.65 mol, 1.3 eq) and cooled to 0°C with 
an ice-water bath. Pivaloylchloride (67.2 ml, 66.3 g, 0.55 mol, 1.1 eq) was then added dropwise 
to the solution. The resulting mixture was warmed to room temperature and stirred for two 
hours. Afterwards, the reaction was quenched by addition of water (100 ml). The phases were 
separated and the aqueous phase was extracted with dichloromethane (2 x 50 ml). The combined 
organic phases were dried over sodium sulfate and concentrated under reduced pressure. The 
yellowish solid was recrystallized three times from diethylether to give N-(6-methylpyridin-2-yl)-
pivalamide (9) as white crystals (95.6 g, 99%). 
 
Molecular Formula: C11H16N2O 
MS (EI+, direct): m/z = 192.12 ([C11H16N2O], calcd. 192.13). 
1H NMR (199.92 MHz, CDCl3): δ = 1.29 (s, 9H, H9), 2.42 (s, 3H, H6), 6.84 (d, 3J = 7.45 Hz, 1H, H2), 
7.54 (t, 3J = 7.89 Hz, 1H, H3), 7.90 (bs, 1H, NH), 8.02 (d, 3J = 8.21 Hz, 1H, H2) ppm. 
13C NMR (100.55 MHz, CDCl3): δ = 24.0 (C6), 27.5 (C9), 39.8 (C8), 110.7 (C2), 119.1 (C3), 138.6 
(C4), 150.9 (C1), 156.7 (C5), 177.0 (C7) ppm. 
Elemental analysis: Calcd. for C11H16N2O: C  68.72%; H  8.39%; N  14.57% 
Found:   C  68.75%; H  8.69%; N  14.64%.  
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N-(6-(bromomethyl)pyridin-2-yl)pivalamide (10) and N-(6-(dibromomethyl)-
pyridin-2-yl)pivalamide (13)  
 
N-(6-bromomethyl)pyridine-2-yl)pivalamide (10) was synthesized by modification of previously 
published procedures.117-119 
N-(6-methylpyridin-2-yl)pivalamide (9) (50.0 g, 0.26 mol, 1.0 eq) was dissolved under argon 
atmosphere in anhydrous carbon tetrachloride (500 ml) and was warmed to 70°C. 
N-bromosuccinimid (15.8 g) and a catalytic amount of AIBN was added and the mixture was 
heated for two hours with stirring while irradiated with a 150W UV lamp. Another portion of 
N-bromosuccinimide (15.8 g) and catalytic amount of AIBN were added. The additions were 
repeated every hour; in total seven additions of NBS (111 g, 0.62 mmol, 2.4 eq) were made. The 
mixture was then refluxed overnight. After cooling to room temperature the succinimide 
obtained was filtered and the filtrate concentrated under reduced pressure. The remaining 
brown oil was taken up in chloroform (400 ml), washed with water (3 x 300 ml), brine (300 ml) 
and dried over sodium sulfate. Removal of the solvent gave an orange oil containing a mixture of 
compound 9, the desired products, 10 and 14, and a ring-brominated species 13. Column 
chromatography (SiO2; Hexan:EtOAc = 4:1; Rf = 0.38) yielded a fraction of pure compound 10 next 
to a mixed fraction of compound 10, compound 13 and compound 14 (Rf = 0.46). The latter was 
separated by column chromatography (SiO2; Hexane:EtOAc = 10:1; Rf = 0.38). Ultra sonication of 
the orange oil obtained, treated with a small amount of hexane, yielded N-(6-bromomethyl)-
pyridine-2-yl)pivalamide (10) as a white solid (30.8 g, 44%). N-(6-(dibromomethyl)pyridin-2-yl)-
pivalamide (14) could not be isolated and was used in form of a mixture with the ring-brominated 
derivate 13 in the following reaction, after which the products were separated. 
 
HRMS (ESI+, CH3OH): m/z = 273.0421 ([C11H16N2OBr]+, calcd. 273.0419).  
1H NMR (600.13 MHz, CDCl3): δ = 1.34 (s, 9H, H9), 4.43 (s, 2H, H6), 7.15 (d, 3J = 7.47 Hz, 1H, H4), 
7.70 (t, 3J = 7.92 Hz, 1H, H3), 8.02 (bs, 1H, NH), 8.19 (d, 3J = 8.38 Hz, 1H, H2) ppm. 
13C NMR (150.90 MHz, CDCl3): δ = 27.5 (C9), 33.4 (C6), 39.8 (C8), 113.3 (C2), 119.2 (C4), 139.4 
(C3), 151.3 (C1), 154.8 (C5), 177.2 (C7) ppm.  
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Elemental analysis: Calcd. for C11H15N2OBr: C  48.72%; H  5.58%; N  10.33% 
Found:    C  48.58%; H  5.90%; N  10.27%. 
N-(6-pivaloylamido-2-pyridylmethyl)-N-(2-pyridylmethyl)amin (18) 
 
N-(6-formylpyridin-2-yl)pivalamide (26) and N-(6-pivaloylamido-2-pyridylmethyl)-N-(2-pyridyl-
methyl)amin (18) were synthesized following literature known procedures.114, 234 
Compound 14 (7.68 g, 21.9 mmol, 1.0 eq), in the form of a 32 w% mixture with compound 13, 
was dissolved in acetone (210 ml) and the flask was covered with aluminium foil. Silver nitrate 
(33.6 g, 200 mmol, 9.0 eq) in water (18 ml) was added and the mixture stirred at room 
temperature overnight in the dark. The obtained precipitate was filtered and washed with 
dichloromethane. The yellow filtrate was concentrated to a brown oil, which was subsequently 
taken up in dichloromethane (300 ml), washed with water (100 ml), 0.5N sodium hydrogen-
carbonate solution (100 ml), brine (100 ml) and dried over sodium sulfate. The successful 
conversion of N-(6-(dibromomethyl)pyridin-2-yl)pivalamide (14) to N-(6-formylpyridin-2-yl)-
pivalamide (26) was controlled via 1H NMR spectroscopy.  
In the next step the 33 w% mixture of N-(6-formylpyridin-2-yl)pivalamide (26) (3.26 g, 15.8 mmol, 
1.0eq) with N-(5-bromo-6-methylpyridin-2-yl)pivalamide (13) were dissolved in methanol 
(64 ml). Then, 2-(aminomethyl)pyridine (1.78 ml, 1.87 g, 17.3 mmol, 1.1 eq) was added dropwise 
and the reaction mixture was stirred for 2.5 hours at room temperature. While cooling in an ice-
water bath sodium borohydride (1.10 g, 29.0 mmol, 1.8 eq) was added in small portions and the 
mixture was stirred at room temperature overnight. The reaction was quenched by addition of 
water (70 ml) and the solution concentrated under reduced pressure. Water (20 ml) was added 
to the remaining oil and extracted with ethyl acetate. Removal of the solvent gave a brown oil, 
which was loaded onto a silica column. Elution with ethyl acetate removed the side products 
before the desired product N-(6-pivaloylamido-2-pyridylmethyl)-N-(2-pyridylmethyl)amin (18) 
was isolated by elution with methanol (4.48 g, 95%).  
 
HRMS (ESI+, CH3OH): m/z = 299.1863 ([C17H23N4O]+, calcd. 299.1866). 
1H NMR (399.89 MHz, CDCl3): δ = 1.31 (s, 9H, H15), 2.73 (bs, 1H, NaminH), 3.85 (s, 2H, H7), 3.95 
(s, 2H, H6), 7.03 (d, 3J = 7.53 Hz, 1H, H9), 7.15 (dd, 3J = 7.40 Hz, 3J = 4.64 Hz, 1H, H2), 7.32 (d, 
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3J = 7.78 Hz, 1H, H4), 7.63 (td, 3J = 7.75 Hz, 4J = 1.97 Hz, 2H, H3, H10), 8.03 (bs, 1H, NamidH), 8.10 
(d, 3J = 8.28 Hz, 1H, H11), 8.55 (d, 3J = 4.64 Hz, 1H, H1) ppm. 
13C NMR (100.55 MHz, CDCl3): δ = 27.4 (C15), 39.7 (C14), 54.2 (C7), 54.6 (C6), 112.0 (C11), 118.0 
(C9), 122.0 (C2), 122.3 (C4), 136.4 (C3), 138.7 (C10), 149.2 (C1), 151.2 (C12), 157.7 (C8), 159.4 
(C5), 177.0 (C13) ppm. 
 
HRMS (EI+, direct): m/z = 270.0374 ([C11H15N2OBr], calcd. 270.0368) 
1H NMR (600.13 MHz, CDCl3): δ = 1.31 (s, 9H, H9), 2.54 (s, 3H, H6), 7.75 (d, 3J = 8.68 Hz, 1H, H3), 
7.97 (d, 3J = 8.73, 2H, NH, H2) ppm. 
13C NMR (100.55 MHz, CDCl3): δ = 24.4 (C6), 27.4 (C9), 39.8 (C8), 112.5 (C2), 114.9 (C4), 141.8 
(C3), 149.7 (C1), 155.2 (C5), 177.0 (C7) ppm. 
11.3.7 N,N-BIS((2-PIVALOYLAMIDOPYRIDIN-6-YL)METHYL)AMIN (3) 
N,N-bis((2-pivaloylamidopyridin-6-yl)methyl)(2-nitrobenzene)sulfonamid 
(11) 
 
N,N-bis((2-pivaloylamidopyridin-6-yl)methyl)(2-nitrobenzene)sulfonamide (11) was prepared 
according to a previously described procedure.119 
Compound 10 (4.90 g, 18.1 mmol, 2.1 eq) was dissolved in dimethylformamide (86 ml) and then 
treated with potassium carbonate (2.97 g, 21.5 mmol, 2.5 eq) and 2-nitrobenzoyl-sulfonamide 
(1.74 g, 8.61 mmol, 1.0 eq). The resulting solution was heated at 70°C for 4 hours. After cooling 
to room temperature the reaction mixture was poured onto a saturated sodium bicarbonate 
solution (90 ml). Afterwards the phases were separated and the aqueous phase was extracted 
with ethyl acetate (5 x 50 ml). Then the combined organic phases were washed with half 
saturated sodium bicarbonate solution (4 x 25 ml) before being dried over sodium sulfate. 
Removal of the solvent under reduced pressure gave a brown oil which was purified by column 
chromatography (SiO2; Ø = 6 cm; L = 23 cm; hexane:EtOAc = 5:4; Rf = 0.17). N,N-bis((2-pivaloyl-
amidopyridin-6-yl)methyl)(2-nitrobenzene)sulfonamide (11) was obtained as a yellowish solid 
(4.91 g, 98%). 
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HRMS (ESI+, CH3OH): m/z = 583.2331 ([C28H35N6O6S]+, calcd. 583.2333). 
1H NMR (600.13 MHz, CDCl3): δ = 1.32 (s, 18H, H9), 4.61 (s, 4H, H6), 6.96 (d, 3J = 7.47 Hz, 2H, 
H4), 7.53 (td, 3J = 7.67 Hz, 4J = 1.31 Hz, 2H, H13), 7.59 (t, 3J = 7.87 Hz, 2H, H3), 7.64 (td, 3J = 7.69 Hz, 
4J = 1.26 Hz, 1H, H12), 7.69 (dd, 3J = 7.98 Hz, 4J = 1.22, 1H, H14), 7.89 (bs, 2H, NH), 7.98 (dd, 
3J = 7.97 Hz, 4J = 1.11 Hz, 1H, H11), 8.07 (d, 3J = 8.28 Hz, 2H, H2) ppm. 
13C NMR (150.90 MHz, CDCl3): δ = 27.1 (C9), 39.8 (C8), 52.6 (C6), 112.6 (C2), 117.8 (C4), 124.1 
(C14), 131.4 (C11), 131.7 (C13), 133.4 (C12), 134.2 (C10), 139.1 (C3), 147.6 (C15), 151.2 (C1), 153.7 
(C5), 177.1 (C7) ppm. 
Elemental analysis: Calcd. for C28H34N6O6S . 0.3 C4H8O2: C  57.58%; H  6.02%; N  13.80% 
Found:     C  56.92%; H  6.06%;N  14.10%. 
N,N-bis((2-pivaloylamidopyridin-6-yl)methyl)amin (3)  
 
N,N-bis((2-pivaloylamidopyridin-6-yl)methyl)amin (3) was synthesized following a previously 
published procedure.119 
A solution of compound 11 (16.0 g, 27.4 mmol, 1.0 eq) in anhydrous dimethylformamide (274 ml) 
was treated with potassium carbonate (5.70 g, 41.1 mmol, 1.5 eq) and thiophenol (3.10 ml, 
30.1 mmol, 1.1 eq) before the reaction mixture was left stirring at room temperature overnight. 
Then, the reaction was quenched via decantation into a saturated sodium bicarbonate solution. 
Subsequently, the product was extracted into ethyl acetate, washed with half saturated sodium 
bicarbonate solution and dried over sodium sulfate. Removal of the solvent gave a crude product, 
which was purified by column chromatography (SiO2; CH2Cl2:MeOH:NEt3 = 980:14:8; Rf = 0.12) 
yielding N,N-bis((2-pivaloylamidopyridin-6-yl)methyl)amin (3) as a yellowish solid (8.78 g, 81 %).  
 
HRMS (ESI+, CH3OH): m/z = 398.2546 ([C22H32N5O2]+, calcd. 398.2551). 
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1H NMR (600.13 MHz, CDCl3): δ = 1.30 (s, 18H, H9), 3.85 (s, 4H, H6), 7.01 (d, 3J = 7.53 Hz, 2H, 
H4), 7.63 (t, 3J = 7.84 Hz, 2H, H3), 8.05 (bs, 2H, NH), 8.10 (d, 3J = 8.28 Hz, 2H, H2) ppm. 
13C NMR (100.55 MHz, CDCl3): δ = 27.4 (C9), 39.7 (C8), 54.0 (C6), 112.0 (C2), 118.0 (C4), 138.7 
(C3), 151.2 (C1), 157.4 (C5), 177.0 (C7) ppm. 
11.4 SYNTHESIS OF LIGAND H3L2 
 
Ligand H3L2 was synthesized following a literature known procedure.114 
A mixture of compound 18 (2.57 g, 8.61 mmol, 2.0 eq) and triethylamine (1.20 ml, 0.86 g, 
8.61 mmol, 2.0 eq) in anhydrous tetrahydrofuran (7.75 ml) was added dropwise to a cold 
suspension of 2,6-bis(chloromethyl)-4-methylphenol (22) (0.89 g, 4.34 mmol, 1.0 eq) in 
anhydrous dichloromethane (6.90 ml) at 0°C. The reaction mixture was allowed to stir for two 
days at room temperature and filtered. The filtrate was concentrated under reduced pressure 
and the remaining residue was taken up in dichloromethane (100 ml), washed with brine (50 ml) 
and dried over sodium sulfate. Removal of solvent gave a crude product, which was purified via 
column chromatography (SiO2; DEE:NH3 (7N in MeOH) = 98:2; Rf = 0.22) yielding the desired 
ligand H3L2 as a white solid (1.14 g, 36%). 
 
HRMS (ESI+, CH3CN): m/z = 729.4235 ([C43H53N8O3]+, calcd. 729.4235). 
1H NMR (500.13 MHz, CD3CN): δ =  1.24 (s, 18H, H36, H39), 2.21 (s, 3H, H17), 3.72 (s, 4H, H13, 
H21), 3.75 (s, 4H, H27, H33), 3.78 (s, 4H, H6, H12), 7.04 (s, 2H, H15, H18), 7.15 (m, 4H, H2, H8, 
H25, H31), 7.46 (d, 3J = 8.07 Hz, 2H, H4, H10), 7.62 (td, 3J = 7.70 Hz, 4J = 1.83 Hz, 2H, H3, H9), 7.64 
(t, 3J = 7.89 Hz, 2H, H24, H30), 7.97 (d, 3J = 8.44 Hz, 2H, H23, H29), 8.28 (bs, 2H, NH), 8.44 (ddd, 
3J = 4.91 Hz, 4J = 1.78 Hz, 5J = 0.93 Hz, 2H, H1, H7) ppm.  
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13C NMR (100.55 MHz, CDCl3): δ = 20.6 (C17), 27.5 (C36, C39), 39.8 (C35, C38), 54.7 (C13, C21), 
59.0 (C27, C33), 59.9 (C6, C12), 111.7 (C23, C29), 118.0 (C25, C31), 121.9 (C2, C8), 122.7 (C4, C10), 
123.8 (C14, C19), 127.6 (C16), 129.7 (C15, C18), 136.5 (C3, C9), 138.9 (C24, C30), 148.7 (C1, C7), 
151.0 (C22, C28), 153.1 (C20), 157.3 (C26, C32), 159.4 (C5, C11), 177.1 (C34, C37) ppm.  
FT-IR spectroscopy: ν = 3438 (ν{N-H}), 3389 (ν{O-H}), 2964 (ν{C-H}), 2869 (ν{C-H}), 2817 (ν{C-H}), 
1686 (ν{C=O}), 1523 (ν{C-N}), δ{CNH}), 1405 (ν{C-(CH3)3}), 797 (δ{py-H}) cm-1.  
Elemental analysis: Calcd. for C43H52N8O3 . CH3OH: C  69.45%; H  7.42%; N  14.73% 
Found:    C  69.47%; H  7.10%; N  14.98%. 
11.5 SYNTHESIS OF LIGAND H3SIM1 
11.5.1 3-((BIS(PYRIDIN-2-YLMETHYL)AMINO)METHYL)-2-HYDROXY-5-
METHYLBENZALDEHYDE (12)  
 
3-((Bis(pyridine-2-ylmethyl)amino)methyl)2-hydroxy-5-methylbenzaldehyde (12) was 
synthesized by modification of the previously reported method.106 
3-(Chloromethyl)-2-hydroxy-5-methylbenzaldehyde (5) (0.54 g, 2.7 mmol, 1.0 eq) was dissolved 
in dichloromethane (4.0 ml) and cooled to 0°C in an water ice bath. A solution of bis(pyridin-2-
ylmethyl)amine (2) (0.50 g, 2.7 mmol, 1.0 eq) in tetrahydrofuran (4.5 ml) which was treated with 
triethylamine (0.70 ml, 0.51 g, 5.0 mmol, 1.9 eq), was added dropwise. Afterwards, the reaction 
mixture was brought to room temperature and stirred for two days. The precipitate obtained 
was filtered and washed with a small amount of dichloromethane. The filtrate was concentrated 
under reduced pressure, taken up in dichloromethane (10 ml), washed with saturated sodium 
bicarbonate solution (10 ml) and dried over sodium sulfate. The yellow oil obtained after removal 
of the solvent solidified while keeping at -8°C. Recrystallisation from dichloromethane/hexane 
(1:1) yield 3-((bis(pyridine-2-ylmethyl)amino)methyl)2-hydroxy-5-methylbenzaldehyde (12) as a 
yellowish solid (0.57 g, 61%). 
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HRMS (ESI+, CH3OH): m/z = 348.1707 ([C21H22N3O2]+, calcd. 348.1707). 
1H NMR (600.13 MHz, CD3CN): δ = 2.25 (s, 3H, H11), 3.78 (s, 2H, H7), 3.84 (s, 4H, H6), 7.22 (ddd, 
3J = 7.42 Hz, 3J = 4.89 Hz, 4J = 1.01 Hz, 2H, H2), 7.27 (d, 4J = 2.32, 1H, H9), 7.36 (d, 3J = 7.87 Hz, 2H, 
H4), 7.40 (d, 4J = 1.61 Hz, 1H, H12), 7.69 (td, 3J = 7.69 Hz, 4J = 1.77 Hz, 2H, H3), 8.46 (ddd, 
3J = 4.95 Hz, 4J = 1.64 Hz, 5J = 0.92 Hz, 2H, H1), 10.41 (s, 1H, H15) ppm. 
13C NMR (150.90 MHz, CD3CN): δ = 20.3 (C11), 56.1 (C7), 59.7 (C6), 123.4 (C2), 123.9 (C13), 124.2 
(C4), 126.6 (C8), 128.3 (C12), 129.0 (C10), 137.9 (C3), 138.8 (C9), 149.8 (C1), 159.4 (C5), 160.3 
(C14), 192.1 (C15) ppm. 
11.5.2 LIGAND H3SIM1  
 
Molecular sieves (4 Å) were added to a solution of compound 12 (3.13 g, 9.0 mmol, 1.0 eq) in 
anhydrous dichloromethane (23 ml), followed by the dropwise addition of a solution of 
compound 3 (3.58 g, 9.0 mmol, 1.0 eq) in anhydrous dichloromethane (10 ml). The mixture was 
stirred for three hours at room temperature. The solution was then treated with sodium 
triacetoxyborohydride (4.20 g, 20 mmol, 2.2 eq) by addition in portions and the mixture stirred 
at room temperature overnight. The reaction was quenched by addition of saturated sodium 
bicarbonate solution (30 ml) and stirring for 45 minutes. The pH value was subsequently adjusted 
to 8 by addition of solid sodium carbonate. The phases were separated and the aqueous phase 
was extracted with dichloromethane (3 x 30 ml). The combined organic phases were washed with 
saturated sodium carbonate solution (20 ml) and brine (20 ml) and dried over sodium sulfate. 
Removal of the solvent under reduced pressure gave a brownish foam. Purification by column 
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chromatography (SiO2; DEE:NH3 (7N in MeOH) = 98:2; Rf = 0.48) yielded H3SIM1 as a white solid 
(1.94 g, 30%).  
 
HRMS (ESI+, CH3CN): m/z = 729.4232 ([C43H53N8O3]+, calcd. 729.4235). 
1H NMR (CD3CN, 500.13 MHz): δ = 1.25 (s, 18H, H36, H39), 2.21 (s, 3H, H17), 3.69 (s, 2H, H21), 
3.73 (s, 4H, H27, H33), 3.74 (s, 2H, H13), 3.79 (s, 4H, H6, H12), 6.88 (d, 4J = 1.74 Hz, 1H, H18), 7.10 
(d, 3J = 8.06 Hz, 2H, H25, H31), 7.15 (d, 4J = 0.92 Hz, 1H, H15), 7.15 (m, 2H, H2, H8), 7.50 (d, 
3J = 8.07 Hz, 2H, H4, H10), 7.62 (t, 3J = 8.44 Hz, 2H, H24, H30), 7.64 (dt, 3J = 7.70 Hz, 4J = 1.83 Hz, 
2H, H3, H9), 7.96 (d, 3J = 8.44 Hz, 2H, H23, H29), 8.28 (bs, 2H, NH), 8.46 (ddd, 3J = 4.83 Hz, 
4J = 1.78 Hz, 5J = 1.05 Hz, 2H, H1, H7) ppm. 
13C NMR (CD3CN, 100.61 MHz): δ = 20.8 (C17), 27.7 (C36, C39), 40.5 (C35, C38), 54.4 (C13), 56.3 
(C21), 59.6 (C27, C33), 60.8 (C6, C12), 112.5 (C23, C29), 119.2 (C25, C31), 123.1 (C2, C8), 123.8 
(C4, C10), 124.7 (C19), 125.6 (C14), 128.5 (C16), 130.7 (C15), 131.0 (C18), 137.4 (C3, C9), 139.9 
(C24, C30), 149.9 (C1, C7), 152.3 (C22, C28), 154.4 (C20), 158.7 (C26, C32), 160.6 (C5, C11), 177.9 
(C34, C37) ppm. 
FT-IR spectroscopy: ν = 3438 (ν{N-H}), 3389 (ν{O-H}), 2964 (ν{C-H}), 2869 (ν{C-H}), 2817 (ν{C-H}), 
1687 (ν{C=O}), 1517 (ν{C-N}, δ{CNH}), 1403 (ν{C-(CH3)3}), 798 (δ{py-H}) cm-1. 
Elemental analysis: Calcd. for C43H52N8O3:  C  70.85%; H  7.19%; N  15.37% 
Found:    C  70.63%; H  7.06%; N  15.29%. 
11.6 SYNTHESIS OF LIGAND HSIM2  
 
A solution of H3SIM1 (300 mg, 0.41 mmol) in ethanol (10 ml) was treated with aqueous sodium 
hydroxide solution (6M, 2.0 ml), after which the mixture was heated at 70°C for three days while 
stirring. Subsequently the solvent was removed under reduced pressure and the remaining solid 
was taken up in water (10 ml). Concentrated hydrochloric acid was added until the pH value 
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reached 1 and the pH value was subsequently adjusted to 7 using saturated sodium bicarbonate 
solution. After the product was extracted into dichloromethane (3 x 10 ml) the combined organic 
phases were washed with saturated sodium bicarbonate solution (10 ml) and dried over sodium 
sulfate. Removal of the solvent yielded a crude product which was purified by column 
chromatography (Aloxneutral; MeOH) yielding the desired product HSIM2 as a white solid (109 mg, 
47%). 
 
HRMS (ESI+, CH3CN): m/z =  561.3080 ([C33H37N8O]+, calcd. 561.3085). 
1H NMR (CD3CN, 500.13 MHz): δ = 2.18 (s, 3H, H17), 3.51 (s, 4H, H27, H33), 3.57 (s, 2H, H21), 
3.70 (s, 2H, H13), 3.77 (s, 4H, H6, H12), 6.35 (d, 3J = 8.07Hz, 2H, H23, H29), 6.61 (d, 3J = 6.97Hz, 
2H, H25, H31), 6.88 (s, 1H, H18), 6.95 (s, 1H, H15), 7.17 (ddd, 3J = 6.24Hz, 3J = 5.14Hz, 4J = 1.10Hz, 
2H, H2, H8), 7.33 (t, 3J = 7.70Hz, 2H, H24, H30), 7.46 (d, 3J = 7.70Hz, 2H, H4, H10), 7.66 (td, 
3J = 7.70Hz, 4J = 1.83Hz, 2H, H3, H9), 8.48 (d, 3J = 5.14Hz, 2H, H1, H7) ppm. 
13C NMR (CD3CN, 100.61 MHz): δ = 20.5 (C17), 52.5 (C13), 55.0 (C21), 60.2 (C27, C33), 60.5 (C6, 
C12), 107.8 (C23, C29), 113.1 (C25, C31), 123.2 (C2, C8), 124.2 (C4, C10), 124.7 (C14), 125.0 (C19), 
131.2 (C15), 131.4 (C18), 137.7 (C3, C9), 139.2 (C24, C30), 149.9 (C1, C7), 157.9 (C26, C32), 160.0 
(C5/C11/C22/C28), 160.2 (C5/C11/C22/C28) ppm. 
FT-IR spectroscopy: ν = 3322 (ν {N-H}), 3199 (ν {N-H}), 3059 (ν{Ar-H}), 3011 (ν{Ar-H}), 2917 
(ν{C-H}), 2816 (ν{C-H}), 1594 (ν{C=C}), 1574 (ν{C=C}), 1466 (ν{C=C}), 1435 (ν{C=C}), 1299 (ν{C-N}), 
1221 (ν{C-N}), 758 (δ{py-H}) cm-1.  
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11.7 SYNTHESIS OF LIGAND H4SIM3  
11.7.1 2-HYDROXY-3-(((2-HYDROXYBENZYL)(PYRIDIN-2-
YLMETHYL)AMINO)METHYL)-5-METHYLBENZALDEHYDE (17)  
 
2-Hydroxy-3-(((2-hydroxybenzyl)(pyridine-2-ylmethyl)amino)methyl)-5-methylbenzaldehyde 
(17) was prepared according to a literature known procedures.311 
3-(Chloromethyl)-2-hydroxy-5-methylbenzaldehyde (5) (4.62 g, 25.0 mmol, 1.0 eq) was dissolved 
in dichloromethane (40.0 ml) and the solution was cooled in a water-ice-bath. Then, a mixture of 
2-(((pyridin-2-ylmethyl)amino)methyl)phenol (16) (5.36 g, 25.0 mmol, 1.0 eq) in tetrahydrofuran 
(45.0 ml), treated with triethylamine (12.8 ml, 9.29 g, 50.0 mmol, 2.0 eq), was added dropwise. 
After stirring the reaction mixture at room temperature for two days the precipitate obtained 
was filtered and washed with a small amount of dichloromethane. The filtrate was concentrated 
under reduced pressure and the residue taken up in dichloromethane (50 ml) before being 
washed with brine (30 ml) and dried over sodium sulfate. Removal of the solvent and 
recrystallization from dichloromethane/hexane (1:1) yielded 2-hydroxy-3-(((2-hydroxybenzyl)-
(pyridine-2-ylmethyl)amino)methyl)-5-methylbenzaldehyde (17) as a pale yellow solid (4.99 g, 
55%). 
 
HRMS (ESI+, CH3OH): m/z = 363.1706 ([C22H23N2O3]+, calcd. 363.1703). 
1H NMR (600.13 MHz, CD3CN): δ = 2.23 (s, 3H, H17), 3.74 (s, 2H, H13), 3.77 (s, 2H, H12), 3.85 (s, 
2H, H6), 6.75 - 6.78 (m, 2H, H7, H9), 7.10 (dd, 3J = 7.27 Hz, 4J = 1.01 Hz, 1H, H10), 7.13 (td, 
3J = 7.70 Hz, 4J = 1.67 Hz, 1H, H8), 7.27 – 7.30 (m, 2H, H2, H4), 7.31 (d, 4J = 1.82 Hz, H15), 7.36 (d, 
4J = 1.61 Hz, H18), 7.74 (td, 3J = 7.67 Hz, 4J = 1.82 Hz, 1H, H3), 8.57 (dd, 3J = 4.95 Hz, 4J = 0.71 Hz, 
H1), 10.07 (s, 1H, H21), 11.09 (bs, 2H, OH) ppm. 
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13C NMR (150.90 MHz, CD3CN): δ = 20.3 (C17), 54.0 (C13), 57.3 (C12), 58.5 (C6), 117.1 (C7), 120.0 
(C9), 122.7 (C19), 123.6 (C11), 123.7 (C2), 124.6 (C4), 126.0 (C14), 129.7 (C16), 130.1 (C8), 131.3 
(C10/C18), 131.3 (C10/C18), 138.4 (C3), 139.5 (C15), 149.3 (C1), 158.2 (C5), 158.5 (C7a), 159.3 
(C20), 195.1 (C21) ppm. 
Elemental analysis: Calcd. for C22H22N2O3 . 0.05 CH2Cl2: C  72.23%; H  6.08%; N  7.64% 
Found:     C  71.76%; H  6.31%; N  7.43%. 
11.7.2 LIGAND H4SIM3 
 
A solution of compound 17 (3.56 g, 9.80 mmol, 1.0 eq) in anhydrous dichloromethane (25 ml) 
was treated with molecular sieves (4 Å) before a solution of compound 3 (4.10 g, 10.3 mmol, 
1.1 eq) in anhydrous dichloromethane (11 ml) was added dropwise. After the mixture was stirred 
for three hours at room temperature sodium triacetoxyborohydride (4.59 g, 21.7 mmol, 2.2 eq) 
was added in small portions and the reaction mixture was left to react at room temperature while 
stirring. The reaction was quenched by addition of saturated sodium bicarbonate solution (30 ml) 
and the mixture was stirred for 45 minutes before the pH value was adjusted to 8 by addition of 
solid sodium carbonate. The phases were separated and the aqueous phase was extracted with 
dichloromethane (3 x 30 ml). The combined organic phases were washed with saturated sodium 
carbonate solution (20 ml), brine (20 ml) and dried over sodium sulfate. Removal of the solvent 
under reduced pressure gave a orange foam. Purification by column chromatography (SiO2; 
DEE:n-hexane:NH3 (7N in MeOH) = 90:8:2; Rf = 0.57) yielded H4SIM3 as a white solid (4.50 g, 62%).  
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Molecular Formula: C44H53N7O4 
HRMS (ESI+, CH3CN): m/z =  744.4231 ([C44H54N7O4]+, calcd. 744.4235). 
1H NMR (500.13 MHz, CD3CN): δ = 1.26 (s, 18H, H36, H39), 2.16 (s, 3H, H17), 3.69 (s, 2H, H21), 
3.74 (s, 4H, H27, H33), 3.75 (s, 2H, H13), 3.76 (s, 2H, H6), 3.78 (s, 2H, H12), 6.74 (m, 2H, H7, H9), 
6.85 (d, 4J = 1.83 Hz, 1H, H18), 6.99 (d, 4J = 1.47 Hz, 1H, H15), 7.05 (d, 3J = 7.34 Hz, 3H, H10, H25, 
H31), 7.11 (td, 3J = 7.70 Hz, 4J = 1.83 Hz, 1H, H8), 7.14 (d, 3J = 7.70 Hz, 1H, H4), 7.19 (ddd, 
3J = 7.70 Hz, 3J = 6.60 Hz, 4J = 1.10 Hz, 1H, H2), 7.58 (td, 3J = 7.70 Hz, 4J = 1.83 Hz, 1H, H3), 7.61 (t, 
3J = 7.70 Hz, 2H, H24, H30), 7.97 (d, 3J = 7.70 Hz, 2H, H23, H29), 8.33 (bs, 2H, NH), 8.52 (ddd, 
3J = 4.95 Hz, 4J = 1.76 Hz, 5J = 0.91 Hz, 1H, H1) ppm. 
13C NMR (100.61 MHz, CD3CN): δ = 20.6 (C17), 27.7 (C36, C39), 40.5 (C35, C38), 53.2 (C13), 57.2 
(C21), 57.9 (C12), 59.3 (C27, C33), 59.4 (C6), 112.6 (C23, C29), 116.9 (C9), 119.1 (C25, C31), 119.9 
(C7), 123.3 (C2), 124.1 (C11), 124.4 (C4), 124.5 (C14/C19), 124.9 (C14/C19), 128.7 (C16), 129.7 
(C8), 130.8 (C10), 131.3 (C18), 131.6 (C15), 137.7 (C3), 140.0 (C24, C30), 149.9 (C1), 152.4 (C22, 
C28), 154.5 (C20), 158.2 (C26, C32), 158.8 (C5/C11), 158.9 (C5/C11), 178.0 (C34, C37) ppm. 
FT-IR spectroscopy: ν = 3392 (ν{N-H}), 2968 (ν{C-H}), 2870 (ν{C-H}), 2824 (ν{C-H}), 1689 (ν{C=O}), 
1522 (ν{C-N}, δ{CNH}), 1450 (ν{C-(CH3)3}), 751 (δ{py-H}) cm-1. 
Elemental analysis: Calcd. for C43H52N8O3:  C  71.04%; H  7.18%; N  13.18 
Found:    C  71.11%; H  7.26%; N  12.93.  
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11.8 SYNTHESIS OF LIGAND H4SIM4 
11.8.1 N-(6-(((3-FORMYL-2-HYDROXY-5-METHYLBENZYL)(PYRIDIN-2-
YLMETHYL)AMINO)METHYL)PYRIDIN-2-YL)PIVALAMIDE (19) 
 
 
N-(6-pivaloylamido-2-pyridylmethyl)-N-(2-pyridylmethyl)amine (18) (4.92 g, 16.5 mmol, 1.0 eq) 
was dissolved in anhydrous dichloromethane (26.5 ml) and treated with triethylamine (4.30 ml, 
3.09 g, 16.5 mmol, 1.0 eq). This solution was then added dropwise to a cold mixture of 
3-(chloromethyl)-2-hydroxy-5-methylbenzaldehyde (5) (3.05 g, 16.5 mmol, 1.0 eq) in 
tetrahydrofuran (30.0 ml) at 0°C. Afterwards the mixture was stirred for two days at room 
temperature and the white precipitate obtained was filtered, washed with a small amount of 
dichloromethane and the filtrate was concentrated under reduced pressure. The remaining 
yellow oil was taken up in dichloromethane (50 ml), washed with half concentrated brine (20 ml) 
and dried over sodium sulfate. The solvent was evaporated under vacuum to yield N-(6-(((3-
formyl-2-hydroxy-5-methylbenzyl)(pyridin-2-ylmethyl)amino)methyl)pyridin-2-yl)pivalamide 
(19) as a yellow solid (7.07 g, 96%). 
 
HRMS (ESI+, CH3OH): m/z = 447.2391 ([C26H31N4O3]+, calcd. 447.2391). 
1H NMR (399.89 MHz, CDCl3): δ = 1.38 (s, 9H, H24), 2,29 (s, 3H, H17), 3.81 (s, 2H, H13), 3.89 (s, 
4H, H6, H12), 6.98 (d, 3J = 7.53 Hz, 1H, H10), 7.15 (dd, 3J = 7.28 Hz, 3J = 5.24 Hz, 1H, H2), 7.20 (d, 
4J = 1.51 Hz, 1H, H15), 7.37 (d, 3J = 7.91 Hz, 1H, H4), 7.49 (d, 4J = 1.63 Hz, 1H, H18), 7.60 -7.67 (m, 
2H, H3, H9), 8.14 (d, 3J = 8.28 Hz, 1H, H8), 8.46 (bs, 1H, NH), 8.52 (d, 3J = 4.77 Hz, 1H, H1), 10.52 
(s, 1H, H21), 11.74 (bs, 1H, OH) ppm. 
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13C NMR (100.55 MHz, CDCl3): δ = 20.2 (C17), 27.4 (C24), 39.8 (C23), 55.7 (C13), 58.3 (C12), 59.4 
(C6), 112.0 (C8), 118.0 (C10), 122.2 (C2), 122.9 (C4), 125.0 (C14), 128.1 (C16, C19), 128.3 (C18), 
136.8 (C3), 137.8 (C15), 139.2 (C9), 148.8 (C1), 151.3 (C7), 156.1 (C11), 158.2 (C5), 158.7 (C20), 
177.2 (C22), 191.1 (C21) ppm. 
11.8.2 N-(6-(((2-HYDROXY-3-(((2-HYDROXYBENZYL)AMINO)METHYL)-
5-METHYLBENZYL)(PYRIDIN-2-YLMETHYL)AMINO)-
METHYL)PYRIDIN-2-YL)PIVALAMIDE (21) 
 
A mixture of compound 19 (6.25 g, 14.0 mmol, 1.0 eq) and 2-(aminomethyl)phenol (20) (2.42 g, 
19.6 mmol, 1.4 eq) in methanol (300 ml) was heated at 50°C for three hours. The solution was 
cooled with an ice-water bath and sodium borohydride (1.99 g, 52.6 mmol, 3.8 eq) was added in 
portions. After addition, the reaction mixture was refluxed for three hours. After cooling to room 
temperature the solution was concentrated under vacuum. The remaining oil was taken up in 
dichloromethane (100 ml) and saturated sodium bicarbonate solution (100 ml) was added 
carefully. Using solid sodium carbonate the pH value was adjusted to 14. The phases were 
separated and the aqeuous phase was extracted with dichloromethane (4 x 75 ml). The combined 
organic phases were washed with brine (20 ml) and dried over sodium sulfate. Removal of the 
solvent yielded N-(6-(((2-hydroxy-3-(((2-hydroxybenzyl)amino)methyl)-5-methylbenzyl)(pyridin-
2-ylmethyl)amino)methyl)pyridin-2-yl)pivalamide (21) as a yellowish solid which was used in the 
next step without further purification. 
 
HRMS (ESI+, CH3OH): m/z = 554.3125 ([C33H40N5O3]+, calcd. 554.3126). 
1H NMR (200.13 MHz, CDCl3): δ = 1.27 (s, 6H, (CH3)C), 1.30 (s, 3H, (CH3)C), 2.17 (s, 3H, CH3), 3.66 
(s, 2H, CH2), 3.75 (s, 2H, CH2), 3.77 (s, 2H, CH2), 3.82 (s, 2H, CH2), 3.86 (s, 2H, CH2), 4.69 (s, 1H, 
NaminH), 6.76 (td, 3J = 7.32, 4J = 1.21, 1H, Haryl), 6.84 – 6.94 (m, 4H, Haryl), 7.03 (s, 1H, Haryl), 
7.09 – 7.22 (m, 3H, Haryl), 7.26 – 7.34 (m, 1H, Haryl), 7.52 – 7.68 (m, 2H, Haryl), 8.13 (d, 3J = 8.34, 2H, 
Haryl), 8.45 (s, 1H, NamidH), 8.51 (ddd, 3J = 4.89, 4J = 1.86, 5J = 0.82, 1H, Haryl) ppm.  
EXPERIMENTAL 
225 
11.8.3 LIGAND H4SIM4  
 
Compound 21 (7.75 g, 14.0 mmol, 1.0 eq) was dissolved in acetonitrile (400 ml) and treated with 
sodium carbonate (1.48 g, 14.0 mmol, 1.0 eq). Then, N-(6-bromomethyl)pyridine-2-yl)pivalamide 
(10) (3.80 g, 14.0 mmol, 1.0 eq) was added and the reaction mixture was stirred at room 
temperature for 24 hours. The solution was concentrated to a brown oil, which was taken up in 
dichloromethane (100 ml) and saturated sodium bicarbonate solution (100 ml). The product was 
extracted into dichloromethane (4 x 50 ml), washed with brine (30 ml) and dried over sodium 
sulfate. After removal of the solvent the crude product was purified via column chromatography 
(SiO2; DEE:n-hexane:NH3 (7N in MeOH) = 90:8:2; Rf = 0.48) to yield H4SIM4 as yellowish solid 
(2.12 g, 22%). 
 
HRMS (ESI+, CH3OH): m/z = 744.4237 ([C44H54N7O4]+, calcd. 744.4232). 
1H NMR (500.13 MHz, CD3CN): δ = 1.28 (s, 9H, H36/39), 1.28 (s, 9H, H36/39), 2.13 (s, 3H, H17), 
3.67 (s, 2H, H13/21), 3.73 (s, 2H, H13/21), 3.74 (s, 4H, H6, H27/H30), 3.76 (s, 2H, H27/H30), 3.77 
(s, 2H, H12), 6.74–6.79 (m, 2H, H7/H9), 6.81 (d, 4J = 1.83 Hz, 1H, H15/H18), 6.84 (dd, 3J = 7.70 Hz, 
4J = 0.73 Hz, 1H, H25/H31), 6.96 (d, 4J = 2.20 Hz, 1H, H15/H18), 6.99 (dd, 3J = 7.70 Hz, 4J = 0.73 Hz, 
1H, H25/H31), 7.09 (dd, 3J = 7.34 Hz, 4J = 1.47 Hz, 1H, H10), 7.12–7.15 (m, 2H, H2/H8), 7.33 (d, 
3J = 7.70 Hz, 1H, H4), 7.56-7.61 (m, 2H, H3, H24/H30), 7.64 (t, 3J = 7.89 Hz, 1H, H24/H30), 7.97 (d, 
3J = 8.07 Hz, 1H, H23/H29), 8.00 (d, 3J = 7.70 Hz, 1H, H23/H29), 8.42 (bs, 1H, NH), 8.45 (ddd, 
3J = 4.86 Hz, 4J = 1.82 Hz, 5J = 0.84 Hz, 1H, H1), 8.48 (bs, 1H, NH) ppm. 
13C NMR (125.76 MHz, CD3CN): δ = 20.6 (C17), 27.6 (C36/C39), 27.7 (C36/C39), 40.5 (C35/C38), 
40.5 (C35/C38), 52.9 (C13/C21), 57.2 (C13/C21), 58.0 (C12), 58.7 (C27/C33), 59.0 (C27/C33), 59.8 
(C6), 112.3 (C23/C29), 112.4 (C23/C29), 116.8 (C7/C9), 119.1 (C25/C31), 119.3 (C25/C31), 119.9 
(C7/C9), 123.1 (C2), 123.9 (C4), 124.29 (C14/C20), 124.4 (C11), 124.9 (C14/C20), 128.5 (C16), 
129.7 (C8), 131.0 (C10, C15/C18), 131.1 (C10, C15/C18), 131.4 (C10, C15/C18), 137.6 (C3), 140.0 
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(C24/C30), 140.0 (C24/C30), 149.8 (C1), 152.3 (C22/C28), 152.4 (C22/C28), 154.5 (C20), 157.7 
(C26/C32), 157.9 (C26/C32), 158.6 (C7a), 159.6 (C5), 177.9 (C34/C37). 
FT-IR spectroscopy: ν = 3669 (ν{O-H}), 3388 (ν{N-H}), 2971 (ν{C-H}), 2901 (ν{C-H}), 2819 (ν{C-H}), 
1688 (ν{C=O}), 1520 (ν{C-N}, δ{CNH}), 1449 (ν{C-(CH3)3}), 755 (δ{py-H}) cm-1. 
Elemental analysis: Calcd. for C44H53N7O4: C  71.04%; H  7.18%; N  13.18% 
Found:   C  70.66%; H  7.31%; N  13.35%. 
11.9 SYNTHESIS OF DIZINC(II) COMPLEXES 
11.9.1 GENERAL PROCEDURE 
 
The ligand (0.137 mmol, 1.0 eq) was dissolved in methanol (5.0 ml) (when H4SIM3 was used as 
ligand the solution was treated with 2M sodium hydroxide solution (69 μl, 1.0 eq)). After addition 
of ZnII acetate (57.8 mg, 0.274 mmol, 2.0 eq) the mixture was heated to 50°C for 20 minutes. 
Sodium hexafluorophosphate (46.0 mg, 0.274 mmol, 2.0 eq) was added to the hot solution. The 
compounds were obtained as colourless crystals upon slow evaporation of solvent and these 
were collected by filtration. 
11.9.2 SYNTHESIS OF [ZNII2(L1)(µ-OAC)2]PF6 
 
Yield: 102.5 mg (81%). 
 
CCDC no.: 998888 
HRMS (ESI+, CH3CN): m/z = 360.0704 ([C35H36N6O3Zn2]2+, calcd. 360.0689); 765.1352 
([C36H37N6O5Zn2]+, calcd. 765.1360).  
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1H NMR (500.13 MHz, CD3CN): δ = 1.95 (s, 3H, H17), 1.99 (s, 6H, H2a, H4a), 3.17 (d, 2J = 11.37 Hz, 
2H, H13, H21), 3.35 (d, 2J = 16.51 Hz, 2H, H12, H33), 3.48 (d, 2J = 16.14 Hz, 2H, H12, H33), 3.88 (d, 
2J = 11.37 Hz, 2H, H13, H21), 3.97 (d, 2J = 14.31 Hz, 2H, H6, H27), 4.50 (d, 2J = 14.31 Hz, 2H, H6, 
H27), 6.40 (s, 2H, H15, H18), 6.44 (d, 3J = 7.70 Hz, 2H, H10, H31), 7.01 (dd, 3J = 7.34 Hz, 3J = 5.14 Hz, 
2H, H8, H29), 7.29 (td, 3J = 7.70 Hz, 4J = 1.47 Hz, 2H, H9, H30), 7.43 (dd, 3J = 7.34 Hz, 3J = 5.14 Hz, 
2H, H2, H23), 7.48 (d, 3J = 8.07 Hz, 2H, H4, H25), 7.92 (td, 3J = 7.79 Hz, 4J = 1.65 Hz, 2H, H3, H24), 
8.24 (d, 3J = 4.77 Hz, 2H, H7, H28), 8.76 (d, 3J = 4.40 Hz, 2H, H1, H22) ppm. 
13C NMR (100.61 MHz, CD3CN): δ = 20.2 (C17), 24.9 (C2a, C4a), 58.5 (C12, C33), 60.7 (C13, C21), 
60.8 (C6, C27), 121.9 (C10, C31), 123.6 (C8, C29), 124.3 (C14, C19), 125.0 (C2, C23), 125.1 (C16), 
125.2 (C4, C25), 131.9 (C15, C18), 138.6 (C9, C30), 140.3 (C3, C24), 147.2 (C7, C28), 148.6 (C1, 
C22), 155.8 (C11, C32), 156.3 (C5, C26), 160.2 (C20), 179.3 (C1a, C3a) ppm. 
FT-IR spectroscopy: ν = 2996 (ν{C-H}), 2931 (ν{C-H}), 2844 (ν{C-H}), 1600 (νa{OAc}), 1406 
(νs{OAc}), 831 (ν{P-F}), 650 (δ{py-H}), 556 (δ{F-P-F}) cm-1. 
Elemental analysis: Calcd. for C37H39N6O5PF6Zn2: C  48.10%; H  4.26%; N  9.11% 
Found:    C  48.10%; H  4.50%; N  9.11%. 
11.9.3 SYNTHESIS OF [ZNII2(H2L2)(µ-OAC)2]PF6 
 
Yield: 116.6 mg (76%). 
 
CCDC no.: 998889 
HRMS (ESI+, CH3CN): m/z = 429.1283 ([C43H50N8O3Zn2]2+, calcd. 429.1268). 
1H NMR (500.13 MHz, CD3CN): δ = 1.27 (s, 18H, H36, H39), 1.91 (s, 3H, H17), 2.12 (s, 6H, H2a, 
H4a), 3.19 (d, 2J = 11.37 Hz, 2H, H13, H21),3.42-3.56 (m, 4H, H6, H12), 3.82 (d, 2J = 11.74 Hz, 2H, 
H13, H21), 3.97 (d, 2J = 15.04 Hz, 2H, H27, H33), 4.59 (d, 2J = 15.04 Hz, 2H, H27, H33), 6.40 (s, 2H, 
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H15, H18), 6.59 (d, 3J = 7.70 Hz, 2H, H4, H10), 7.05 (dd, 3J = 6.79 Hz, 3J = 6.05 Hz, 2H, H2, H8), 7.16 
(d, 3J = 7.70 Hz, 2H, H25, H31), 7.38 (td, 3J = 7.70 Hz, 4J = 1.47 Hz, 2H, H3, H9), 7.85 (t, 3J = 7.70 Hz, 
2H, H24, H30), 8.14 (d, 3J = 8.44 Hz, 2H, H23, H29), 8.39 (m, 2H, H1, H7), 9.89 (s, 2H, NH) ppm. 
13C NMR (100.61 MHz, CD3CN): δ = 19.2 (C17), 25.3 (C2a, C4a) 26.7 (C36, C39), 39.8 (C35, C38), 
57.1 (C6, C12), 60.2 (C13, C21), 61.1 (C27, C33), 115.9 (C23, C29), 119.1 (C25, C31), 121.7 (C4, 
C10), 122.9 (C2/C8/C14/C19), 122.9 (C2/C8/C14/C19), 124.7 (C16), 130.4 (C15, C18), 138.9 (C3, 
C9), 141.0 (C24, C30), 146.2 (C1, C7), 151.98 (C22, C28), 154.4 (C26, C32), 155.1 (C5, C11), 159.0 
(C20), 177.8 (C34, C37), 178.9 (C1a, C3a) ppm. 
31P NMR (100.61 MHz, CD3CN): δ = -144.3 (sep, PF6-) ppm. 
FT-IR spectroscopy: ν = 3293 (ν{N-H}), 2976 (ν{C-H}), 2924 (ν{C-H}), 2877 (ν{C-H}), 1700 (ν{C=O}), 
1600 (νa{OAc}), 1536 (ν{C-N}, δ{CNH}), 1458 (ν{C-(CH3)3}), 1406 (νs{OAc}), 1277 (ν{C-N}), 841 (ν{P-
F}), 650 (δ{py-H}), 557 (δ{F-P-F}) cm-1. 
Elemental analysis: Calcd. for C47H57N8O7PF6Zn2: C  50.32%; H  5.12%; N  9.99% 
Found:    C  50.09%; H  5.26%; N  9.96%. 
11.9.4 SYNTHESIS OF [ZNII2(H2SIM1)(µ-OAC)(OH)]PF6 
 
Yield: 23.2 mg (16%). 
 
CCDC no.: 998887 
HRMS (ESI+, CH3CN): m/z = 429.1298 ([C43H50N8O3Zn2]2+, calcd. 429.1268); 877.2596 
([C43H50N8O3Zn2F]+, calcd. 877.2525). 
1H NMR (500.13 MHz, CD3CN): δ = 0.85 (s, 9H, H36/H39), 1.35 (s, 9H, H36/H39), 1.99 (s, 3H, H17), 
2.03 (s, 3H, H2a), 3.36 (d, 2J = 11.74 Hz, 1H, H13), 3.40 (d, 2J = 11.74 Hz, 1H, H21), 3.56 (d, 
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2J = 15.77 Hz, 1H, H27), 3.67 (d, 2J = 15.41 Hz, 1H, H27), 3.78 (d, 2J = 16.87 Hz, 1H, H12), 3.84 (d, 
2J = 17.24 Hz, 1H, H12), 3.92 (d, 2J = 14.31 Hz, 1H, H33), 4.03 (d, 2J = 11.37 Hz, 1H, H13), 4.12-4.21 
(m, 2H, H6, H21), 4.28 (d, 2J = 17.97 Hz, 1H, H6), 4.38 (d, 2J = 14.31 Hz, 1H, H33), 6.29 (d, 
3J = 7.34 Hz, 1H, H25), 6.61 (d, 4J = 1.83 Hz, 1H, H15), 6.64 (d, 4J = 1.83 Hz, 1H, H18), 7.10 (d, 
3J = 7.70 Hz, 1H, H31), 7.14 (d, 3J = 7.70 Hz, 1H, H10), 7.25 (dd, 3J = 8.44 Hz, 3J = 7.70 Hz, 1H, H24), 
7.36 (dd, 3J = 6.20 Hz, 1H, H8), 7.53 (d, 3J = 8.07 Hz, 1H, H4), 7.60 (dd, 3J = 7.59 Hz, 3J = 6.20 Hz, 
1H, H2), 7.80 (td, 3J = 7.79 Hz, 4J = 1.65 Hz, 1H, H9), 7.81-7.87 (m, 2H, H23, H30), 8.08 (td, 
3J = 7.79 Hz, 4J = 1.65 Hz, 1H, H3), 8.33 (d, 3J = 8.44 Hz, 1H, H29), 8.59 (d, 3J = 4.77 Hz, 1H, H7), 
8.80 (d, 3J = 5.14 Hz, 1H, H1) ppm. 
13C NMR (125.76 MHz, CD3CN): δ = 20.2 (C17), 27.8 (C16/C39), 27.9 (C16/C39), 40.5 (C35/C38), 
41.2 (C35/C38), 57.7 (C12), 58.9 (C13), 59.9 (C27), 61.3 (C33), 61.4 (C6), 61.7 (C21), 114.6 (C23), 
115.7 (C29), 117.7 (C25), 119.2 (C31), 124.7 (C10/C14), 124.7 (C10/C14), 125.0 (C4), 125.3 
(C8/C19), 125.3 (C8/C19), 126.1 (C2), 127.4 (C16), 133.2 (C18), 133.4 (C15), 139.9 (C24), 141.4 
(C30), 141.7 (C9), 142.6 (C3), 149.1 (C7), 149.8 (C1), 153.4 (C22/C28), 153.7 (C26), 154.3 (C32), 
155.1 (C22/C28), 156.6 (C5), 157.1 (C11), 160.0 (C20), 179.60 (C34/C37), 179.6 (C34/C37), 180.7 
(C1a) ppm. 
31P NMR (100.61 MHz, CD3CN): δ = -144.3 (sep, PF6-) ppm. 
FT-IR spectroscopy: ν = 2982 (ν{C-H}), 2937 (ν{C-H}), 2876 (ν{C-H}), 1687 (ν{C=O}), 1581 (νa{OAc}), 
1545 (ν{C-N}, δ{CNH}), 1461 (ν{C-(CH3)3}), 1442 (νs{OAc}), 1306 (ν{C-N}), 834 (ν{P-F}), 650 (δ{py-
H}), 556 (δ{F-P-F}) cm-1. 
Elemental analysis: Calcd. for C45H55N8O6PF6Zn2: C  50.06%; H  5.13%; N  10.38% 
Found:    C  50.46%; H  5.38%; N  10.57%. 
11.9.5 SYNTHESIS OF [ZNII2(SIM2)(µ-OAC)2]PF6 
 
Yield: 47.5 mg (50%). 
EXPERIMENTAL 
230 
 
CCDC no.: 998890 
HRMS (ESI+, CH3CN): m/z = 344.0747 ([C33H34N8OZn2]2+, calcd. 344.0698); 749.1529 
([C33H34N8OZn2CH3COO]+, calcd. 749.1524). 
1H NMR (500.13 MHz, CD3CN): δ = 1.85 (s, 3H, H2a/H4a), 1.94 (s, 3H, H17), 2.05 (s, 3H, H2a/H4a), 
3.02 (d, 2J = 11.37 Hz, 1H, H13/H21), 3.17 (d, 2J = 15.77 Hz, 1H, H33), 3.24 (d, 2J = 15.77 Hz, 1H, 
H33), 3.28 (d, 2J = 10.64 Hz, 1H, H13/H21), 3.35 (d, 2J = 16.51 Hz, 1H, H12), 3.50 (d, 2J = 16.51 Hz, 
1H, H12), 3.57 (d, 2J = 13.94 Hz, 1H, H27), 3.80 (d, 2J = 11.37 Hz, 1H, H13/H21), 4.03 (d, 
2J = 14.67 Hz, 1H, H6), 4.33 (d, 2J = 10.64 Hz, 1H, H13/H21), 4.40 (dd, 2J = 14.12 Hz, 2J = 10.09 Hz, 
2H, H6, H27), 5.58 (d, 3J = 7.34 Hz, 1H, H31), 5.78 (bs, 2H, NH2), 6.05 (d, 3J = 8.10 Hz, 1H, H29), 
6.29 (d, 4J = 1.83 Hz, 1H, H15/H18), 6.45-6.53 (m, 3H, H10, H15/H18, H23), 6.55 (d, 3J = 7.34 Hz, 
1H, H25), 6.67 (bs, 2H, NH2), 6.88 (dd, 3J = 8.44 Hz, 3J = 7.34 Hz, 1H, H30), 6.98-7.03 (m, 1H, H8), 
7.33 (td, 3J = 7.61 Hz, 4J = 1.65 Hz, 1H, H9), 7.41-7.50 (m, 3H, H2, H4, H24), 7.93 (td, 3J = 7.79 Hz, 
4J = 1.65 Hz, 1H, H3), 8.28 (m, 1H, H7), 8.72 (m, 1H, H1) ppm. 
13C NMR (100.62 MHz, CD3CN): δ = 20.2 (C17), 25.0 (C2a/C4a) 25.9 (C2a/C4a), 58.7 (C12), 58.7 
(C33), 60.4 (C13/C21), 60.7 (C6), 60.8 (C27), 61.0 (C13/C21), 108.7 (C29), 110.5 (C31), 110.8 
(C23/C25), 112.7 (C23/C25), 122.0 (C10), 123.6 (C8), 124.4 (C19/C14), 124.9 (C2/C19/C14), 125.0 
(C2/C19/C14), 125.2 (C4/C16), 125.3 (C4/C16), 131.6 (C15/C18), 131.7 (C15/C18), 138.9 (C9), 
139.2 (C30), 140.3 (C3), 140.6 (C24), 147.1 (C7), 148.5 (C1), 153.9 (C26/C32), 153.9 (C26/C32), 
156.1 (C5/C11), 156.1 (C5/C11), 160.0 (C28), 160.4 (C22), 160.51 (C20), 179.1 (C1a/C3a), 179.3 
(C1a/C3a) ppm.  
31P NMR (100.61 MHz, CD3CN): δ = -144.3 (sep, PF6-) ppm. 
FT-IR spectroscopy: ν = 3484 (ν{N-H}), 3332 (ν{N-H}), 3218 (ν{N-H}), 2984 (ν{C-H}), 2935 (ν{C-H}), 
2906 (ν{C-H}), 1643 (δ{CNH}), 1606 (νa{OAc}), 1476 (νs{OAc}), 1275 (ν{C-N}), 827 (ν{P-F}), 658 
(δ{py-H}), 557 (δ{F-P-F}) cm-1. 
Elemental analysis: Calcd. for C37H41N8O5PF6Zn2: C  46.61%; H  4.33%; N  11.75% 
Found:    C  46.42%; H  4.34%; N  11.74%.  
EXPERIMENTAL 
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11.9.6 SYNTHESIS OF [ZN2(H2SIM3)(µ-OAC)(OH)] 
 
Yield: 85.7 mg (67%). 
 
CCDC no.: 1009842 
HRMS (ESI+, CH3CN): m/z = 434.6237 ([C44H51N7O4Zn2]2+, calcd. 434.6287). 
1H NMR (500.13 MHz, CD3CN (0.4 vol% HClO4)): δ = 1.35 (s, 18H, H36, H39), 1.95 (s, 3H, H2a), 
2.29 (s, 3H, H17), 3.82 (d, 2J = 16.51 Hz, 2H, H27, H33), 3.96 (s, 2H, H21), 4.11 (d, 2J = 16.14 Hz, 
2H, H27, H33), 4.40 (s, 2H, H6, H12), 4.41 (s, 2H, H6, H12), 4.43 (s, 2H, H13), 6.87 (d, 3J = 8.07 Hz, 
1H, H7), 6.92 (t, 3J = 7.34 Hz, 1H, H9), 7.20-7.39 (m, 9H, H4, H8, H10, H15, H18, H23, H25, H29, 
H31), 7.39 (dd, 3J = 6.97 Hz, 3J = 5.50 Hz, 1H, H2), 7.82 (t, 3J = 7.70 Hz, 1H, H3), 8.02 (t, 3J = 7.89 Hz, 
2H, H24, H30), 8.48 (d, 3J = 4.40 Hz, 1H, H1), 9.26 (s, 2H, NH) ppm. 
13C NMR (125.76 MHz, CD3CN (0.4 vol% HClO4)): δ = 20.5 (C17), 20.7 (C2a), 27.4 (C36), 41.9 (C35), 
52.0 (C21), 55.6 (C27), 56.7 (C6, C12/C13), 56.8 (C6, C12/C13), 116.4 (C23), 116.5 (C7), 117.5 
(C7a), 121.8 (C10), 121.9 (C25), 125.3 (C4), 125.5 (C2), 132.2 (C16), 132.7 (C8/C9), 133.2 (C8/C9), 
135.2 (C15/C18), 137.1 (C15/C18), 139.9 (C3), 143.5 (C24), 149.4 (C1), 153.4 (C26), 153.8 
(C14/C19), 156.4 (C5/C11), 180.8 (C1a) ppm. 
FT-IR spectroscopy: ν = 2978 (ν(C-H)), 2932 (ν(C-H)), 2867 (ν(C-H)), 1681 (ν(C=O)), 1581 (νa(OAc)), 
1453 (ν(C-(CH3)3), 1433 (νs(OAc)), 1305 (ν(C-N)), 770 (δ(py-H)) cm-1. 
Elemental analysis: Calcd. for C46H55N7O7Zn2: C  58.24%; H  5.84%; N  10.33% 
Found:    C  58.02%; H  5.57%; N  10.19%.  
EXPERIMENTAL 
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11.10 SYNTHESES OF DIIRON(II) COMPLEXES 
11.10.1 GENERAL PROCEDURE 
 
The ligand (68.6 µmol, 1.0 eq) was dissolved under inert atmosphere in anhydrous, degassed 
methanol (2.5 ml). The solution was treated with iron(II) acetate (137 µmol, 2.0 eq) and stirred 
at room temperature overnight. Sodium hexafluorophosphate (140 µmol, 2.0 eq) was added and 
the mixture stirred for ten minutes before filtration through a syringe filter. Crystallization from 
the filtrate was achieved with diffusion of diethyl ether, whereby yellow crystals were obtained, 
which were collected by filtration. 
11.10.2 SYNTHESIS OF [FEII2(H2SIM1)(µ-OAC)2]PF6 
 
Yield: 37.0 mg (49%). 
HRMS (ESI+, CH2Cl2): m/z = 957.3087 ([C47H57N8O7Fe2]+, calcd. 957.3046). 
1H NMR (500.13 MHz, CD3CN): δ = -31.71 (bs, 1H), -17.11 (bs, 1H), -12.52 (bs, 1H), -5.86 (bs, 1H), 
-1.20 (s, 1H), 3.86 (s, 9H), 4.08 (s, 9H), 7.49 (s, 1H), 9.48 (s, 1H), 9.67 (s, 1H), 12.52 (s, 1H), 17.21 
(bs, 1H), 22.61 (s, 1H), 27.49 (s, 1H), 32.89 (s, 1H), 36.04 (s, 1H), 36.11 (s, 4H), 41.10 (s, 3H), 41.55 
(s, 1H), 46.06 (s, 1H), 50.39 (s, 2H), 52.42 (s, 1H), 57.01 (s, 3H), 67.36 (s, 1H), 69.39 (s, 1H), 73.79 
(s, 1H), 77.16 (s, 1H), 93.51 (s, 1H), 120.21 (bs, 1H), 148.20 (bs, 1H), 166.91 (s, 1H), 189.14 (s, 1H) 
ppm. 
Elemental analysis: Calcd. for C47H57N8O7Fe2PF6: C  51.20%; H  5.21%; N  10.16% 
Found:    C  51.17%; H  5.30%; N  10.05%.  
EXPERIMENTAL 
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11.10.3 SYNTHESIS OF [FEII2(H2L2)(µ-OAC)2]PF6 
 
Yield: 48.2 mg (63%). 
HRMS (ESI+, CH2Cl2): m/z = 957.3074  ([C47H57N8O7Fe2]+, calcd. 957.3046). 
1H NMR (500.13 MHz, CD3CN): δ = 2.12 (s, 2H), 5.40 (s, 18H), 5.68 (s, 2H), 5.76 (s, 2H), 10.70 (bs, 
2H), 13.00 (bs, 2H), 17.06 (s, 2H), 26.15 (s, 2H), 29.54 (s, 3H), 41.15 (s, 3H), 41.37 (s, 5H), 45.70 
(bs, 2H), 55.14 (s, 2H), 57.07 (s, 2H), 80.81 (bs, 2H), 107.33 (bs, 2H), 157.62 (bs, 2H), 188.50 (s, 
2H) ppm. 
Elemental analysis: Calcd. for C47H57N8O7Fe2PF6: C  51.20%; H  5.21%; N  10.16% 
   Found:    C  51.28%; H  5.46%; N  10.20%.  
EXPERIMENTAL 
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11.11 SYNTHESES OF PHOSPHOESTER SUBSTRATES 
11.11.1 SYNTHESIS OF BDNPP 
 
BDNPP was synthesized following published procedures with minor modifications.312 
Dried 2,6-dinitrophenol (4.15 g, 22.5 mmol, 2.8 eq) was dissolved in anhydrous acetonitrile 
(45 ml) and anhydrous pyridine (3.60 ml, 3.68 g, 46.5 mmol, 5.7 eq) was added. The solution was 
cooled to 0°C with an ice-water bath and freshly distilled phosphoryl chloride (0.75 ml, 1.24 g, 
8.1 mmol, 1.0 eq) was added dropwise. After stirring for 15 minutes the mixture was poured onto 
an ice-water mixture (400 ml) and the mixture was kept in the fridge overnight. The resulting 
precipitate was filtered and washed with a small amount of cold water. The crude product was 
recrystallized three times from hot acetone yielding BDNPP pyridinium salt as a white powder 
(2.81 g, 69%). 
 
Molecular Formula: C17H12N5O12P 
1H NMR (399.89 MHz, CD3COCD3): δ = 8.12 (d, 3J = 9.25 Hz, 2H, H3), 8.25 (bs, 2H, H5), 8.50 (dd, 
3J = 9.25 Hz, 4J = 3.13 Hz, 2H, H2), 8.71 (d, 4J = 2.78 Hz, 2H, H1), 8.77 (t, 3J = 7.65 Hz, 1H, H6), 9.03 
(bs, 2H, H4) ppm. 
31P NMR (161.88 MHz, CD3COCD3): δ = -14.2 ppm. 
Elemental analysis: Calcd. for C17H12N5O12P: C  40.09%; H  2.37%; N  13.75% 
   Found:    C  40.06%; H  2.29%; N  13.65%.  
EXPERIMENTAL 
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11.11.2 SYNTHESIS OF DNPP 
 
DNPP was synthesized following a published procedure.313 
BDNPP pyridinium salt (1.28 g, 2.83 mmol, 1.0 eq) dissolved in methanol (700 ml) was passed 
through a Dowex 50 WX2 ion exchange column (sodium form). The solvent was removed in 
vacuum (T < 40°C) and the successful exchange of the pyridinium ion for sodium ion was 
controlled via 1H NMR spectroscopy. BDNPP sodium salt was treated with 0.3M sodium 
hydroxide solution (50 ml) at room temperature for one hour. Then the solution was made 
strongly acidic by addition of 5M hydrochloric acid (~ 15 ml) and the resulting precipitate was 
removed by filtration. The filtrate was concentrated and the residue was taken up in diethyl ether 
(50 ml). The colorless solution was filtered and 2,6-lutidine (0.33 ml, 0.30 g, 2.83 mmol, 1.0 eq) 
was added dropwise while stirring until the solution turned slightly yellow. Filtration of the 
obtained precipitate and recrystallization from hot ethanol gave DNPP lutidinium salt as 
yellowish needles (0.16 g, 15%). 
 
1H NMR (400.13 MHz, CD3CN): δ = 2.66 (s, 6H, H4), 7.47 (d, 3J = 7.92 Hz, 2H, H5), 7.93 (dd, 
3J = 9.39 Hz, 5J = 0.88 Hz, 1H, H3), 8.11 (t, 3J = 7.92 Hz, 1H, H6), 8.32 (dd, 3J = 9.24 Hz, 4J = 2.79 Hz, 
1H, H2), 8.57 (dd, 4J = 2.93 Hz, 5J = 0.88 Hz, 1H, H1) ppm. 
31P NMR (161.98 MHz, CD3CN): δ = -5.0 ppm. 
Elemental analysis: Calcd. for C13H14N3O8P: C  42.06%; H  3.80%; N  11.32% 
   Found:    C  41.92%; H  3.81%; N  11.34%. 
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Table 30: Crystallographic data for [GaIII(H2SIM1)(µ-OH)]2(ClO4)2·CH3CN·Et2O, 
[GaIIIZnII(H2SIM1)(OAc)2(OH)]PF6·Et2O and [CuII2(HSIM1)(µ-OAc)]PF6. 
 [GaIII(H2SIM1)(µ-OH)]2(ClO4)2 
·CH3CN·Et2O 
[GaIIIZnII(H2SIM1)(OAc)2(OH)]PF6 
·Et2O 
[CuII2(HSIM1)(µ-OAc)]PF6 
Empirical 
formula 
C49H65Cl2GaN9O13 C51H68F6GaN8O9PZn C45H53Cu2F6N8O5P 
Formula weight 1128.72 1217.19 1058.00 
Temperature (K) 120(1) 200(2) 100(1) 
Wavelength (Å) 1.54184 0.71073 0.71073 
Crystal system Triclinic Monoclinic Triclinic 
Space group P -1 C 1 2/c 1 P -1 
a (Å) 10.5436(3) 18.8817(7) 12.887(7) 
b (Å) 13.6018(4) 18.7090(10) 13.394(8) 
c (Å) 19.3106(6) 32.536(2) 15.137(9) 
α (⁰) 78.857(3) 90 79.960(13) 
β (⁰) 82.0085(3) 103.756(5) 73.452(17) 
γ (⁰) 77.117(3) 90 70.673(11) 
Vol (Å3) 2635.77(15) 11163.9(10) 2354(2) 
Z 2 8 2 
µ (mm-1) 2.248 1.022 1.015 
F(000) 1182 5056 1092 
Ρ (Mg/m3) 1.422 1.448 1.492 
Reflections 
collected 
59276 23354 56089 
Independent 
reflections [Rint] 
9785 [0.0736] 9829 [0.0556] 14368 [0.0424] 
Ѳ range for data 
collection (⁰) 
3.777 – 70.622 2.91 - 29.24 1.727 – 30.555 
GOOF on F2 1.059 1.035 1.014 
Final R indices R1 = 0.0827 R1 = 0.0772 R1 = 0.0382 
[I>2σ(I)] wR2 = 0.2212 wR2 = 0.1893 wR2 = 0.0873 
R indices R1 = 0.1090 R1 = 0.1089 R1 = 0.0632 
(all data) wR2 = 0.2400 wR2 = 0.2103 wR2 = 0.0993 
Largest diff. 
peak and hole 
(e Å-3) 
1.347 and -0.796 1.223 and -0.695 0.669 and -0.394 
Identification 
code 
co_sb15 - co_sb14 
CCDC number - 1024620 - 
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Figure 70: ORTEP plots of a) [GaIII(H2SIM1)(µ-OH)]ClO4 and b) the respective dimer [GaIII(H2SIM1)(µ-OH)]22+ with 
50% probability level of thermal ellipsoids. Counter ions, non-coordinated solvent molecules and hydrogen 
atoms not involved in hydrogen bonding are omitted for clarity. 
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Figure 71: ORTEP plots of a) [GaIIIZnII(H2SIM1)(OAc)2(OH)]PF6 and b) the respective dimeric structure with 50% 
probability level of thermal ellipsoids showing hydrogen bonds as green, dotted lines. Counter ions, non-
coordinated solvent molecules and hydrogen atoms not involved in hydrogen bonding are omitted for clarity. 
 
 
Figure 72: ORTEP plot of [CuII2(HSIM1)(µ-OAc)]PF6 with 50% probability level of thermal ellipsoids showing 
hydrogen bonds as green, dotted lines. Counter ion and hydrogen atoms not involved in hydrogen bonding are 
omitted for clarity. 
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Table 31: Crystallographic data for {Na[FeIII(H2SIM2)]2(µ-OAc)(µ-OH2)}(BF4)2·3H2O. 
 {Na[Fe(H2L4)]2(µ-OAc)(µ-OH2)}(BF4)2·3H2O 
Empirical formula C45H53N7O6BF4Na0.5Fe 
Formula weight 942.10 
Temperature (K) 293(2) 
Wavelength (Å) 0.71073 
Crystal system Triclinic 
Space group P-1 
a (Å) 17.6526(17) 
b (Å) 17.6900(17) 
c (Å) 19.16(3) 
α (⁰) 77.164(10) 
β (⁰) 63.144(12) 
γ (⁰) 84.177(8) 
Vol (Å3) 5204(8) 
Z 4 
µ (mm-1) 0.357 
F(000) 1970 
Ρ (Mg/m3) 1.202 
Reflections collected 39653 
Independent reflections [Rint] 18269 [0.1091] 
Ѳ range for data collection (⁰) 2.84 - 25.00 
GOOF on F2 0.976 
Final R indices R1 = 0.1245 
[I>2σ(I)] wR2 = 0.2919 
R indices R1 = 0.2396 
(all data) wR2 = 0.3768 
Largest diff. peak and hole (e Å-3) 0.667 and -0.507 
 
 
Figure 73: ORTEP plot of the monomeric structure of {Na[FeIII(H2SIM2)]2(µ-OAc)(µ-OH2)}(BF4)2 including bridging 
acetate and aqua ligands with 50% probability level of thermal ellipsoids. Counter ion and hydrogen atoms not 
involved in hydrogen bonding are omitted for clarity.  
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Table 32: Atomic coordinates (·104) and equivalent isotropic displacement parameters (Å2·103) for 
{Na[FeIII(H2SIM2)]2(µ-OAc)(µ-OH2)}(BF4)2; U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
  x  y  z  U(eq)  
Fe(1)  6817(1)  1666(1)  2786(1)  53(1) 
Fe(2)  7525(1)  617(1)  4202(1)  53(1) 
C(28`) 9046(5)  4446(5)  3652(6)  73(3) 
O(1)  7668(3)  1468(3)  1778(3)  56(1) 
O(1A) 6990(3)  2797(3)  2502(3)  54(1) 
O(1A`) 6852(3)  1026(3)  5114(3)  60(2) 
O(1`)  8592(3)  983(3)  4059(3)  54(1) 
C(29)  9814(5)  4897(5)  1163(6)  81(3) 
C(34`) 13920(6)  1685(6)  1044(8)  88(3) 
N(5)  9373(4)  2569(3)  364(4)  54(2) 
O(6)  7464(3)  1472(3)  3402(3)  49(1) 
N(6`)  9211(4)  3817(4)  3348(4)  64(2) 
C(37)  11742(6)  4812(7)  476(8)  96(4) 
C(3)  4193(6)  2608(5)  4695(8)  89(4) 
N(2)  5930(4)  1810(4)  2246(4)  57(2) 
O(2)  6367(3)  570(3)  3195(4)  68(2) 
O(4`)  14449(4)  1808(5)  1249(5)  112(3) 
N(4`)  11868(4)  2042(4)  2538(5)  64(2) 
N(5`)  10029(4)  2241(4)  3172(4)  59(2) 
O(2`)  6495(4)  72(3)  4295(4)  75(2) 
C(28)  10300(5)  4298(5)  830(6)  69(3) 
C(23`) 13110(7)  2646(6)  2376(8)  88(3) 
N(6)  9993(4)  3669(4)  801(4)  66(2) 
N(2`)  7687(4)  -457(3)  4967(4)  55(2) 
N(1)  5641(4)  1934(4)  3739(5)  67(2) 
C(14`) 9220(5)  -171(4)  4466(5)  57(2) 
C(20`) 9279(4)  541(4)  3970(5)  54(2) 
C(33`) 10197(5)  2955(4)  2551(5)  61(2) 
N(7`)  13099(4)  1826(4)  1466(5)  79(2) 
N(8`)  8200(4)  4634(4)  4117(5)  80(3) 
N(4)  10631(6)  2804(5)  -1148(5)  84(3) 
C(4)  4231(5)  2347(5)  4068(7)  70(3) 
C(32)  9139(5)  3625(4)  1085(5)  54(2) 
C(16`) 10724(5)  -414(5)  3699(6)  69(3) 
C(32`) 10021(5)  3673(5)  2885(5)  60(2) 
C(11`) 6640(5)  -3(6)  6210(5)  65(2) 
N(1`)  8269(4)  -103(4)  3369(4)  62(2) 
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C(24`) 12657(9)  2951(7)  3013(9)  108(4) 
C(39A) 12926(8)  4295(12)  -653(12)  197(10) 
C(11)  5864(5)  3251(5)  2168(6)  63(3) 
O(5)  11481(4)  5386(4)  710(6)  121(4) 
C(19)  8466(6)  1516(5)  439(6)  71(3) 
C(26)  9852(7)  3004(5)  -1097(6)  76(3) 
C(18`) 10760(5)  299(5)  3228(5)  63(2) 
F(4)  1712(5)  3813(4)  5661(4)  128(3) 
C(5)  4967(5)  2021(5)  3586(5)  60(2) 
C(7)  6275(5)  3945(5)  2876(5)  69(3) 
C(21`) 10128(5)  1536(5)  2791(5)  63(2) 
C(13`) 8373(5)  -395(4)  5189(5)  56(2) 
C(38)  12663(7)  4617(8)  112(12)  138(7) 
C(22`) 12703(5)  2182(5)  2160(6)  69(3) 
O(5`)  7490(4)  3561(4)  4355(5)  106(3) 
C(33)  8847(5)  2847(4)  1125(5)  58(2) 
C(15`) 9929(5)  -627(5)  4335(6)  67(3) 
C(21)  9255(5)  1713(4)  443(5)  62(2) 
C(13)  6113(5)  1218(6)  1777(5)  69(3) 
N(8)  11199(4)  4277(4)  532(5)  87(3) 
C(19`) 10066(4)  784(4)  3341(5)  51(2) 
F(1)  2375(5)  3124(6)  4759(7)  205(5) 
N(7)  12038(6)  2577(7)  -1872(6)  136(4) 
C(27`) 10522(6)  2187(5)  3642(6)  77(3) 
C(25)  9691(7)  3159(5)  -1722(7)  80(3) 
F(2)  1057(6)  2959(4)  5449(6)  171(4) 
C(17`) 11472(6)  -929(6)  3566(7)  97(4) 
F(3)  1561(6)  4028(4)  4585(6)  168(4) 
C(26`) 11444(6)  2364(5)  3173(7)  74(3) 
C(7A) 6398(5)  3331(5)  2511(5)  62(2) 
C(7A`) 6624(5)  782(6)  5890(6)  68(3) 
C(27)  9208(6)  3051(6)  -270(6)  78(3) 
C(30)  8957(6)  4841(5)  1420(6)  77(3) 
C(35)  13574(14) 2320(20)  -2341(11) 230(14) 
C(38`) 6677(6)  4635(6)  4854(8)  91(4) 
C(31)  8610(5)  4193(5)  1393(6)  69(3) 
C(12`) 6879(5)  -616(5)  5728(5)  69(3) 
C(18)  8496(7)  1395(7)  -277(7)  100(4) 
C(22)  11271(7)  2787(5)  -1871(6)  83(3) 
O(4)  12893(7)  2658(8)  -3172(6)  181(5) 
C(14)  6961(5)  1299(5)  1058(6)  67(2) 
APPENDIX 
255 
C(12)  6009(5)  2608(5)  1729(6)  78(3) 
C(1)  5604(5)  2190(5)  4357(6)  61(2) 
C(4`)  8971(7)  -1322(5)  3234(7)  98(4) 
C(2`)  9307(8)  -326(6)  2105(6)  110(4) 
C(37`) 7502(6)  4235(6)  4413(6)  81(3) 
C(5`)  8386(6)  -849(5)  3696(5)  66(2) 
C(8`)  6096(7)  1088(8)  7184(7)  111(4) 
C(23)  11137(8)  2966(6)  -2542(7)  93(3) 
C(2)  4900(6)  2519(5)  4854(6)  67(3) 
C(6)  5067(4)  1693(5)  2913(6)  67(3) 
C(31`) 10676(6)  4150(5)  2689(7)  84(3) 
C(8)  5669(7)  4473(6)  2890(7)  89(4) 
C(24)  10321(8)  3155(6)  -2462(7)  97(3) 
C(39D) 5952(6)  4100(7)  5122(8)  129(6) 
C(35`) 14183(7)  1403(8)  308(8)  98(4) 
C(6`)  7830(6)  -1105(4)  4548(5)  66(3) 
C(9)  5175(7)  4429(7)  2546(8)  111(5) 
C(25`) 11818(9)  2820(6)  3422(8)  97(4) 
C(36B) 13596(10) 2943(16)  -1864(14) 253(14) 
C(20)  7697(5)  1416(4)  1113(5)  62(2) 
C(7`)  6366(5)  1326(6)  6377(6)  81(3) 
C(10)  5241(5)  3797(6)  2192(7)  92(4) 
C(10`) 6389(6)  -209(7)  7036(6)  88(3) 
C(16)  7809(9)  1219(9)  -337(8)  131(5) 
C(9`)  6109(7)  328(8)  7516(7)  103(4) 
C(3`)  9478(9)  -1067(6)  2432(8)  129(6) 
C(1`)  8715(6)  134(5)  2599(6)  75(3) 
C(39C) 13161(8)  5357(9)  -122(12)  200(9) 
C(2A) 5507(8)  -491(7)  4067(8)  136(5) 
C(39E) 6593(7)  5391(7)  4311(10)  142(6) 
C(1A) 6178(6)  87(5)  3828(6)  69(3) 
C(29`) 9655(6)  4935(5)  3510(8)  110(5) 
C(36D) 15111(7)  1124(9)  16(9)  146(6) 
C(34)  12799(10) 2559(11)  -2512(9)  166(8) 
C(15)  7031(7)  1202(8)  336(7)  117(4) 
C(39B) 12856(7)  3990(10)  662(11)  198(10) 
C(39F) 6695(7)  4825(9)  5562(9)  149(6) 
C(36E) 13644(8)  749(9)  425(9)  139(5) 
C(36F) 14073(9)  2053(10)  -308(8)  168(7) 
B(1)  1723(8)  3461(8)  5115(8)  79(4) 
C(17)  7872(9)  1066(11)  -1100(8)  189(9) 
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C(30`) 10477(7)  4779(7)  3034(10)  132(6) 
C(36A) 13523(17) 1564(14)  -1878(14) 305(19) 
C(36C) 14383(10) 2522(15)  -3127(11) 265(14) 
F(5)  603(3)  1941(3)  884(4)  99(2) 
F(6)  1773(4)  1479(7)  942(5)  182(4) 
F(8)  1702(5)  2623(7)  491(15)  393(16) 
B(2)  1490(12)  1989(11)  605(12)  174(13) 
F(7)  1807(8)  1875(13)  -150(6)  299(9) 
O(9)  8545(4)  2292(3)  4613(4)  79(2) 
Na(1) 8251(3)  2827(3)  2974(3)  133(2) 
O(8)  9030(20)  3694(18)  -4100(20) 259(14) 
O(7)  11161(13) 6458(12)  3191(16)  165(8) 
 
 
Table 33: Crystallographic data for [ZnII2(L1)(µ-OAc)2]PF6, [ZnII2(H2L2)(µ-OAc)2]PF6·0.5H2O·0.5 CH3COCH3 and 
[ZnII2(SIM2)(µ-OAc)2]PF6. 
 [Zn2(L1)(µ-OAc)2]PF6 [Zn2(H2L2)(µ-OAc)2]PF6 
·0.5H2O·0.5 CH3COCH3 
[Zn2(SIM2)(µ-OAc)2]PF6 
Empirical formula C37H39F6N6O5PZn2 C48.50H61F6N8O8PZn2 C37H41F6N8O5PZn2 
Formula weight 923.45 1159.76 953.49 
Temperature (K) 293(2) 293(2) 200(2) 
Wavelength (Å) 1.54180 0.71073 0.71073 
Crystal system Triclinic Monoclinic Orthorhombic 
Space group P-1 P21/n P21 21 21 
a (Å) 10.2562(4) 16.2410(10) 11.1444(6) 
b (Å) 12.5876(5) 21.5930(10) 17.0144(9) 
c (Å) 16.7528(7) 16.3693(8) 20.6731(8) 
α (⁰) 89.561(3) 90 90 
β (⁰) 74.354(3) 100.533(6) 90 
γ (⁰) 74.696(3) 90 90 
Vol (Å3) 2004.11(14) 5643.9(5) 3919.9(3) 
Z 2 4 4 
µ (mm-1) 2.531 0.953 1.348 
F(000) 944 2404 1952 
Ρ (Mg/m3) 1.530 1.365 1.616 
Reflections collected 17469 25999 10212 
Independent 
reflections [Rint] 
6308 [0.0222] 9929 [0.0342] 6482 [0.0394] 
Ѳ range for data 
collection (⁰) 
3.65 - 62.25 3.10 – 25.00 2.94 – 25.00 
GOOF on F2 1.026 1.058 1.025 
Final R indices R1 = 0.0303 R1 = 0.0564 R1 = 0.0523 
[I>2σ(I)] wR2 = 0.0792 wR2 = 0.1520 wR2 = 0.1185 
R indices R1 = 0.0362 R1 = 0.0775 R1 = 0.0629 
(all data) wR2 = 0.0847 wR2 = 0.1643 wR2 = 0.1263 
Largest diff. peak and 
hole (e Å-3) 
0.371 and -0.251 1.013 and -0.340 1.087 and -0.363 
CCDC number 998888 998889 998890 
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Table 34: Crystallographic data for [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6, [ZnII2(H2SIM3)(µ-O3POC6H4NO2)]PF6 
·H2O·CH3OH and [ZnII2(H2SIM3)(µ-OAc)(OH)]. 
 [Zn2(H2SIM1)(µ-OAc)(OH)]PF6 [Zn2(H2SIM1)(µ-O3POC6H4NO2)]PF6 
·H2O·CH3OH 
[Zn2(H2SIM3)(µ-OAc)(OH)] 
Empirical formula C45H55F6N8O6PZn2 C50H61F6N9O11P2Zn2 C46H55N7O7Zn2 
Formula weight 1079.68 1270.76 948.71 
Temperature (K) 293(2) 190(2) 200(2) 
Wavelength (Å) 1.54180 0.71073 1.54180 
Crystal system Monoclinic Monoclinic Triclinic 
Space group P21/n P21/n P-1 
a (Å) 16.8815(6) 14.5695(6) 13.3627(8) 
b (Å) 13.5366(5) 23.3831(8) 14.0727(8) 
c (Å) 21.8837(9) 17.1987(5) 14.7688(10) 
α (⁰) 90 90 70.854(6) 
β (⁰) 105.077(4) 107.817(4) 66.835(6) 
γ (⁰) 90 90 62.523(6) 
Vol (Å3) 4828.7(3) 5578.2(3) 2228.5(2) 
Z 4 4 2 
µ (mm-1) 2.215 1.004 1.803 
F(000) 2232 2624 992 
Ρ (Mg/m3) 1.485 1.513 1.414 
Reflections 
collected 
53093 22528 20772 
Independent 
reflections [Rint] 
7633 [0.0738] 9829 [0.0664] 6963 [0.0508] 
Ѳ range for data 
collection (⁰) 
2.96 - 62.39 2.89 – 25.00 3.31 - 62.41 
GOOF on F2 1.018 1.030 1.051 
Final R indices R1 = 0.0485 R1 = 0.0671 R1 = 0.049 
[I>2σ(I)] wR2 = 0.1198 wR2 = 0.1291 wR2 = 0.127 
R indices R1 = 0.0669 R1 = 0.1115 R1 = 0.0563 
(all data) wR2 = 0.1324 wR2 = 0.1482 wR2 = 0.1359 
Largest diff. peak 
and hole (e Å-3) 
0.513 and -0.386 0.883 and -0.690 1.038 and  
-0.382 
CCDC number 998887 998891 1009842 
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Figure 74: ORTEP plots of a) [ZnII2(L1)(µ-OAc)2]PF6, b) [ZnII2(H2L2)(µ-OAc)2]PF6, c) [ZnII2(H2SIM1)(µ-OAc)(OH)]PF6, 
d) [ZnII2(H2SIM1)(µ-O3POC6H4NO2)]PF6, e) [ZnII2(SIM2)(µ-OAc)2]PF6 and f) [ZnII2(H2SIM3)(µ-OAc)(OH)] with 50% 
probability level of thermal ellipsoids. Counter ions, non-coordinated solvent molecules and hydrogen atoms 
not involved in hydrogen bonding are omitted for clarity. 
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Table 35: Crystallographic data for [FeII2(H2SIM1)(µ-OAc)2]PF6, [FeII2(H2L2)(µ-OAc)2]PF6·Et2O and 
{Na[FeII2(H2SIM3)(µ-OAc)2]2}PF6. 
 [FeII2(H2SIM1)(µ-OAc)2]PF6 [FeII2(H2L2)(µ-OAc)2]PF6 
·Et2O 
{Na[FeII2(H2SIM3)(µ-OAc)2]2}PF6 
Empirical formula C47H57F6Fe2N8O7P C51H67F6Fe2N8O8P C96H114F6Fe4N14NaO16P 
Formula weight 1102.67 1176.79 2111.36 
Temperature (K) 120(1) 110(1) 100(1) 
Wavelength (Å) 0.71073 0.7107 0.71073 
Crystal system Monoclinic Monoclinic Monoclinic 
Space group P 21/n P 21/n P 21/n 
a (Å) 14.9220(5) 14.79581(6) 20.237(9) 
b (Å) 19.7653(5) 22.51003(10) 25.243(12) 
c (Å) 18.4489(5) 16.47614(8) 23.062(12) 
α (⁰) 90 90 90 
β (⁰) 91.110(3) 94.4616(4) 109.169(16) 
γ (⁰) 90 90 90 
Vol (Å3) 5440.3(3) 5470.82(4) 11128(9) 
Z 4 4 4 
µ (mm-1) 0.637 0.639 0.603 
F(000) 2288 2456 4400 
Ρ (Mg/m3) 1.346 1.429 1.260 
Reflections 
collected 
77359 236690 195127 
Independent 
reflections [Rint] 
9711 [0.0887] 13964 [0.0358] 21219 [0.0778] 
Ѳ range for data 
collection (⁰) 
3.298 - 25.142 3.243 - 28.909 1.336 - 25.740 
GOOF on F2 1.031 1.038 1.024 
Final R indices R1 = 0.0908 R1 = 0.0437 R1 = 0.0634 
[I>2σ(I)] wR2 = 0.2418 wR2 = 0.1087 wR2 = 0.1589 
R indices R1 = 0.1223 R1 = 0.0499 R1 = 0.0859 
(all data) wR2 = 0.2675 wR2 = 0.1125 wR2 = 0.1733 
Largest diff. peak 
and hole (e Å-3) 
1.714 and -0.890  1.044 and -0.867 1.655 and -1.052 
Identification code co_sb12 co_sb4 co_sb5 
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Figure 75: ORTEP plots of a) [FeII2(H2SIM1)(µ-OAc)2]PF6, b) [FeII2(H2L2)(µ-OAc)2]PF6, c) 
{Na[FeII2(H2SIM3)(µ-OAc)2]2}PF6 and d) the respective monomer [FeII2(H2SIM3)(µ-OAc)2] with 50% probability 
level of thermal ellipsoids showing hydrogen bonds as green, dotted lines. Counter ions, non-coordinated 
solvent molecules and hydrogen atoms not involved in hydrogen bonding are omitted for clarity. 
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Table 36: Crystallographic data for [FeIIINa(H2SIM1)(µ-OAc)2]PF6. 
 [FeIIINa(H2SIM1)(µ-OAc)2]PF6 
Empirical formula C47H57F6FeN8NaO7P 
Formula weight 1069.81 
Temperature (K) 110(1) 
Wavelength (Å) 0.7107 
Crystal system Monoclinic 
Space group P 21/c 
a (Å) 22.1770(3) 
b (Å) 14.66804(16) 
c (Å) 15.3946(2) 
α (⁰) 90 
β (⁰) 99.1136(12) 
γ (⁰) 90 
Vol (Å3) 4944.54(11) 
Z 4 
µ (mm-1) 0.428 
F(000) 2228 
Ρ (Mg/m3) 1.437 
Reflections collected 156660 
Independent reflections [Rint] 15102 [0.0720] 
Ѳ range for data collection (⁰) 3.214 - 30.548 
GOOF on F2 1.035 
Final R indices R1 = 0.0424 
[I>2σ(I)] wR2 = 0.0957 
R indices R1 = 0.0568 
(all data) wR2 = 0.1027 
Largest diff. peak and hole (e Å-3) 0.625 and -0.440 
Identification code co_sb8 
 
Figure 76: ORTEP plot of [FeIIINa(H2SIM1)(µ-OAc)2]PF6 with 50% probability level of thermal ellipsoids showing 
hydrogen bonds as green, dotted lines. Counter ions, non-coordinated solvent molecules and hydrogen atoms 
not involved in hydrogen bonding are omitted for clarity. 
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